'en:stye'
(id=6890590 ; fe=en:stye ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=88558 creation date=2017-06-25 touchdate=2025-07-01 16:10:40.000) ≈ 1943 relations sortantes
- en:stye --
r_associated #0: 309 / 1 ->
maladies de l'oeil
n1=en:stye | n2=maladies de l'oeil | rel=r_associated | relid=0 | w=309
- en:stye --
r_associated #0: 307 / 0.994 ->
maladies des yeux
n1=en:stye | n2=maladies des yeux | rel=r_associated | relid=0 | w=307
- en:stye --
r_associated #0: 60 / 0.194 ->
orgelets
n1=en:stye | n2=orgelets | rel=r_associated | relid=0 | w=60
- en:stye --
r_associated #0: 57 / 0.184 ->
furoncle de la paupière
n1=en:stye | n2=furoncle de la paupière | rel=r_associated | relid=0 | w=57
- en:stye --
r_associated #0: 56 / 0.181 ->
clou palpébral
n1=en:stye | n2=clou palpébral | rel=r_associated | relid=0 | w=56
- en:stye --
r_associated #0: 55 / 0.178 ->
compère-loriot
n1=en:stye | n2=compère-loriot | rel=r_associated | relid=0 | w=55
- en:stye --
r_associated #0: 54 / 0.175 ->
hordéole
n1=en:stye | n2=hordéole | rel=r_associated | relid=0 | w=54
- en:stye --
r_associated #0: 49 / 0.159 ->
orgeolet
n1=en:stye | n2=orgeolet | rel=r_associated | relid=0 | w=49
- en:stye --
r_associated #0: 42 / 0.136 ->
petit furoncle
n1=en:stye | n2=petit furoncle | rel=r_associated | relid=0 | w=42
- en:stye --
r_associated #0: 41 / 0.133 ->
en:hordeolum
n1=en:stye | n2=en:hordeolum | rel=r_associated | relid=0 | w=41
- en:stye --
r_associated #0: 35 / 0.113 ->
en:sty
n1=en:stye | n2=en:sty | rel=r_associated | relid=0 | w=35
- en:stye --
r_associated #0: 30 / 0.097 ->
abcès
n1=en:stye | n2=abcès | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
acné
n1=en:stye | n2=acné | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
acné ciliaire
n1=en:stye | n2=acné ciliaire | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
ampoule
n1=en:stye | n2=ampoule | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
ampoule
(cloque)
n1=en:stye | n2=ampoule (cloque) | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
anatomie
n1=en:stye | n2=anatomie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
bactérie
n1=en:stye | n2=bactérie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
blépharo-conjonctivite de l'acné rosacée
n1=en:stye | n2=blépharo-conjonctivite de l'acné rosacée | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
bosse
n1=en:stye | n2=bosse | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
cancer
n1=en:stye | n2=cancer | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
cancérologie
n1=en:stye | n2=cancérologie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
carcinologie
n1=en:stye | n2=carcinologie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
chalaze
n1=en:stye | n2=chalaze | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
chalazion
n1=en:stye | n2=chalazion | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
compère loriot
n1=en:stye | n2=compère loriot | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
compère-loriot
(orgelet)
n1=en:stye | n2=compère-loriot (orgelet) | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:acne ciliaris
n1=en:stye | n2=en:acne ciliaris | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:bartonella henselae neuroretinitis
n1=en:stye | n2=en:bartonella henselae neuroretinitis | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:chalazion
n1=en:stye | n2=en:chalazion | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:choroid hemangioma
n1=en:stye | n2=en:choroid hemangioma | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:congenital blepharophimosis
n1=en:stye | n2=en:congenital blepharophimosis | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:enophthalmos
n1=en:stye | n2=en:enophthalmos | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:ethnologic
n1=en:stye | n2=en:ethnologic | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:etiology aspects
n1=en:stye | n2=en:etiology aspects | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:eye discharge
n1=en:stye | n2=en:eye discharge | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:floppy lid syndrome
n1=en:stye | n2=en:floppy lid syndrome | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:friction blister with infection
n1=en:stye | n2=en:friction blister with infection | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:hypopigmentation of eyelid
n1=en:stye | n2=en:hypopigmentation of eyelid | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:impetigo of eyelid
n1=en:stye | n2=en:impetigo of eyelid | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:medicine
n1=en:stye | n2=en:medicine | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:neoplasm
n1=en:stye | n2=en:neoplasm | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:pediatric adverse events terminology
n1=en:stye | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:sensorineural hearing loss
n1=en:stye | n2=en:sensorineural hearing loss | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
en:xanthoma
n1=en:stye | n2=en:xanthoma | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
enflure
n1=en:stye | n2=enflure | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
excroissance
n1=en:stye | n2=excroissance | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
fibrome
n1=en:stye | n2=fibrome | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
furoncle
n1=en:stye | n2=furoncle | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
glande de Meibomius
n1=en:stye | n2=glande de Meibomius | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
glande de Zeis
n1=en:stye | n2=glande de Zeis | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
grain d'orge
n1=en:stye | n2=grain d'orge | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
infection
n1=en:stye | n2=infection | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
kyste
n1=en:stye | n2=kyste | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
Lens
n1=en:stye | n2=Lens | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
loriot
n1=en:stye | n2=loriot | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
loupe
n1=en:stye | n2=loupe | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
maladie
n1=en:stye | n2=maladie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
maladie de l'oeil
n1=en:stye | n2=maladie de l'oeil | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
maladie des yeux
n1=en:stye | n2=maladie des yeux | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
maladies
n1=en:stye | n2=maladies | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
médecine
n1=en:stye | n2=médecine | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
médecine spécialisée
n1=en:stye | n2=médecine spécialisée | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
néoplasme
n1=en:stye | n2=néoplasme | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
oeil
n1=en:stye | n2=oeil | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
œil
n1=en:stye | n2=œil | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
oncologie
n1=en:stye | n2=oncologie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
ophtalmologie
n1=en:stye | n2=ophtalmologie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
orgelet externe
n1=en:stye | n2=orgelet externe | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
pathologie
n1=en:stye | n2=pathologie | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
petit oeil
n1=en:stye | n2=petit oeil | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
processus pathologique
n1=en:stye | n2=processus pathologique | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
spécialités médicales
n1=en:stye | n2=spécialités médicales | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
troubles de la vision
n1=en:stye | n2=troubles de la vision | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
tubérosité
n1=en:stye | n2=tubérosité | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
tuméfaction
n1=en:stye | n2=tuméfaction | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
tumeur
n1=en:stye | n2=tumeur | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
tumeurs
n1=en:stye | n2=tumeurs | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 30 / 0.097 ->
yeux
n1=en:stye | n2=yeux | rel=r_associated | relid=0 | w=30
- en:stye --
r_associated #0: 29 / 0.094 ->
carcinologie
(oncologie)
n1=en:stye | n2=carcinologie (oncologie) | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:anophthalmos
n1=en:stye | n2=en:anophthalmos | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:benign essential blepharospasm
n1=en:stye | n2=en:benign essential blepharospasm | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:corneal abrasion
n1=en:stye | n2=en:corneal abrasion | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:dacryocystitis
n1=en:stye | n2=en:dacryocystitis | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:districhiasis
n1=en:stye | n2=en:districhiasis | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:gonococcal infection of eye
n1=en:stye | n2=en:gonococcal infection of eye | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:jaundice
n1=en:stye | n2=en:jaundice | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:marcus gunn phenomenon
n1=en:stye | n2=en:marcus gunn phenomenon | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:ocular syphilis
n1=en:stye | n2=en:ocular syphilis | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:periumbilical abscess
n1=en:stye | n2=en:periumbilical abscess | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:poor visual acuity
n1=en:stye | n2=en:poor visual acuity | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:retinal hemangioma
n1=en:stye | n2=en:retinal hemangioma | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:roentgenographic
n1=en:stye | n2=en:roentgenographic | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:short palpebral fissure
n1=en:stye | n2=en:short palpebral fissure | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:strabismus (in some patients)
n1=en:stye | n2=en:strabismus (in some patients) | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:tearing
n1=en:stye | n2=en:tearing | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 29 / 0.094 ->
en:telecanthus
n1=en:stye | n2=en:telecanthus | rel=r_associated | relid=0 | w=29
- en:stye --
r_associated #0: 28 / 0.091 ->
en:aspects of mortality statistics
n1=en:stye | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:chemically induced
n1=en:stye | n2=en:chemically induced | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:conjunctiva
n1=en:stye | n2=en:conjunctiva | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:corneal erosion
n1=en:stye | n2=en:corneal erosion | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:entropion
n1=en:stye | n2=en:entropion | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:eyelid disorder
n1=en:stye | n2=en:eyelid disorder | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:glaucoma
n1=en:stye | n2=en:glaucoma | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:hemangioma of eyelid
n1=en:stye | n2=en:hemangioma of eyelid | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:infective corneal ulcer
n1=en:stye | n2=en:infective corneal ulcer | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:nail bed infection
n1=en:stye | n2=en:nail bed infection | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:nail infection
n1=en:stye | n2=en:nail infection | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:ocular infections (smq)
n1=en:stye | n2=en:ocular infections (smq) | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:oculoglandular syndrome
n1=en:stye | n2=en:oculoglandular syndrome | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:optic disc edema
n1=en:stye | n2=en:optic disc edema | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:periorbital edema
n1=en:stye | n2=en:periorbital edema | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:periorbital infection
n1=en:stye | n2=en:periorbital infection | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 28 / 0.091 ->
en:sinusitis
n1=en:stye | n2=en:sinusitis | rel=r_associated | relid=0 | w=28
- en:stye --
r_associated #0: 27 / 0.087 ->
en:abscess of external auditory canal
n1=en:stye | n2=en:abscess of external auditory canal | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:abscess of eye
n1=en:stye | n2=en:abscess of eye | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:concretion in palpebral conjunctiva
n1=en:stye | n2=en:concretion in palpebral conjunctiva | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:conductive hearing loss
n1=en:stye | n2=en:conductive hearing loss | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:congenital cataract
n1=en:stye | n2=en:congenital cataract | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:congenital eye disorder
n1=en:stye | n2=en:congenital eye disorder | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:downbeat nystagmus
n1=en:stye | n2=en:downbeat nystagmus | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:embryonal nuclear cataract (disorder)
n1=en:stye | n2=en:embryonal nuclear cataract (disorder) | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:enzymology
n1=en:stye | n2=en:enzymology | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:eye and eyelid infections
n1=en:stye | n2=en:eye and eyelid infections | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:eye infection
n1=en:stye | n2=en:eye infection | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:eyelid vascular disorder
n1=en:stye | n2=en:eyelid vascular disorder | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:folliculitis of lids
n1=en:stye | n2=en:folliculitis of lids | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:horizontal gaze palsy
n1=en:stye | n2=en:horizontal gaze palsy | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:infectious iridocyclitis
n1=en:stye | n2=en:infectious iridocyclitis | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:inflamed lacrimal canaliculus with calculus
n1=en:stye | n2=en:inflamed lacrimal canaliculus with calculus | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:kayser-fleischer ring
n1=en:stye | n2=en:kayser-fleischer ring | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:microbiological
n1=en:stye | n2=en:microbiological | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:open angle glaucoma
n1=en:stye | n2=en:open angle glaucoma | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:perforation of cornea
n1=en:stye | n2=en:perforation of cornea | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:psychology qualifier
n1=en:stye | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:staphylococcal eye infection
n1=en:stye | n2=en:staphylococcal eye infection | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:tuberculosis, ocular
n1=en:stye | n2=en:tuberculosis, ocular | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:upward slant of palpebral fissure
n1=en:stye | n2=en:upward slant of palpebral fissure | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:vitreoretinochoroidopathy (disorder)
n1=en:stye | n2=en:vitreoretinochoroidopathy (disorder) | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
en:vitreous body
n1=en:stye | n2=en:vitreous body | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
organisateur (centre)
n1=en:stye | n2=organisateur (centre) | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 27 / 0.087 ->
orgelet
n1=en:stye | n2=orgelet | rel=r_associated | relid=0 | w=27
- en:stye --
r_associated #0: 26 / 0.084 ->
en:choroideremia
n1=en:stye | n2=en:choroideremia | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:congenital blepharophimosis of upper eyelid
n1=en:stye | n2=en:congenital blepharophimosis of upper eyelid | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:corneal abscess
n1=en:stye | n2=en:corneal abscess | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:endophthalmitis
n1=en:stye | n2=en:endophthalmitis | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:eye infection intraocular
n1=en:stye | n2=en:eye infection intraocular | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:eye infections, bacterial
n1=en:stye | n2=en:eye infections, bacterial | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:eyelid erythema
n1=en:stye | n2=en:eyelid erythema | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:eyelid rash
n1=en:stye | n2=en:eyelid rash | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:hypopyon
n1=en:stye | n2=en:hypopyon | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:injury to eyelid
n1=en:stye | n2=en:injury to eyelid | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 26 / 0.084 ->
en:irregular nystagmus
n1=en:stye | n2=en:irregular nystagmus | rel=r_associated | relid=0 | w=26
- en:stye --
r_associated #0: 25 / 0.081 ->
en:bacterial endophthalmitis
n1=en:stye | n2=en:bacterial endophthalmitis | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:congenital blepharophimosis of lower eyelid
n1=en:stye | n2=en:congenital blepharophimosis of lower eyelid | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:deformity of eyelid
n1=en:stye | n2=en:deformity of eyelid | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:epidemiologic
n1=en:stye | n2=en:epidemiologic | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:external ophthalmoplegia
n1=en:stye | n2=en:external ophthalmoplegia | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:eyelid margin crusting
n1=en:stye | n2=en:eyelid margin crusting | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:gum infection
n1=en:stye | n2=en:gum infection | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:infective scleritis
n1=en:stye | n2=en:infective scleritis | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:infective uveitis
n1=en:stye | n2=en:infective uveitis | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:neovascularization
n1=en:stye | n2=en:neovascularization | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:recurrent erosion of cornea
n1=en:stye | n2=en:recurrent erosion of cornea | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
en:vesicular herpes simplex eyelid dermatitis
n1=en:stye | n2=en:vesicular herpes simplex eyelid dermatitis | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 25 / 0.081 ->
perte d'audition sensorineurale
n1=en:stye | n2=perte d'audition sensorineurale | rel=r_associated | relid=0 | w=25
- en:stye --
r_associated #0: 24 / 0.078 ->
conjonctive
n1=en:stye | n2=conjonctive | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:compression of optic nerve
n1=en:stye | n2=en:compression of optic nerve | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:congenital bilateral cataracts
n1=en:stye | n2=en:congenital bilateral cataracts | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:disease transmission qualifier
n1=en:stye | n2=en:disease transmission qualifier | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:excess skin and muscle of eyelid
n1=en:stye | n2=en:excess skin and muscle of eyelid | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:furunculus
n1=en:stye | n2=en:furunculus | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:lens
n1=en:stye | n2=en:lens | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:macrosaccadic oscillations
n1=en:stye | n2=en:macrosaccadic oscillations | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:open eye
n1=en:stye | n2=en:open eye | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:pediatric terminology
n1=en:stye | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:skin abscess
n1=en:stye | n2=en:skin abscess | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 24 / 0.078 ->
en:trachoma
n1=en:stye | n2=en:trachoma | rel=r_associated | relid=0 | w=24
- en:stye --
r_associated #0: 23 / 0.074 ->
en:aspects of radionuclide imaging
n1=en:stye | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:corneal scar
n1=en:stye | n2=en:corneal scar | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:eyelid thickening
n1=en:stye | n2=en:eyelid thickening | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:furuncle
n1=en:stye | n2=en:furuncle | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:leukocoria
n1=en:stye | n2=en:leukocoria | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:pharmacotherapeutic
n1=en:stye | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:retinitis punctata albescens (disorder)
n1=en:stye | n2=en:retinitis punctata albescens (disorder) | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:skin and subcutaneous tissue infections nec
n1=en:stye | n2=en:skin and subcutaneous tissue infections nec | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:skin graft infection
n1=en:stye | n2=en:skin graft infection | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:skin photosensitivity
n1=en:stye | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
en:therapeutic aspects
n1=en:stye | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 23 / 0.074 ->
tunique conjonctive
n1=en:stye | n2=tunique conjonctive | rel=r_associated | relid=0 | w=23
- en:stye --
r_associated #0: 22 / 0.071 ->
cancer
(maladie)
n1=en:stye | n2=cancer (maladie) | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:aniridia
n1=en:stye | n2=en:aniridia | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:blepharitis
n1=en:stye | n2=en:blepharitis | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:complication aspects
n1=en:stye | n2=en:complication aspects | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:decreased visual acuity
n1=en:stye | n2=en:decreased visual acuity | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:eye irritation
n1=en:stye | n2=en:eye irritation | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:parasitology
n1=en:stye | n2=en:parasitology | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:ptosis
n1=en:stye | n2=en:ptosis | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:stenosis of nasolacrimal duct
n1=en:stye | n2=en:stenosis of nasolacrimal duct | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:tumor
n1=en:stye | n2=en:tumor | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:vertical gaze palsy
n1=en:stye | n2=en:vertical gaze palsy | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:visual disturbance
n1=en:stye | n2=en:visual disturbance | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:vitreous detachment
n1=en:stye | n2=en:vitreous detachment | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
en:vitreous hemorrhage
n1=en:stye | n2=en:vitreous hemorrhage | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
orgelet externe (incorrect)
n1=en:stye | n2=orgelet externe (incorrect) | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 22 / 0.071 ->
trachoma
n1=en:stye | n2=trachoma | rel=r_associated | relid=0 | w=22
- en:stye --
r_associated #0: 21 / 0.068 ->
corps vitré
n1=en:stye | n2=corps vitré | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:atopic conjunctivitis
n1=en:stye | n2=en:atopic conjunctivitis | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:broad nasal tip
n1=en:stye | n2=en:broad nasal tip | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:exophthalmos
n1=en:stye | n2=en:exophthalmos | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:eye pain
n1=en:stye | n2=en:eye pain | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:eyelid malposition
n1=en:stye | n2=en:eyelid malposition | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:faucial diphtheria
n1=en:stye | n2=en:faucial diphtheria | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:focal acute inflammation
n1=en:stye | n2=en:focal acute inflammation | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:macular corneal dystrophy
n1=en:stye | n2=en:macular corneal dystrophy | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 21 / 0.068 ->
en:meibomian gland discharge
n1=en:stye | n2=en:meibomian gland discharge | rel=r_associated | relid=0 | w=21
- en:stye --
r_associated #0: 20 / 0.065 ->
abcès cutané
n1=en:stye | n2=abcès cutané | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
acanthosis
n1=en:stye | n2=acanthosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
acuité visuelle normale
n1=en:stye | n2=acuité visuelle normale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
affection de l'oeil
n1=en:stye | n2=affection de l'oeil | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
affection oculaire congénitale
n1=en:stye | n2=affection oculaire congénitale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
affection ophtalmologique
n1=en:stye | n2=affection ophtalmologique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
amauroses
n1=en:stye | n2=amauroses | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ambliopie
n1=en:stye | n2=ambliopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
amblyopie
n1=en:stye | n2=amblyopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
amblyopie crépusculaire
n1=en:stye | n2=amblyopie crépusculaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
angine diphtérique commune
n1=en:stye | n2=angine diphtérique commune | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
anomalie congénitale de l'oeil
n1=en:stye | n2=anomalie congénitale de l'oeil | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
anophtalmie bilatérale complète (vraie ou primitive)
n1=en:stye | n2=anophtalmie bilatérale complète (vraie ou primitive) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
apprendre [qch] à
n1=en:stye | n2=apprendre [qch] à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
apprendre [qch] à [qqn]
n1=en:stye | n2=apprendre [qch] à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
apprendre quelque chose à quelqu'un
n1=en:stye | n2=apprendre quelque chose à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
arc juvénile
n1=en:stye | n2=arc juvénile | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
arc sénile
n1=en:stye | n2=arc sénile | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
asynergie oculo-palpébrale
n1=en:stye | n2=asynergie oculo-palpébrale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
asynergie oculopalpébrale
n1=en:stye | n2=asynergie oculopalpébrale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique
n1=en:stye | n2=atrophie optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique infantile héréditaire compliquée de Behr
n1=en:stye | n2=atrophie optique infantile héréditaire compliquée de Behr | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique liée au sexe
n1=en:stye | n2=atrophie optique liée au sexe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique liée au sexe de Völker-Dieben
n1=en:stye | n2=atrophie optique liée au sexe de Völker-Dieben | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique tardive liée au sexe
n1=en:stye | n2=atrophie optique tardive liée au sexe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique-paraplégie spastique
n1=en:stye | n2=atrophie optique-paraplégie spastique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique, cataracte, et troubles neurologiques
n1=en:stye | n2=atrophie optique, cataracte, et troubles neurologiques | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
atrophie optique, surdité, épilepsie, spasticité et décès précoce
n1=en:stye | n2=atrophie optique, surdité, épilepsie, spasticité et décès précoce | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
avertir [qqn] que
n1=en:stye | n2=avertir [qqn] que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
avertir qn de qch
n1=en:stye | n2=avertir qn de qch | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
avertir qn de quelque chose
n1=en:stye | n2=avertir qn de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
avertir quelqu'un de quelque chose
n1=en:stye | n2=avertir quelqu'un de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
avertir quelqu'un que
n1=en:stye | n2=avertir quelqu'un que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
blépharite
n1=en:stye | n2=blépharite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
blindness
n1=en:stye | n2=blindness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cataracte congénitale
n1=en:stye | n2=cataracte congénitale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cataracte congénitale, microcornée ou microphtalmie légère
n1=en:stye | n2=cataracte congénitale, microcornée ou microphtalmie légère | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cécité
n1=en:stye | n2=cécité | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cécité au rouge
n1=en:stye | n2=cécité au rouge | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cécité nocturne
n1=en:stye | n2=cécité nocturne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
chagrin d'amour
n1=en:stye | n2=chagrin d'amour | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Coeur brisé
n1=en:stye | n2=Coeur brisé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
coeur brisé
n1=en:stye | n2=coeur brisé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cœur brisé
n1=en:stye | n2=cœur brisé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
colobome de l'iris avec ptosis, hypertélorisme et retard mental
n1=en:stye | n2=colobome de l'iris avec ptosis, hypertélorisme et retard mental | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
colobome de l'oeil
n1=en:stye | n2=colobome de l'oeil | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
colobome oculaire
n1=en:stye | n2=colobome oculaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
conjonctivite
n1=en:stye | n2=conjonctivite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
conjonctivite lacrymale
n1=en:stye | n2=conjonctivite lacrymale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
corps hyalin
n1=en:stye | n2=corps hyalin | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Corps vitré
n1=en:stye | n2=Corps vitré | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cyclopia
n1=en:stye | n2=cyclopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
cyclopie
n1=en:stye | n2=cyclopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
d' Hérelle (phénomène de)
n1=en:stye | n2=d' Hérelle (phénomène de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryadénite
n1=en:stye | n2=dacryadénite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryoadénite
n1=en:stye | n2=dacryoadénite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryoadénite non précisée
n1=en:stye | n2=dacryoadénite non précisée | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryocystite
n1=en:stye | n2=dacryocystite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryocystite non précisée
n1=en:stye | n2=dacryocystite non précisée | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dacryocystites
n1=en:stye | n2=dacryocystites | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
décharge du bord de la paupière
n1=en:stye | n2=décharge du bord de la paupière | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
déchirement
n1=en:stye | n2=déchirement | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
déchirement intérieur
n1=en:stye | n2=déchirement intérieur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
décollement du corps vitré
n1=en:stye | n2=décollement du corps vitré | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
décollement du vitré
n1=en:stye | n2=décollement du vitré | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
décollement vitréen
n1=en:stye | n2=décollement vitréen | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
déficience visuelle
n1=en:stye | n2=déficience visuelle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dégénérescence maculaire liée à l'âge
n1=en:stye | n2=dégénérescence maculaire liée à l'âge | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dégénérescence maculaire sénile
n1=en:stye | n2=dégénérescence maculaire sénile | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
diplopie
n1=en:stye | n2=diplopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
disque optique
n1=en:stye | n2=disque optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Disque optique
n1=en:stye | n2=Disque optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
distichiasis
n1=en:stye | n2=distichiasis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Duane (syndrome de)
n1=en:stye | n2=Duane (syndrome de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dyschromatopsie
n1=en:stye | n2=dyschromatopsie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dyskératose cornéenne
n1=en:stye | n2=dyskératose cornéenne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique
n1=en:stye | n2=dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dystrophie des cônes liée au sexe
n1=en:stye | n2=dystrophie des cônes liée au sexe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dystrophie des cônes liée au sexe avec reflet rétinien jaune-vert
n1=en:stye | n2=dystrophie des cônes liée au sexe avec reflet rétinien jaune-vert | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dystrophie rétinienne
n1=en:stye | n2=dystrophie rétinienne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
dystrophie rétinienne réticulée pigmentée du pôle postérieur
n1=en:stye | n2=dystrophie rétinienne réticulée pigmentée du pôle postérieur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ectopie maculaire
n1=en:stye | n2=ectopie maculaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
emmétropie
n1=en:stye | n2=emmétropie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:'empty' vitreous with fibrillary condensations (childhood)
n1=en:stye | n2=en:'empty' vitreous with fibrillary condensations (childhood) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:'key-hole' iris, retina, choroid coloboma
n1=en:stye | n2=en:'key-hole' iris, retina, choroid coloboma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:'moth-eaten' pattern of peripupillary atrophy
n1=en:stye | n2=en:'moth-eaten' pattern of peripupillary atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:'sunflower' cataract (in some patients)
n1=en:stye | n2=en:'sunflower' cataract (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abducens palsy
n1=en:stye | n2=en:abducens palsy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abduction deficits (about half of patients)
n1=en:stye | n2=en:abduction deficits (about half of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abduction palsy, usually bilateral
n1=en:stye | n2=en:abduction palsy, usually bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium (rpe) on optical coherence tomography (oct)
n1=en:stye | n2=en:abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium (rpe) on optical coherence tomography (oct) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal appearance of eyes
n1=en:stye | n2=en:abnormal appearance of eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal color vision
n1=en:stye | n2=en:abnormal color vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal conjugate eye movement
n1=en:stye | n2=en:abnormal conjugate eye movement | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal dark-adaptation, midperipheral scotoma
n1=en:stye | n2=en:abnormal dark-adaptation, midperipheral scotoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal distribution of retinal arterioles and venules
n1=en:stye | n2=en:abnormal distribution of retinal arterioles and venules | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal electrooculogram (eog)
n1=en:stye | n2=en:abnormal electrooculogram (eog) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal eyebrows
n1=en:stye | n2=en:abnormal eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal fibrils in stroma on electron microscopy
n1=en:stye | n2=en:abnormal fibrils in stroma on electron microscopy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal flash visual evoked potentials (vep)
n1=en:stye | n2=en:abnormal flash visual evoked potentials (vep) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal iris pigmentation
n1=en:stye | n2=en:abnormal iris pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal iris vasculature
n1=en:stye | n2=en:abnormal iris vasculature | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal lens suspensory ligament
n1=en:stye | n2=en:abnormal lens suspensory ligament | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal light- and dark-adapted electroretinogram
n1=en:stye | n2=en:abnormal light- and dark-adapted electroretinogram | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal ocular motility
n1=en:stye | n2=en:abnormal ocular motility | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal ocular movements (in some patients)
n1=en:stye | n2=en:abnormal ocular movements (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal pupillary light reflex
n1=en:stye | n2=en:abnormal pupillary light reflex | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal pursuit
n1=en:stye | n2=en:abnormal pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal retinal pigment epithelium
n1=en:stye | n2=en:abnormal retinal pigment epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal retinal vessels
n1=en:stye | n2=en:abnormal retinal vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal saccades
n1=en:stye | n2=en:abnormal saccades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal vestibuloocular reflex (vor)
n1=en:stye | n2=en:abnormal vestibuloocular reflex (vor) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal visual evoked potential
n1=en:stye | n2=en:abnormal visual evoked potential | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal visual evoked potential (vep)
n1=en:stye | n2=en:abnormal visual evoked potential (vep) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal visual evoked responses (vep)
n1=en:stye | n2=en:abnormal visual evoked responses (vep) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal visual pursuit
n1=en:stye | n2=en:abnormal visual pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal, jerky eye movements
n1=en:stye | n2=en:abnormal, jerky eye movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormal/absent meibomian glands
n1=en:stye | n2=en:abnormal/absent meibomian glands | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of retinal pigmentation
n1=en:stye | n2=en:abnormality of retinal pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of the eyebrow
n1=en:stye | n2=en:abnormality of the eyebrow | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of the eyelashes
n1=en:stye | n2=en:abnormality of the eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of the lacrimal duct
n1=en:stye | n2=en:abnormality of the lacrimal duct | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of the optic disc
n1=en:stye | n2=en:abnormality of the optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abnormality of the optic nerve
n1=en:stye | n2=en:abnormality of the optic nerve | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abolished electroretinogram (erg) (76%)
n1=en:stye | n2=en:abolished electroretinogram (erg) (76%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:abscess of eyelid
n1=en:stye | n2=en:abscess of eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of central fovea of macula on optical coherence tomography
n1=en:stye | n2=en:absence of central fovea of macula on optical coherence tomography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of exophthalmos
n1=en:stye | n2=en:absence of exophthalmos | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of eyebrows
n1=en:stye | n2=en:absence of eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of flash-evoked visual responses (ver)
n1=en:stye | n2=en:absence of flash-evoked visual responses (ver) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of foveal hyperpigmentation
n1=en:stye | n2=en:absence of foveal hyperpigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of foveal pit
n1=en:stye | n2=en:absence of foveal pit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of foveal pit on optical coherence tomography
n1=en:stye | n2=en:absence of foveal pit on optical coherence tomography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of ophthalmoparesis
n1=en:stye | n2=en:absence of ophthalmoparesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absence of ptosis
n1=en:stye | n2=en:absence of ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent a- and b-waves under scotopic conditions
n1=en:stye | n2=en:absent a- and b-waves under scotopic conditions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent abducens nerve on the affected side of synergistic divergence
n1=en:stye | n2=en:absent abducens nerve on the affected side of synergistic divergence | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent anterior chamber of eye
n1=en:stye | n2=en:absent anterior chamber of eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent corneal reflex response
n1=en:stye | n2=en:absent corneal reflex response | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent eyebrows (in some patients)
n1=en:stye | n2=en:absent eyebrows (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent eyebrows and eyelashes
n1=en:stye | n2=en:absent eyebrows and eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent eyelashes (in some patients)
n1=en:stye | n2=en:absent eyelashes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent foveal reflex (in some patients)
n1=en:stye | n2=en:absent foveal reflex (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent iris pigment
n1=en:stye | n2=en:absent iris pigment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent iris stromal pattern
n1=en:stye | n2=en:absent iris stromal pattern | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent macular reflex
n1=en:stye | n2=en:absent macular reflex | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent miebomian glands
n1=en:stye | n2=en:absent miebomian glands | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent night vision
n1=en:stye | n2=en:absent night vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent peripapillary choriocapillaris
n1=en:stye | n2=en:absent peripapillary choriocapillaris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent pupillary reaction
n1=en:stye | n2=en:absent pupillary reaction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent retinal pigment
n1=en:stye | n2=en:absent retinal pigment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent rod-and cone-mediated responses on erg (late)
n1=en:stye | n2=en:absent rod-and cone-mediated responses on erg (late) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent stereopsis due to anomalous decussation at the optic chiasm
n1=en:stye | n2=en:absent stereopsis due to anomalous decussation at the optic chiasm | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent tears
n1=en:stye | n2=en:absent tears | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent upper-lid skin crease
n1=en:stye | n2=en:absent upper-lid skin crease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:absent visual evoked potentials
n1=en:stye | n2=en:absent visual evoked potentials | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:acanthosis
n1=en:stye | n2=en:acanthosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:achromatic retinal patches
n1=en:stye | n2=en:achromatic retinal patches | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:achromatopsia 1
n1=en:stye | n2=en:achromatopsia 1 | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:acute intraocular hypertension (rare)
n1=en:stye | n2=en:acute intraocular hypertension (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:acute lacrimal canaliculitis
n1=en:stye | n2=en:acute lacrimal canaliculitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:acute vision loss due to optic nerve infarction (rare)
n1=en:stye | n2=en:acute vision loss due to optic nerve infarction (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:adduction palsy, usually bilateral
n1=en:stye | n2=en:adduction palsy, usually bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:advise sb of sth
n1=en:stye | n2=en:advise sb of sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:advise somebody of something
n1=en:stye | n2=en:advise somebody of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:advise somebody something
n1=en:stye | n2=en:advise somebody something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:advise somebody that something
n1=en:stye | n2=en:advise somebody that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:age related macular degeneration
n1=en:stye | n2=en:age related macular degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:age-related macular degeneration
n1=en:stye | n2=en:age-related macular degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:alacrima - hypolacrimation
n1=en:stye | n2=en:alacrima - hypolacrimation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:alacrima - hypolacrimation, severe
n1=en:stye | n2=en:alacrima - hypolacrimation, severe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:alacrima (dry eye syndrome)
n1=en:stye | n2=en:alacrima (dry eye syndrome) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:albinism, ocular
n1=en:stye | n2=en:albinism, ocular | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:albinoid fundi
n1=en:stye | n2=en:albinoid fundi | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:albinotic optic disc
n1=en:stye | n2=en:albinotic optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:almond-shaped eyes
n1=en:stye | n2=en:almond-shaped eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:almond-shaped eyes (1 patient)
n1=en:stye | n2=en:almond-shaped eyes (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:almond-shaped eyes (rare)
n1=en:stye | n2=en:almond-shaped eyes (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:altered retinal vascular permeability with lipid exudation
n1=en:stye | n2=en:altered retinal vascular permeability with lipid exudation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:altered vertical eye movements
n1=en:stye | n2=en:altered vertical eye movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:altered visual acuity
n1=en:stye | n2=en:altered visual acuity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:altered visual evoked potentials (1/4 patients)
n1=en:stye | n2=en:altered visual evoked potentials (1/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:alternating esotropia (in some patients)
n1=en:stye | n2=en:alternating esotropia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:amauroses
n1=en:stye | n2=en:amauroses | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:amblyopia
n1=en:stye | n2=en:amblyopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:amblyopia (1 patient)
n1=en:stye | n2=en:amblyopia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:amblyopia (reported in 1 family)
n1=en:stye | n2=en:amblyopia (reported in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:amyloid deposition in the vitreous humor (variable expression)
n1=en:stye | n2=en:amyloid deposition in the vitreous humor (variable expression) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:angioid streaks of the retina (85% of patients)
n1=en:stye | n2=en:angioid streaks of the retina (85% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anisocoria
n1=en:stye | n2=en:anisocoria | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anisocoria (in 1 patient)
n1=en:stye | n2=en:anisocoria (in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anisocoria (unequal pupal size)
n1=en:stye | n2=en:anisocoria (unequal pupal size) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anisocoria due to autonomic dysfunction
n1=en:stye | n2=en:anisocoria due to autonomic dysfunction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anisometropia
n1=en:stye | n2=en:anisometropia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ankyloblepharon filiforme
n1=en:stye | n2=en:ankyloblepharon filiforme | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:announce something to somebody
n1=en:stye | n2=en:announce something to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:announce sth to sb
n1=en:stye | n2=en:announce sth to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anomalous discs
n1=en:stye | n2=en:anomalous discs | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anomalous optic disc
n1=en:stye | n2=en:anomalous optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anophthalmia, clinical, unilateral or bilateral
n1=en:stye | n2=en:anophthalmia, clinical, unilateral or bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior chamber angle open with grade iii-iv gonioscopy
n1=en:stye | n2=en:anterior chamber angle open with grade iii-iv gonioscopy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior chamber anomalies
n1=en:stye | n2=en:anterior chamber anomalies | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior chamber depth increased
n1=en:stye | n2=en:anterior chamber depth increased | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior chamber dysgenesis
n1=en:stye | n2=en:anterior chamber dysgenesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior cortical cataract
n1=en:stye | n2=en:anterior cortical cataract | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior eye defects
n1=en:stye | n2=en:anterior eye defects | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior eye segment
n1=en:stye | n2=en:anterior eye segment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior segment dysgenesis (in some patients)
n1=en:stye | n2=en:anterior segment dysgenesis (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior stromal haziness
n1=en:stye | n2=en:anterior stromal haziness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:anterior uveitis
n1=en:stye | n2=en:anterior uveitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:antimongoloid slant (in some patients)
n1=en:stye | n2=en:antimongoloid slant (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:aphakia, congenital primary
n1=en:stye | n2=en:aphakia, congenital primary | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:aphakic glaucoma
n1=en:stye | n2=en:aphakic glaucoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:aplasia or atrophy of the dilatator pupillae muscle
n1=en:stye | n2=en:aplasia or atrophy of the dilatator pupillae muscle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:aplastic/hypoplastic lacrimal glands
n1=en:stye | n2=en:aplastic/hypoplastic lacrimal glands | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:aplastic/hypoplastic lacrimal puncta
n1=en:stye | n2=en:aplastic/hypoplastic lacrimal puncta | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:apparent hypertelorism
n1=en:stye | n2=en:apparent hypertelorism | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:apprise somebody of something
n1=en:stye | n2=en:apprise somebody of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:apprise somebody that something
n1=en:stye | n2=en:apprise somebody that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:apraxia of eyelid
n1=en:stye | n2=en:apraxia of eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:apraxia of eyelid opening
n1=en:stye | n2=en:apraxia of eyelid opening | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arched eyebrows (1/4 patients)
n1=en:stye | n2=en:arched eyebrows (1/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arched eyebrows (in some patients)
n1=en:stye | n2=en:arched eyebrows (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arched, sparse eyebrows
n1=en:stye | n2=en:arched, sparse eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arcus adiposus
n1=en:stye | n2=en:arcus adiposus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arcus juvenilis
n1=en:stye | n2=en:arcus juvenilis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arcus senilis
n1=en:stye | n2=en:arcus senilis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arterial attenuation
n1=en:stye | n2=en:arterial attenuation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:arteriolar attenuation (in some patients)
n1=en:stye | n2=en:arteriolar attenuation (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asteroid hyalosis
n1=en:stye | n2=en:asteroid hyalosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:astigmatism (1 family)
n1=en:stye | n2=en:astigmatism (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:astigmatism (1 patient)
n1=en:stye | n2=en:astigmatism (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:astigmatism (in some patients)
n1=en:stye | n2=en:astigmatism (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:astigmatism (rare)
n1=en:stye | n2=en:astigmatism (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:astigmatism, variable
n1=en:stye | n2=en:astigmatism, variable | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asymmetric palpebral fissure
n1=en:stye | n2=en:asymmetric palpebral fissure | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asymmetric pendular movements
n1=en:stye | n2=en:asymmetric pendular movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asymmetric pupils (rare)
n1=en:stye | n2=en:asymmetric pupils (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asymmetric visual evoked potentials
n1=en:stye | n2=en:asymmetric visual evoked potentials | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:asymmetry of intraocular pressure
n1=en:stye | n2=en:asymmetry of intraocular pressure | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:atretic lacrimal punctum
n1=en:stye | n2=en:atretic lacrimal punctum | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:atrophic macular disease
n1=en:stye | n2=en:atrophic macular disease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:atrophic optic fundi
n1=en:stye | n2=en:atrophic optic fundi | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:atrophic retina
n1=en:stye | n2=en:atrophic retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:atrophy around the optic disc (in carrier females)
n1=en:stye | n2=en:atrophy around the optic disc (in carrier females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuated arteries
n1=en:stye | n2=en:attenuated arteries | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuated blood vessels in periphery
n1=en:stye | n2=en:attenuated blood vessels in periphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuated retinal blood vessels
n1=en:stye | n2=en:attenuated retinal blood vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuated vessels
n1=en:stye | n2=en:attenuated vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuation of retinal arterioles
n1=en:stye | n2=en:attenuation of retinal arterioles | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuation of retinal blood vessels
n1=en:stye | n2=en:attenuation of retinal blood vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:attenuation of retinal vessels
n1=en:stye | n2=en:attenuation of retinal vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:avascular patches on conjunctiva and other eye regions
n1=en:stye | n2=en:avascular patches on conjunctiva and other eye regions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:axenfeld-rieger anomalies (in some patients)
n1=en:stye | n2=en:axenfeld-rieger anomalies (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:axenfeld-rieger syndrome
n1=en:stye | n2=en:axenfeld-rieger syndrome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:b-scan ultrasound shows echogenic, placoid calcified lesions at the level of the sclera and choroid
n1=en:stye | n2=en:b-scan ultrasound shows echogenic, placoid calcified lesions at the level of the sclera and choroid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bacterial conjunctivitis
n1=en:stye | n2=en:bacterial conjunctivitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bacterial corneal ulcer
n1=en:stye | n2=en:bacterial corneal ulcer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bacterial dacryocystitis
n1=en:stye | n2=en:bacterial dacryocystitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bacterial keratitis
n1=en:stye | n2=en:bacterial keratitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bags under eyes
n1=en:stye | n2=en:bags under eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:band keratopathy
n1=en:stye | n2=en:band keratopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:band-shaped opacity
n1=en:stye | n2=en:band-shaped opacity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:band-shaped spheroid corneal degeneration
n1=en:stye | n2=en:band-shaped spheroid corneal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:band-shaped, whorled microcystic dystrophy of the corneal epithelium
n1=en:stye | n2=en:band-shaped, whorled microcystic dystrophy of the corneal epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be in contact with somebody
n1=en:stye | n2=en:be in contact with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be in touch with sb
n1=en:stye | n2=en:be in touch with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be in touch with somebody
n1=en:stye | n2=en:be in touch with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be on the phone to somebody
n1=en:stye | n2=en:be on the phone to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be on the phone with somebody
n1=en:stye | n2=en:be on the phone with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be speaking to somebody
n1=en:stye | n2=en:be speaking to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be speaking with somebody
n1=en:stye | n2=en:be speaking with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:be talking to somebody
n1=en:stye | n2=en:be talking to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral cataracts
n1=en:stye | n2=en:bilateral cataracts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral chorioretinopathy
n1=en:stye | n2=en:bilateral chorioretinopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral congenital cataracts (males)
n1=en:stye | n2=en:bilateral congenital cataracts (males) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral hyperopia
n1=en:stye | n2=en:bilateral hyperopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral infraducted eye position (downward gaze)
n1=en:stye | n2=en:bilateral infraducted eye position (downward gaze) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral intraocular pressures greater than or equal to 22 mmhg
n1=en:stye | n2=en:bilateral intraocular pressures greater than or equal to 22 mmhg | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral macular retinal pigment epithelial atrophy
n1=en:stye | n2=en:bilateral macular retinal pigment epithelial atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral macular retinal pigment epithelial mottling
n1=en:stye | n2=en:bilateral macular retinal pigment epithelial mottling | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral microphthalmos
n1=en:stye | n2=en:bilateral microphthalmos | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral nuclear cataract, congenital
n1=en:stye | n2=en:bilateral nuclear cataract, congenital | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral posterior subcapsular cataracts
n1=en:stye | n2=en:bilateral posterior subcapsular cataracts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral ptosis
n1=en:stye | n2=en:bilateral ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral red-speckled retinal pigment epithelium
n1=en:stye | n2=en:bilateral red-speckled retinal pigment epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bilateral subretinal masses
n1=en:stye | n2=en:bilateral subretinal masses | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharitis, recurrent, due to infection with staphylococcus aureus
n1=en:stye | n2=en:blepharitis, recurrent, due to infection with staphylococcus aureus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharophimosis (36%)
n1=en:stye | n2=en:blepharophimosis (36%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharophimosis (uncommon)
n1=en:stye | n2=en:blepharophimosis (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharophimosis, mild
n1=en:stye | n2=en:blepharophimosis, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharoptosis (in some patients)
n1=en:stye | n2=en:blepharoptosis (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blepharospasm may occur
n1=en:stye | n2=en:blepharospasm may occur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blind hypotensive eye
n1=en:stye | n2=en:blind hypotensive eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness
n1=en:stye | n2=en:blindness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness (6 to 14 years)
n1=en:stye | n2=en:blindness (6 to 14 years) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness (in some patients)
n1=en:stye | n2=en:blindness (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness (onset in fourth or fifth decade)
n1=en:stye | n2=en:blindness (onset in fourth or fifth decade) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness (rare)
n1=en:stye | n2=en:blindness (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness (wws)
n1=en:stye | n2=en:blindness (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness by age 2
n1=en:stye | n2=en:blindness by age 2 | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness by third decade
n1=en:stye | n2=en:blindness by third decade | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness in infancy or very early childhood
n1=en:stye | n2=en:blindness in infancy or very early childhood | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness may occur in affected infants
n1=en:stye | n2=en:blindness may occur in affected infants | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blindness, postretinal
n1=en:stye | n2=en:blindness, postretinal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blockage of the lacrimal ducts
n1=en:stye | n2=en:blockage of the lacrimal ducts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue eyes (japanese patients)
n1=en:stye | n2=en:blue eyes (japanese patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue sclera
n1=en:stye | n2=en:blue sclera | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue sclera in infancy
n1=en:stye | n2=en:blue sclera in infancy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue sclerae (in some patients)
n1=en:stye | n2=en:blue sclerae (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue sclerae (rare)
n1=en:stye | n2=en:blue sclerae (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue sclerae at birth becoming normal with age
n1=en:stye | n2=en:blue sclerae at birth becoming normal with age | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue-gray irides (adult)
n1=en:stye | n2=en:blue-gray irides (adult) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue-green irides
n1=en:stye | n2=en:blue-green irides | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue-white dots throughout lens, more numerous in cortex
n1=en:stye | n2=en:blue-white dots throughout lens, more numerous in cortex | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blue/yellow color vision defect
n1=en:stye | n2=en:blue/yellow color vision defect | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bluish sclerae in infancy (rare)
n1=en:stye | n2=en:bluish sclerae in infancy (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blurred vision
n1=en:stye | n2=en:blurred vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blurred vision (early symptom)
n1=en:stye | n2=en:blurred vision (early symptom) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:blurred vision, episodic
n1=en:stye | n2=en:blurred vision, episodic | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone corpuscle-like pigmentation in equatorial and peripheral areas
n1=en:stye | n2=en:bone corpuscle-like pigmentation in equatorial and peripheral areas | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule pigment deposits in periphery and mid periphery
n1=en:stye | n2=en:bone spicule pigment deposits in periphery and mid periphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule pigment in periphery
n1=en:stye | n2=en:bone spicule pigment in periphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule pigmentation
n1=en:stye | n2=en:bone spicule pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule pigmentation of retina (in some patients)
n1=en:stye | n2=en:bone spicule pigmentation of retina (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule-like pigmentation
n1=en:stye | n2=en:bone spicule-like pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicule-like pigmentation (in some patients)
n1=en:stye | n2=en:bone spicule-like pigmentation (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone spicules
n1=en:stye | n2=en:bone spicules | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone-spicule pattern of pigmentary deposits in retinal midperiphery
n1=en:stye | n2=en:bone-spicule pattern of pigmentary deposits in retinal midperiphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone-spicule pigment depositions (in some patients)
n1=en:stye | n2=en:bone-spicule pigment depositions (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone-spicule pigment deposits, retinal
n1=en:stye | n2=en:bone-spicule pigment deposits, retinal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone-spicule pigmentation in periphery
n1=en:stye | n2=en:bone-spicule pigmentation in periphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bone-spicule-like pigmentary changes
n1=en:stye | n2=en:bone-spicule-like pigmentary changes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:both eyes
n1=en:stye | n2=en:both eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:breakdown of the blood retinal barrier with retinal neovascularization
n1=en:stye | n2=en:breakdown of the blood retinal barrier with retinal neovascularization | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bright blue eyes
n1=en:stye | n2=en:bright blue eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bright blue irides
n1=en:stye | n2=en:bright blue irides | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:brittle and sparse eyelashes
n1=en:stye | n2=en:brittle and sparse eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:broad dense laterally descending eyebrows
n1=en:stye | n2=en:broad dense laterally descending eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:broad palpebral fissures (1 patient)
n1=en:stye | n2=en:broad palpebral fissures (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:broken heart
n1=en:stye | n2=en:broken heart | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:brown accumulation of gaucher cells at corneoscleral limbus
n1=en:stye | n2=en:brown accumulation of gaucher cells at corneoscleral limbus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bulbar conjunctivitis
n1=en:stye | n2=en:bulbar conjunctivitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bulging eyes (in some patients)
n1=en:stye | n2=en:bulging eyes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bull's eye maculae
n1=en:stye | n2=en:bull's eye maculae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bull's eye macular lesion
n1=en:stye | n2=en:bull's eye macular lesion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bull's eye maculopathy (in some patients)
n1=en:stye | n2=en:bull's eye maculopathy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:bull's-eye macular retinal pigment epithelium changes
n1=en:stye | n2=en:bull's-eye macular retinal pigment epithelium changes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:buphthalmia
n1=en:stye | n2=en:buphthalmia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:buphthalmos (in some patients)
n1=en:stye | n2=en:buphthalmos (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:buphthalmos (wws)
n1=en:stye | n2=en:buphthalmos (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:canaliculitis
n1=en:stye | n2=en:canaliculitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cararacts
n1=en:stye | n2=en:cararacts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract (28%)
n1=en:stye | n2=en:cataract (28%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract (alport syndrome with macrothrombocytopenia)
n1=en:stye | n2=en:cataract (alport syndrome with macrothrombocytopenia) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract (in 2 brothers)
n1=en:stye | n2=en:cataract (in 2 brothers) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, adult-onset (punctate cortical)
n1=en:stye | n2=en:cataract, adult-onset (punctate cortical) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, anterior polar
n1=en:stye | n2=en:cataract, anterior polar | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, anterior polar, congenital or early-onset (in some patients)
n1=en:stye | n2=en:cataract, anterior polar, congenital or early-onset (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, anterior polar, nonprogressive
n1=en:stye | n2=en:cataract, anterior polar, nonprogressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, complete (in affected males)
n1=en:stye | n2=en:cataract, complete (in affected males) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, congenital (nuclear, sutural, or stellate cortical)
n1=en:stye | n2=en:cataract, congenital (nuclear, sutural, or stellate cortical) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, congenital (rare)
n1=en:stye | n2=en:cataract, congenital (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, coppock-like
n1=en:stye | n2=en:cataract, coppock-like | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, fan-shaped
n1=en:stye | n2=en:cataract, fan-shaped | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, lamellar (in some patients)
n1=en:stye | n2=en:cataract, lamellar (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, laminar
n1=en:stye | n2=en:cataract, laminar | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, marner type
n1=en:stye | n2=en:cataract, marner type | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, nuclear (in some patients)
n1=en:stye | n2=en:cataract, nuclear (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, nuclear coralliform
n1=en:stye | n2=en:cataract, nuclear coralliform | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, posterior polar (in some patients)
n1=en:stye | n2=en:cataract, posterior polar (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, posterior polar, congenital progressive
n1=en:stye | n2=en:cataract, posterior polar, congenital progressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, posterior subcapsular (in some patients)
n1=en:stye | n2=en:cataract, posterior subcapsular (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, postnatal, bilateral dense nuclear
n1=en:stye | n2=en:cataract, postnatal, bilateral dense nuclear | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, progressive (in some patients)
n1=en:stye | n2=en:cataract, progressive (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, progressive, juvenile-onset (lamellar, cortical, nuclear embryonic, or y-sutural)
n1=en:stye | n2=en:cataract, progressive, juvenile-onset (lamellar, cortical, nuclear embryonic, or y-sutural) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, pulverulent
n1=en:stye | n2=en:cataract, pulverulent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, zonular central nuclear
n1=en:stye | n2=en:cataract, zonular central nuclear | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataract, zonular pulverulent 1
n1=en:stye | n2=en:cataract, zonular pulverulent 1 | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (1 patient)
n1=en:stye | n2=en:cataracts (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (e.g. 180380.0016)
n1=en:stye | n2=en:cataracts (e.g. 180380.0016) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (in older patients)
n1=en:stye | n2=en:cataracts (in older patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (in some patients)
n1=en:stye | n2=en:cataracts (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (later onset)
n1=en:stye | n2=en:cataracts (later onset) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (less common)
n1=en:stye | n2=en:cataracts (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts (rare)
n1=en:stye | n2=en:cataracts (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts develop in second or third decade
n1=en:stye | n2=en:cataracts develop in second or third decade | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, bilateral nuclear, present at birth or developing in infancy
n1=en:stye | n2=en:cataracts, bilateral nuclear, present at birth or developing in infancy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, congenital (in some patients)
n1=en:stye | n2=en:cataracts, congenital (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, cortical pulverulent, juvenile-onset
n1=en:stye | n2=en:cataracts, cortical pulverulent, juvenile-onset | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, crenated
n1=en:stye | n2=en:cataracts, crenated | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, postnatal
n1=en:stye | n2=en:cataracts, postnatal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, rapid-onset
n1=en:stye | n2=en:cataracts, rapid-onset | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cataracts, usually congenital
n1=en:stye | n2=en:cataracts, usually congenital | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central cataracts
n1=en:stye | n2=en:central cataracts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central corneal thickness decreased
n1=en:stye | n2=en:central corneal thickness decreased | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central guttae, unilateral or bilateral
n1=en:stye | n2=en:central guttae, unilateral or bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central hypofluorescence or hyperfluorescence on fluorescein angiography
n1=en:stye | n2=en:central hypofluorescence or hyperfluorescence on fluorescein angiography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central islands of vision only (late)
n1=en:stye | n2=en:central islands of vision only (late) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central macular atrophy (in some patients)
n1=en:stye | n2=en:central macular atrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central retinal vessel vascular tortuosity (acute phase)
n1=en:stye | n2=en:central retinal vessel vascular tortuosity (acute phase) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central scotoma on visual field testing
n1=en:stye | n2=en:central scotoma on visual field testing | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central scotomata on photopic and dark-adapted perimetry testing
n1=en:stye | n2=en:central scotomata on photopic and dark-adapted perimetry testing | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:central/paracentral scotomata
n1=en:stye | n2=en:central/paracentral scotomata | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:centrocecal scotoma (acute phase)
n1=en:stye | n2=en:centrocecal scotoma (acute phase) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cherry-red maculae (50%)
n1=en:stye | n2=en:cherry-red maculae (50%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cherry-red maculae (less common)
n1=en:stye | n2=en:cherry-red maculae (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cherry-red spot (type ii, infantile and juvenile and type i)
n1=en:stye | n2=en:cherry-red spot (type ii, infantile and juvenile and type i) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorio-retinitis
n1=en:stye | n2=en:chorio-retinitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choriocapillaris atrophy
n1=en:stye | n2=en:choriocapillaris atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioectopia
n1=en:stye | n2=en:chorioectopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioretinal atrophic lacunae
n1=en:stye | n2=en:chorioretinal atrophic lacunae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioretinal atrophy
n1=en:stye | n2=en:chorioretinal atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioretinal coloboma (rare)
n1=en:stye | n2=en:chorioretinal coloboma (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioretinal degeneration
n1=en:stye | n2=en:chorioretinal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chorioretinal dystrophy
n1=en:stye | n2=en:chorioretinal dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroid atrophy (in some patients)
n1=en:stye | n2=en:choroid atrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidal and/or chorioretinal disorder
n1=en:stye | n2=en:choroidal and/or chorioretinal disorder | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidal atrophy (rare)
n1=en:stye | n2=en:choroidal atrophy (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidal neovascularization (in some patients)
n1=en:stye | n2=en:choroidal neovascularization (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidal sclerosis (in some patients)
n1=en:stye | n2=en:choroidal sclerosis (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidal vessels visible
n1=en:stye | n2=en:choroidal vessels visible | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidoretinal degeneration (1 patient)
n1=en:stye | n2=en:choroidoretinal degeneration (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:choroidoretinal degeneration (starting in the midperiphery of the fundus and progressing centrally and peripherally)
n1=en:stye | n2=en:choroidoretinal degeneration (starting in the midperiphery of the fundus and progressing centrally and peripherally) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chronic blepharitis
n1=en:stye | n2=en:chronic blepharitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:chronic tearing
n1=en:stye | n2=en:chronic tearing | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cicatricial ectropion
n1=en:stye | n2=en:cicatricial ectropion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:circumpapillary telangiectatic microangiopathy (acute phase)
n1=en:stye | n2=en:circumpapillary telangiectatic microangiopathy (acute phase) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:clear cornea
n1=en:stye | n2=en:clear cornea | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:clear corneas
n1=en:stye | n2=en:clear corneas | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:clear to faintly hazy corneas
n1=en:stye | n2=en:clear to faintly hazy corneas | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:clinical anophthalmia, unilateral/bilateral (87%)
n1=en:stye | n2=en:clinical anophthalmia, unilateral/bilateral (87%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:clinically 'silent' nystagmus evident on eye movement recording in carrier females
n1=en:stye | n2=en:clinically 'silent' nystagmus evident on eye movement recording in carrier females | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cloudy corneas (in some patients)
n1=en:stye | n2=en:cloudy corneas (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cogwheel ocular pursuit
n1=en:stye | n2=en:cogwheel ocular pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma (1 patient)
n1=en:stye | n2=en:coloboma (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma (in some patients with larger microdeletion)
n1=en:stye | n2=en:coloboma (in some patients with larger microdeletion) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma (in some patients)
n1=en:stye | n2=en:coloboma (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma (iris, optic nerve)
n1=en:stye | n2=en:coloboma (iris, optic nerve) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma (wws)
n1=en:stye | n2=en:coloboma (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of choroid
n1=en:stye | n2=en:coloboma of choroid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of eyelids, iris, and choroid
n1=en:stye | n2=en:coloboma of eyelids, iris, and choroid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of optic disc
n1=en:stye | n2=en:coloboma of optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of optic nerve (rare)
n1=en:stye | n2=en:coloboma of optic nerve (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the eye
n1=en:stye | n2=en:coloboma of the eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the iris
n1=en:stye | n2=en:coloboma of the iris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the iris (in some patients)
n1=en:stye | n2=en:coloboma of the iris (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the iris (rare)
n1=en:stye | n2=en:coloboma of the iris (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the lower eyelids (rare)
n1=en:stye | n2=en:coloboma of the lower eyelids (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma of the retina
n1=en:stye | n2=en:coloboma of the retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma, choreoretinal
n1=en:stye | n2=en:coloboma, choreoretinal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma, choroid (rare)
n1=en:stye | n2=en:coloboma, choroid (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma, isolated (in some patients)
n1=en:stye | n2=en:coloboma, isolated (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:coloboma, retinochoroidal (rare)
n1=en:stye | n2=en:coloboma, retinochoroidal (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:colobomas (iris, choroid, retina, disc, and optic nerve)
n1=en:stye | n2=en:colobomas (iris, choroid, retina, disc, and optic nerve) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:colobomas of optic disk, choroid, ciliary body, and iris
n1=en:stye | n2=en:colobomas of optic disk, choroid, ciliary body, and iris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:color blindness, red
n1=en:stye | n2=en:color blindness, red | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:color vision defect
n1=en:stye | n2=en:color vision defect | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:color vision deficit, green or red-green
n1=en:stye | n2=en:color vision deficit, green or red-green | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:color vision disturbance in protan, deutan, and tritan axes
n1=en:stye | n2=en:color vision disturbance in protan, deutan, and tritan axes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:colorblindness, blue cone monochromacy type
n1=en:stye | n2=en:colorblindness, blue cone monochromacy type | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:colorblindness, severe to complete
n1=en:stye | n2=en:colorblindness, severe to complete | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:combined hamartoma of the retinal pigment epithelium and retina
n1=en:stye | n2=en:combined hamartoma of the retinal pigment epithelium and retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:complete blindness between ages 40-50 years
n1=en:stye | n2=en:complete blindness between ages 40-50 years | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:complicated strabismus
n1=en:stye | n2=en:complicated strabismus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:concentric constriction of visual fields bilaterally
n1=en:stye | n2=en:concentric constriction of visual fields bilaterally | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone and rod responses borderline or nondetectable on electroretinography (erg) by the second decade of life
n1=en:stye | n2=en:cone and rod responses borderline or nondetectable on electroretinography (erg) by the second decade of life | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone implicit times consistent with progressive disease
n1=en:stye | n2=en:cone implicit times consistent with progressive disease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone responses decreased on erg
n1=en:stye | n2=en:cone responses decreased on erg | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone-driven 1-hz response with unusual waveform on electroretinography
n1=en:stye | n2=en:cone-driven 1-hz response with unusual waveform on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone-dystrophy
n1=en:stye | n2=en:cone-dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cone-first retinal dystrophy
n1=en:stye | n2=en:cone-first retinal dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital absence of tears
n1=en:stye | n2=en:congenital absence of tears | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital ankyloblepharon
n1=en:stye | n2=en:congenital ankyloblepharon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital ankyloblepharon filiforme
n1=en:stye | n2=en:congenital ankyloblepharon filiforme | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital bilateral ptosis
n1=en:stye | n2=en:congenital bilateral ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital cataract (males)
n1=en:stye | n2=en:congenital cataract (males) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital cataracts (1 family)
n1=en:stye | n2=en:congenital cataracts (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital complete achromatopsia
n1=en:stye | n2=en:congenital complete achromatopsia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital epicanthus
n1=en:stye | n2=en:congenital epicanthus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital fibrosis of the extraocular muscles (1 family)
n1=en:stye | n2=en:congenital fibrosis of the extraocular muscles (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital fibrosis of the extraocular muscles (9%)
n1=en:stye | n2=en:congenital fibrosis of the extraocular muscles (9%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital hypertrophy of retinal pigment epithelium
n1=en:stye | n2=en:congenital hypertrophy of retinal pigment epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital keratoglobus
n1=en:stye | n2=en:congenital keratoglobus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital myopia
n1=en:stye | n2=en:congenital myopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital nuclear cataract (in some patients)
n1=en:stye | n2=en:congenital nuclear cataract (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital stapes ankylosis
n1=en:stye | n2=en:congenital stapes ankylosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital stationary
n1=en:stye | n2=en:congenital stationary | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:congenital strabismus
n1=en:stye | n2=en:congenital strabismus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjugated horizontal gaze palsy
n1=en:stye | n2=en:conjugated horizontal gaze palsy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctiva shows dilated blood vessels
n1=en:stye | n2=en:conjunctiva shows dilated blood vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival
n1=en:stye | n2=en:conjunctival | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival crystals
n1=en:stye | n2=en:conjunctival crystals | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival injection, ipsilateral
n1=en:stye | n2=en:conjunctival injection, ipsilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival irritation
n1=en:stye | n2=en:conjunctival irritation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival telangiectasia (reported in 1 family)
n1=en:stye | n2=en:conjunctival telangiectasia (reported in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctival whitish salt-like deposits
n1=en:stye | n2=en:conjunctival whitish salt-like deposits | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctive
n1=en:stye | n2=en:conjunctive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctivitis
n1=en:stye | n2=en:conjunctivitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctivitis, episodic
n1=en:stye | n2=en:conjunctivitis, episodic | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:conjunctivitis, recurrent
n1=en:stye | n2=en:conjunctivitis, recurrent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:constricted visual fields (occurs second)
n1=en:stye | n2=en:constricted visual fields (occurs second) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:constricted visual fields by age 20 years
n1=en:stye | n2=en:constricted visual fields by age 20 years | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:contact
n1=en:stye | n2=en:contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:contact lens
n1=en:stye | n2=en:contact lens | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:contact somebody
n1=en:stye | n2=en:contact somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:controlling officer
n1=en:stye | n2=en:controlling officer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corectopia (in some patients)
n1=en:stye | n2=en:corectopia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cornea plana (in some patients)
n1=en:stye | n2=en:cornea plana (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal and lenticular opacities
n1=en:stye | n2=en:corneal and lenticular opacities | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal and retinal calcification
n1=en:stye | n2=en:corneal and retinal calcification | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal clouding (detroit type 107680.0011, apoa1 deficiency 107680.0014)
n1=en:stye | n2=en:corneal clouding (detroit type 107680.0011, apoa1 deficiency 107680.0014) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal clouding (in some)
n1=en:stye | n2=en:corneal clouding (in some) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal clouding (rare)
n1=en:stye | n2=en:corneal clouding (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal crystalline deposits
n1=en:stye | n2=en:corneal crystalline deposits | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal dermoid cyst (rare)
n1=en:stye | n2=en:corneal dermoid cyst (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal diameter, normal
n1=en:stye | n2=en:corneal diameter, normal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal drying
n1=en:stye | n2=en:corneal drying | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal dyskeratosis
n1=en:stye | n2=en:corneal dyskeratosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal dystrophy (onset early in childhood)
n1=en:stye | n2=en:corneal dystrophy (onset early in childhood) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal endothelial dystrophy (guttata)
n1=en:stye | n2=en:corneal endothelial dystrophy (guttata) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal endothelial dystrophy (in some patients)
n1=en:stye | n2=en:corneal endothelial dystrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal endothelial guttata and folds
n1=en:stye | n2=en:corneal endothelial guttata and folds | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal erosions (1 patient)
n1=en:stye | n2=en:corneal erosions (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal flatness
n1=en:stye | n2=en:corneal flatness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal hypoesthesia
n1=en:stye | n2=en:corneal hypoesthesia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal infection
n1=en:stye | n2=en:corneal infection | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal lens
n1=en:stye | n2=en:corneal lens | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal lipid deposit
n1=en:stye | n2=en:corneal lipid deposit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal opacification, partial or total
n1=en:stye | n2=en:corneal opacification, partial or total | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal opacities (in some patients)
n1=en:stye | n2=en:corneal opacities (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal opacities on slit-lamp examination
n1=en:stye | n2=en:corneal opacities on slit-lamp examination | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal reflex absent
n1=en:stye | n2=en:corneal reflex absent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal reflex reduced
n1=en:stye | n2=en:corneal reflex reduced | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal rupture
n1=en:stye | n2=en:corneal rupture | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal sensitivity impairment (hypesthesia)
n1=en:stye | n2=en:corneal sensitivity impairment (hypesthesia) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corneal vascularization extending to central cornea
n1=en:stye | n2=en:corneal vascularization extending to central cornea | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:corpus vitreum
n1=en:stye | n2=en:corpus vitreum | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical blindness (1 patient)
n1=en:stye | n2=en:cortical blindness (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical blindness (in 1 moroccan patient)
n1=en:stye | n2=en:cortical blindness (in 1 moroccan patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical blindness (in one patient)
n1=en:stye | n2=en:cortical blindness (in one patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical cataract
n1=en:stye | n2=en:cortical cataract | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical punctate or pulverulent opacities (in carrier females)
n1=en:stye | n2=en:cortical punctate or pulverulent opacities (in carrier females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cortical visual impairment (in some patients)
n1=en:stye | n2=en:cortical visual impairment (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cryptophthalmia
n1=en:stye | n2=en:cryptophthalmia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cupping of optic nerve head
n1=en:stye | n2=en:cupping of optic nerve head | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:curled eyelashes
n1=en:stye | n2=en:curled eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:curly eyebrows
n1=en:stye | n2=en:curly eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cutaneolacrimal fistulae
n1=en:stye | n2=en:cutaneolacrimal fistulae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cyclopia
n1=en:stye | n2=en:cyclopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cyclopia (5%)
n1=en:stye | n2=en:cyclopia (5%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cyst associated with dysplastic globe (in some patients)
n1=en:stye | n2=en:cyst associated with dysplastic globe (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cystic degeneration of the macula (rare)
n1=en:stye | n2=en:cystic degeneration of the macula (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cystic maculopathy
n1=en:stye | n2=en:cystic maculopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cystic retinal degeneration
n1=en:stye | n2=en:cystic retinal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cystoid macular edema (in some patients)
n1=en:stye | n2=en:cystoid macular edema (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cystoid macular retinal degeneration
n1=en:stye | n2=en:cystoid macular retinal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:cytoid body
n1=en:stye | n2=en:cytoid body | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dacryoadenitis
n1=en:stye | n2=en:dacryoadenitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dacryoadenitis acquired
n1=en:stye | n2=en:dacryoadenitis acquired | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dacryocystitis (in some patients)
n1=en:stye | n2=en:dacryocystitis (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dark choroid (rare)
n1=en:stye | n2=en:dark choroid (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deafness
n1=en:stye | n2=en:deafness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased electroretinogram (erg)
n1=en:stye | n2=en:decreased electroretinogram (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased electroretinogram (erg) response
n1=en:stye | n2=en:decreased electroretinogram (erg) response | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased iris pigment
n1=en:stye | n2=en:decreased iris pigment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased lacrimation
n1=en:stye | n2=en:decreased lacrimation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased light- and dark-adapted electroretinogram amplitude
n1=en:stye | n2=en:decreased light- and dark-adapted electroretinogram amplitude | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased night vision
n1=en:stye | n2=en:decreased night vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased night vision (early in course of disease)
n1=en:stye | n2=en:decreased night vision (early in course of disease) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased night vision, childhood-onset
n1=en:stye | n2=en:decreased night vision, childhood-onset | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased or absent corneal reflexes
n1=en:stye | n2=en:decreased or absent corneal reflexes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased or absent electroretinogram (erg)
n1=en:stye | n2=en:decreased or absent electroretinogram (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased or absent electroretinogram (erg) responses
n1=en:stye | n2=en:decreased or absent electroretinogram (erg) responses | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased pupillary accommodation
n1=en:stye | n2=en:decreased pupillary accommodation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity (in some patients)
n1=en:stye | n2=en:decreased visual acuity (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity (rare)
n1=en:stye | n2=en:decreased visual acuity (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity in early childhood
n1=en:stye | n2=en:decreased visual acuity in early childhood | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity, in some female carriers
n1=en:stye | n2=en:decreased visual acuity, in some female carriers | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity, nonprogressive
n1=en:stye | n2=en:decreased visual acuity, nonprogressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity, progressive
n1=en:stye | n2=en:decreased visual acuity, progressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:decreased visual acuity, slowly progressive
n1=en:stye | n2=en:decreased visual acuity, slowly progressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deep-set eyes (1 patient)
n1=en:stye | n2=en:deep-set eyes (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deep-set eyes (in 2 patients)
n1=en:stye | n2=en:deep-set eyes (in 2 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deep-set eyes (in early childhood)
n1=en:stye | n2=en:deep-set eyes (in early childhood) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deep-set eyes (in some patients)
n1=en:stye | n2=en:deep-set eyes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deep-set eyes (rare)
n1=en:stye | n2=en:deep-set eyes (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deeper, fusiform lattice deposits develop later
n1=en:stye | n2=en:deeper, fusiform lattice deposits develop later | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:deformed pupils
n1=en:stye | n2=en:deformed pupils | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:degenerative vitreoretinopathy
n1=en:stye | n2=en:degenerative vitreoretinopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:delayed eye opening as a neonate (up to 2 weeks)
n1=en:stye | n2=en:delayed eye opening as a neonate (up to 2 weeks) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:delayed pupillary responses (in some patients)
n1=en:stye | n2=en:delayed pupillary responses (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:delayed visual-evoked potential
n1=en:stye | n2=en:delayed visual-evoked potential | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dense, posterior cortical cataract (carrier females)
n1=en:stye | n2=en:dense, posterior cortical cataract (carrier females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dermoid choristoma of eye proper
n1=en:stye | n2=en:dermoid choristoma of eye proper | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:desk officer
n1=en:stye | n2=en:desk officer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:detached retina (in some patients)
n1=en:stye | n2=en:detached retina (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:difficulties with night vision (reported in 1 family)
n1=en:stye | n2=en:difficulties with night vision (reported in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:difficulty reading
n1=en:stye | n2=en:difficulty reading | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diffuse or localized pigmentary changes, with bone spicules in some patients
n1=en:stye | n2=en:diffuse or localized pigmentary changes, with bone spicules in some patients | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diffuse pigment epithelial disturbances
n1=en:stye | n2=en:diffuse pigment epithelial disturbances | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diffuse pigmentary stippling of peripheral retina
n1=en:stye | n2=en:diffuse pigmentary stippling of peripheral retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dilated superficial vessels give 'red eye' appearance
n1=en:stye | n2=en:dilated superficial vessels give 'red eye' appearance | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diminished amplitude on erg
n1=en:stye | n2=en:diminished amplitude on erg | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diminished pupillary light responses
n1=en:stye | n2=en:diminished pupillary light responses | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diminished visual acuity (1 patient)
n1=en:stye | n2=en:diminished visual acuity (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diplopia
n1=en:stye | n2=en:diplopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:diplopias, intermittent
n1=en:stye | n2=en:diplopias, intermittent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:disc hemorrhage
n1=en:stye | n2=en:disc hemorrhage | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:discontinuity and degeneration of the endothelial cell layer
n1=en:stye | n2=en:discontinuity and degeneration of the endothelial cell layer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:discus nervi optici
n1=en:stye | n2=en:discus nervi optici | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dislocated lens (upward)
n1=en:stye | n2=en:dislocated lens (upward) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:disorder of eye
n1=en:stye | n2=en:disorder of eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:disorder of macula of retina
n1=en:stye | n2=en:disorder of macula of retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:displaced pupils
n1=en:stye | n2=en:displaced pupils | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:displacement of pupil, inferior (in some patients)
n1=en:stye | n2=en:displacement of pupil, inferior (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:distichiasis
n1=en:stye | n2=en:distichiasis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:distinctive electroretinogram - focal macular cone erg is well-preserved
n1=en:stye | n2=en:distinctive electroretinogram - focal macular cone erg is well-preserved | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:divergent strabismus
n1=en:stye | n2=en:divergent strabismus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:divide
n1=en:stye | n2=en:divide | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dominance, ocular
n1=en:stye | n2=en:dominance, ocular | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downslanting palpebral fissure (male)
n1=en:stye | n2=en:downslanting palpebral fissure (male) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downslanting palpebral fissures (6 of 22)
n1=en:stye | n2=en:downslanting palpebral fissures (6 of 22) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downslanting palpebral fissures (in 1 of 2 patients)
n1=en:stye | n2=en:downslanting palpebral fissures (in 1 of 2 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downslanting palpebral fissures (in 2/4 patients)
n1=en:stye | n2=en:downslanting palpebral fissures (in 2/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downslanting palpebral fissures (in some patients)
n1=en:stye | n2=en:downslanting palpebral fissures (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:downward gaze
n1=en:stye | n2=en:downward gaze | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:drooping eyelid
n1=en:stye | n2=en:drooping eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dry conjunctival mucosae
n1=en:stye | n2=en:dry conjunctival mucosae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dual waveform jerk movements
n1=en:stye | n2=en:dual waveform jerk movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:duane anomaly (less common)
n1=en:stye | n2=en:duane anomaly (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:duane anomaly (rare)
n1=en:stye | n2=en:duane anomaly (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:duane retraction syndrome (34%)
n1=en:stye | n2=en:duane retraction syndrome (34%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:duane syndrome
n1=en:stye | n2=en:duane syndrome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:duane syndrome (abducens palsy with retracted globe)
n1=en:stye | n2=en:duane syndrome (abducens palsy with retracted globe) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:Duane's syndrome
n1=en:stye | n2=en:Duane's syndrome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dyschromatopsia
n1=en:stye | n2=en:dyschromatopsia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dyschromatopsia (1 patient)
n1=en:stye | n2=en:dyschromatopsia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dyschromatopsia (some)
n1=en:stye | n2=en:dyschromatopsia (some) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dysmetric saccades
n1=en:stye | n2=en:dysmetric saccades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dystopia canthorum absent
n1=en:stye | n2=en:dystopia canthorum absent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:dystrophy does not recur after penetrating keratoplasty
n1=en:stye | n2=en:dystrophy does not recur after penetrating keratoplasty | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:early glaucoma
n1=en:stye | n2=en:early glaucoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:early onset night blindness and abnormal fundus (e.g. 180380.0013)
n1=en:stye | n2=en:early onset night blindness and abnormal fundus (e.g. 180380.0013) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:early onset of decreased visual acuity: nonrecordable cone pattern on electroretinogram
n1=en:stye | n2=en:early onset of decreased visual acuity: nonrecordable cone pattern on electroretinogram | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:early-onset corneal degeneration
n1=en:stye | n2=en:early-onset corneal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eccentric or ectopic pupils
n1=en:stye | n2=en:eccentric or ectopic pupils | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eccentric pupil (rare)
n1=en:stye | n2=en:eccentric pupil (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopia lentis (6%)
n1=en:stye | n2=en:ectopia lentis (6%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopia lentis (64%)
n1=en:stye | n2=en:ectopia lentis (64%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopia lentis (84%)
n1=en:stye | n2=en:ectopia lentis (84%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopia lentis spherophakia (in some patients)
n1=en:stye | n2=en:ectopia lentis spherophakia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopia lentis, isolated (congenital lens dislocation)
n1=en:stye | n2=en:ectopia lentis, isolated (congenital lens dislocation) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectopic lens
n1=en:stye | n2=en:ectopic lens | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectropion (in some patients)
n1=en:stye | n2=en:ectropion (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ectropion, bilateral (in some patients)
n1=en:stye | n2=en:ectropion, bilateral (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eczematous dermatitis of eyelid
n1=en:stye | n2=en:eczematous dermatitis of eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:edematous eyelids
n1=en:stye | n2=en:edematous eyelids | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:electroretinograms markedly reduced or completely extinct
n1=en:stye | n2=en:electroretinograms markedly reduced or completely extinct | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:electroretinograms unrecordable at birth or in infancy
n1=en:stye | n2=en:electroretinograms unrecordable at birth or in infancy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:electroretinography (erg) shows decreased amplitudes
n1=en:stye | n2=en:electroretinography (erg) shows decreased amplitudes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:electroretinography responses diminished or undetectable
n1=en:stye | n2=en:electroretinography responses diminished or undetectable | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:electroretinography responses nondetectable (in most patients)
n1=en:stye | n2=en:electroretinography responses nondetectable (in most patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:elevated intraocular pressure (in some patients)
n1=en:stye | n2=en:elevated intraocular pressure (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:elevated papillomacular retinal fold
n1=en:stye | n2=en:elevated papillomacular retinal fold | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:elicited repetitive daily blindness (erdb)
n1=en:stye | n2=en:elicited repetitive daily blindness (erdb) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:elongated palpebral fissures
n1=en:stye | n2=en:elongated palpebral fissures | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:emmetropia
n1=en:stye | n2=en:emmetropia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:endophtalmy
n1=en:stye | n2=en:endophtalmy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:endothelial cell death with hypertrophy and polymorphism of surviving cells
n1=en:stye | n2=en:endothelial cell death with hypertrophy and polymorphism of surviving cells | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:enlarged corneal diameters (in some patients)
n1=en:stye | n2=en:enlarged corneal diameters (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:enlarged globes
n1=en:stye | n2=en:enlarged globes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:enlarged lacrimal glands
n1=en:stye | n2=en:enlarged lacrimal glands | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds (3/4 patients)
n1=en:stye | n2=en:epicanthal folds (3/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds (39%)
n1=en:stye | n2=en:epicanthal folds (39%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds (68%)
n1=en:stye | n2=en:epicanthal folds (68%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds (89%)
n1=en:stye | n2=en:epicanthal folds (89%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds (in some patients)
n1=en:stye | n2=en:epicanthal folds (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthal folds, mild
n1=en:stye | n2=en:epicanthal folds, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthic folds (in some patients)
n1=en:stye | n2=en:epicanthic folds (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthus (in one family)
n1=en:stye | n2=en:epicanthus (in one family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epicanthus (in some patients)
n1=en:stye | n2=en:epicanthus (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epiphora (classic feature)
n1=en:stye | n2=en:epiphora (classic feature) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epiphora, severe
n1=en:stye | n2=en:epiphora, severe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:epiretinal membranes, with wrinkling of retina
n1=en:stye | n2=en:epiretinal membranes, with wrinkling of retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:episodic ptosis
n1=en:stye | n2=en:episodic ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropia (1 patient)
n1=en:stye | n2=en:esotropia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropia (about half of patients)
n1=en:stye | n2=en:esotropia (about half of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropia (in some patients)
n1=en:stye | n2=en:esotropia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropia with accommodative compensation
n1=en:stye | n2=en:esotropia with accommodative compensation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropia with hypermetropia and strabismus (rare)
n1=en:stye | n2=en:esotropia with hypermetropia and strabismus (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:esotropias, secondary
n1=en:stye | n2=en:esotropias, secondary | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eventual loss of peripheral vision and night blindness
n1=en:stye | n2=en:eventual loss of peripheral vision and night blindness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eversion of lateral third of lower eyelids
n1=en:stye | n2=en:eversion of lateral third of lower eyelids | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eversion of the lower eyelids
n1=en:stye | n2=en:eversion of the lower eyelids | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:excavation of optic disc (pits)
n1=en:stye | n2=en:excavation of optic disc (pits) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exophthalmos due to hyperthyroidism
n1=en:stye | n2=en:exophthalmos due to hyperthyroidism | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exophthalmos, bilateral
n1=en:stye | n2=en:exophthalmos, bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exophthalmos, mild
n1=en:stye | n2=en:exophthalmos, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exotropia (1 patient)
n1=en:stye | n2=en:exotropia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exotropia (females)
n1=en:stye | n2=en:exotropia (females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exotropia (less common)
n1=en:stye | n2=en:exotropia (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exotropia (severe cases)
n1=en:stye | n2=en:exotropia (severe cases) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exotropia, secondary
n1=en:stye | n2=en:exotropia, secondary | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exposure conjunctivitis/keratitis
n1=en:stye | n2=en:exposure conjunctivitis/keratitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extensive geographic retinal atrophy (butterfly pattern in some patients)
n1=en:stye | n2=en:extensive geographic retinal atrophy (butterfly pattern in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extensive lesions may impair vision (in some patients)
n1=en:stye | n2=en:extensive lesions may impair vision (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:external ophthalmoplegia (in some patients)
n1=en:stye | n2=en:external ophthalmoplegia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:external ophthalmoplegia (less common)
n1=en:stye | n2=en:external ophthalmoplegia (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:external ophthalmoplegia (uncommon)
n1=en:stye | n2=en:external ophthalmoplegia (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:external ophthalmoplegia affecting upward and lateral gaze
n1=en:stye | n2=en:external ophthalmoplegia affecting upward and lateral gaze | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:external ophthalmoplegia, progressive (rare)
n1=en:stye | n2=en:external ophthalmoplegia, progressive (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extinction of electroretinogram (before age 10)
n1=en:stye | n2=en:extinction of electroretinogram (before age 10) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extinguished electroretinograms in second or third decade
n1=en:stye | n2=en:extinguished electroretinograms in second or third decade | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extinguished responses on electroretinography
n1=en:stye | n2=en:extinguished responses on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extraocular movement difficulties
n1=en:stye | n2=en:extraocular movement difficulties | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extraocular muscle fibrosis
n1=en:stye | n2=en:extraocular muscle fibrosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extraocular muscle weakness (in some patients)
n1=en:stye | n2=en:extraocular muscle weakness (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extraocular muscle weakness, mild (1 patient)
n1=en:stye | n2=en:extraocular muscle weakness, mild (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:extraocular muscles are not involved
n1=en:stye | n2=en:extraocular muscles are not involved | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exudative maculopathy
n1=en:stye | n2=en:exudative maculopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:exudative vitreoretinopathy (in some patients)
n1=en:stye | n2=en:exudative vitreoretinopathy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eye
n1=en:stye | n2=en:eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eye anomalies, variable
n1=en:stye | n2=en:eye anomalies, variable | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eye disorder
n1=en:stye | n2=en:eye disorder | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eye inflammation (1 patient)
n1=en:stye | n2=en:eye inflammation (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eye poking
n1=en:stye | n2=en:eye poking | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyebrow hypoplasia (in some patients)
n1=en:stye | n2=en:eyebrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyebrows slanted upward
n1=en:stye | n2=en:eyebrows slanted upward | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyebrows wiry and disorganized
n1=en:stye | n2=en:eyebrows wiry and disorganized | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelash absence
n1=en:stye | n2=en:eyelash absence | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid and corneal neuromas
n1=en:stye | n2=en:eyelid and corneal neuromas | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid colobomata (in some patients)
n1=en:stye | n2=en:eyelid colobomata (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid cyst
n1=en:stye | n2=en:eyelid cyst | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid edema, ipsilateral
n1=en:stye | n2=en:eyelid edema, ipsilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid hooding
n1=en:stye | n2=en:eyelid hooding | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid infection
n1=en:stye | n2=en:eyelid infection | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid infiltrates
n1=en:stye | n2=en:eyelid infiltrates | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid irritation
n1=en:stye | n2=en:eyelid irritation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid margin cysts (hidrocystoma)
n1=en:stye | n2=en:eyelid margin cysts (hidrocystoma) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid myoclonus
n1=en:stye | n2=en:eyelid myoclonus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid myotonia
n1=en:stye | n2=en:eyelid myotonia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid myxoma
n1=en:stye | n2=en:eyelid myxoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid neoplasm
n1=en:stye | n2=en:eyelid neoplasm | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelid xanthoma
n1=en:stye | n2=en:eyelid xanthoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyelids (symptom)
n1=en:stye | n2=en:eyelids (symptom) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyes fixed in extreme abduction (exotropia strabismus fixus)
n1=en:stye | n2=en:eyes fixed in extreme abduction (exotropia strabismus fixus) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:eyes fixed in hypotrophic eye position (severe cases)
n1=en:stye | n2=en:eyes fixed in hypotrophic eye position (severe cases) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:failure to fixate on objects
n1=en:stye | n2=en:failure to fixate on objects | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fear of eye disease
n1=en:stye | n2=en:fear of eye disease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fine corneal opacities
n1=en:stye | n2=en:fine corneal opacities | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fine horizontal nystagmus
n1=en:stye | n2=en:fine horizontal nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fine lens opacities (carrier females)
n1=en:stye | n2=en:fine lens opacities (carrier females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fine peripheral pigmentary mottling
n1=en:stye | n2=en:fine peripheral pigmentary mottling | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fixation nystagmus
n1=en:stye | n2=en:fixation nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:flat anterior chamber (in some patients)
n1=en:stye | n2=en:flat anterior chamber (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:flat electroretinogram (erg)
n1=en:stye | n2=en:flat electroretinogram (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:flat-appearing iris
n1=en:stye | n2=en:flat-appearing iris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:flattened or absent electroretinogram (erg)
n1=en:stye | n2=en:flattened or absent electroretinogram (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:floaters, flashing lights, visual field cuts
n1=en:stye | n2=en:floaters, flashing lights, visual field cuts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:focal atrophy of choroid
n1=en:stye | n2=en:focal atrophy of choroid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:focal retinal edema
n1=en:stye | n2=en:focal retinal edema | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:focal retinal infarction
n1=en:stye | n2=en:focal retinal infarction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:foreign body sensation if erosions occur
n1=en:stye | n2=en:foreign body sensation if erosions occur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:foreign-body sensation (early symptom)
n1=en:stye | n2=en:foreign-body sensation (early symptom) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:formation of mucosal pseudomembranes that progress to plaques
n1=en:stye | n2=en:formation of mucosal pseudomembranes that progress to plaques | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:foveal hyperfluorescence
n1=en:stye | n2=en:foveal hyperfluorescence | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:foveolar reflex indistinct
n1=en:stye | n2=en:foveolar reflex indistinct | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:foveoschisis
n1=en:stye | n2=en:foveoschisis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:frequent blinking
n1=en:stye | n2=en:frequent blinking | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:frontalis overaction, pronounced
n1=en:stye | n2=en:frontalis overaction, pronounced | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundi show dilated blood vessels with corkscrew-like tortuosity
n1=en:stye | n2=en:fundi show dilated blood vessels with corkscrew-like tortuosity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundoscopy normal
n1=en:stye | n2=en:fundoscopy normal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundus albipunctatus
n1=en:stye | n2=en:fundus albipunctatus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundus atrophy
n1=en:stye | n2=en:fundus atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundus dystrophy
n1=en:stye | n2=en:fundus dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fundus pigment lumps, bone-corpuscle/bone-spicule pattern
n1=en:stye | n2=en:fundus pigment lumps, bone-corpuscle/bone-spicule pattern | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:funduscopic examination normal
n1=en:stye | n2=en:funduscopic examination normal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:fused eyes (1 family)
n1=en:stye | n2=en:fused eyes (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gaze limitation
n1=en:stye | n2=en:gaze limitation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gaze-evoked horizontal nystagmus (not always present)
n1=en:stye | n2=en:gaze-evoked horizontal nystagmus (not always present) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gaze-evoked nystagmus (33%)
n1=en:stye | n2=en:gaze-evoked nystagmus (33%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gerontotoxon
n1=en:stye | n2=en:gerontotoxon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gerontoxon
n1=en:stye | n2=en:gerontoxon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get in contact with
n1=en:stye | n2=en:get in contact with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get in contact with somebody
n1=en:stye | n2=en:get in contact with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get in touch with
n1=en:stye | n2=en:get in touch with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get in touch with sb
n1=en:stye | n2=en:get in touch with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get in touch with somebody
n1=en:stye | n2=en:get in touch with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:get the word out to somebody
n1=en:stye | n2=en:get the word out to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give advance warning
n1=en:stye | n2=en:give advance warning | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give some advance warning
n1=en:stye | n2=en:give some advance warning | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody a heads up
n1=en:stye | n2=en:give somebody a heads up | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody advance warning
n1=en:stye | n2=en:give somebody advance warning | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody notice of something
n1=en:stye | n2=en:give somebody notice of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody notice that something
n1=en:stye | n2=en:give somebody notice that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody some advance warning
n1=en:stye | n2=en:give somebody some advance warning | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody updates
n1=en:stye | n2=en:give somebody updates | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give somebody updates on something
n1=en:stye | n2=en:give somebody updates on something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:give updates
n1=en:stye | n2=en:give updates | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma (50% of males)
n1=en:stye | n2=en:glaucoma (50% of males) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma (75%)
n1=en:stye | n2=en:glaucoma (75%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma (in 80% of patients)
n1=en:stye | n2=en:glaucoma (in 80% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma (rare)
n1=en:stye | n2=en:glaucoma (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma may precede development of neuropathy
n1=en:stye | n2=en:glaucoma may precede development of neuropathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma of childhood
n1=en:stye | n2=en:glaucoma of childhood | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma, chronic angle-closure, in older patients
n1=en:stye | n2=en:glaucoma, chronic angle-closure, in older patients | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glaucoma, open-angle, early-onset (occurs in patients with nonsense or truncating mutations in the sbf2 gene)
n1=en:stye | n2=en:glaucoma, open-angle, early-onset (occurs in patients with nonsense or truncating mutations in the sbf2 gene) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gliosis of optic nerve
n1=en:stye | n2=en:gliosis of optic nerve | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glistening white dots in fundus
n1=en:stye | n2=en:glistening white dots in fundus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:globe retraction and deviation on adduction
n1=en:stye | n2=en:globe retraction and deviation on adduction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:globular deposits along major vascular arcades
n1=en:stye | n2=en:globular deposits along major vascular arcades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:glomeruloid vascular proliferation in the retina
n1=en:stye | n2=en:glomeruloid vascular proliferation in the retina | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:good visual acuity
n1=en:stye | n2=en:good visual acuity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gradual progressive loss of central visual acuity
n1=en:stye | n2=en:gradual progressive loss of central visual acuity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:granular deposits replace epithelial basement membrane
n1=en:stye | n2=en:granular deposits replace epithelial basement membrane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:granular fundus
n1=en:stye | n2=en:granular fundus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gray, crumb-like granular deposits in anterior third of stroma
n1=en:stye | n2=en:gray, crumb-like granular deposits in anterior third of stroma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:gray, granular-appearing maculae
n1=en:stye | n2=en:gray, granular-appearing maculae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:greatly reduced light-adapted scotopic and photopic erg by 7th decade
n1=en:stye | n2=en:greatly reduced light-adapted scotopic and photopic erg by 7th decade | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:head-eye lag
n1=en:stye | n2=en:head-eye lag | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hearing loss, sensorineural, progressive post-lingual
n1=en:stye | n2=en:hearing loss, sensorineural, progressive post-lingual | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:heartache
n1=en:stye | n2=en:heartache | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:heartbreak
n1=en:stye | n2=en:heartbreak | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:heavy horizontal eyebrows
n1=en:stye | n2=en:heavy horizontal eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:heavy, arched eyebrows
n1=en:stye | n2=en:heavy, arched eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hemeralopia
n1=en:stye | n2=en:hemeralopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hemianopsia
n1=en:stye | n2=en:hemianopsia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hemorrhage beneath internal limiting membrane due to leaking macroaneurysms
n1=en:stye | n2=en:hemorrhage beneath internal limiting membrane due to leaking macroaneurysms | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hereditary macular coloboma
n1=en:stye | n2=en:hereditary macular coloboma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:heterochromia iridis (complete or partial)
n1=en:stye | n2=en:heterochromia iridis (complete or partial) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high arched eyebrows
n1=en:stye | n2=en:high arched eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high intraocular pressure (reported in 1 family)
n1=en:stye | n2=en:high intraocular pressure (reported in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high lens-to-eye volume ratio
n1=en:stye | n2=en:high lens-to-eye volume ratio | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high myopia (1 patient)
n1=en:stye | n2=en:high myopia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high myopia (in some patients)
n1=en:stye | n2=en:high myopia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high myopia, severe
n1=en:stye | n2=en:high myopia, severe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high reflectivity of fundus (in some patients)
n1=en:stye | n2=en:high reflectivity of fundus (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high refractive errors (hyperopia, myopia, with-the-rule astigmatism)
n1=en:stye | n2=en:high refractive errors (hyperopia, myopia, with-the-rule astigmatism) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:high-arched, dense eyebrows
n1=en:stye | n2=en:high-arched, dense eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:histiocytic deposits in eyelids
n1=en:stye | n2=en:histiocytic deposits in eyelids | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:histology shows degeneration of retinal ganglion cells
n1=en:stye | n2=en:histology shows degeneration of retinal ganglion cells | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:histopathology shows fusiform amyloid deposits in the deeper stroma as seen in lattice dystrophy
n1=en:stye | n2=en:histopathology shows fusiform amyloid deposits in the deeper stroma as seen in lattice dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:histopathology shows hyaline changes consistent with granular dystrophy in the anterior stroma
n1=en:stye | n2=en:histopathology shows hyaline changes consistent with granular dystrophy in the anterior stroma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hooded eyelids
n1=en:stye | n2=en:hooded eyelids | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hordeolum externum
n1=en:stye | n2=en:hordeolum externum | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal gaze nystagmus
n1=en:stye | n2=en:horizontal gaze nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal nystagmus (5%)
n1=en:stye | n2=en:horizontal nystagmus (5%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal nystagmus (in 1 patient)
n1=en:stye | n2=en:horizontal nystagmus (in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal nystagmus (in some patients)
n1=en:stye | n2=en:horizontal nystagmus (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal or rotary nystagmus
n1=en:stye | n2=en:horizontal or rotary nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal oval-shaped fovea (in some patients)
n1=en:stye | n2=en:horizontal oval-shaped fovea (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal pendular nystagmus
n1=en:stye | n2=en:horizontal pendular nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horizontal saccades
n1=en:stye | n2=en:horizontal saccades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:horner syndrome
n1=en:stye | n2=en:horner syndrome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:humor vitreus
n1=en:stye | n2=en:humor vitreus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyaline body
n1=en:stye | n2=en:hyaline body | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperfluorescent ring in area of macular lesions on fluorescein angiography
n1=en:stye | n2=en:hyperfluorescent ring in area of macular lesions on fluorescein angiography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypermetropia (1 patient)
n1=en:stye | n2=en:hypermetropia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypermetropia (36%)
n1=en:stye | n2=en:hypermetropia (36%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypermetropia (meb)
n1=en:stye | n2=en:hypermetropia (meb) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypermetropic astigmatism (in some patients)
n1=en:stye | n2=en:hypermetropic astigmatism (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypermyelinated retinal nerve fibers
n1=en:stye | n2=en:hypermyelinated retinal nerve fibers | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperopia (in some patients)
n1=en:stye | n2=en:hyperopia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperopia, high
n1=en:stye | n2=en:hyperopia, high | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperpigmentation of the macula (rare)
n1=en:stye | n2=en:hyperpigmentation of the macula (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperplastic primary vitreous (wws)
n1=en:stye | n2=en:hyperplastic primary vitreous (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperplastic vitreous
n1=en:stye | n2=en:hyperplastic vitreous | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperreflectivity of ganglion cell layer
n1=en:stye | n2=en:hyperreflectivity of ganglion cell layer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hyperreflectivity of nerve cell layer
n1=en:stye | n2=en:hyperreflectivity of nerve cell layer | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism
n1=en:stye | n2=en:hypertelorism | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (100%)
n1=en:stye | n2=en:hypertelorism (100%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (2/4 patients)
n1=en:stye | n2=en:hypertelorism (2/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (25%)
n1=en:stye | n2=en:hypertelorism (25%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (in 1 family)
n1=en:stye | n2=en:hypertelorism (in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (major feature)
n1=en:stye | n2=en:hypertelorism (major feature) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (males and females)
n1=en:stye | n2=en:hypertelorism (males and females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism (reported in 1 patient)
n1=en:stye | n2=en:hypertelorism (reported in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertelorism, mild
n1=en:stye | n2=en:hypertelorism, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertrichosis of eyebrows, mild
n1=en:stye | n2=en:hypertrichosis of eyebrows, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertrophic conjunctivae
n1=en:stye | n2=en:hypertrophic conjunctivae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertropia
n1=en:stye | n2=en:hypertropia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypertropia (in some patients)
n1=en:stye | n2=en:hypertropia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypesthetic cornea
n1=en:stye | n2=en:hypesthetic cornea | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypometric horizontal saccades
n1=en:stye | n2=en:hypometric horizontal saccades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypometric saccades (about half of patients)
n1=en:stye | n2=en:hypometric saccades (about half of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypometric saccades (in some patients)
n1=en:stye | n2=en:hypometric saccades (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypometric vertical saccades
n1=en:stye | n2=en:hypometric vertical saccades | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypopigmented iris
n1=en:stye | n2=en:hypopigmented iris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypopigmented ocular fundus
n1=en:stye | n2=en:hypopigmented ocular fundus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypopion
n1=en:stye | n2=en:hypopion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplasia of the ciliary body
n1=en:stye | n2=en:hypoplasia of the ciliary body | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplasia of the ocular nerve
n1=en:stye | n2=en:hypoplasia of the ocular nerve | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplasia or absence of optic nerve
n1=en:stye | n2=en:hypoplasia or absence of optic nerve | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplastic eyebrows
n1=en:stye | n2=en:hypoplastic eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplastic iris stroma
n1=en:stye | n2=en:hypoplastic iris stroma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplastic lacrimal duct
n1=en:stye | n2=en:hypoplastic lacrimal duct | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplastic oculomotor nerves, bilateral
n1=en:stye | n2=en:hypoplastic oculomotor nerves, bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypoplastic orbital ridges
n1=en:stye | n2=en:hypoplastic orbital ridges | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypotelorism (1 patient)
n1=en:stye | n2=en:hypotelorism (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypotelorism (19%)
n1=en:stye | n2=en:hypotelorism (19%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypotelorism (in 2 patients)
n1=en:stye | n2=en:hypotelorism (in 2 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypotelorism (in some patients)
n1=en:stye | n2=en:hypotelorism (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:hypotelorism (rare)
n1=en:stye | n2=en:hypotelorism (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ictal and interictal diplopia
n1=en:stye | n2=en:ictal and interictal diplopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired corneal reflex
n1=en:stye | n2=en:impaired corneal reflex | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired horizontal smooth pursuit
n1=en:stye | n2=en:impaired horizontal smooth pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired night vision
n1=en:stye | n2=en:impaired night vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired ocular abduction
n1=en:stye | n2=en:impaired ocular abduction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired ocular adduction
n1=en:stye | n2=en:impaired ocular adduction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired ocular movements
n1=en:stye | n2=en:impaired ocular movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired pupillary constriction to light
n1=en:stye | n2=en:impaired pupillary constriction to light | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired pupillary response to light
n1=en:stye | n2=en:impaired pupillary response to light | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired pursuit initiation and maintenance
n1=en:stye | n2=en:impaired pursuit initiation and maintenance | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired retinal vasculogenesis
n1=en:stye | n2=en:impaired retinal vasculogenesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired smooth pursuit
n1=en:stye | n2=en:impaired smooth pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired smooth pursuit in adult patients
n1=en:stye | n2=en:impaired smooth pursuit in adult patients | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired vestibuloocular reflex (vor)
n1=en:stye | n2=en:impaired vestibuloocular reflex (vor) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired visual fields
n1=en:stye | n2=en:impaired visual fields | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impaired visually enhanced vestibuloocular reflex (vvor)
n1=en:stye | n2=en:impaired visually enhanced vestibuloocular reflex (vvor) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impairment of compensatory eye movement reflexes
n1=en:stye | n2=en:impairment of compensatory eye movement reflexes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:impairment of extraocular movement (in some patients)
n1=en:stye | n2=en:impairment of extraocular movement (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inability to fully close eyes during sleep
n1=en:stye | n2=en:inability to fully close eyes during sleep | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inability to raise eyes above horizontal midline
n1=en:stye | n2=en:inability to raise eyes above horizontal midline | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inability to raise eyes above midline
n1=en:stye | n2=en:inability to raise eyes above midline | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inability to raise one or both eyes above midline
n1=en:stye | n2=en:inability to raise one or both eyes above midline | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inability to suppress vestibuloocular reflex (vor)
n1=en:stye | n2=en:inability to suppress vestibuloocular reflex (vor) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased axial globe length
n1=en:stye | n2=en:increased axial globe length | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased density of the upper eyelid eyelashes
n1=en:stye | n2=en:increased density of the upper eyelid eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased error rates of memory-guided saccades (40%)
n1=en:stye | n2=en:increased error rates of memory-guided saccades (40%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased intercanthal distance
n1=en:stye | n2=en:increased intercanthal distance | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased ocular axial length (35 mm vs. 24 mm in normal non-myopes)
n1=en:stye | n2=en:increased ocular axial length (35 mm vs. 24 mm in normal non-myopes) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased retinal vascular permeability
n1=en:stye | n2=en:increased retinal vascular permeability | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased retinal vascularity
n1=en:stye | n2=en:increased retinal vascularity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:increased vascular tortuosity (in some patients)
n1=en:stye | n2=en:increased vascular tortuosity (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:infantile nystagmus
n1=en:stye | n2=en:infantile nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:infectious crystalline keratopathy
n1=en:stye | n2=en:infectious crystalline keratopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:infectious keratitis
n1=en:stye | n2=en:infectious keratitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inferior and inferonasal retinal pigmentation (e.g. 180380.0004 and 180380.0025)
n1=en:stye | n2=en:inferior and inferonasal retinal pigmentation (e.g. 180380.0004 and 180380.0025) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inferonasal iris coloboma
n1=en:stye | n2=en:inferonasal iris coloboma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inform sb of sth
n1=en:stye | n2=en:inform sb of sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inform somebody of something
n1=en:stye | n2=en:inform somebody of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inform somebody something
n1=en:stye | n2=en:inform somebody something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inform somebody that
n1=en:stye | n2=en:inform somebody that | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inform somebody that something
n1=en:stye | n2=en:inform somebody that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:infra-orbital crease
n1=en:stye | n2=en:infra-orbital crease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:infra-orbital fold
n1=en:stye | n2=en:infra-orbital fold | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:initial loss of central visual acuity and color vision
n1=en:stye | n2=en:initial loss of central visual acuity and color vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:inner heartache
n1=en:stye | n2=en:inner heartache | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:insidious, painless, nonpitting eyelid edema
n1=en:stye | n2=en:insidious, painless, nonpitting eyelid edema | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:interictal downbeat nystagmus
n1=en:stye | n2=en:interictal downbeat nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:internal hordeolum
n1=en:stye | n2=en:internal hordeolum | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:interpupillary:len:pt:face:qn
n1=en:stye | n2=en:interpupillary:len:pt:face:qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:intraretinal pigment deposition extending to posterior pole (in some patients)
n1=en:stye | n2=en:intraretinal pigment deposition extending to posterior pole (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:intraretinal pigmentation
n1=en:stye | n2=en:intraretinal pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:intraretinal pigmentation in the midperiphery
n1=en:stye | n2=en:intraretinal pigmentation in the midperiphery | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:intraretinal splitting
n1=en:stye | n2=en:intraretinal splitting | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:involuntary spasms of eyelid closure (blepharospasm)
n1=en:stye | n2=en:involuntary spasms of eyelid closure (blepharospasm) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irides blue-gray to light brown
n1=en:stye | n2=en:irides blue-gray to light brown | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridescent posterior subcapsular cataract
n1=en:stye | n2=en:iridescent posterior subcapsular cataract | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridocorneal adhesions
n1=en:stye | n2=en:iridocorneal adhesions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridocorneal angle maldevelopment
n1=en:stye | n2=en:iridocorneal angle maldevelopment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridodonesis
n1=en:stye | n2=en:iridodonesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridogoniodysgenesis (rare)
n1=en:stye | n2=en:iridogoniodysgenesis (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iridoretinal coloboma
n1=en:stye | n2=en:iridoretinal coloboma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris color blue to brown
n1=en:stye | n2=en:iris color blue to brown | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris discoloration
n1=en:stye | n2=en:iris discoloration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris dysplasia (goniodysgenesis)
n1=en:stye | n2=en:iris dysplasia (goniodysgenesis) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris hypoperfusion resulting from degenerated stromal vessels
n1=en:stye | n2=en:iris hypoperfusion resulting from degenerated stromal vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris hypopigmentation
n1=en:stye | n2=en:iris hypopigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris malformation or hypoplasia (wws)
n1=en:stye | n2=en:iris malformation or hypoplasia (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris rigidity
n1=en:stye | n2=en:iris rigidity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris strands attached to schwalbe line bridging the iridocorneal angle
n1=en:stye | n2=en:iris strands attached to schwalbe line bridging the iridocorneal angle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris stromal atrophy (rare)
n1=en:stye | n2=en:iris stromal atrophy (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:iris transillumination with pigment dispersion
n1=en:stye | n2=en:iris transillumination with pigment dispersion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irregular eyebrows
n1=en:stye | n2=en:irregular eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irregular pigmentation of fovea with atrophy of rpe (in some patients)
n1=en:stye | n2=en:irregular pigmentation of fovea with atrophy of rpe (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irregular pigmentation of fundus (in carrier females)
n1=en:stye | n2=en:irregular pigmentation of fundus (in carrier females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irregular pursuit
n1=en:stye | n2=en:irregular pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irregular white dots at the vitreoretinal interface
n1=en:stye | n2=en:irregular white dots at the vitreoretinal interface | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:irritation of eye with itching (in some patients)
n1=en:stye | n2=en:irritation of eye with itching (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:juvenile cortical cataract
n1=en:stye | n2=en:juvenile cortical cataract | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:juvenile posterior subcapsular lenticular opacities
n1=en:stye | n2=en:juvenile posterior subcapsular lenticular opacities | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep in the loop
n1=en:stye | n2=en:keep in the loop | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep informed
n1=en:stye | n2=en:keep informed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep posted
n1=en:stye | n2=en:keep posted | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep sb informed
n1=en:stye | n2=en:keep sb informed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody in the loop
n1=en:stye | n2=en:keep somebody in the loop | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody in the loop about something
n1=en:stye | n2=en:keep somebody in the loop about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody informed
n1=en:stye | n2=en:keep somebody informed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody informed about something
n1=en:stye | n2=en:keep somebody informed about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody informed of something
n1=en:stye | n2=en:keep somebody informed of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody posted
n1=en:stye | n2=en:keep somebody posted | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody posted about something
n1=en:stye | n2=en:keep somebody posted about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody up to date
n1=en:stye | n2=en:keep somebody up to date | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody up to date about something
n1=en:stye | n2=en:keep somebody up to date about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody up to date on something
n1=en:stye | n2=en:keep somebody up to date on something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody up to date with something
n1=en:stye | n2=en:keep somebody up to date with something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody updated
n1=en:stye | n2=en:keep somebody updated | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep somebody updated on something
n1=en:stye | n2=en:keep somebody updated on something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep someone in the loop
n1=en:stye | n2=en:keep someone in the loop | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep someone informed
n1=en:stye | n2=en:keep someone informed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep someone posted
n1=en:stye | n2=en:keep someone posted | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep someone up to speed
n1=en:stye | n2=en:keep someone up to speed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keep up to date
n1=en:stye | n2=en:keep up to date | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keratoconus, bilateral
n1=en:stye | n2=en:keratoconus, bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keratoconus, severe anterior (in some patients)
n1=en:stye | n2=en:keratoconus, severe anterior (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:keratoglobus
n1=en:stye | n2=en:keratoglobus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of blink reflex (in some patients)
n1=en:stye | n2=en:lack of blink reflex (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of fixation
n1=en:stye | n2=en:lack of fixation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of ocular fixation (1 patient)
n1=en:stye | n2=en:lack of ocular fixation (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of pupillary dilation in the dark
n1=en:stye | n2=en:lack of pupillary dilation in the dark | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of visual contact
n1=en:stye | n2=en:lack of visual contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of visual fixation
n1=en:stye | n2=en:lack of visual fixation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lack of visual tracking
n1=en:stye | n2=en:lack of visual tracking | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal apparatus
n1=en:stye | n2=en:lacrimal apparatus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal duct aplasia or stenosis (25% of patients)
n1=en:stye | n2=en:lacrimal duct aplasia or stenosis (25% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal duct defect
n1=en:stye | n2=en:lacrimal duct defect | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal duct fistula (in some patients)
n1=en:stye | n2=en:lacrimal duct fistula (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal duct imperforation (rare)
n1=en:stye | n2=en:lacrimal duct imperforation (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal duct obstruction
n1=en:stye | n2=en:lacrimal duct obstruction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal gland
n1=en:stye | n2=en:lacrimal gland | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal gland aplasia/hypoplasia
n1=en:stye | n2=en:lacrimal gland aplasia/hypoplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimal puncta, absence of
n1=en:stye | n2=en:lacrimal puncta, absence of | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimation, episodic
n1=en:stye | n2=en:lacrimation, episodic | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lacrimation, ipsilateral
n1=en:stye | n2=en:lacrimation, ipsilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lagophthalmos (rare)
n1=en:stye | n2=en:lagophthalmos (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:large eyebrows
n1=en:stye | n2=en:large eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:large prominent eyes
n1=en:stye | n2=en:large prominent eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:large-appearing eyes
n1=en:stye | n2=en:large-appearing eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:large, prominent eyebrow
n1=en:stye | n2=en:large, prominent eyebrow | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:late-onset corneal degeneration
n1=en:stye | n2=en:late-onset corneal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lateral displacement of medial canthi
n1=en:stye | n2=en:lateral displacement of medial canthi | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:laterally displaced inner canthi (dystopia canthorum) (95 to 99%)
n1=en:stye | n2=en:laterally displaced inner canthi (dystopia canthorum) (95 to 99%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:left eye
n1=en:stye | n2=en:left eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lens opacities (type ii, infantile and juvenile)
n1=en:stye | n2=en:lens opacities (type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lens opacity, mild (in some patients)
n1=en:stye | n2=en:lens opacity, mild (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lens subluxation (in some patients)
n1=en:stye | n2=en:lens subluxation (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lens subluxation or dislocation
n1=en:stye | n2=en:lens subluxation or dislocation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lenticular 'spoke-like' opacities
n1=en:stye | n2=en:lenticular 'spoke-like' opacities | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let know
n1=en:stye | n2=en:let know | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let somebody know
n1=en:stye | n2=en:let somebody know | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let somebody know about something
n1=en:stye | n2=en:let somebody know about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let somebody know something
n1=en:stye | n2=en:let somebody know something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let somebody know that
n1=en:stye | n2=en:let somebody know that | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let somebody know that something
n1=en:stye | n2=en:let somebody know that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:let someone know
n1=en:stye | n2=en:let someone know | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:liaise with somebody
n1=en:stye | n2=en:liaise with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lid lag
n1=en:stye | n2=en:lid lag | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lid margin discharge
n1=en:stye | n2=en:lid margin discharge | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lid, lash and lacrimal infections, irritations and inflammations
n1=en:stye | n2=en:lid, lash and lacrimal infections, irritations and inflammations | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:limbal stem cell insufficiency
n1=en:stye | n2=en:limbal stem cell insufficiency | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:limbitis
n1=en:stye | n2=en:limbitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:limited extraocular movements (1 family)
n1=en:stye | n2=en:limited extraocular movements (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:limited eyelid closure (1/4 patients)
n1=en:stye | n2=en:limited eyelid closure (1/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lipemia retinalis (in severe cases)
n1=en:stye | n2=en:lipemia retinalis (in severe cases) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lisch nodules (iris hamartomas)
n1=en:stye | n2=en:lisch nodules (iris hamartomas) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lisch nodules (iris hamartomas) may or may not be present
n1=en:stye | n2=en:lisch nodules (iris hamartomas) may or may not be present | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long curly eyelashes
n1=en:stye | n2=en:long curly eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long eyelashes
n1=en:stye | n2=en:long eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long eyelashes (54%)
n1=en:stye | n2=en:long eyelashes (54%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long eyelashes (in some patients)
n1=en:stye | n2=en:long eyelashes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long eyelashes in irregular rows
n1=en:stye | n2=en:long eyelashes in irregular rows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long narrow palpebral fissures (1 patient)
n1=en:stye | n2=en:long narrow palpebral fissures (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long palpebral fissure
n1=en:stye | n2=en:long palpebral fissure | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long upslanting palpebral fissures (1/4 patients)
n1=en:stye | n2=en:long upslanting palpebral fissures (1/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long, curly dark upper eyelashes (in some patients)
n1=en:stye | n2=en:long, curly dark upper eyelashes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long, curved eyelashes
n1=en:stye | n2=en:long, curved eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long, prominent eyelashes
n1=en:stye | n2=en:long, prominent eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:long, straight eyelashes
n1=en:stye | n2=en:long, straight eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of central vision between ages 25-30 years
n1=en:stye | n2=en:loss of central vision between ages 25-30 years | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of color vision, progressive
n1=en:stye | n2=en:loss of color vision, progressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of eye contact
n1=en:stye | n2=en:loss of eye contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of periorbital fat
n1=en:stye | n2=en:loss of periorbital fat | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of peripheral visual fields (in some patients)
n1=en:stye | n2=en:loss of peripheral visual fields (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of vision
n1=en:stye | n2=en:loss of vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of vision (34%)
n1=en:stye | n2=en:loss of vision (34%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of vision (rare)
n1=en:stye | n2=en:loss of vision (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loss of visual acuity (late)
n1=en:stye | n2=en:loss of visual acuity (late) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lost love
n1=en:stye | n2=en:lost love | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:love pain
n1=en:stye | n2=en:love pain | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:low arden ratio on electrooculography
n1=en:stye | n2=en:low arden ratio on electrooculography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:low intraocular pressure (in some patients)
n1=en:stye | n2=en:low intraocular pressure (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lower eyelid coloboma
n1=en:stye | n2=en:lower eyelid coloboma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lower eyelid ectropion
n1=en:stye | n2=en:lower eyelid ectropion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lower eyelid epiblepharon
n1=en:stye | n2=en:lower eyelid epiblepharon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:lower lacrimal dystopia
n1=en:stye | n2=en:lower lacrimal dystopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:loxophthalmus
n1=en:stye | n2=en:loxophthalmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular atrophy (1 patient)
n1=en:stye | n2=en:macular atrophy (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular atrophy (in some patients)
n1=en:stye | n2=en:macular atrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular atrophy, marked
n1=en:stye | n2=en:macular atrophy, marked | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular atrophy, mild (in some patients)
n1=en:stye | n2=en:macular atrophy, mild (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular cherry-red spots (in some patients)
n1=en:stye | n2=en:macular cherry-red spots (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular degeneration
n1=en:stye | n2=en:macular degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular dysfunction, marked, on electroretinography
n1=en:stye | n2=en:macular dysfunction, marked, on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular ectopia
n1=en:stye | n2=en:macular ectopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular edema
n1=en:stye | n2=en:macular edema | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular exudates and hemorrhages
n1=en:stye | n2=en:macular exudates and hemorrhages | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular hypoplasia
n1=en:stye | n2=en:macular hypoplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular or extramacular punctate yellow lesions
n1=en:stye | n2=en:macular or extramacular punctate yellow lesions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular pallor with prominence of fovea centralis (cherry red spot)
n1=en:stye | n2=en:macular pallor with prominence of fovea centralis (cherry red spot) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular pigment migration
n1=en:stye | n2=en:macular pigment migration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular pigmentary changes
n1=en:stye | n2=en:macular pigmentary changes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular retinal pigment epithelial changes (in some patients)
n1=en:stye | n2=en:macular retinal pigment epithelial changes (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular striae
n1=en:stye | n2=en:macular striae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:macular translucency (variable)
n1=en:stye | n2=en:macular translucency (variable) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:maculopathy (uncommon)
n1=en:stye | n2=en:maculopathy (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:make contact with
n1=en:stye | n2=en:make contact with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:make contact with sb
n1=en:stye | n2=en:make contact with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:make contact with somebody
n1=en:stye | n2=en:make contact with somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:make something public
n1=en:stye | n2=en:make something public | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:marcus gunn jaw winking (in some patients)
n1=en:stye | n2=en:marcus gunn jaw winking (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:marked amplitude reduction and delay of a- and b-waves on electroretinography, more severe in scotopic than photopic system
n1=en:stye | n2=en:marked amplitude reduction and delay of a- and b-waves on electroretinography, more severe in scotopic than photopic system | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:marked macular degeneration
n1=en:stye | n2=en:marked macular degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:marked pallor of mucous membranes
n1=en:stye | n2=en:marked pallor of mucous membranes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:marked thickening of descemet membrane
n1=en:stye | n2=en:marked thickening of descemet membrane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:markedly constricted visual fields
n1=en:stye | n2=en:markedly constricted visual fields | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:medial flaring of the eyebrow
n1=en:stye | n2=en:medial flaring of the eyebrow | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:medially flared eyebrows
n1=en:stye | n2=en:medially flared eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:medullated corneal nerve fibers
n1=en:stye | n2=en:medullated corneal nerve fibers | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:megaloblepharon (large eyelids)
n1=en:stye | n2=en:megaloblepharon (large eyelids) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:megalocornea (in some patients)
n1=en:stye | n2=en:megalocornea (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:megophthalmos
n1=en:stye | n2=en:megophthalmos | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mental retardation
n1=en:stye | n2=en:mental retardation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microblepharon
n1=en:stye | n2=en:microblepharon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microcornea (2 of 5 patients)
n1=en:stye | n2=en:microcornea (2 of 5 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microcornea (in some patients)
n1=en:stye | n2=en:microcornea (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microcystic epithelial edema
n1=en:stye | n2=en:microcystic epithelial edema | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:micronystagmus (rare)
n1=en:stye | n2=en:micronystagmus (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (1 patient)
n1=en:stye | n2=en:microphthalmia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (15%)
n1=en:stye | n2=en:microphthalmia (15%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (ipsilateral to facial hemangioma)
n1=en:stye | n2=en:microphthalmia (ipsilateral to facial hemangioma) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (rare)
n1=en:stye | n2=en:microphthalmia (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (some)
n1=en:stye | n2=en:microphthalmia (some) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia (wws)
n1=en:stye | n2=en:microphthalmia (wws) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, bilateral (isolated feature in some patients)
n1=en:stye | n2=en:microphthalmia, bilateral (isolated feature in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, mild
n1=en:stye | n2=en:microphthalmia, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, mild (in some patients)
n1=en:stye | n2=en:microphthalmia, mild (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, posterior (nanophthalmos)
n1=en:stye | n2=en:microphthalmia, posterior (nanophthalmos) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, severe, bilateral
n1=en:stye | n2=en:microphthalmia, severe, bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmia, unilateral or bilateral
n1=en:stye | n2=en:microphthalmia, unilateral or bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microphthalmos
n1=en:stye | n2=en:microphthalmos | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microsaccadic pursuit
n1=en:stye | n2=en:microsaccadic pursuit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microsclerocornea
n1=en:stye | n2=en:microsclerocornea | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microspherophakia (small, spherical lens) (74%)
n1=en:stye | n2=en:microspherophakia (small, spherical lens) (74%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:microspherophakia (small, spherical lens) (94%)
n1=en:stye | n2=en:microspherophakia (small, spherical lens) (94%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild depression and delay in both scotopic and photopic function on electroretinography
n1=en:stye | n2=en:mild depression and delay in both scotopic and photopic function on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild palpebral ptosis
n1=en:stye | n2=en:mild palpebral ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild peripheral retinal pigmentary changes
n1=en:stye | n2=en:mild peripheral retinal pigmentary changes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild photophobia
n1=en:stye | n2=en:mild photophobia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild proptosis
n1=en:stye | n2=en:mild proptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild retinal arteriolar constriction
n1=en:stye | n2=en:mild retinal arteriolar constriction | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild retinopathy
n1=en:stye | n2=en:mild retinopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild temporal optic nerve pallor
n1=en:stye | n2=en:mild temporal optic nerve pallor | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild transient cherry-red spot
n1=en:stye | n2=en:mild transient cherry-red spot | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mild vision impairment
n1=en:stye | n2=en:mild vision impairment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mildly downslanting palpebral fissures
n1=en:stye | n2=en:mildly downslanting palpebral fissures | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mildly reduced visual acuity
n1=en:stye | n2=en:mildly reduced visual acuity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:minor photophobia
n1=en:stye | n2=en:minor photophobia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:miosis due to decreased function of dilator muscle
n1=en:stye | n2=en:miosis due to decreased function of dilator muscle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:misrouting of the optic nerves at the chiasm
n1=en:stye | n2=en:misrouting of the optic nerves at the chiasm | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:mizuo-nakamura phenomenon (fundus color changes from red in the dark-adapted state to golden after light exposure)
n1=en:stye | n2=en:mizuo-nakamura phenomenon (fundus color changes from red in the dark-adapted state to golden after light exposure) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:moderate atrophy of optic disc
n1=en:stye | n2=en:moderate atrophy of optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:moderate central loss of visual acuity in males (20/60)
n1=en:stye | n2=en:moderate central loss of visual acuity in males (20/60) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:monopia
n1=en:stye | n2=en:monopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:morning glory disc anomaly (1 family)
n1=en:stye | n2=en:morning glory disc anomaly (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:morning glory optic disc
n1=en:stye | n2=en:morning glory optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:morning glory-like dysplastic macropapillae
n1=en:stye | n2=en:morning glory-like dysplastic macropapillae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:movement of visual image - finding
n1=en:stye | n2=en:movement of visual image - finding | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:multiple retinal holes
n1=en:stye | n2=en:multiple retinal holes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:multiple rows of eyelashes
n1=en:stye | n2=en:multiple rows of eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia (1/4 patients)
n1=en:stye | n2=en:myopia (1/4 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia (in most patients)
n1=en:stye | n2=en:myopia (in most patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia (onset before 6 years)
n1=en:stye | n2=en:myopia (onset before 6 years) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia (onset in first decade)
n1=en:stye | n2=en:myopia (onset in first decade) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia (reported in 1 family)
n1=en:stye | n2=en:myopia (reported in 1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia of variable severity
n1=en:stye | n2=en:myopia of variable severity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, apparent with age
n1=en:stye | n2=en:myopia, apparent with age | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, high-grade bilateral (range -5.50 to -50 diopters, average adult refractive error -13.925 diopters)
n1=en:stye | n2=en:myopia, high-grade bilateral (range -5.50 to -50 diopters, average adult refractive error -13.925 diopters) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, infantile
n1=en:stye | n2=en:myopia, infantile | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, low to moderate (-12.12 d to +7.25 d)
n1=en:stye | n2=en:myopia, low to moderate (-12.12 d to +7.25 d) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, mild
n1=en:stye | n2=en:myopia, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, moderate to high
n1=en:stye | n2=en:myopia, moderate to high | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:myopia, progressive severe
n1=en:stye | n2=en:myopia, progressive severe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nasolacrimal duct obstruction (classic feature)
n1=en:stye | n2=en:nasolacrimal duct obstruction (classic feature) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nasolacrimal duct obstruction due to ectropion of lower eyelids (rare)
n1=en:stye | n2=en:nasolacrimal duct obstruction due to ectropion of lower eyelids (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:neutral palpebral fissures
n1=en:stye | n2=en:neutral palpebral fissures | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness
n1=en:stye | n2=en:night blindness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness (infancy and early childhood)
n1=en:stye | n2=en:night blindness (infancy and early childhood) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness (onset in first decade)
n1=en:stye | n2=en:night blindness (onset in first decade) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness (onset in teens)
n1=en:stye | n2=en:night blindness (onset in teens) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness beginning in the 6th decade
n1=en:stye | n2=en:night blindness beginning in the 6th decade | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness followed by complete blindness
n1=en:stye | n2=en:night blindness followed by complete blindness | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness onset during teen years
n1=en:stye | n2=en:night blindness onset during teen years | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:night blindness, stationary
n1=en:stye | n2=en:night blindness, stationary | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no cataract (epstein syndrome)
n1=en:stye | n2=en:no cataract (epstein syndrome) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no cataracts
n1=en:stye | n2=en:no cataracts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no cherry red spots
n1=en:stye | n2=en:no cherry red spots | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no corneal erosions
n1=en:stye | n2=en:no corneal erosions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no corneal opacities
n1=en:stye | n2=en:no corneal opacities | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no heterochromia irides
n1=en:stye | n2=en:no heterochromia irides | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no light-evoked response on electroretinogram (erg)
n1=en:stye | n2=en:no light-evoked response on electroretinogram (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no lisch nodules
n1=en:stye | n2=en:no lisch nodules | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no nystagmus
n1=en:stye | n2=en:no nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no ocular symptoms
n1=en:stye | n2=en:no ocular symptoms | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no other ocular defects
n1=en:stye | n2=en:no other ocular defects | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no response to dim stimuli in dark-adapted state on electroretinography
n1=en:stye | n2=en:no response to dim stimuli in dark-adapted state on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no retinal degeneration
n1=en:stye | n2=en:no retinal degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no retinitis pigmentosa
n1=en:stye | n2=en:no retinitis pigmentosa | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no retinopathy
n1=en:stye | n2=en:no retinopathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no visual attention
n1=en:stye | n2=en:no visual attention | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:no visual tracking
n1=en:stye | n2=en:no visual tracking | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nonaxial myopia
n1=en:stye | n2=en:nonaxial myopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nondetectable electroretinogram, all components, in older individuals
n1=en:stye | n2=en:nondetectable electroretinogram, all components, in older individuals | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nondetectable scotopic electroretinogram with relative preservation of photopic and pattern elements in younger patients
n1=en:stye | n2=en:nondetectable scotopic electroretinogram with relative preservation of photopic and pattern elements in younger patients | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nonprogressive restrictive ophthalmoplegia (superior rectus, inferior oblique, levator palpebralis dysfunction)
n1=en:stye | n2=en:nonprogressive restrictive ophthalmoplegia (superior rectus, inferior oblique, levator palpebralis dysfunction) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nonreactive, fixed narrowing of the pupil ('microcoria')
n1=en:stye | n2=en:nonreactive, fixed narrowing of the pupil ('microcoria') | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nonrecordable or severely reduced rod pattern on electroretinogram
n1=en:stye | n2=en:nonrecordable or severely reduced rod pattern on electroretinogram | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nonspecific granular appearance of retinal pigment epithelium
n1=en:stye | n2=en:nonspecific granular appearance of retinal pigment epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal color vision
n1=en:stye | n2=en:normal color vision | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal eyelashes
n1=en:stye | n2=en:normal eyelashes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal eyelashes, eyebrows
n1=en:stye | n2=en:normal eyelashes, eyebrows | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal eyelid
n1=en:stye | n2=en:normal eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal fundus on ophthalmoscopy
n1=en:stye | n2=en:normal fundus on ophthalmoscopy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal lacrimal puncta
n1=en:stye | n2=en:normal lacrimal puncta | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal lacrimation
n1=en:stye | n2=en:normal lacrimation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal or decreased arden ratios on electrooculography
n1=en:stye | n2=en:normal or decreased arden ratios on electrooculography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal or decreased cone and rod responses on electroretinography
n1=en:stye | n2=en:normal or decreased cone and rod responses on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal or mildly reduced cone responses under photopic conditions
n1=en:stye | n2=en:normal or mildly reduced cone responses under photopic conditions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal or reduced electrooculographic (eog) results
n1=en:stye | n2=en:normal or reduced electrooculographic (eog) results | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal or reduced responses on electroretinography
n1=en:stye | n2=en:normal or reduced responses on electroretinography | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal palpebral fissures
n1=en:stye | n2=en:normal palpebral fissures | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal photopic and scotopic responses on electroretinography (erg)
n1=en:stye | n2=en:normal photopic and scotopic responses on electroretinography (erg) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal retinal and pupillary reflexes between episodes
n1=en:stye | n2=en:normal retinal and pupillary reflexes between episodes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal rod function on erg
n1=en:stye | n2=en:normal rod function on erg | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal sclerae
n1=en:stye | n2=en:normal sclerae | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal scotopic responses on rod electroretinogram (in some patients)
n1=en:stye | n2=en:normal scotopic responses on rod electroretinogram (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal to near-normal visual acuity in carrier females (20/30-20/20)
n1=en:stye | n2=en:normal to near-normal visual acuity in carrier females (20/30-20/20) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal vision (females)
n1=en:stye | n2=en:normal vision (females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal visual acuity
n1=en:stye | n2=en:normal visual acuity | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:normal vitreous
n1=en:stye | n2=en:normal vitreous | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:notify somebody that
n1=en:stye | n2=en:notify somebody that | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nuclear cataract
n1=en:stye | n2=en:nuclear cataract | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nuclear cataract (in some patients) retinal dystrophy (in some patients)
n1=en:stye | n2=en:nuclear cataract (in some patients) retinal dystrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:null point shifts every few seconds to minutes
n1=en:stye | n2=en:null point shifts every few seconds to minutes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nyctalopia
n1=en:stye | n2=en:nyctalopia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nyctalopia (in some patients)
n1=en:stye | n2=en:nyctalopia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nyctalopia, congenital (in some patients)
n1=en:stye | n2=en:nyctalopia, congenital (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus
n1=en:stye | n2=en:nystagmus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (1 family)
n1=en:stye | n2=en:nystagmus (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (1 patient)
n1=en:stye | n2=en:nystagmus (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (females)
n1=en:stye | n2=en:nystagmus (females) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (in some patients)
n1=en:stye | n2=en:nystagmus (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (infancy)
n1=en:stye | n2=en:nystagmus (infancy) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (may be permanent in 50% of patients)
n1=en:stye | n2=en:nystagmus (may be permanent in 50% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (patient a)
n1=en:stye | n2=en:nystagmus (patient a) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (rare)
n1=en:stye | n2=en:nystagmus (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (reported in 1 patient)
n1=en:stye | n2=en:nystagmus (reported in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (type i)
n1=en:stye | n2=en:nystagmus (type i) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus (uncommon)
n1=en:stye | n2=en:nystagmus (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus in adult patients
n1=en:stye | n2=en:nystagmus in adult patients | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus on lateral gaze
n1=en:stye | n2=en:nystagmus on lateral gaze | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, congenital horizontal pendular
n1=en:stye | n2=en:nystagmus, congenital horizontal pendular | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, horizontal
n1=en:stye | n2=en:nystagmus, horizontal | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, horizontal (rare)
n1=en:stye | n2=en:nystagmus, horizontal (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, horizontal gaze-evoked
n1=en:stye | n2=en:nystagmus, horizontal gaze-evoked | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, horizontal, mild
n1=en:stye | n2=en:nystagmus, horizontal, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, horizontal, mild (44%)
n1=en:stye | n2=en:nystagmus, horizontal, mild (44%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, intermittent (1 of 2 sibs)
n1=en:stye | n2=en:nystagmus, intermittent (1 of 2 sibs) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, jerky
n1=en:stye | n2=en:nystagmus, jerky | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, jerky, horizontal, congenital
n1=en:stye | n2=en:nystagmus, jerky, horizontal, congenital | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, mild
n1=en:stye | n2=en:nystagmus, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, minimal rotational (rare)
n1=en:stye | n2=en:nystagmus, minimal rotational (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, moderate
n1=en:stye | n2=en:nystagmus, moderate | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, pendular (primarily in childhood)
n1=en:stye | n2=en:nystagmus, pendular (primarily in childhood) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, rotary (in some patients)
n1=en:stye | n2=en:nystagmus, rotary (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:nystagmus, vertical (rare)
n1=en:stye | n2=en:nystagmus, vertical (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oblique palpebral fissures
n1=en:stye | n2=en:oblique palpebral fissures | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:obliteration of peripheral retinal blood vessels (in some patients)
n1=en:stye | n2=en:obliteration of peripheral retinal blood vessels (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:occasional cataracts
n1=en:stye | n2=en:occasional cataracts | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular abnormalities often persist between attacks
n1=en:stye | n2=en:ocular abnormalities often persist between attacks | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular albinism (reported in 1 patient)
n1=en:stye | n2=en:ocular albinism (reported in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular albinism, tyrosinase-positive
n1=en:stye | n2=en:ocular albinism, tyrosinase-positive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular colobomas (rare)
n1=en:stye | n2=en:ocular colobomas (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular cyst, inferior
n1=en:stye | n2=en:ocular cyst, inferior | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular disturbances, nonspecific
n1=en:stye | n2=en:ocular disturbances, nonspecific | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular flutter
n1=en:stye | n2=en:ocular flutter | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular foreign body
n1=en:stye | n2=en:ocular foreign body | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular gaze palsies (onset in second decade)
n1=en:stye | n2=en:ocular gaze palsies (onset in second decade) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular globe large
n1=en:stye | n2=en:ocular globe large | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular hypopigmentation
n1=en:stye | n2=en:ocular hypopigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular hypoplasia (1 patient)
n1=en:stye | n2=en:ocular hypoplasia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular muscle
n1=en:stye | n2=en:ocular muscle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular muscle palsies
n1=en:stye | n2=en:ocular muscle palsies | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular pain, episodic
n1=en:stye | n2=en:ocular pain, episodic | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular paresis
n1=en:stye | n2=en:ocular paresis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular pursuit poor or absent
n1=en:stye | n2=en:ocular pursuit poor or absent | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular rupture
n1=en:stye | n2=en:ocular rupture | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ocular telangiectasia
n1=en:stye | n2=en:ocular telangiectasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculocutaneous hypopigmentation (in some patients)
n1=en:stye | n2=en:oculocutaneous hypopigmentation (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculodigital reflex (in some patients)
n1=en:stye | n2=en:oculodigital reflex (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculodigital sign of franceschetti
n1=en:stye | n2=en:oculodigital sign of franceschetti | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculogyric crisis
n1=en:stye | n2=en:oculogyric crisis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculogyric dystonic spasms
n1=en:stye | n2=en:oculogyric dystonic spasms | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculogyric eye movements
n1=en:stye | n2=en:oculogyric eye movements | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia
n1=en:stye | n2=en:oculomotor apraxia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia (56% of patients)
n1=en:stye | n2=en:oculomotor apraxia (56% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia (in 86% of patients)
n1=en:stye | n2=en:oculomotor apraxia (in 86% of patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia (in some patients)
n1=en:stye | n2=en:oculomotor apraxia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia (rare)
n1=en:stye | n2=en:oculomotor apraxia (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor apraxia (variable)
n1=en:stye | n2=en:oculomotor apraxia (variable) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculomotor nerve paralysis
n1=en:stye | n2=en:oculomotor nerve paralysis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculopalpebral synechia
n1=en:stye | n2=en:oculopalpebral synechia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:oculus dexter
n1=en:stye | n2=en:oculus dexter | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:only upward-growing eyebrows (uncommon)
n1=en:stye | n2=en:only upward-growing eyebrows (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:opacification of the corneal epithelium
n1=en:stye | n2=en:opacification of the corneal epithelium | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:opacities in embryonal nuclei
n1=en:stye | n2=en:opacities in embryonal nuclei | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:opacities in embryonic, fetal, and infantile nuclei
n1=en:stye | n2=en:opacities in embryonic, fetal, and infantile nuclei | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:open-angle glaucoma
n1=en:stye | n2=en:open-angle glaucoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:open-angle glaucoma due to pupillary and ciliary block
n1=en:stye | n2=en:open-angle glaucoma due to pupillary and ciliary block | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoparesis
n1=en:stye | n2=en:ophthalmoparesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoparesis (less common)
n1=en:stye | n2=en:ophthalmoparesis (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoparesis (with longer disease duration)
n1=en:stye | n2=en:ophthalmoparesis (with longer disease duration) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoparesis, progressive, external
n1=en:stye | n2=en:ophthalmoparesis, progressive, external | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia (1 family)
n1=en:stye | n2=en:ophthalmoplegia (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia (in 20%)
n1=en:stye | n2=en:ophthalmoplegia (in 20%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia (in some patients)
n1=en:stye | n2=en:ophthalmoplegia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia (in some)
n1=en:stye | n2=en:ophthalmoplegia (in some) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia, mild
n1=en:stye | n2=en:ophthalmoplegia, mild | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ophthalmoplegia, nonprogressive restrictive, bilateral or unilateral
n1=en:stye | n2=en:ophthalmoplegia, nonprogressive restrictive, bilateral or unilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy
n1=en:stye | n2=en:optic atrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (1 family)
n1=en:stye | n2=en:optic atrophy (1 family) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (1 patient)
n1=en:stye | n2=en:optic atrophy (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (67%)
n1=en:stye | n2=en:optic atrophy (67%) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (chronic phase)
n1=en:stye | n2=en:optic atrophy (chronic phase) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (in 1 of 3 patients)
n1=en:stye | n2=en:optic atrophy (in 1 of 3 patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (in some patients)
n1=en:stye | n2=en:optic atrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (may be asymptomatic in some patients)
n1=en:stye | n2=en:optic atrophy (may be asymptomatic in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (patient a)
n1=en:stye | n2=en:optic atrophy (patient a) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (rare)
n1=en:stye | n2=en:optic atrophy (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (reported in 1 patient)
n1=en:stye | n2=en:optic atrophy (reported in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (seen in patients older than 45 years)
n1=en:stye | n2=en:optic atrophy (seen in patients older than 45 years) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy (uncommon)
n1=en:stye | n2=en:optic atrophy (uncommon) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy by 2 years of age
n1=en:stye | n2=en:optic atrophy by 2 years of age | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy, bilateral (in some patients)
n1=en:stye | n2=en:optic atrophy, bilateral (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy, congenital
n1=en:stye | n2=en:optic atrophy, congenital | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy, isolated
n1=en:stye | n2=en:optic atrophy, isolated | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic atrophy, mild (in 1 patient)
n1=en:stye | n2=en:optic atrophy, mild (in 1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic cupping
n1=en:stye | n2=en:optic cupping | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic degeneration
n1=en:stye | n2=en:optic degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc
n1=en:stye | n2=en:optic disc | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc atrophy (in some older patients)
n1=en:stye | n2=en:optic disc atrophy (in some older patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc drusen (in some patients)
n1=en:stye | n2=en:optic disc drusen (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc dysplasia
n1=en:stye | n2=en:optic disc dysplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc hyperplasia
n1=en:stye | n2=en:optic disc hyperplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc pallor (in older patients)
n1=en:stye | n2=en:optic disc pallor (in older patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc pallor (in some patients)
n1=en:stye | n2=en:optic disc pallor (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc pallor (less common)
n1=en:stye | n2=en:optic disc pallor (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc pallor (rare)
n1=en:stye | n2=en:optic disc pallor (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disc pallor in fourth decade of life
n1=en:stye | n2=en:optic disc pallor in fourth decade of life | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic disk
n1=en:stye | n2=en:optic disk | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic dysplasia
n1=en:stye | n2=en:optic dysplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic head drusen (yellowish-white irregularities of optic disc)
n1=en:stye | n2=en:optic head drusen (yellowish-white irregularities of optic disc) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve atrophy (in some patients)
n1=en:stye | n2=en:optic nerve atrophy (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve atrophy, bilateral
n1=en:stye | n2=en:optic nerve atrophy, bilateral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve atrophy, progressive
n1=en:stye | n2=en:optic nerve atrophy, progressive | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve dysplasia
n1=en:stye | n2=en:optic nerve dysplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve excavation (rare)
n1=en:stye | n2=en:optic nerve excavation (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve glioma
n1=en:stye | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve head
n1=en:stye | n2=en:optic nerve head | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia
n1=en:stye | n2=en:optic nerve hypoplasia | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia (1 patient)
n1=en:stye | n2=en:optic nerve hypoplasia (1 patient) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia (in some patients)
n1=en:stye | n2=en:optic nerve hypoplasia (in some patients) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia (less common)
n1=en:stye | n2=en:optic nerve hypoplasia (less common) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia or agenesis
n1=en:stye | n2=en:optic nerve hypoplasia or agenesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic nerve hypoplasia, segmental (rare)
n1=en:stye | n2=en:optic nerve hypoplasia, segmental (rare) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optic neuropathy
n1=en:stye | n2=en:optic neuropathy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optical coherence tomography shows normal retina and retinal pigment epithelium overlying the sclerochoroidal lesions
n1=en:stye | n2=en:optical coherence tomography shows normal retina and retinal pigment epithelium overlying the sclerochoroidal lesions | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:optical disk
n1=en:stye | n2=en:optical disk | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:orbicularis oculi
n1=en:stye | n2=en:orbicularis oculi | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:orbital cyst
n1=en:stye | n2=en:orbital cyst | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:orbital separation diminished
n1=en:stye | n2=en:orbital separation diminished | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:other disorders of eye
n1=en:stye | n2=en:other disorders of eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:other visual disturbances
n1=en:stye | n2=en:other visual disturbances | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:papilledema
n1=en:stye | n2=en:papilledema | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:parakeratosis
n1=en:stye | n2=en:parakeratosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:paralysis of vertical gaze
n1=en:stye | n2=en:paralysis of vertical gaze | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:periorbital hyperpigmentation
n1=en:stye | n2=en:periorbital hyperpigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:periorbital wrinkles
n1=en:stye | n2=en:periorbital wrinkles | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:persistent hyperplastic primary vitreous
n1=en:stye | n2=en:persistent hyperplastic primary vitreous | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:phlegmonous dacryocystitis
n1=en:stye | n2=en:phlegmonous dacryocystitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:photosensitivity of skin
n1=en:stye | n2=en:photosensitivity of skin | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:posterior eyeball segment structure
n1=en:stye | n2=en:posterior eyeball segment structure | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:prominent eyes
n1=en:stye | n2=en:prominent eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:prominent supraorbital ridges
n1=en:stye | n2=en:prominent supraorbital ridges | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:proptosis
n1=en:stye | n2=en:proptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:protopsis
n1=en:stye | n2=en:protopsis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:punctate keratitis
n1=en:stye | n2=en:punctate keratitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:pupil diameter:len:pt:eye.right:qn:manual
n1=en:stye | n2=en:pupil diameter:len:pt:eye.right:qn:manual | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:put somebody in danger
n1=en:stye | n2=en:put somebody in danger | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:put sth to sb
n1=en:stye | n2=en:put sth to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:pyogenic uveitis
n1=en:stye | n2=en:pyogenic uveitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:reaction absents, pupil
n1=en:stye | n2=en:reaction absents, pupil | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:repeat something to somebody
n1=en:stye | n2=en:repeat something to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retina abnormality
n1=en:stye | n2=en:retina abnormality | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinal dystrophy
n1=en:stye | n2=en:retinal dystrophy | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinal hemorrhage
n1=en:stye | n2=en:retinal hemorrhage | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinal microaneurysm
n1=en:stye | n2=en:retinal microaneurysm | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinal pigmentation
n1=en:stye | n2=en:retinal pigmentation | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinal thinning
n1=en:stye | n2=en:retinal thinning | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retinoblastoma
n1=en:stye | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:retrobulbar venous varix
n1=en:stye | n2=en:retrobulbar venous varix | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:right eye
n1=en:stye | n2=en:right eye | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:ripping
n1=en:stye | n2=en:ripping | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:sees haloes around lights
n1=en:stye | n2=en:sees haloes around lights | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:send word to somebody
n1=en:stye | n2=en:send word to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:senile macular degeneration
n1=en:stye | n2=en:senile macular degeneration | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:sensorimotor disorder of eyelid
n1=en:stye | n2=en:sensorimotor disorder of eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:septic rash
n1=en:stye | n2=en:septic rash | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:shallow orbits
n1=en:stye | n2=en:shallow orbits | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:shredding
n1=en:stye | n2=en:shredding | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:signal to somebody
n1=en:stye | n2=en:signal to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:sinuitis
n1=en:stye | n2=en:sinuitis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:slanted eyes
n1=en:stye | n2=en:slanted eyes | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:small vessel retinal infarcts and aneurysms
n1=en:stye | n2=en:small vessel retinal infarcts and aneurysms | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:soft lens
n1=en:stye | n2=en:soft lens | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:sorrow of love
n1=en:stye | n2=en:sorrow of love | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:stargardt disease
n1=en:stye | n2=en:stargardt disease | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:stenosis of lacrimal punctum
n1=en:stye | n2=en:stenosis of lacrimal punctum | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:strabismus
n1=en:stye | n2=en:strabismus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:strabismus syndrome
n1=en:stye | n2=en:strabismus syndrome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:swollen tear duct
n1=en:stye | n2=en:swollen tear duct | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:symblepharon
n1=en:stye | n2=en:symblepharon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tap somebody 's phone
n1=en:stye | n2=en:tap somebody 's phone | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tarsal cyst
n1=en:stye | n2=en:tarsal cyst | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:teach somebody something
n1=en:stye | n2=en:teach somebody something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:teach something to somebody
n1=en:stye | n2=en:teach something to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell sb something
n1=en:stye | n2=en:tell sb something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell sb sth
n1=en:stye | n2=en:tell sb sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell somebody about something
n1=en:stye | n2=en:tell somebody about something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell somebody of something
n1=en:stye | n2=en:tell somebody of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell somebody something
n1=en:stye | n2=en:tell somebody something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tell somebody that something
n1=en:stye | n2=en:tell somebody that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to advise sb of sth
n1=en:stye | n2=en:to advise sb of sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to announce sth to sb
n1=en:stye | n2=en:to announce sth to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to be in touch with sb
n1=en:stye | n2=en:to be in touch with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to beckon to sb
n1=en:stye | n2=en:to beckon to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to contact
n1=en:stye | n2=en:to contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to get in contact with
n1=en:stye | n2=en:to get in contact with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to get in touch with
n1=en:stye | n2=en:to get in touch with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to get in touch with sb
n1=en:stye | n2=en:to get in touch with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to inform sb of sth
n1=en:stye | n2=en:to inform sb of sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to keep sb informed
n1=en:stye | n2=en:to keep sb informed | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to make contact with
n1=en:stye | n2=en:to make contact with | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to make contact with sb
n1=en:stye | n2=en:to make contact with sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to put sth to sb
n1=en:stye | n2=en:to put sth to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to tell sb sth
n1=en:stye | n2=en:to tell sb sth | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to wave at sb
n1=en:stye | n2=en:to wave at sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:to wave to sb
n1=en:stye | n2=en:to wave to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tortuosity of conjunctival vessels
n1=en:stye | n2=en:tortuosity of conjunctival vessels | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tremulousness of the iris
n1=en:stye | n2=en:tremulousness of the iris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:tunica conjunctiva
n1=en:stye | n2=en:tunica conjunctiva | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:type Völker-Dieben
n1=en:stye | n2=en:type Völker-Dieben | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:type Went
n1=en:stye | n2=en:type Went | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:unhappy love affair
n1=en:stye | n2=en:unhappy love affair | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:upper eyelid
n1=en:stye | n2=en:upper eyelid | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:uvea
n1=en:stye | n2=en:uvea | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:uveitis, suppurative
n1=en:stye | n2=en:uveitis, suppurative | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:visual acuity log mar.left:cmplx:pt:eye.left:qn
n1=en:stye | n2=en:visual acuity log mar.left:cmplx:pt:eye.left:qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:visual acuity log mar.right:cmplx:pt:eye.right:qn
n1=en:stye | n2=en:visual acuity log mar.right:cmplx:pt:eye.right:qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:visual cortex disorder
n1=en:stye | n2=en:visual cortex disorder | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:visual impairment
n1=en:stye | n2=en:visual impairment | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:vitreous humor
n1=en:stye | n2=en:vitreous humor | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:vitreous humour
n1=en:stye | n2=en:vitreous humour | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:warn
n1=en:stye | n2=en:warn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:warn somebody of something
n1=en:stye | n2=en:warn somebody of something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:warn somebody something
n1=en:stye | n2=en:warn somebody something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:warn somebody that something
n1=en:stye | n2=en:warn somebody that something | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:wave at sb
n1=en:stye | n2=en:wave at sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:wave at somebody
n1=en:stye | n2=en:wave at somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:wave to sb
n1=en:stye | n2=en:wave to sb | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:wave to somebody
n1=en:stye | n2=en:wave to somebody | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:weak extraocular muscles
n1=en:stye | n2=en:weak extraocular muscles | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:weakness of orbicularis oculi muscle
n1=en:stye | n2=en:weakness of orbicularis oculi muscle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:whitlow
n1=en:stye | n2=en:whitlow | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:wide-angle glaucoma
n1=en:stye | n2=en:wide-angle glaucoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
en:X-linked
n1=en:stye | n2=en:X-linked | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
endophtalmie
n1=en:stye | n2=endophtalmie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
énophtalmie
n1=en:stye | n2=énophtalmie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
enseigner quelque chose à
n1=en:stye | n2=enseigner quelque chose à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en contact avec
n1=en:stye | n2=entrer en contact avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en contact avec [qqn]
n1=en:stye | n2=entrer en contact avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en contact avec quelqu'un
n1=en:stye | n2=entrer en contact avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en liaison avec
n1=en:stye | n2=entrer en liaison avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en relation avec
n1=en:stye | n2=entrer en relation avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en relation avec [qqn]
n1=en:stye | n2=entrer en relation avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entrer en relation avec quelqu'un
n1=en:stye | n2=entrer en relation avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entretenir [qqn] de [qch]
n1=en:stye | n2=entretenir [qqn] de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entropion
n1=en:stye | n2=entropion | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
entropion palpébral
n1=en:stye | n2=entropion palpébral | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
enzymologie
n1=en:stye | n2=enzymologie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
enzymology
n1=en:stye | n2=enzymology | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
épidémiologique
n1=en:stye | n2=épidémiologique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
érosion cornéenne
n1=en:stye | n2=érosion cornéenne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ethnologique
n1=en:stye | n2=ethnologique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en communication avec
n1=en:stye | n2=être en communication avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en communication avec [qqn]
n1=en:stye | n2=être en communication avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en communication avec quelqu'un
n1=en:stye | n2=être en communication avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en contact avec
n1=en:stye | n2=être en contact avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en contact avec [qqn]
n1=en:stye | n2=être en contact avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en contact avec qn
n1=en:stye | n2=être en contact avec qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en contact avec quelqu'un
n1=en:stye | n2=être en contact avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en liaison avec
n1=en:stye | n2=être en liaison avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en liaison avec [qqn]
n1=en:stye | n2=être en liaison avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en liaison avec quelqu'un
n1=en:stye | n2=être en liaison avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en rapport avec
n1=en:stye | n2=être en rapport avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en rapport avec [qqn]
n1=en:stye | n2=être en rapport avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en rapport avec qn
n1=en:stye | n2=être en rapport avec qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
être en rapport avec quelqu'un
n1=en:stye | n2=être en rapport avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
exophtalmie
n1=en:stye | n2=exophtalmie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
exophthalmie
n1=en:stye | n2=exophthalmie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de [qch] à
n1=en:stye | n2=faire part de [qch] à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de [qch] à [qqn]
n1=en:stye | n2=faire part de [qch] à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de qch à qn
n1=en:stye | n2=faire part de qch à qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de qch à quelqu'un
n1=en:stye | n2=faire part de qch à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de quelque chose à
n1=en:stye | n2=faire part de quelque chose à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire part de quelque chose à quelqu'un
n1=en:stye | n2=faire part de quelque chose à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir [qch] à
n1=en:stye | n2=faire savoir [qch] à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir [qch] à [qqn]
n1=en:stye | n2=faire savoir [qch] à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir qch à qn
n1=en:stye | n2=faire savoir qch à qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir qch à quelqu'un
n1=en:stye | n2=faire savoir qch à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir quelque chose à
n1=en:stye | n2=faire savoir quelque chose à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire savoir quelque chose à quelqu'un
n1=en:stye | n2=faire savoir quelque chose à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe à [qqn]
n1=en:stye | n2=faire signe à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe à qn
n1=en:stye | n2=faire signe à qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe à quelqu'un
n1=en:stye | n2=faire signe à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe de la main à
n1=en:stye | n2=faire signe de la main à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe de la main à [qqn]
n1=en:stye | n2=faire signe de la main à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire signe de la main à quelqu'un
n1=en:stye | n2=faire signe de la main à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire un signe de la main à qn
n1=en:stye | n2=faire un signe de la main à qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
faire un signe de la main à quelqu'un
n1=en:stye | n2=faire un signe de la main à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique
n1=en:stye | n2=fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
fundus albipunctatus
n1=en:stye | n2=fundus albipunctatus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
gérontoxon
n1=en:stye | n2=gérontoxon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
glande lacrymale
n1=en:stye | n2=glande lacrymale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Glande lacrymale
n1=en:stye | n2=Glande lacrymale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Glasgow (score de)
n1=en:stye | n2=Glasgow (score de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
glaucoma
n1=en:stye | n2=glaucoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
glaucome
n1=en:stye | n2=glaucome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
glaucome à angle ouvert
n1=en:stye | n2=glaucome à angle ouvert | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
héméralopie
n1=en:stye | n2=héméralopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
héméralopie congénitale stationnaire avec myopie
n1=en:stye | n2=héméralopie congénitale stationnaire avec myopie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
héméralopie congénitale stationnaire de type III apparentée à la rhodopsine
n1=en:stye | n2=héméralopie congénitale stationnaire de type III apparentée à la rhodopsine | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
héméralopie congénitale stationnaire dominante de type III
n1=en:stye | n2=héméralopie congénitale stationnaire dominante de type III | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémi-anopsie
n1=en:stye | n2=hémi-anopsie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémianopsie
n1=en:stye | n2=hémianopsie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémianopsies
n1=en:stye | n2=hémianopsies | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémorragie du corps vitré
n1=en:stye | n2=hémorragie du corps vitré | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémorragie du vitré
n1=en:stye | n2=hémorragie du vitré | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hémorragie vitréenne
n1=en:stye | n2=hémorragie vitréenne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hernie diaphragmatique, exomphalocèle, absence de corps calleux, hypertélorisme, myopie et surdité neurosensorielle
n1=en:stye | n2=hernie diaphragmatique, exomphalocèle, absence de corps calleux, hypertélorisme, myopie et surdité neurosensorielle | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
humeur vitrée
n1=en:stye | n2=humeur vitrée | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hyalosis astéroïde
n1=en:stye | n2=hyalosis astéroïde | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hyperacanthose
n1=en:stye | n2=hyperacanthose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hyperplasie du vitré primitif
n1=en:stye | n2=hyperplasie du vitré primitif | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypertélorisme
n1=en:stye | n2=hypertélorisme | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypertélorisme-microtie-fente faciale
n1=en:stye | n2=hypertélorisme-microtie-fente faciale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypertélorisme, hypospadias, polysyndactylie (syndrome)
n1=en:stye | n2=hypertélorisme, hypospadias, polysyndactylie (syndrome) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypertrophie chronique de la glande lacrymale
n1=en:stye | n2=hypertrophie chronique de la glande lacrymale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypoesthésie cornéenne familiale
n1=en:stye | n2=hypoesthésie cornéenne familiale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypoplasie du nerf optique
n1=en:stye | n2=hypoplasie du nerf optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypoplasie du nerf optique bilatérale et familiale
n1=en:stye | n2=hypoplasie du nerf optique bilatérale et familiale | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypoplasie papillaire
n1=en:stye | n2=hypoplasie papillaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
hypopyon
n1=en:stye | n2=hypopyon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
inculquer quelque chose à
n1=en:stye | n2=inculquer quelque chose à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
indiquer qch à quelqu'un
n1=en:stye | n2=indiquer qch à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
indiquer quelque chose à quelqu'un
n1=en:stye | n2=indiquer quelque chose à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
informer [qqn] de [qch]
n1=en:stye | n2=informer [qqn] de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
informer [qqn] que [qch]...
n1=en:stye | n2=informer [qqn] que [qch]... | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
informer quelqu'un de qqch
n1=en:stye | n2=informer quelqu'un de qqch | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
informer quelqu'un de quelque chose
n1=en:stye | n2=informer quelqu'un de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
informer quelqu'un que quelque chose...
n1=en:stye | n2=informer quelqu'un que quelque chose... | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
instruire qn de qch
n1=en:stye | n2=instruire qn de qch | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
instruire qn de quelque chose
n1=en:stye | n2=instruire qn de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
instruire quelqu'un de quelque chose
n1=en:stye | n2=instruire quelqu'un de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
iridodonesis
n1=en:stye | n2=iridodonesis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
iridodonésis
n1=en:stye | n2=iridodonésis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
iris trémulant
n1=en:stye | n2=iris trémulant | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
kératite en bandelette
n1=en:stye | n2=kératite en bandelette | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Kjer (atrophie optique de type)
n1=en:stye | n2=Kjer (atrophie optique de type) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
lens
n1=en:stye | n2=lens | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
lentille cornéenne
n1=en:stye | n2=lentille cornéenne | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
lentille de contact
n1=en:stye | n2=lentille de contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
lentille souple
n1=en:stye | n2=lentille souple | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
leucocorie
n1=en:stye | n2=leucocorie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
maladie de Benson
n1=en:stye | n2=maladie de Benson | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
maladie occulaire
n1=en:stye | n2=maladie occulaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre [qqn]
n1=en:stye | n2=mettre [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre [qqn] en danger
n1=en:stye | n2=mettre [qqn] en danger | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre [qqn] en garde
n1=en:stye | n2=mettre [qqn] en garde | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre en danger
n1=en:stye | n2=mettre en danger | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre en danger [qqn]
n1=en:stye | n2=mettre en danger [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre en garde [qqn]
n1=en:stye | n2=mettre en garde [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre quelqu'un
n1=en:stye | n2=mettre quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
mettre quelqu'un en danger
n1=en:stye | n2=mettre quelqu'un en danger | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
microbiologique
n1=en:stye | n2=microbiologique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
monochromatopsie du rouge
n1=en:stye | n2=monochromatopsie du rouge | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
néoformation de vaisseaux sanguins
n1=en:stye | n2=néoformation de vaisseaux sanguins | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
neuropathie optique
n1=en:stye | n2=neuropathie optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
non précisée, dacryoadénite
n1=en:stye | n2=non précisée, dacryoadénite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
non précisée, dacryocystite
n1=en:stye | n2=non précisée, dacryocystite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Nougaret (héméralopie essentielle de)
n1=en:stye | n2=Nougaret (héméralopie essentielle de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
nystagmus de fixation pathologique
n1=en:stye | n2=nystagmus de fixation pathologique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
nystagmus lié au sexe
n1=en:stye | n2=nystagmus lié au sexe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
oeil droit
n1=en:stye | n2=oeil droit | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
officier traitant
n1=en:stye | n2=officier traitant | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ophtalmopathie
n1=en:stye | n2=ophtalmopathie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ophtalmoplégie externe
n1=en:stye | n2=ophtalmoplégie externe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
panaris
n1=en:stye | n2=panaris | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
papille optique
n1=en:stye | n2=papille optique | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
parakératose
n1=en:stye | n2=parakératose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
paralysie de la verticalité du regard
n1=en:stye | n2=paralysie de la verticalité du regard | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
paralysie oculomotrice extrinsèque
n1=en:stye | n2=paralysie oculomotrice extrinsèque | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
paraplégie spastique avec atrophie optique et démence
n1=en:stye | n2=paraplégie spastique avec atrophie optique et démence | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
parasitologie
n1=en:stye | n2=parasitologie | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
passer le mot à
n1=en:stye | n2=passer le mot à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
passer le mot à [qqn]
n1=en:stye | n2=passer le mot à [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
passer le mot à quelqu'un
n1=en:stye | n2=passer le mot à quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
peine d'amour
n1=en:stye | n2=peine d'amour | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
peine de cœur
n1=en:stye | n2=peine de cœur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
peine de coeur
n1=en:stye | n2=peine de coeur | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
persistance du vitré primitif
n1=en:stye | n2=persistance du vitré primitif | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prendre contact avec
n1=en:stye | n2=prendre contact avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir [qqn]
n1=en:stye | n2=prévenir [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir [qqn] de [qch]
n1=en:stye | n2=prévenir [qqn] de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir [qqn] que
n1=en:stye | n2=prévenir [qqn] que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir quelqu'un
n1=en:stye | n2=prévenir quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir quelqu'un de quelque chose
n1=en:stye | n2=prévenir quelqu'un de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
prévenir quelqu'un que
n1=en:stye | n2=prévenir quelqu'un que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
proptose
n1=en:stye | n2=proptose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ptose
n1=en:stye | n2=ptose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ptôse
n1=en:stye | n2=ptôse | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ptosis
n1=en:stye | n2=ptosis | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
retard mental, retard de croissance, surdité, microgénitalisme lié au sexe
n1=en:stye | n2=retard mental, retard de croissance, surdité, microgénitalisme lié au sexe | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
rétinoblastome
n1=en:stye | n2=rétinoblastome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
ripping
n1=en:stye | n2=ripping | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
s'aboucher avec
n1=en:stye | n2=s'aboucher avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
s'aboucher avec [qqn]
n1=en:stye | n2=s'aboucher avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
s'aboucher avec qqn
n1=en:stye | n2=s'aboucher avec qqn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
s'aboucher avec quelqu'un
n1=en:stye | n2=s'aboucher avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
saluer qn de la main
n1=en:stye | n2=saluer qn de la main | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
saluer quelqu'un de la main
n1=en:stye | n2=saluer quelqu'un de la main | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en contact avec
n1=en:stye | n2=se mettre en contact avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en contact avec [qqn]
n1=en:stye | n2=se mettre en contact avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en contact avec qn
n1=en:stye | n2=se mettre en contact avec qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en contact avec quelqu'un
n1=en:stye | n2=se mettre en contact avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en rapport avec
n1=en:stye | n2=se mettre en rapport avec | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en rapport avec [qqn]
n1=en:stye | n2=se mettre en rapport avec [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en rapport avec qn
n1=en:stye | n2=se mettre en rapport avec qn | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se mettre en rapport avec quelqu'un
n1=en:stye | n2=se mettre en rapport avec quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
se tenir informé
n1=en:stye | n2=se tenir informé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
signaler à
n1=en:stye | n2=signaler à | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
signaler à [qqn] que
n1=en:stye | n2=signaler à [qqn] que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
signaler à quelqu'un que
n1=en:stye | n2=signaler à quelqu'un que | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
sinusite
n1=en:stye | n2=sinusite | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
strabisme
n1=en:stye | n2=strabisme | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
strabismus
n1=en:stye | n2=strabismus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
symblépharon
n1=en:stye | n2=symblépharon | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de Duane
n1=en:stye | n2=syndrome de Duane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de duane
n1=en:stye | n2=syndrome de duane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de Stilling-Türk-Duane
n1=en:stye | n2=syndrome de Stilling-Türk-Duane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de Treft-Sanborn-Carey
n1=en:stye | n2=syndrome de Treft-Sanborn-Carey | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de Türk-Stilling-Duane
n1=en:stye | n2=syndrome de Türk-Stilling-Duane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome de türk-stilling-duane
n1=en:stye | n2=syndrome de türk-stilling-duane | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
syndrome des cils longs
n1=en:stye | n2=syndrome des cils longs | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
télécanthus
n1=en:stye | n2=télécanthus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
télécanthus-hypertélorisme-strabisme (syndrome)
n1=en:stye | n2=télécanthus-hypertélorisme-strabisme (syndrome) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn]
n1=en:stye | n2=tenir [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] au courant
n1=en:stye | n2=tenir [qqn] au courant | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] au courant de [qch]
n1=en:stye | n2=tenir [qqn] au courant de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] au jus
n1=en:stye | n2=tenir [qqn] au jus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] de [qch]
n1=en:stye | n2=tenir [qqn] de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] informé
n1=en:stye | n2=tenir [qqn] informé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir [qqn] informé de [qch]
n1=en:stye | n2=tenir [qqn] informé de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir au courant
n1=en:stye | n2=tenir au courant | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir au jus
n1=en:stye | n2=tenir au jus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir au jus [qqn]
n1=en:stye | n2=tenir au jus [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir au jus quelqu'un
n1=en:stye | n2=tenir au jus quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir informé
n1=en:stye | n2=tenir informé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir informé [qqn]
n1=en:stye | n2=tenir informé [qqn] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir informé [qqn] de [qch]
n1=en:stye | n2=tenir informé [qqn] de [qch] | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir informé quelqu'un
n1=en:stye | n2=tenir informé quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir informé quelqu'un de quelque chose
n1=en:stye | n2=tenir informé quelqu'un de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir qn informé
n1=en:stye | n2=tenir qn informé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir quelqu'un
n1=en:stye | n2=tenir quelqu'un | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir quelqu'un au courant
n1=en:stye | n2=tenir quelqu'un au courant | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir quelqu'un au courant de quelque chose
n1=en:stye | n2=tenir quelqu'un au courant de quelque chose | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir quelqu'un au jus
n1=en:stye | n2=tenir quelqu'un au jus | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
tenir quelqu'un informé
n1=en:stye | n2=tenir quelqu'un informé | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
trachome
n1=en:stye | n2=trachome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
trouble de l'oeil
n1=en:stye | n2=trouble de l'oeil | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
trouble de la vue
n1=en:stye | n2=trouble de la vue | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
trouble oculaire
n1=en:stye | n2=trouble oculaire | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Türk-Stilling-Duane (syndrome de)
n1=en:stye | n2=Türk-Stilling-Duane (syndrome de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Uukuniemi (virus)
n1=en:stye | n2=Uukuniemi (virus) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
UUKV
n1=en:stye | n2=UUKV | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
uvée
n1=en:stye | n2=uvée | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
uvéite antérieure
n1=en:stye | n2=uvéite antérieure | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
uvéite purulente
n1=en:stye | n2=uvéite purulente | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
uvéite suppurée
n1=en:stye | n2=uvéite suppurée | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
verre de contact
n1=en:stye | n2=verre de contact | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
vision trouble
n1=en:stye | n2=vision trouble | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Völker-Dieben (atrophie optique liée au sexe de)
n1=en:stye | n2=Völker-Dieben (atrophie optique liée au sexe de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
Went (atrophie optique liée au sexe de)
n1=en:stye | n2=Went (atrophie optique liée au sexe de) | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
xanthoma
n1=en:stye | n2=xanthoma | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
xanthome
n1=en:stye | n2=xanthome | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 20 / 0.065 ->
yeux bridés
n1=en:stye | n2=yeux bridés | rel=r_associated | relid=0 | w=20
- en:stye --
r_associated #0: 15 / 0.049 ->
en:oncology
n1=en:stye | n2=en:oncology | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 15 / 0.049 ->
en:ophthalmology
n1=en:stye | n2=en:ophthalmology | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 15 / 0.049 ->
loucher sur
n1=en:stye | n2=loucher sur | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 15 / 0.049 ->
maladies occulaire
n1=en:stye | n2=maladies occulaire | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 15 / 0.049 ->
maladies oculaires
n1=en:stye | n2=maladies oculaires | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 15 / 0.049 ->
Spécialités médicales
n1=en:stye | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
- en:stye --
r_associated #0: 10 / 0.032 ->
en:acne
n1=en:stye | n2=en:acne | rel=r_associated | relid=0 | w=10
- en:stye --
r_associated #0: 10 / 0.032 ->
eye
n1=en:stye | n2=eye | rel=r_associated | relid=0 | w=10
- en:stye --
r_associated #0: 10 / 0.032 ->
orge
n1=en:stye | n2=orge | rel=r_associated | relid=0 | w=10
- en:stye --
r_associated #0: -20 / -0.065 ->
tenir quelqu'un informé de qqch
n1=en:stye | n2=tenir quelqu'un informé de qqch | rel=r_associated | relid=0 | w=-20
| ≈ 2427 relations entrantes
- vitré
(Nom) ---
r_associated #0: 675 -->
en:stye
n1=vitré (Nom) | n2=en:stye | rel=r_associated | relid=0 | w=675
- maladies de l'oeil ---
r_associated #0: 299 -->
en:stye
n1=maladies de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=299
- maladies des yeux ---
r_associated #0: 282 -->
en:stye
n1=maladies des yeux | n2=en:stye | rel=r_associated | relid=0 | w=282
- arc juvénile ---
r_associated #0: 242 -->
en:stye
n1=arc juvénile | n2=en:stye | rel=r_associated | relid=0 | w=242
- monochromatopsie du rouge ---
r_associated #0: 242 -->
en:stye
n1=monochromatopsie du rouge | n2=en:stye | rel=r_associated | relid=0 | w=242
- cécité au rouge ---
r_associated #0: 240 -->
en:stye
n1=cécité au rouge | n2=en:stye | rel=r_associated | relid=0 | w=240
- en:arcus juvenilis ---
r_associated #0: 240 -->
en:stye
n1=en:arcus juvenilis | n2=en:stye | rel=r_associated | relid=0 | w=240
- en:color blindness, red ---
r_associated #0: 240 -->
en:stye
n1=en:color blindness, red | n2=en:stye | rel=r_associated | relid=0 | w=240
- conjonctive ---
r_associated #0: 222 -->
en:stye
n1=conjonctive | n2=en:stye | rel=r_associated | relid=0 | w=222
- en:conjunctiva ---
r_associated #0: 221 -->
en:stye
n1=en:conjunctiva | n2=en:stye | rel=r_associated | relid=0 | w=221
- héméralopie ---
r_associated #0: 221 -->
en:stye
n1=héméralopie | n2=en:stye | rel=r_associated | relid=0 | w=221
- en:hemeralopia ---
r_associated #0: 220 -->
en:stye
n1=en:hemeralopia | n2=en:stye | rel=r_associated | relid=0 | w=220
- en:trachoma ---
r_associated #0: 210 -->
en:stye
n1=en:trachoma | n2=en:stye | rel=r_associated | relid=0 | w=210
- trachoma ---
r_associated #0: 209 -->
en:stye
n1=trachoma | n2=en:stye | rel=r_associated | relid=0 | w=209
- anomalie congénitale de l'oeil ---
r_associated #0: 208 -->
en:stye
n1=anomalie congénitale de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=208
- dacryocystite ---
r_associated #0: 207 -->
en:stye
n1=dacryocystite | n2=en:stye | rel=r_associated | relid=0 | w=207
- dacryadénite ---
r_associated #0: 205 -->
en:stye
n1=dacryadénite | n2=en:stye | rel=r_associated | relid=0 | w=205
- dacryoadénite ---
r_associated #0: 205 -->
en:stye
n1=dacryoadénite | n2=en:stye | rel=r_associated | relid=0 | w=205
- en:congenital eye disorder ---
r_associated #0: 205 -->
en:stye
n1=en:congenital eye disorder | n2=en:stye | rel=r_associated | relid=0 | w=205
- en:dacryoadenitis ---
r_associated #0: 205 -->
en:stye
n1=en:dacryoadenitis | n2=en:stye | rel=r_associated | relid=0 | w=205
- hypertrophie chronique de la glande lacrymale ---
r_associated #0: 205 -->
en:stye
n1=hypertrophie chronique de la glande lacrymale | n2=en:stye | rel=r_associated | relid=0 | w=205
- non précisée, dacryoadénite ---
r_associated #0: 205 -->
en:stye
n1=non précisée, dacryoadénite | n2=en:stye | rel=r_associated | relid=0 | w=205
- en:dacryocystitis ---
r_associated #0: 202 -->
en:stye
n1=en:dacryocystitis | n2=en:stye | rel=r_associated | relid=0 | w=202
- en:enzymology ---
r_associated #0: 201 -->
en:stye
n1=en:enzymology | n2=en:stye | rel=r_associated | relid=0 | w=201
- dacryocystites ---
r_associated #0: 200 -->
en:stye
n1=dacryocystites | n2=en:stye | rel=r_associated | relid=0 | w=200
- enzymologie ---
r_associated #0: 200 -->
en:stye
n1=enzymologie | n2=en:stye | rel=r_associated | relid=0 | w=200
- tunique conjonctive ---
r_associated #0: 197 -->
en:stye
n1=tunique conjonctive | n2=en:stye | rel=r_associated | relid=0 | w=197
- dacryoadénite non précisée ---
r_associated #0: 195 -->
en:stye
n1=dacryoadénite non précisée | n2=en:stye | rel=r_associated | relid=0 | w=195
- hémi-anopsie ---
r_associated #0: 190 -->
en:stye
n1=hémi-anopsie | n2=en:stye | rel=r_associated | relid=0 | w=190
- non précisée, dacryocystite ---
r_associated #0: 190 -->
en:stye
n1=non précisée, dacryocystite | n2=en:stye | rel=r_associated | relid=0 | w=190
- trachome ---
r_associated #0: 190 -->
en:stye
n1=trachome | n2=en:stye | rel=r_associated | relid=0 | w=190
- dystrophie rétinienne ---
r_associated #0: 186 -->
en:stye
n1=dystrophie rétinienne | n2=en:stye | rel=r_associated | relid=0 | w=186
- hémianopsie ---
r_associated #0: 186 -->
en:stye
n1=hémianopsie | n2=en:stye | rel=r_associated | relid=0 | w=186
- dacryocystite non précisée ---
r_associated #0: 185 -->
en:stye
n1=dacryocystite non précisée | n2=en:stye | rel=r_associated | relid=0 | w=185
- en:hemianopsia ---
r_associated #0: 185 -->
en:stye
n1=en:hemianopsia | n2=en:stye | rel=r_associated | relid=0 | w=185
- en:retinal dystrophy ---
r_associated #0: 185 -->
en:stye
n1=en:retinal dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=185
- en:age-related macular degeneration ---
r_associated #0: 184 -->
en:stye
n1=en:age-related macular degeneration | n2=en:stye | rel=r_associated | relid=0 | w=184
- dégénérescence maculaire sénile ---
r_associated #0: 181 -->
en:stye
n1=dégénérescence maculaire sénile | n2=en:stye | rel=r_associated | relid=0 | w=181
- en:sensorineural hearing loss ---
r_associated #0: 181 -->
en:stye
n1=en:sensorineural hearing loss | n2=en:stye | rel=r_associated | relid=0 | w=181
- affection oculaire congénitale ---
r_associated #0: 180 -->
en:stye
n1=affection oculaire congénitale | n2=en:stye | rel=r_associated | relid=0 | w=180
- perte d'audition sensorineurale ---
r_associated #0: 179 -->
en:stye
n1=perte d'audition sensorineurale | n2=en:stye | rel=r_associated | relid=0 | w=179
- en:parasitology ---
r_associated #0: 162 -->
en:stye
n1=en:parasitology | n2=en:stye | rel=r_associated | relid=0 | w=162
- parasitologie ---
r_associated #0: 160 -->
en:stye
n1=parasitologie | n2=en:stye | rel=r_associated | relid=0 | w=160
- enzymology ---
r_associated #0: 155 -->
en:stye
n1=enzymology | n2=en:stye | rel=r_associated | relid=0 | w=155
- hémianopsies ---
r_associated #0: 152 -->
en:stye
n1=hémianopsies | n2=en:stye | rel=r_associated | relid=0 | w=152
- en:disorder of eye ---
r_associated #0: 141 -->
en:stye
n1=en:disorder of eye | n2=en:stye | rel=r_associated | relid=0 | w=141
- maladie de l'oeil ---
r_associated #0: 141 -->
en:stye
n1=maladie de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=141
- trouble oculaire ---
r_associated #0: 141 -->
en:stye
n1=trouble oculaire | n2=en:stye | rel=r_associated | relid=0 | w=141
- amblyopie ---
r_associated #0: 140 -->
en:stye
n1=amblyopie | n2=en:stye | rel=r_associated | relid=0 | w=140
- en:eye disorder ---
r_associated #0: 140 -->
en:stye
n1=en:eye disorder | n2=en:stye | rel=r_associated | relid=0 | w=140
- maladie occulaire ---
r_associated #0: 140 -->
en:stye
n1=maladie occulaire | n2=en:stye | rel=r_associated | relid=0 | w=140
- en:amblyopia ---
r_associated #0: 139 -->
en:stye
n1=en:amblyopia | n2=en:stye | rel=r_associated | relid=0 | w=139
- affection de l'oeil ---
r_associated #0: 135 -->
en:stye
n1=affection de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=135
- ophtalmopathie ---
r_associated #0: 135 -->
en:stye
n1=ophtalmopathie | n2=en:stye | rel=r_associated | relid=0 | w=135
- en:right eye ---
r_associated #0: 133 -->
en:stye
n1=en:right eye | n2=en:stye | rel=r_associated | relid=0 | w=133
- corps vitré ---
r_associated #0: 132 -->
en:stye
n1=corps vitré | n2=en:stye | rel=r_associated | relid=0 | w=132
- acuité visuelle normale ---
r_associated #0: 130 -->
en:stye
n1=acuité visuelle normale | n2=en:stye | rel=r_associated | relid=0 | w=130
- maladie des yeux ---
r_associated #0: 130 -->
en:stye
n1=maladie des yeux | n2=en:stye | rel=r_associated | relid=0 | w=130
- oeil droit ---
r_associated #0: 130 -->
en:stye
n1=oeil droit | n2=en:stye | rel=r_associated | relid=0 | w=130
- trouble de l'oeil ---
r_associated #0: 130 -->
en:stye
n1=trouble de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=130
- en:vitreous body ---
r_associated #0: 128 -->
en:stye
n1=en:vitreous body | n2=en:stye | rel=r_associated | relid=0 | w=128
- colobome de l'oeil ---
r_associated #0: 127 -->
en:stye
n1=colobome de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=127
- en:coloboma of the eye ---
r_associated #0: 127 -->
en:stye
n1=en:coloboma of the eye | n2=en:stye | rel=r_associated | relid=0 | w=127
- colobome oculaire ---
r_associated #0: 126 -->
en:stye
n1=colobome oculaire | n2=en:stye | rel=r_associated | relid=0 | w=126
- en:normal visual acuity ---
r_associated #0: 126 -->
en:stye
n1=en:normal visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=126
- disque optique ---
r_associated #0: 125 -->
en:stye
n1=disque optique | n2=en:stye | rel=r_associated | relid=0 | w=125
- en:optic disc ---
r_associated #0: 124 -->
en:stye
n1=en:optic disc | n2=en:stye | rel=r_associated | relid=0 | w=124
- en:chalazion ---
r_associated #0: 123 -->
en:stye
n1=en:chalazion | n2=en:stye | rel=r_associated | relid=0 | w=123
- chalazion ---
r_associated #0: 119 -->
en:stye
n1=chalazion | n2=en:stye | rel=r_associated | relid=0 | w=119
- en:lid margin discharge ---
r_associated #0: 119 -->
en:stye
n1=en:lid margin discharge | n2=en:stye | rel=r_associated | relid=0 | w=119
- iridodonesis ---
r_associated #0: 117 -->
en:stye
n1=iridodonesis | n2=en:stye | rel=r_associated | relid=0 | w=117
- décharge du bord de la paupière ---
r_associated #0: 116 -->
en:stye
n1=décharge du bord de la paupière | n2=en:stye | rel=r_associated | relid=0 | w=116
- iridodonésis ---
r_associated #0: 116 -->
en:stye
n1=iridodonésis | n2=en:stye | rel=r_associated | relid=0 | w=116
- en:iridodonesis ---
r_associated #0: 115 -->
en:stye
n1=en:iridodonesis | n2=en:stye | rel=r_associated | relid=0 | w=115
- en:optic disk ---
r_associated #0: 115 -->
en:stye
n1=en:optic disk | n2=en:stye | rel=r_associated | relid=0 | w=115
- symblépharon ---
r_associated #0: 111 -->
en:stye
n1=symblépharon | n2=en:stye | rel=r_associated | relid=0 | w=111
- syndrome de Duane ---
r_associated #0: 111 -->
en:stye
n1=syndrome de Duane | n2=en:stye | rel=r_associated | relid=0 | w=111
- papille optique ---
r_associated #0: 110 -->
en:stye
n1=papille optique | n2=en:stye | rel=r_associated | relid=0 | w=110
- ptosis ---
r_associated #0: 110 -->
en:stye
n1=ptosis | n2=en:stye | rel=r_associated | relid=0 | w=110
- en:symblepharon ---
r_associated #0: 109 -->
en:stye
n1=en:symblepharon | n2=en:stye | rel=r_associated | relid=0 | w=109
- syndrome de duane ---
r_associated #0: 108 -->
en:stye
n1=syndrome de duane | n2=en:stye | rel=r_associated | relid=0 | w=108
- dyskératose cornéenne ---
r_associated #0: 106 -->
en:stye
n1=dyskératose cornéenne | n2=en:stye | rel=r_associated | relid=0 | w=106
- en:ptosis ---
r_associated #0: 106 -->
en:stye
n1=en:ptosis | n2=en:stye | rel=r_associated | relid=0 | w=106
- ambliopie ---
r_associated #0: 105 -->
en:stye
n1=ambliopie | n2=en:stye | rel=r_associated | relid=0 | w=105
- en:corneal dyskeratosis ---
r_associated #0: 104 -->
en:stye
n1=en:corneal dyskeratosis | n2=en:stye | rel=r_associated | relid=0 | w=104
- en:vitreous hemorrhage ---
r_associated #0: 102 -->
en:stye
n1=en:vitreous hemorrhage | n2=en:stye | rel=r_associated | relid=0 | w=102
- hémorragie vitréenne ---
r_associated #0: 101 -->
en:stye
n1=hémorragie vitréenne | n2=en:stye | rel=r_associated | relid=0 | w=101
- exophtalmie ---
r_associated #0: 100 -->
en:stye
n1=exophtalmie | n2=en:stye | rel=r_associated | relid=0 | w=100
- cœur brisé ---
r_associated #0: 97 -->
en:stye
n1=cœur brisé | n2=en:stye | rel=r_associated | relid=0 | w=97
- coeur brisé ---
r_associated #0: 96 -->
en:stye
n1=coeur brisé | n2=en:stye | rel=r_associated | relid=0 | w=96
- hypertélorisme ---
r_associated #0: 96 -->
en:stye
n1=hypertélorisme | n2=en:stye | rel=r_associated | relid=0 | w=96
- proptose ---
r_associated #0: 96 -->
en:stye
n1=proptose | n2=en:stye | rel=r_associated | relid=0 | w=96
- en:duane syndrome ---
r_associated #0: 95 -->
en:stye
n1=en:duane syndrome | n2=en:stye | rel=r_associated | relid=0 | w=95
- exophthalmie ---
r_associated #0: 95 -->
en:stye
n1=exophthalmie | n2=en:stye | rel=r_associated | relid=0 | w=95
- en:hypertelorism ---
r_associated #0: 92 -->
en:stye
n1=en:hypertelorism | n2=en:stye | rel=r_associated | relid=0 | w=92
- en:age related macular degeneration ---
r_associated #0: 90 -->
en:stye
n1=en:age related macular degeneration | n2=en:stye | rel=r_associated | relid=0 | w=90
- hémorragie du corps vitré ---
r_associated #0: 90 -->
en:stye
n1=hémorragie du corps vitré | n2=en:stye | rel=r_associated | relid=0 | w=90
- hémorragie du vitré ---
r_associated #0: 90 -->
en:stye
n1=hémorragie du vitré | n2=en:stye | rel=r_associated | relid=0 | w=90
- tenir [qqn] informé ---
r_associated #0: 87 -->
en:stye
n1=tenir [qqn] informé | n2=en:stye | rel=r_associated | relid=0 | w=87
- en:tell somebody about something ---
r_associated #0: 86 -->
en:stye
n1=en:tell somebody about something | n2=en:stye | rel=r_associated | relid=0 | w=86
- faire part de qch à qn ---
r_associated #0: 86 -->
en:stye
n1=faire part de qch à qn | n2=en:stye | rel=r_associated | relid=0 | w=86
- faire part de qch à quelqu'un ---
r_associated #0: 86 -->
en:stye
n1=faire part de qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=86
- humeur vitrée ---
r_associated #0: 86 -->
en:stye
n1=humeur vitrée | n2=en:stye | rel=r_associated | relid=0 | w=86
- tenir [qqn] au courant ---
r_associated #0: 86 -->
en:stye
n1=tenir [qqn] au courant | n2=en:stye | rel=r_associated | relid=0 | w=86
- en:exophthalmos ---
r_associated #0: 85 -->
en:stye
n1=en:exophthalmos | n2=en:stye | rel=r_associated | relid=0 | w=85
- iris trémulant ---
r_associated #0: 85 -->
en:stye
n1=iris trémulant | n2=en:stye | rel=r_associated | relid=0 | w=85
- tenir informé quelqu'un ---
r_associated #0: 85 -->
en:stye
n1=tenir informé quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=85
- avertir qn de qch ---
r_associated #0: 83 -->
en:stye
n1=avertir qn de qch | n2=en:stye | rel=r_associated | relid=0 | w=83
- en:keep somebody informed ---
r_associated #0: 83 -->
en:stye
n1=en:keep somebody informed | n2=en:stye | rel=r_associated | relid=0 | w=83
- faire part de quelque chose à ---
r_associated #0: 83 -->
en:stye
n1=faire part de quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=83
- prévenir [qqn] que ---
r_associated #0: 83 -->
en:stye
n1=prévenir [qqn] que | n2=en:stye | rel=r_associated | relid=0 | w=83
- tenir informé [qqn] ---
r_associated #0: 83 -->
en:stye
n1=tenir informé [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=83
- tenir quelqu'un informé ---
r_associated #0: 83 -->
en:stye
n1=tenir quelqu'un informé | n2=en:stye | rel=r_associated | relid=0 | w=83
- en:inform somebody of something ---
r_associated #0: 82 -->
en:stye
n1=en:inform somebody of something | n2=en:stye | rel=r_associated | relid=0 | w=82
- en:let somebody know ---
r_associated #0: 82 -->
en:stye
n1=en:let somebody know | n2=en:stye | rel=r_associated | relid=0 | w=82
- en:put sth to sb ---
r_associated #0: 82 -->
en:stye
n1=en:put sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=82
- informer [qqn] de [qch] ---
r_associated #0: 82 -->
en:stye
n1=informer [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=82
- crève-coeur ---
r_associated #0: 81 -->
en:stye
n1=crève-coeur | n2=en:stye | rel=r_associated | relid=0 | w=81
- entropion ---
r_associated #0: 81 -->
en:stye
n1=entropion | n2=en:stye | rel=r_associated | relid=0 | w=81
- faire part de [qch] à ---
r_associated #0: 81 -->
en:stye
n1=faire part de [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=81
- hypoplasie du nerf optique ---
r_associated #0: 81 -->
en:stye
n1=hypoplasie du nerf optique | n2=en:stye | rel=r_associated | relid=0 | w=81
- crève-cœur ---
r_associated #0: 80 -->
en:stye
n1=crève-cœur | n2=en:stye | rel=r_associated | relid=0 | w=80
- crève-cœur ---
r_associated #0: 80 -->
en:stye
n1=crève-cœur | n2=en:stye | rel=r_associated | relid=0 | w=80
- en:let somebody know something ---
r_associated #0: 80 -->
en:stye
n1=en:let somebody know something | n2=en:stye | rel=r_associated | relid=0 | w=80
- en:optic nerve hypoplasia ---
r_associated #0: 80 -->
en:stye
n1=en:optic nerve hypoplasia | n2=en:stye | rel=r_associated | relid=0 | w=80
- syndrome de Türk-Stilling-Duane ---
r_associated #0: 80 -->
en:stye
n1=syndrome de Türk-Stilling-Duane | n2=en:stye | rel=r_associated | relid=0 | w=80
- uvéite suppurée ---
r_associated #0: 80 -->
en:stye
n1=uvéite suppurée | n2=en:stye | rel=r_associated | relid=0 | w=80
- en:entropion ---
r_associated #0: 79 -->
en:stye
n1=en:entropion | n2=en:stye | rel=r_associated | relid=0 | w=79
- en:uveitis, suppurative ---
r_associated #0: 79 -->
en:stye
n1=en:uveitis, suppurative | n2=en:stye | rel=r_associated | relid=0 | w=79
- en:keep somebody posted ---
r_associated #0: 78 -->
en:stye
n1=en:keep somebody posted | n2=en:stye | rel=r_associated | relid=0 | w=78
- prévenir quelqu'un que ---
r_associated #0: 78 -->
en:stye
n1=prévenir quelqu'un que | n2=en:stye | rel=r_associated | relid=0 | w=78
- en:announce something to somebody ---
r_associated #0: 77 -->
en:stye
n1=en:announce something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=77
- en:warn somebody that something ---
r_associated #0: 77 -->
en:stye
n1=en:warn somebody that something | n2=en:stye | rel=r_associated | relid=0 | w=77
- informer quelqu'un de quelque chose ---
r_associated #0: 77 -->
en:stye
n1=informer quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=77
- prévenir quelqu'un de quelque chose ---
r_associated #0: 77 -->
en:stye
n1=prévenir quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=77
- en:amauroses ---
r_associated #0: 76 -->
en:stye
n1=en:amauroses | n2=en:stye | rel=r_associated | relid=0 | w=76
- en:announce sth to sb ---
r_associated #0: 76 -->
en:stye
n1=en:announce sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=76
- en:keep informed ---
r_associated #0: 76 -->
en:stye
n1=en:keep informed | n2=en:stye | rel=r_associated | relid=0 | w=76
- en:lens ---
r_associated #0: 76 -->
en:stye
n1=en:lens | n2=en:stye | rel=r_associated | relid=0 | w=76
- en:to inform sb of sth ---
r_associated #0: 76 -->
en:stye
n1=en:to inform sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=76
- prévenir [qqn] ---
r_associated #0: 76 -->
en:stye
n1=prévenir [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=76
- uvéite purulente ---
r_associated #0: 76 -->
en:stye
n1=uvéite purulente | n2=en:stye | rel=r_associated | relid=0 | w=76
- en:vitreous humour ---
r_associated #0: 75 -->
en:stye
n1=en:vitreous humour | n2=en:stye | rel=r_associated | relid=0 | w=75
- faire part de [qch] à [qqn] ---
r_associated #0: 75 -->
en:stye
n1=faire part de [qch] à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=75
- lens ---
r_associated #0: 75 -->
en:stye
n1=lens | n2=en:stye | rel=r_associated | relid=0 | w=75
- prévenir quelqu'un ---
r_associated #0: 75 -->
en:stye
n1=prévenir quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=75
- tenir quelqu'un au jus ---
r_associated #0: 75 -->
en:stye
n1=tenir quelqu'un au jus | n2=en:stye | rel=r_associated | relid=0 | w=75
- amauroses ---
r_associated #0: 74 -->
en:stye
n1=amauroses | n2=en:stye | rel=r_associated | relid=0 | w=74
- en:inform sb of sth ---
r_associated #0: 74 -->
en:stye
n1=en:inform sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=74
- en:tell somebody something ---
r_associated #0: 74 -->
en:stye
n1=en:tell somebody something | n2=en:stye | rel=r_associated | relid=0 | w=74
- saluer qn de la main ---
r_associated #0: 74 -->
en:stye
n1=saluer qn de la main | n2=en:stye | rel=r_associated | relid=0 | w=74
- en:to wave at sb ---
r_associated #0: 73 -->
en:stye
n1=en:to wave at sb | n2=en:stye | rel=r_associated | relid=0 | w=73
- en:warn somebody something ---
r_associated #0: 73 -->
en:stye
n1=en:warn somebody something | n2=en:stye | rel=r_associated | relid=0 | w=73
- prévenir [qqn] de [qch] ---
r_associated #0: 73 -->
en:stye
n1=prévenir [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=73
- tenir [qqn] au jus ---
r_associated #0: 73 -->
en:stye
n1=tenir [qqn] au jus | n2=en:stye | rel=r_associated | relid=0 | w=73
- tenir informé ---
r_associated #0: 73 -->
en:stye
n1=tenir informé | n2=en:stye | rel=r_associated | relid=0 | w=73
- en:give somebody updates ---
r_associated #0: 72 -->
en:stye
n1=en:give somebody updates | n2=en:stye | rel=r_associated | relid=0 | w=72
- en:to wave to sb ---
r_associated #0: 72 -->
en:stye
n1=en:to wave to sb | n2=en:stye | rel=r_associated | relid=0 | w=72
- tenir quelqu'un au courant ---
r_associated #0: 72 -->
en:stye
n1=tenir quelqu'un au courant | n2=en:stye | rel=r_associated | relid=0 | w=72
- en:tell somebody of something ---
r_associated #0: 71 -->
en:stye
n1=en:tell somebody of something | n2=en:stye | rel=r_associated | relid=0 | w=71
- faire signe à quelqu'un ---
r_associated #0: 71 -->
en:stye
n1=faire signe à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=71
- signaler à quelqu'un que ---
r_associated #0: 71 -->
en:stye
n1=signaler à quelqu'un que | n2=en:stye | rel=r_associated | relid=0 | w=71
- avertir quelqu'un de quelque chose ---
r_associated #0: 70 -->
en:stye
n1=avertir quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=70
- en:keep somebody informed about something ---
r_associated #0: 70 -->
en:stye
n1=en:keep somebody informed about something | n2=en:stye | rel=r_associated | relid=0 | w=70
- en:keep somebody up to date ---
r_associated #0: 70 -->
en:stye
n1=en:keep somebody up to date | n2=en:stye | rel=r_associated | relid=0 | w=70
- en:optic nerve head ---
r_associated #0: 70 -->
en:stye
n1=en:optic nerve head | n2=en:stye | rel=r_associated | relid=0 | w=70
- en:to announce sth to sb ---
r_associated #0: 70 -->
en:stye
n1=en:to announce sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=70
- en:wave to sb ---
r_associated #0: 70 -->
en:stye
n1=en:wave to sb | n2=en:stye | rel=r_associated | relid=0 | w=70
- faire part de quelque chose à quelqu'un ---
r_associated #0: 70 -->
en:stye
n1=faire part de quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=70
- ptose ---
r_associated #0: 70 -->
en:stye
n1=ptose | n2=en:stye | rel=r_associated | relid=0 | w=70
- tenir [qqn] informé de [qch] ---
r_associated #0: 70 -->
en:stye
n1=tenir [qqn] informé de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=70
- tenir informé [qqn] de [qch] ---
r_associated #0: 70 -->
en:stye
n1=tenir informé [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=70
- corps hyalin ---
r_associated #0: 69 -->
en:stye
n1=corps hyalin | n2=en:stye | rel=r_associated | relid=0 | w=69
- en:hypopyon ---
r_associated #0: 69 -->
en:stye
n1=en:hypopyon | n2=en:stye | rel=r_associated | relid=0 | w=69
- en:let know ---
r_associated #0: 69 -->
en:stye
n1=en:let know | n2=en:stye | rel=r_associated | relid=0 | w=69
- saluer quelqu'un de la main ---
r_associated #0: 69 -->
en:stye
n1=saluer quelqu'un de la main | n2=en:stye | rel=r_associated | relid=0 | w=69
- syndrome de türk-stilling-duane ---
r_associated #0: 69 -->
en:stye
n1=syndrome de türk-stilling-duane | n2=en:stye | rel=r_associated | relid=0 | w=69
- en:cyclopia ---
r_associated #0: 68 -->
en:stye
n1=en:cyclopia | n2=en:stye | rel=r_associated | relid=0 | w=68
- en:keep somebody up to date with something ---
r_associated #0: 68 -->
en:stye
n1=en:keep somebody up to date with something | n2=en:stye | rel=r_associated | relid=0 | w=68
- faire signe à [qqn] ---
r_associated #0: 68 -->
en:stye
n1=faire signe à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=68
- hypopyon ---
r_associated #0: 68 -->
en:stye
n1=hypopyon | n2=en:stye | rel=r_associated | relid=0 | w=68
- cyclopia ---
r_associated #0: 67 -->
en:stye
n1=cyclopia | n2=en:stye | rel=r_associated | relid=0 | w=67
- en:keep posted ---
r_associated #0: 67 -->
en:stye
n1=en:keep posted | n2=en:stye | rel=r_associated | relid=0 | w=67
- en:tell somebody that something ---
r_associated #0: 67 -->
en:stye
n1=en:tell somebody that something | n2=en:stye | rel=r_associated | relid=0 | w=67
- signaler à [qqn] que ---
r_associated #0: 67 -->
en:stye
n1=signaler à [qqn] que | n2=en:stye | rel=r_associated | relid=0 | w=67
- tenir au jus [qqn] ---
r_associated #0: 67 -->
en:stye
n1=tenir au jus [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=67
- tenir au jus quelqu'un ---
r_associated #0: 67 -->
en:stye
n1=tenir au jus quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=67
- cyclopie ---
r_associated #0: 66 -->
en:stye
n1=cyclopie | n2=en:stye | rel=r_associated | relid=0 | w=66
- en:give updates ---
r_associated #0: 66 -->
en:stye
n1=en:give updates | n2=en:stye | rel=r_associated | relid=0 | w=66
- en:keep somebody in the loop ---
r_associated #0: 66 -->
en:stye
n1=en:keep somebody in the loop | n2=en:stye | rel=r_associated | relid=0 | w=66
- faire signe à qn ---
r_associated #0: 66 -->
en:stye
n1=faire signe à qn | n2=en:stye | rel=r_associated | relid=0 | w=66
- faire un signe de la main à quelqu'un ---
r_associated #0: 66 -->
en:stye
n1=faire un signe de la main à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=66
- vision trouble ---
r_associated #0: 66 -->
en:stye
n1=vision trouble | n2=en:stye | rel=r_associated | relid=0 | w=66
- avertir qn de quelque chose ---
r_associated #0: 65 -->
en:stye
n1=avertir qn de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=65
- en:conjunctivitis ---
r_associated #0: 65 -->
en:stye
n1=en:conjunctivitis | n2=en:stye | rel=r_associated | relid=0 | w=65
- en:inform somebody that ---
r_associated #0: 65 -->
en:stye
n1=en:inform somebody that | n2=en:stye | rel=r_associated | relid=0 | w=65
- en:to get in touch with sb ---
r_associated #0: 65 -->
en:stye
n1=en:to get in touch with sb | n2=en:stye | rel=r_associated | relid=0 | w=65
- être en communication avec [qqn] ---
r_associated #0: 65 -->
en:stye
n1=être en communication avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=65
- en:external ophthalmoplegia ---
r_associated #0: 64 -->
en:stye
n1=en:external ophthalmoplegia | n2=en:stye | rel=r_associated | relid=0 | w=64
- en:warn ---
r_associated #0: 64 -->
en:stye
n1=en:warn | n2=en:stye | rel=r_associated | relid=0 | w=64
- orgelet ---
r_associated #0: 64 -->
en:stye
n1=orgelet | n2=en:stye | rel=r_associated | relid=0 | w=64
- ptôse ---
r_associated #0: 64 -->
en:stye
n1=ptôse | n2=en:stye | rel=r_associated | relid=0 | w=64
- tenir [qqn] au courant de [qch] ---
r_associated #0: 64 -->
en:stye
n1=tenir [qqn] au courant de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=64
- en:be on the phone to somebody ---
r_associated #0: 63 -->
en:stye
n1=en:be on the phone to somebody | n2=en:stye | rel=r_associated | relid=0 | w=63
- en:give somebody advance warning ---
r_associated #0: 63 -->
en:stye
n1=en:give somebody advance warning | n2=en:stye | rel=r_associated | relid=0 | w=63
- en:keep somebody up to date about something ---
r_associated #0: 63 -->
en:stye
n1=en:keep somebody up to date about something | n2=en:stye | rel=r_associated | relid=0 | w=63
- en:night blindness ---
r_associated #0: 63 -->
en:stye
n1=en:night blindness | n2=en:stye | rel=r_associated | relid=0 | w=63
- en:to put sth to sb ---
r_associated #0: 63 -->
en:stye
n1=en:to put sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=63
- faire savoir [qch] à [qqn] ---
r_associated #0: 63 -->
en:stye
n1=faire savoir [qch] à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=63
- lentille souple ---
r_associated #0: 63 -->
en:stye
n1=lentille souple | n2=en:stye | rel=r_associated | relid=0 | w=63
- ophtalmoplégie externe ---
r_associated #0: 63 -->
en:stye
n1=ophtalmoplégie externe | n2=en:stye | rel=r_associated | relid=0 | w=63
- orgeolet ---
r_associated #0: 63 -->
en:stye
n1=orgeolet | n2=en:stye | rel=r_associated | relid=0 | w=63
- en:blurred vision ---
r_associated #0: 62 -->
en:stye
n1=en:blurred vision | n2=en:stye | rel=r_associated | relid=0 | w=62
- en:contact lens ---
r_associated #0: 62 -->
en:stye
n1=en:contact lens | n2=en:stye | rel=r_associated | relid=0 | w=62
- en:inform sb of something ---
r_associated #0: 62 -->
en:stye
n1=en:inform sb of something | n2=en:stye | rel=r_associated | relid=0 | w=62
- en:wave to somebody ---
r_associated #0: 62 -->
en:stye
n1=en:wave to somebody | n2=en:stye | rel=r_associated | relid=0 | w=62
- en:keep somebody up to date on something ---
r_associated #0: 61 -->
en:stye
n1=en:keep somebody up to date on something | n2=en:stye | rel=r_associated | relid=0 | w=61
- en:wave at sb ---
r_associated #0: 61 -->
en:stye
n1=en:wave at sb | n2=en:stye | rel=r_associated | relid=0 | w=61
- glaucome à angle ouvert ---
r_associated #0: 61 -->
en:stye
n1=glaucome à angle ouvert | n2=en:stye | rel=r_associated | relid=0 | w=61
- tenir quelqu'un ---
r_associated #0: 61 -->
en:stye
n1=tenir quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=61
- Went (atrophie optique liée au sexe de) ---
r_associated #0: 60 -->
en:stye
n1=Went (atrophie optique liée au sexe de) | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:advise somebody of something ---
r_associated #0: 60 -->
en:stye
n1=en:advise somebody of something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:apprise somebody of something ---
r_associated #0: 60 -->
en:stye
n1=en:apprise somebody of something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:apprise somebody that something ---
r_associated #0: 60 -->
en:stye
n1=en:apprise somebody that something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:get in touch with sb ---
r_associated #0: 60 -->
en:stye
n1=en:get in touch with sb | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:inform somebody something ---
r_associated #0: 60 -->
en:stye
n1=en:inform somebody something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:inform somebody that something ---
r_associated #0: 60 -->
en:stye
n1=en:inform somebody that something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:let somebody know that ---
r_associated #0: 60 -->
en:stye
n1=en:let somebody know that | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:let somebody know that something ---
r_associated #0: 60 -->
en:stye
n1=en:let somebody know that something | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:open-angle glaucoma ---
r_associated #0: 60 -->
en:stye
n1=en:open-angle glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:tremulousness of the iris ---
r_associated #0: 60 -->
en:stye
n1=en:tremulousness of the iris | n2=en:stye | rel=r_associated | relid=0 | w=60
- instruire qn de quelque chose ---
r_associated #0: 60 -->
en:stye
n1=instruire qn de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=60
- instruire quelqu'un de quelque chose ---
r_associated #0: 60 -->
en:stye
n1=instruire quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=60
- tenir informé quelqu'un de quelque chose ---
r_associated #0: 60 -->
en:stye
n1=tenir informé quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=60
- verre de contact ---
r_associated #0: 60 -->
en:stye
n1=verre de contact | n2=en:stye | rel=r_associated | relid=0 | w=60
- en:give somebody some advance warning ---
r_associated #0: 59 -->
en:stye
n1=en:give somebody some advance warning | n2=en:stye | rel=r_associated | relid=0 | w=59
- en:optic atrophy ---
r_associated #0: 59 -->
en:stye
n1=en:optic atrophy | n2=en:stye | rel=r_associated | relid=0 | w=59
- en:warn somebody of something ---
r_associated #0: 59 -->
en:stye
n1=en:warn somebody of something | n2=en:stye | rel=r_associated | relid=0 | w=59
- faire un signe de la main à qn ---
r_associated #0: 59 -->
en:stye
n1=faire un signe de la main à qn | n2=en:stye | rel=r_associated | relid=0 | w=59
- informer quelqu'un que quelque chose... ---
r_associated #0: 59 -->
en:stye
n1=informer quelqu'un que quelque chose... | n2=en:stye | rel=r_associated | relid=0 | w=59
- en:be on the phone with somebody ---
r_associated #0: 58 -->
en:stye
n1=en:be on the phone with somebody | n2=en:stye | rel=r_associated | relid=0 | w=58
- tenir [qqn] ---
r_associated #0: 58 -->
en:stye
n1=tenir [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=58
- en:keep in the loop ---
r_associated #0: 57 -->
en:stye
n1=en:keep in the loop | n2=en:stye | rel=r_associated | relid=0 | w=57
- lentille cornéenne ---
r_associated #0: 57 -->
en:stye
n1=lentille cornéenne | n2=en:stye | rel=r_associated | relid=0 | w=57
- tenir [qqn] de [qch] ---
r_associated #0: 57 -->
en:stye
n1=tenir [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=57
- en:give somebody a heads up ---
r_associated #0: 56 -->
en:stye
n1=en:give somebody a heads up | n2=en:stye | rel=r_associated | relid=0 | w=56
- en:give somebody updates on something ---
r_associated #0: 56 -->
en:stye
n1=en:give somebody updates on something | n2=en:stye | rel=r_associated | relid=0 | w=56
- en:keep somebody in the loop about something ---
r_associated #0: 56 -->
en:stye
n1=en:keep somebody in the loop about something | n2=en:stye | rel=r_associated | relid=0 | w=56
- en:keep somebody posted about something ---
r_associated #0: 56 -->
en:stye
n1=en:keep somebody posted about something | n2=en:stye | rel=r_associated | relid=0 | w=56
- lentille de contact ---
r_associated #0: 56 -->
en:stye
n1=lentille de contact | n2=en:stye | rel=r_associated | relid=0 | w=56
- tenir quelqu'un au courant de quelque chose ---
r_associated #0: 56 -->
en:stye
n1=tenir quelqu'un au courant de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=56
- Völker-Dieben (atrophie optique liée au sexe de) ---
r_associated #0: 55 -->
en:stye
n1=Völker-Dieben (atrophie optique liée au sexe de) | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:advise somebody that something ---
r_associated #0: 55 -->
en:stye
n1=en:advise somebody that something | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:get in touch with somebody ---
r_associated #0: 55 -->
en:stye
n1=en:get in touch with somebody | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:give somebody notice that something ---
r_associated #0: 55 -->
en:stye
n1=en:give somebody notice that something | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:hordeolum ---
r_associated #0: 55 -->
en:stye
n1=en:hordeolum | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:wide-angle glaucoma ---
r_associated #0: 55 -->
en:stye
n1=en:wide-angle glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=55
- faire savoir quelque chose à quelqu'un ---
r_associated #0: 55 -->
en:stye
n1=faire savoir quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=55
- néoformation de vaisseaux sanguins ---
r_associated #0: 55 -->
en:stye
n1=néoformation de vaisseaux sanguins | n2=en:stye | rel=r_associated | relid=0 | w=55
- se mettre en contact avec qn ---
r_associated #0: 55 -->
en:stye
n1=se mettre en contact avec qn | n2=en:stye | rel=r_associated | relid=0 | w=55
- se mettre en contact avec quelqu'un ---
r_associated #0: 55 -->
en:stye
n1=se mettre en contact avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=55
- se mettre en rapport avec [qqn] ---
r_associated #0: 55 -->
en:stye
n1=se mettre en rapport avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=55
- télécanthus-hypertélorisme-strabisme (syndrome) ---
r_associated #0: 55 -->
en:stye
n1=télécanthus-hypertélorisme-strabisme (syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=55
- être en communication avec quelqu'un ---
r_associated #0: 55 -->
en:stye
n1=être en communication avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=55
- en:X-linked ---
r_associated #0: 54 -->
en:stye
n1=en:X-linked | n2=en:stye | rel=r_associated | relid=0 | w=54
- en:telecanthus ---
r_associated #0: 54 -->
en:stye
n1=en:telecanthus | n2=en:stye | rel=r_associated | relid=0 | w=54
- passer le mot à [qqn] ---
r_associated #0: 54 -->
en:stye
n1=passer le mot à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=54
- en:be speaking to somebody ---
r_associated #0: 53 -->
en:stye
n1=en:be speaking to somebody | n2=en:stye | rel=r_associated | relid=0 | w=53
- en:keep up to date ---
r_associated #0: 53 -->
en:stye
n1=en:keep up to date | n2=en:stye | rel=r_associated | relid=0 | w=53
- en:make contact with somebody ---
r_associated #0: 53 -->
en:stye
n1=en:make contact with somebody | n2=en:stye | rel=r_associated | relid=0 | w=53
- en:neovascularization ---
r_associated #0: 53 -->
en:stye
n1=en:neovascularization | n2=en:stye | rel=r_associated | relid=0 | w=53
- faire signe de la main à [qqn] ---
r_associated #0: 53 -->
en:stye
n1=faire signe de la main à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=53
- informer [qqn] que [qch]... ---
r_associated #0: 53 -->
en:stye
n1=informer [qqn] que [qch]... | n2=en:stye | rel=r_associated | relid=0 | w=53
- tenir au courant ---
r_associated #0: 53 -->
en:stye
n1=tenir au courant | n2=en:stye | rel=r_associated | relid=0 | w=53
- tenir au jus ---
r_associated #0: 53 -->
en:stye
n1=tenir au jus | n2=en:stye | rel=r_associated | relid=0 | w=53
- en:advise sb of sth ---
r_associated #0: 52 -->
en:stye
n1=en:advise sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=52
- être en liaison avec quelqu'un ---
r_associated #0: 52 -->
en:stye
n1=être en liaison avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=52
- dégénérescence maculaire liée à l'âge ---
r_associated #0: 51 -->
en:stye
n1=dégénérescence maculaire liée à l'âge | n2=en:stye | rel=r_associated | relid=0 | w=51
- en:acanthosis ---
r_associated #0: 51 -->
en:stye
n1=en:acanthosis | n2=en:stye | rel=r_associated | relid=0 | w=51
- xanthome ---
r_associated #0: 51 -->
en:stye
n1=xanthome | n2=en:stye | rel=r_associated | relid=0 | w=51
- être en liaison avec [qqn] ---
r_associated #0: 51 -->
en:stye
n1=être en liaison avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=51
- Corps vitré ---
r_associated #0: 50 -->
en:stye
n1=Corps vitré | n2=en:stye | rel=r_associated | relid=0 | w=50
- Disque optique ---
r_associated #0: 50 -->
en:stye
n1=Disque optique | n2=en:stye | rel=r_associated | relid=0 | w=50
- atrophie optique liée au sexe de Völker-Dieben ---
r_associated #0: 50 -->
en:stye
n1=atrophie optique liée au sexe de Völker-Dieben | n2=en:stye | rel=r_associated | relid=0 | w=50
- avertir [qqn] que ---
r_associated #0: 50 -->
en:stye
n1=avertir [qqn] que | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:advise somebody something ---
r_associated #0: 50 -->
en:stye
n1=en:advise somebody something | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:be in contact with somebody ---
r_associated #0: 50 -->
en:stye
n1=en:be in contact with somebody | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:contact somebody ---
r_associated #0: 50 -->
en:stye
n1=en:contact somebody | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:distichiasis ---
r_associated #0: 50 -->
en:stye
n1=en:distichiasis | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:give somebody notice of something ---
r_associated #0: 50 -->
en:stye
n1=en:give somebody notice of something | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:optical disk ---
r_associated #0: 50 -->
en:stye
n1=en:optical disk | n2=en:stye | rel=r_associated | relid=0 | w=50
- en:tunica conjunctiva ---
r_associated #0: 50 -->
en:stye
n1=en:tunica conjunctiva | n2=en:stye | rel=r_associated | relid=0 | w=50
- entrer en contact avec [qqn] ---
r_associated #0: 50 -->
en:stye
n1=entrer en contact avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=50
- glaucome ---
r_associated #0: 50 -->
en:stye
n1=glaucome | n2=en:stye | rel=r_associated | relid=0 | w=50
- instruire qn de qch ---
r_associated #0: 50 -->
en:stye
n1=instruire qn de qch | n2=en:stye | rel=r_associated | relid=0 | w=50
- se mettre en contact avec [qqn] ---
r_associated #0: 50 -->
en:stye
n1=se mettre en contact avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=50
- se mettre en rapport avec qn ---
r_associated #0: 50 -->
en:stye
n1=se mettre en rapport avec qn | n2=en:stye | rel=r_associated | relid=0 | w=50
- se mettre en rapport avec quelqu'un ---
r_associated #0: 50 -->
en:stye
n1=se mettre en rapport avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=50
- signaler à ---
r_associated #0: 50 -->
en:stye
n1=signaler à | n2=en:stye | rel=r_associated | relid=0 | w=50
- être en contact avec [qqn] ---
r_associated #0: 50 -->
en:stye
n1=être en contact avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=50
- être en contact avec quelqu'un ---
r_associated #0: 50 -->
en:stye
n1=être en contact avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=50
- avertir quelqu'un que ---
r_associated #0: 49 -->
en:stye
n1=avertir quelqu'un que | n2=en:stye | rel=r_associated | relid=0 | w=49
- en:be speaking with somebody ---
r_associated #0: 49 -->
en:stye
n1=en:be speaking with somebody | n2=en:stye | rel=r_associated | relid=0 | w=49
- en:xanthoma ---
r_associated #0: 49 -->
en:stye
n1=en:xanthoma | n2=en:stye | rel=r_associated | relid=0 | w=49
- faire signe de la main à quelqu'un ---
r_associated #0: 49 -->
en:stye
n1=faire signe de la main à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=49
- hypertélorisme-microtie-fente faciale ---
r_associated #0: 49 -->
en:stye
n1=hypertélorisme-microtie-fente faciale | n2=en:stye | rel=r_associated | relid=0 | w=49
- en:signal to somebody ---
r_associated #0: 48 -->
en:stye
n1=en:signal to somebody | n2=en:stye | rel=r_associated | relid=0 | w=48
- en:to make contact with sb ---
r_associated #0: 48 -->
en:stye
n1=en:to make contact with sb | n2=en:stye | rel=r_associated | relid=0 | w=48
- en:to warn sb of sth ---
r_associated #0: 48 -->
en:stye
n1=en:to warn sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=48
- télécanthus ---
r_associated #0: 48 -->
en:stye
n1=télécanthus | n2=en:stye | rel=r_associated | relid=0 | w=48
- xanthoma ---
r_associated #0: 48 -->
en:stye
n1=xanthoma | n2=en:stye | rel=r_associated | relid=0 | w=48
- acanthosis ---
r_associated #0: 47 -->
en:stye
n1=acanthosis | n2=en:stye | rel=r_associated | relid=0 | w=47
- distichiasis ---
r_associated #0: 47 -->
en:stye
n1=distichiasis | n2=en:stye | rel=r_associated | relid=0 | w=47
- en:blindness ---
r_associated #0: 47 -->
en:stye
n1=en:blindness | n2=en:stye | rel=r_associated | relid=0 | w=47
- en:make contact with sb ---
r_associated #0: 47 -->
en:stye
n1=en:make contact with sb | n2=en:stye | rel=r_associated | relid=0 | w=47
- en:proptosis ---
r_associated #0: 47 -->
en:stye
n1=en:proptosis | n2=en:stye | rel=r_associated | relid=0 | w=47
- en:pyogenic uveitis ---
r_associated #0: 47 -->
en:stye
n1=en:pyogenic uveitis | n2=en:stye | rel=r_associated | relid=0 | w=47
- hyperacanthose ---
r_associated #0: 47 -->
en:stye
n1=hyperacanthose | n2=en:stye | rel=r_associated | relid=0 | w=47
- en:be talking to somebody ---
r_associated #0: 46 -->
en:stye
n1=en:be talking to somebody | n2=en:stye | rel=r_associated | relid=0 | w=46
- en:glaucoma ---
r_associated #0: 46 -->
en:stye
n1=en:glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=46
- en:hypopion ---
r_associated #0: 46 -->
en:stye
n1=en:hypopion | n2=en:stye | rel=r_associated | relid=0 | w=46
- en:to warn sb about sth ---
r_associated #0: 46 -->
en:stye
n1=en:to warn sb about sth | n2=en:stye | rel=r_associated | relid=0 | w=46
- en:warn sb about sth ---
r_associated #0: 46 -->
en:stye
n1=en:warn sb about sth | n2=en:stye | rel=r_associated | relid=0 | w=46
- en:warn sb of sth ---
r_associated #0: 46 -->
en:stye
n1=en:warn sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=46
- érosion cornéenne ---
r_associated #0: 46 -->
en:stye
n1=érosion cornéenne | n2=en:stye | rel=r_associated | relid=0 | w=46
- affection ophtalmologique ---
r_associated #0: 45 -->
en:stye
n1=affection ophtalmologique | n2=en:stye | rel=r_associated | relid=0 | w=45
- blindness ---
r_associated #0: 45 -->
en:stye
n1=blindness | n2=en:stye | rel=r_associated | relid=0 | w=45
- décollement du corps vitré ---
r_associated #0: 45 -->
en:stye
n1=décollement du corps vitré | n2=en:stye | rel=r_associated | relid=0 | w=45
- en:be in touch with somebody ---
r_associated #0: 45 -->
en:stye
n1=en:be in touch with somebody | n2=en:stye | rel=r_associated | relid=0 | w=45
- en:get in contact with somebody ---
r_associated #0: 45 -->
en:stye
n1=en:get in contact with somebody | n2=en:stye | rel=r_associated | relid=0 | w=45
- en:liaise with somebody ---
r_associated #0: 45 -->
en:stye
n1=en:liaise with somebody | n2=en:stye | rel=r_associated | relid=0 | w=45
- en:put a tap on somebody ---
r_associated #0: 45 -->
en:stye
n1=en:put a tap on somebody | n2=en:stye | rel=r_associated | relid=0 | w=45
- en:tap somebody 's phone ---
r_associated #0: 45 -->
en:stye
n1=en:tap somebody 's phone | n2=en:stye | rel=r_associated | relid=0 | w=45
- entrer en contact avec quelqu'un ---
r_associated #0: 45 -->
en:stye
n1=entrer en contact avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=45
- entrer en relation avec [qqn] ---
r_associated #0: 45 -->
en:stye
n1=entrer en relation avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=45
- entrer en relation avec quelqu'un ---
r_associated #0: 45 -->
en:stye
n1=entrer en relation avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=45
- hypertélorisme, hypospadias, polysyndactylie (syndrome) ---
r_associated #0: 45 -->
en:stye
n1=hypertélorisme, hypospadias, polysyndactylie (syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=45
- kératite en bandelette ---
r_associated #0: 45 -->
en:stye
n1=kératite en bandelette | n2=en:stye | rel=r_associated | relid=0 | w=45
- mettre [qqn] ---
r_associated #0: 45 -->
en:stye
n1=mettre [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=45
- passer le mot à quelqu'un ---
r_associated #0: 45 -->
en:stye
n1=passer le mot à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=45
- s'aboucher avec [qqn] ---
r_associated #0: 45 -->
en:stye
n1=s'aboucher avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=45
- s'aboucher avec quelqu'un ---
r_associated #0: 45 -->
en:stye
n1=s'aboucher avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=45
- Nougaret (héméralopie essentielle de) ---
r_associated #0: 44 -->
en:stye
n1=Nougaret (héméralopie essentielle de) | n2=en:stye | rel=r_associated | relid=0 | w=44
- en:inform somebody ---
r_associated #0: 44 -->
en:stye
n1=en:inform somebody | n2=en:stye | rel=r_associated | relid=0 | w=44
- en:put somebody in danger ---
r_associated #0: 44 -->
en:stye
n1=en:put somebody in danger | n2=en:stye | rel=r_associated | relid=0 | w=44
- en:type Völker-Dieben ---
r_associated #0: 44 -->
en:stye
n1=en:type Völker-Dieben | n2=en:stye | rel=r_associated | relid=0 | w=44
- en:vitreous humor ---
r_associated #0: 44 -->
en:stye
n1=en:vitreous humor | n2=en:stye | rel=r_associated | relid=0 | w=44
- syndrome de Treft-Sanborn-Carey ---
r_associated #0: 44 -->
en:stye
n1=syndrome de Treft-Sanborn-Carey | n2=en:stye | rel=r_associated | relid=0 | w=44
- diplopie ---
r_associated #0: 43 -->
en:stye
n1=diplopie | n2=en:stye | rel=r_associated | relid=0 | w=43
- décollement du vitré ---
r_associated #0: 43 -->
en:stye
n1=décollement du vitré | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:abnormal light- and dark-adapted electroretinogram ---
r_associated #0: 43 -->
en:stye
n1=en:abnormal light- and dark-adapted electroretinogram | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:abnormal ocular movements (in some patients) ---
r_associated #0: 43 -->
en:stye
n1=en:abnormal ocular movements (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:absent peripapillary choriocapillaris ---
r_associated #0: 43 -->
en:stye
n1=en:absent peripapillary choriocapillaris | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:anterior chamber depth increased ---
r_associated #0: 43 -->
en:stye
n1=en:anterior chamber depth increased | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:diffuse pigmentary stippling of peripheral retina ---
r_associated #0: 43 -->
en:stye
n1=en:diffuse pigmentary stippling of peripheral retina | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:distinctive electroretinogram - focal macular cone erg is well-preserved ---
r_associated #0: 43 -->
en:stye
n1=en:distinctive electroretinogram - focal macular cone erg is well-preserved | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:endophthalmitis ---
r_associated #0: 43 -->
en:stye
n1=en:endophthalmitis | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:enlarged globes ---
r_associated #0: 43 -->
en:stye
n1=en:enlarged globes | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:fundoscopy normal ---
r_associated #0: 43 -->
en:stye
n1=en:fundoscopy normal | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:horizontal pendular nystagmus ---
r_associated #0: 43 -->
en:stye
n1=en:horizontal pendular nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:inferior and inferonasal retinal pigmentation (e.g. 180380.0004 and 180380.0025) ---
r_associated #0: 43 -->
en:stye
n1=en:inferior and inferonasal retinal pigmentation (e.g. 180380.0004 and 180380.0025) | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:irregular pigmentation of fundus (in carrier females) ---
r_associated #0: 43 -->
en:stye
n1=en:irregular pigmentation of fundus (in carrier females) | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:mildly downslanting palpebral fissures ---
r_associated #0: 43 -->
en:stye
n1=en:mildly downslanting palpebral fissures | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:normal or mildly reduced cone responses under photopic conditions ---
r_associated #0: 43 -->
en:stye
n1=en:normal or mildly reduced cone responses under photopic conditions | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:ophthalmoplegia (in some patients) ---
r_associated #0: 43 -->
en:stye
n1=en:ophthalmoplegia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=43
- en:periumbilical abscess ---
r_associated #0: 43 -->
en:stye
n1=en:periumbilical abscess | n2=en:stye | rel=r_associated | relid=0 | w=43
- atrophie optique liée au sexe ---
r_associated #0: 42 -->
en:stye
n1=atrophie optique liée au sexe | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:'moth-eaten' pattern of peripupillary atrophy ---
r_associated #0: 42 -->
en:stye
n1=en:'moth-eaten' pattern of peripupillary atrophy | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:cataracts, postnatal ---
r_associated #0: 42 -->
en:stye
n1=en:cataracts, postnatal | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:congenital absence of tears ---
r_associated #0: 42 -->
en:stye
n1=en:congenital absence of tears | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:congenital myopia ---
r_associated #0: 42 -->
en:stye
n1=en:congenital myopia | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:corneal abrasion ---
r_associated #0: 42 -->
en:stye
n1=en:corneal abrasion | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:decreased visual acuity, in some female carriers ---
r_associated #0: 42 -->
en:stye
n1=en:decreased visual acuity, in some female carriers | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:dyschromatopsia ---
r_associated #0: 42 -->
en:stye
n1=en:dyschromatopsia | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:etiology aspects ---
r_associated #0: 42 -->
en:stye
n1=en:etiology aspects | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:eye anomalies, variable ---
r_associated #0: 42 -->
en:stye
n1=en:eye anomalies, variable | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:eye pain ---
r_associated #0: 42 -->
en:stye
n1=en:eye pain | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:eyelids (symptom) ---
r_associated #0: 42 -->
en:stye
n1=en:eyelids (symptom) | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:fear of eye disease ---
r_associated #0: 42 -->
en:stye
n1=en:fear of eye disease | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:fundus pigment lumps, bone-corpuscle/bone-spicule pattern ---
r_associated #0: 42 -->
en:stye
n1=en:fundus pigment lumps, bone-corpuscle/bone-spicule pattern | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:lack of fixation ---
r_associated #0: 42 -->
en:stye
n1=en:lack of fixation | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:limbitis ---
r_associated #0: 42 -->
en:stye
n1=en:limbitis | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:loss of eye contact ---
r_associated #0: 42 -->
en:stye
n1=en:loss of eye contact | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:myopia, progressive severe ---
r_associated #0: 42 -->
en:stye
n1=en:myopia, progressive severe | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:optic atrophy, bilateral (in some patients) ---
r_associated #0: 42 -->
en:stye
n1=en:optic atrophy, bilateral (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:optic neuropathy ---
r_associated #0: 42 -->
en:stye
n1=en:optic neuropathy | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:weakness of orbicularis oculi muscle ---
r_associated #0: 42 -->
en:stye
n1=en:weakness of orbicularis oculi muscle | n2=en:stye | rel=r_associated | relid=0 | w=42
- en:absent night vision ---
r_associated #0: 41 -->
en:stye
n1=en:absent night vision | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:band keratopathy ---
r_associated #0: 41 -->
en:stye
n1=en:band keratopathy | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:bilateral congenital cataracts (males) ---
r_associated #0: 41 -->
en:stye
n1=en:bilateral congenital cataracts (males) | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:clear cornea ---
r_associated #0: 41 -->
en:stye
n1=en:clear cornea | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:coloboma of the iris ---
r_associated #0: 41 -->
en:stye
n1=en:coloboma of the iris | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:corneal diameter, normal ---
r_associated #0: 41 -->
en:stye
n1=en:corneal diameter, normal | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:glaucoma (75%) ---
r_associated #0: 41 -->
en:stye
n1=en:glaucoma (75%) | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:hypertelorism (25%) ---
r_associated #0: 41 -->
en:stye
n1=en:hypertelorism (25%) | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:macular atrophy (in some patients) ---
r_associated #0: 41 -->
en:stye
n1=en:macular atrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:optic atrophy, isolated ---
r_associated #0: 41 -->
en:stye
n1=en:optic atrophy, isolated | n2=en:stye | rel=r_associated | relid=0 | w=41
- en:photosensitivity of skin ---
r_associated #0: 41 -->
en:stye
n1=en:photosensitivity of skin | n2=en:stye | rel=r_associated | relid=0 | w=41
- endophtalmie ---
r_associated #0: 41 -->
en:stye
n1=endophtalmie | n2=en:stye | rel=r_associated | relid=0 | w=41
- faire savoir [qch] à ---
r_associated #0: 41 -->
en:stye
n1=faire savoir [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=41
- faire savoir quelque chose à ---
r_associated #0: 41 -->
en:stye
n1=faire savoir quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=41
- glaucoma ---
r_associated #0: 41 -->
en:stye
n1=glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=41
- strabisme ---
r_associated #0: 41 -->
en:stye
n1=strabisme | n2=en:stye | rel=r_associated | relid=0 | w=41
- énophtalmie ---
r_associated #0: 41 -->
en:stye
n1=énophtalmie | n2=en:stye | rel=r_associated | relid=0 | w=41
- UUKV ---
r_associated #0: 40 -->
en:stye
n1=UUKV | n2=en:stye | rel=r_associated | relid=0 | w=40
- conjonctivite ---
r_associated #0: 40 -->
en:stye
n1=conjonctivite | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:absent macular reflex ---
r_associated #0: 40 -->
en:stye
n1=en:absent macular reflex | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:cataract, anterior polar, nonprogressive ---
r_associated #0: 40 -->
en:stye
n1=en:cataract, anterior polar, nonprogressive | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:chorio-retinitis ---
r_associated #0: 40 -->
en:stye
n1=en:chorio-retinitis | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:conjunctival ---
r_associated #0: 40 -->
en:stye
n1=en:conjunctival | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:conjunctive ---
r_associated #0: 40 -->
en:stye
n1=en:conjunctive | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:decreased visual acuity ---
r_associated #0: 40 -->
en:stye
n1=en:decreased visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:heartbreak ---
r_associated #0: 40 -->
en:stye
n1=en:heartbreak | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:hypertelorism (reported in 1 patient) ---
r_associated #0: 40 -->
en:stye
n1=en:hypertelorism (reported in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:keep somebody informed of something ---
r_associated #0: 40 -->
en:stye
n1=en:keep somebody informed of something | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:keep somebody updated ---
r_associated #0: 40 -->
en:stye
n1=en:keep somebody updated | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:keep somebody updated on something ---
r_associated #0: 40 -->
en:stye
n1=en:keep somebody updated on something | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:let somebody know about something ---
r_associated #0: 40 -->
en:stye
n1=en:let somebody know about something | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:mild transient cherry-red spot ---
r_associated #0: 40 -->
en:stye
n1=en:mild transient cherry-red spot | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:notify somebody that ---
r_associated #0: 40 -->
en:stye
n1=en:notify somebody that | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:oculus dexter ---
r_associated #0: 40 -->
en:stye
n1=en:oculus dexter | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:send word to somebody ---
r_associated #0: 40 -->
en:stye
n1=en:send word to somebody | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:skin photosensitivity ---
r_associated #0: 40 -->
en:stye
n1=en:skin photosensitivity | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:to advise sb of sth ---
r_associated #0: 40 -->
en:stye
n1=en:to advise sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=40
- en:vitreous detachment ---
r_associated #0: 40 -->
en:stye
n1=en:vitreous detachment | n2=en:stye | rel=r_associated | relid=0 | w=40
- faire savoir qch à quelqu'un ---
r_associated #0: 40 -->
en:stye
n1=faire savoir qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=40
- hypoplasie du nerf optique bilatérale et familiale ---
r_associated #0: 40 -->
en:stye
n1=hypoplasie du nerf optique bilatérale et familiale | n2=en:stye | rel=r_associated | relid=0 | w=40
- maladie de Benson ---
r_associated #0: 40 -->
en:stye
n1=maladie de Benson | n2=en:stye | rel=r_associated | relid=0 | w=40
- mettre quelqu'un ---
r_associated #0: 40 -->
en:stye
n1=mettre quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=40
- microbiologique ---
r_associated #0: 40 -->
en:stye
n1=microbiologique | n2=en:stye | rel=r_associated | relid=0 | w=40
- paralysie oculomotrice extrinsèque ---
r_associated #0: 40 -->
en:stye
n1=paralysie oculomotrice extrinsèque | n2=en:stye | rel=r_associated | relid=0 | w=40
- syndrome des cils longs ---
r_associated #0: 40 -->
en:stye
n1=syndrome des cils longs | n2=en:stye | rel=r_associated | relid=0 | w=40
- être en rapport avec [qqn] ---
r_associated #0: 40 -->
en:stye
n1=être en rapport avec [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=40
- être en rapport avec quelqu'un ---
r_associated #0: 40 -->
en:stye
n1=être en rapport avec quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=40
- angine diphtérique commune ---
r_associated #0: 39 -->
en:stye
n1=angine diphtérique commune | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:abduction deficits (about half of patients) ---
r_associated #0: 39 -->
en:stye
n1=en:abduction deficits (about half of patients) | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:axenfeld-rieger syndrome ---
r_associated #0: 39 -->
en:stye
n1=en:axenfeld-rieger syndrome | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:congenital bilateral ptosis ---
r_associated #0: 39 -->
en:stye
n1=en:congenital bilateral ptosis | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:diplopia ---
r_associated #0: 39 -->
en:stye
n1=en:diplopia | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:displacement of pupil, inferior (in some patients) ---
r_associated #0: 39 -->
en:stye
n1=en:displacement of pupil, inferior (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:eye ---
r_associated #0: 39 -->
en:stye
n1=en:eye | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:eyelid and corneal neuromas ---
r_associated #0: 39 -->
en:stye
n1=en:eyelid and corneal neuromas | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:keep someone posted ---
r_associated #0: 39 -->
en:stye
n1=en:keep someone posted | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:keep someone up to speed ---
r_associated #0: 39 -->
en:stye
n1=en:keep someone up to speed | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:let someone know ---
r_associated #0: 39 -->
en:stye
n1=en:let someone know | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:long eyelashes ---
r_associated #0: 39 -->
en:stye
n1=en:long eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:optic nerve excavation (rare) ---
r_associated #0: 39 -->
en:stye
n1=en:optic nerve excavation (rare) | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:optic nerve glioma ---
r_associated #0: 39 -->
en:stye
n1=en:optic nerve glioma | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:strabismus ---
r_associated #0: 39 -->
en:stye
n1=en:strabismus | n2=en:stye | rel=r_associated | relid=0 | w=39
- en:type Went ---
r_associated #0: 39 -->
en:stye
n1=en:type Went | n2=en:stye | rel=r_associated | relid=0 | w=39
- hernie diaphragmatique, exomphalocèle, absence de corps calleux, hypertélorisme, myopie et surdité neurosensorielle ---
r_associated #0: 39 -->
en:stye
n1=hernie diaphragmatique, exomphalocèle, absence de corps calleux, hypertélorisme, myopie et surdité neurosensorielle | n2=en:stye | rel=r_associated | relid=0 | w=39
- hordéole ---
r_associated #0: 39 -->
en:stye
n1=hordéole | n2=en:stye | rel=r_associated | relid=0 | w=39
- apprendre [qch] à [qqn] ---
r_associated #0: 38 -->
en:stye
n1=apprendre [qch] à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=38
- avertir qn que ---
r_associated #0: 38 -->
en:stye
n1=avertir qn que | n2=en:stye | rel=r_associated | relid=0 | w=38
- déficience visuelle ---
r_associated #0: 38 -->
en:stye
n1=déficience visuelle | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:anterior chamber anomalies ---
r_associated #0: 38 -->
en:stye
n1=en:anterior chamber anomalies | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:aspects of mortality statistics ---
r_associated #0: 38 -->
en:stye
n1=en:aspects of mortality statistics | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:concentric constriction of visual fields bilaterally ---
r_associated #0: 38 -->
en:stye
n1=en:concentric constriction of visual fields bilaterally | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:cone-first retinal dystrophy ---
r_associated #0: 38 -->
en:stye
n1=en:cone-first retinal dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:decreased lacrimation ---
r_associated #0: 38 -->
en:stye
n1=en:decreased lacrimation | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:decreased visual acuity, progressive ---
r_associated #0: 38 -->
en:stye
n1=en:decreased visual acuity, progressive | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:ectopia lentis (84%) ---
r_associated #0: 38 -->
en:stye
n1=en:ectopia lentis (84%) | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:epiphora, severe ---
r_associated #0: 38 -->
en:stye
n1=en:epiphora, severe | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:glaucoma of childhood ---
r_associated #0: 38 -->
en:stye
n1=en:glaucoma of childhood | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:iris rigidity ---
r_associated #0: 38 -->
en:stye
n1=en:iris rigidity | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:macular exudates and hemorrhages ---
r_associated #0: 38 -->
en:stye
n1=en:macular exudates and hemorrhages | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:megalocornea (in some patients) ---
r_associated #0: 38 -->
en:stye
n1=en:megalocornea (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:night blindness, stationary ---
r_associated #0: 38 -->
en:stye
n1=en:night blindness, stationary | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:no corneal opacities ---
r_associated #0: 38 -->
en:stye
n1=en:no corneal opacities | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:nyctalopia ---
r_associated #0: 38 -->
en:stye
n1=en:nyctalopia | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:nystagmus (in some patients) ---
r_associated #0: 38 -->
en:stye
n1=en:nystagmus (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:ocular foreign body ---
r_associated #0: 38 -->
en:stye
n1=en:ocular foreign body | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:open angle glaucoma ---
r_associated #0: 38 -->
en:stye
n1=en:open angle glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=38
- en:teach somebody something ---
r_associated #0: 38 -->
en:stye
n1=en:teach somebody something | n2=en:stye | rel=r_associated | relid=0 | w=38
- faire signe de la main à ---
r_associated #0: 38 -->
en:stye
n1=faire signe de la main à | n2=en:stye | rel=r_associated | relid=0 | w=38
- hypoplasie papillaire ---
r_associated #0: 38 -->
en:stye
n1=hypoplasie papillaire | n2=en:stye | rel=r_associated | relid=0 | w=38
- retard mental, retard de croissance, surdité, microgénitalisme lié au sexe ---
r_associated #0: 38 -->
en:stye
n1=retard mental, retard de croissance, surdité, microgénitalisme lié au sexe | n2=en:stye | rel=r_associated | relid=0 | w=38
- Türk-Stilling-Duane (syndrome de) ---
r_associated #0: 37 -->
en:stye
n1=Türk-Stilling-Duane (syndrome de) | n2=en:stye | rel=r_associated | relid=0 | w=37
- dystrophie rétinienne réticulée pigmentée du pôle postérieur ---
r_associated #0: 37 -->
en:stye
n1=dystrophie rétinienne réticulée pigmentée du pôle postérieur | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:anterior cortical cataract ---
r_associated #0: 37 -->
en:stye
n1=en:anterior cortical cataract | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:aplasia or atrophy of the dilatator pupillae muscle ---
r_associated #0: 37 -->
en:stye
n1=en:aplasia or atrophy of the dilatator pupillae muscle | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:asteroid hyalosis ---
r_associated #0: 37 -->
en:stye
n1=en:asteroid hyalosis | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:blue/yellow color vision defect ---
r_associated #0: 37 -->
en:stye
n1=en:blue/yellow color vision defect | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:corneal drying ---
r_associated #0: 37 -->
en:stye
n1=en:corneal drying | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:cryptophthalmia ---
r_associated #0: 37 -->
en:stye
n1=en:cryptophthalmia | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:dacryocystitis (in some patients) ---
r_associated #0: 37 -->
en:stye
n1=en:dacryocystitis (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:eczematous dermatitis of eyelid ---
r_associated #0: 37 -->
en:stye
n1=en:eczematous dermatitis of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:enophthalmos ---
r_associated #0: 37 -->
en:stye
n1=en:enophthalmos | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:epicanthal folds (39%) ---
r_associated #0: 37 -->
en:stye
n1=en:epicanthal folds (39%) | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:epicanthal folds (89%) ---
r_associated #0: 37 -->
en:stye
n1=en:epicanthal folds (89%) | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:esotropia (1 patient) ---
r_associated #0: 37 -->
en:stye
n1=en:esotropia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:impaired horizontal smooth pursuit ---
r_associated #0: 37 -->
en:stye
n1=en:impaired horizontal smooth pursuit | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:infectious iridocyclitis ---
r_associated #0: 37 -->
en:stye
n1=en:infectious iridocyclitis | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:interictal downbeat nystagmus ---
r_associated #0: 37 -->
en:stye
n1=en:interictal downbeat nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:macrosaccadic oscillations ---
r_associated #0: 37 -->
en:stye
n1=en:macrosaccadic oscillations | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:ocular hypopigmentation ---
r_associated #0: 37 -->
en:stye
n1=en:ocular hypopigmentation | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:pediatric terminology ---
r_associated #0: 37 -->
en:stye
n1=en:pediatric terminology | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:protopsis ---
r_associated #0: 37 -->
en:stye
n1=en:protopsis | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:put somebody at risk ---
r_associated #0: 37 -->
en:stye
n1=en:put somebody at risk | n2=en:stye | rel=r_associated | relid=0 | w=37
- entropion palpébral ---
r_associated #0: 37 -->
en:stye
n1=entropion palpébral | n2=en:stye | rel=r_associated | relid=0 | w=37
- neuropathie optique ---
r_associated #0: 37 -->
en:stye
n1=neuropathie optique | n2=en:stye | rel=r_associated | relid=0 | w=37
- en:abnormality of the eyelashes ---
r_associated #0: 36 -->
en:stye
n1=en:abnormality of the eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:abnormality of the lacrimal duct ---
r_associated #0: 36 -->
en:stye
n1=en:abnormality of the lacrimal duct | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:angioid streaks of the retina (85% of patients) ---
r_associated #0: 36 -->
en:stye
n1=en:angioid streaks of the retina (85% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:aspects of radionuclide imaging ---
r_associated #0: 36 -->
en:stye
n1=en:aspects of radionuclide imaging | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:corneal flatness ---
r_associated #0: 36 -->
en:stye
n1=en:corneal flatness | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:corneal lens ---
r_associated #0: 36 -->
en:stye
n1=en:corneal lens | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:detached retina (in some patients) ---
r_associated #0: 36 -->
en:stye
n1=en:detached retina (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:eye infection ---
r_associated #0: 36 -->
en:stye
n1=en:eye infection | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:eyelid margin cysts (hidrocystoma) ---
r_associated #0: 36 -->
en:stye
n1=en:eyelid margin cysts (hidrocystoma) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:flattened or absent electroretinogram (erg) ---
r_associated #0: 36 -->
en:stye
n1=en:flattened or absent electroretinogram (erg) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:floppy lid syndrome ---
r_associated #0: 36 -->
en:stye
n1=en:floppy lid syndrome | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:infectious crystalline keratopathy ---
r_associated #0: 36 -->
en:stye
n1=en:infectious crystalline keratopathy | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:keep someone informed ---
r_associated #0: 36 -->
en:stye
n1=en:keep someone informed | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:microbiological ---
r_associated #0: 36 -->
en:stye
n1=en:microbiological | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:nystagmus, intermittent (1 of 2 sibs) ---
r_associated #0: 36 -->
en:stye
n1=en:nystagmus, intermittent (1 of 2 sibs) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:ocular telangiectasia ---
r_associated #0: 36 -->
en:stye
n1=en:ocular telangiectasia | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:ophthalmoparesis, progressive, external ---
r_associated #0: 36 -->
en:stye
n1=en:ophthalmoparesis, progressive, external | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:optic atrophy (chronic phase) ---
r_associated #0: 36 -->
en:stye
n1=en:optic atrophy (chronic phase) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:optic disc pallor (rare) ---
r_associated #0: 36 -->
en:stye
n1=en:optic disc pallor (rare) | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:posterior eyeball segment structure ---
r_associated #0: 36 -->
en:stye
n1=en:posterior eyeball segment structure | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:reaction absents, pupil ---
r_associated #0: 36 -->
en:stye
n1=en:reaction absents, pupil | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:retrobulbar venous varix ---
r_associated #0: 36 -->
en:stye
n1=en:retrobulbar venous varix | n2=en:stye | rel=r_associated | relid=0 | w=36
- en:sinusitis ---
r_associated #0: 36 -->
en:stye
n1=en:sinusitis | n2=en:stye | rel=r_associated | relid=0 | w=36
- hyalosis astéroïde ---
r_associated #0: 36 -->
en:stye
n1=hyalosis astéroïde | n2=en:stye | rel=r_associated | relid=0 | w=36
- héméralopie congénitale stationnaire avec myopie ---
r_associated #0: 36 -->
en:stye
n1=héméralopie congénitale stationnaire avec myopie | n2=en:stye | rel=r_associated | relid=0 | w=36
- nystagmus lié au sexe ---
r_associated #0: 36 -->
en:stye
n1=nystagmus lié au sexe | n2=en:stye | rel=r_associated | relid=0 | w=36
- paraplégie spastique avec atrophie optique et démence ---
r_associated #0: 36 -->
en:stye
n1=paraplégie spastique avec atrophie optique et démence | n2=en:stye | rel=r_associated | relid=0 | w=36
- passer le mot à ---
r_associated #0: 36 -->
en:stye
n1=passer le mot à | n2=en:stye | rel=r_associated | relid=0 | w=36
- uvéite antérieure ---
r_associated #0: 36 -->
en:stye
n1=uvéite antérieure | n2=en:stye | rel=r_associated | relid=0 | w=36
- œil ---
r_associated #0: 35 -->
en:stye
n1=œil | n2=en:stye | rel=r_associated | relid=0 | w=35
- abcès cutané ---
r_associated #0: 35 -->
en:stye
n1=abcès cutané | n2=en:stye | rel=r_associated | relid=0 | w=35
- apprendre quelque chose à quelqu'un ---
r_associated #0: 35 -->
en:stye
n1=apprendre quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=35
- déchirement ---
r_associated #0: 35 -->
en:stye
n1=déchirement | n2=en:stye | rel=r_associated | relid=0 | w=35
- décollement vitréen ---
r_associated #0: 35 -->
en:stye
n1=décollement vitréen | n2=en:stye | rel=r_associated | relid=0 | w=35
- ectopie maculaire ---
r_associated #0: 35 -->
en:stye
n1=ectopie maculaire | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:'sunflower' cataract (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:'sunflower' cataract (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:abducens palsy ---
r_associated #0: 35 -->
en:stye
n1=en:abducens palsy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:abnormal retinal pigment epithelium ---
r_associated #0: 35 -->
en:stye
n1=en:abnormal retinal pigment epithelium | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:abnormal visual pursuit ---
r_associated #0: 35 -->
en:stye
n1=en:abnormal visual pursuit | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:abnormality of the optic disc ---
r_associated #0: 35 -->
en:stye
n1=en:abnormality of the optic disc | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:absence of foveal pit on optical coherence tomography ---
r_associated #0: 35 -->
en:stye
n1=en:absence of foveal pit on optical coherence tomography | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:absent stereopsis due to anomalous decussation at the optic chiasm ---
r_associated #0: 35 -->
en:stye
n1=en:absent stereopsis due to anomalous decussation at the optic chiasm | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:absent upper-lid skin crease ---
r_associated #0: 35 -->
en:stye
n1=en:absent upper-lid skin crease | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:alacrima - hypolacrimation ---
r_associated #0: 35 -->
en:stye
n1=en:alacrima - hypolacrimation | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:almond-shaped eyes (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:almond-shaped eyes (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:aplastic/hypoplastic lacrimal puncta ---
r_associated #0: 35 -->
en:stye
n1=en:aplastic/hypoplastic lacrimal puncta | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:asymmetric visual evoked potentials ---
r_associated #0: 35 -->
en:stye
n1=en:asymmetric visual evoked potentials | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:atrophic retina ---
r_associated #0: 35 -->
en:stye
n1=en:atrophic retina | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:attenuated vessels ---
r_associated #0: 35 -->
en:stye
n1=en:attenuated vessels | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:b-scan ultrasound shows echogenic, placoid calcified lesions at the level of the sclera and choroid ---
r_associated #0: 35 -->
en:stye
n1=en:b-scan ultrasound shows echogenic, placoid calcified lesions at the level of the sclera and choroid | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:bags under eyes ---
r_associated #0: 35 -->
en:stye
n1=en:bags under eyes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:bilateral macular retinal pigment epithelial atrophy ---
r_associated #0: 35 -->
en:stye
n1=en:bilateral macular retinal pigment epithelial atrophy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:blepharitis ---
r_associated #0: 35 -->
en:stye
n1=en:blepharitis | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:blind hypotensive eye ---
r_associated #0: 35 -->
en:stye
n1=en:blind hypotensive eye | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:blindness by age 2 ---
r_associated #0: 35 -->
en:stye
n1=en:blindness by age 2 | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:blue sclerae (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:blue sclerae (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:breakdown of the blood retinal barrier with retinal neovascularization ---
r_associated #0: 35 -->
en:stye
n1=en:breakdown of the blood retinal barrier with retinal neovascularization | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:bright blue eyes ---
r_associated #0: 35 -->
en:stye
n1=en:bright blue eyes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:broken heart ---
r_associated #0: 35 -->
en:stye
n1=en:broken heart | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:brown accumulation of gaucher cells at corneoscleral limbus ---
r_associated #0: 35 -->
en:stye
n1=en:brown accumulation of gaucher cells at corneoscleral limbus | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cataract (28%) ---
r_associated #0: 35 -->
en:stye
n1=en:cataract (28%) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cataract, adult-onset (punctate cortical) ---
r_associated #0: 35 -->
en:stye
n1=en:cataract, adult-onset (punctate cortical) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cataract, zonular central nuclear ---
r_associated #0: 35 -->
en:stye
n1=en:cataract, zonular central nuclear | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cataracts, usually congenital ---
r_associated #0: 35 -->
en:stye
n1=en:cataracts, usually congenital | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:central islands of vision only (late) ---
r_associated #0: 35 -->
en:stye
n1=en:central islands of vision only (late) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:central macular atrophy (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:central macular atrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:central scotoma on visual field testing ---
r_associated #0: 35 -->
en:stye
n1=en:central scotoma on visual field testing | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:central/paracentral scotomata ---
r_associated #0: 35 -->
en:stye
n1=en:central/paracentral scotomata | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:chorioretinal atrophy ---
r_associated #0: 35 -->
en:stye
n1=en:chorioretinal atrophy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:choroid hemangioma ---
r_associated #0: 35 -->
en:stye
n1=en:choroid hemangioma | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cicatricial ectropion ---
r_associated #0: 35 -->
en:stye
n1=en:cicatricial ectropion | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:circumpapillary telangiectatic microangiopathy (acute phase) ---
r_associated #0: 35 -->
en:stye
n1=en:circumpapillary telangiectatic microangiopathy (acute phase) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:coloboma (iris, optic nerve) ---
r_associated #0: 35 -->
en:stye
n1=en:coloboma (iris, optic nerve) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:coloboma of the lower eyelids (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:coloboma of the lower eyelids (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:coloboma, choroid (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:coloboma, choroid (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:complication aspects ---
r_associated #0: 35 -->
en:stye
n1=en:complication aspects | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:congenital epicanthus ---
r_associated #0: 35 -->
en:stye
n1=en:congenital epicanthus | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:constricted visual fields (occurs second) ---
r_associated #0: 35 -->
en:stye
n1=en:constricted visual fields (occurs second) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:corectopia (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:corectopia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:corneal dermoid cyst (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:corneal dermoid cyst (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:corneal endothelial dystrophy (guttata) ---
r_associated #0: 35 -->
en:stye
n1=en:corneal endothelial dystrophy (guttata) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:corneal erosion ---
r_associated #0: 35 -->
en:stye
n1=en:corneal erosion | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:cortical cataract ---
r_associated #0: 35 -->
en:stye
n1=en:cortical cataract | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:dacryoadenitis acquired ---
r_associated #0: 35 -->
en:stye
n1=en:dacryoadenitis acquired | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:decreased or absent corneal reflexes ---
r_associated #0: 35 -->
en:stye
n1=en:decreased or absent corneal reflexes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:decreased or absent electroretinogram (erg) responses ---
r_associated #0: 35 -->
en:stye
n1=en:decreased or absent electroretinogram (erg) responses | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:degenerative vitreoretinopathy ---
r_associated #0: 35 -->
en:stye
n1=en:degenerative vitreoretinopathy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:diminished visual acuity (1 patient) ---
r_associated #0: 35 -->
en:stye
n1=en:diminished visual acuity (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:dual waveform jerk movements ---
r_associated #0: 35 -->
en:stye
n1=en:dual waveform jerk movements | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eccentric or ectopic pupils ---
r_associated #0: 35 -->
en:stye
n1=en:eccentric or ectopic pupils | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:ectopia lentis (6%) ---
r_associated #0: 35 -->
en:stye
n1=en:ectopia lentis (6%) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:ectropion, bilateral (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:ectropion, bilateral (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:edematous eyelids ---
r_associated #0: 35 -->
en:stye
n1=en:edematous eyelids | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:embryonal nuclear cataract (disorder) ---
r_associated #0: 35 -->
en:stye
n1=en:embryonal nuclear cataract (disorder) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:epicanthus (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:epicanthus (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:exotropia (females) ---
r_associated #0: 35 -->
en:stye
n1=en:exotropia (females) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:extensive geographic retinal atrophy (butterfly pattern in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:extensive geographic retinal atrophy (butterfly pattern in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:extensive lesions may impair vision (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:extensive lesions may impair vision (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:external ophthalmoplegia (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:external ophthalmoplegia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:extinction of electroretinogram (before age 10) ---
r_associated #0: 35 -->
en:stye
n1=en:extinction of electroretinogram (before age 10) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:extraocular muscle weakness (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:extraocular muscle weakness (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:exudative maculopathy ---
r_associated #0: 35 -->
en:stye
n1=en:exudative maculopathy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eye infection intraocular ---
r_associated #0: 35 -->
en:stye
n1=en:eye infection intraocular | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyebrow hypoplasia (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:eyebrow hypoplasia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyelash absence ---
r_associated #0: 35 -->
en:stye
n1=en:eyelash absence | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyelid infiltrates ---
r_associated #0: 35 -->
en:stye
n1=en:eyelid infiltrates | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyelid myxoma ---
r_associated #0: 35 -->
en:stye
n1=en:eyelid myxoma | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyelid neoplasm ---
r_associated #0: 35 -->
en:stye
n1=en:eyelid neoplasm | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:eyelid vascular disorder ---
r_associated #0: 35 -->
en:stye
n1=en:eyelid vascular disorder | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:faucial diphtheria ---
r_associated #0: 35 -->
en:stye
n1=en:faucial diphtheria | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:formation of mucosal pseudomembranes that progress to plaques ---
r_associated #0: 35 -->
en:stye
n1=en:formation of mucosal pseudomembranes that progress to plaques | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:foveolar reflex indistinct ---
r_associated #0: 35 -->
en:stye
n1=en:foveolar reflex indistinct | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:frequent blinking ---
r_associated #0: 35 -->
en:stye
n1=en:frequent blinking | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:gaze-evoked nystagmus (33%) ---
r_associated #0: 35 -->
en:stye
n1=en:gaze-evoked nystagmus (33%) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:get the word out to somebody ---
r_associated #0: 35 -->
en:stye
n1=en:get the word out to somebody | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:glaucoma (in 80% of patients) ---
r_associated #0: 35 -->
en:stye
n1=en:glaucoma (in 80% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:glaucoma (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:glaucoma (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:glaucoma, chronic angle-closure, in older patients ---
r_associated #0: 35 -->
en:stye
n1=en:glaucoma, chronic angle-closure, in older patients | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hemangioma of eyelid ---
r_associated #0: 35 -->
en:stye
n1=en:hemangioma of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:high myopia, severe ---
r_associated #0: 35 -->
en:stye
n1=en:high myopia, severe | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:high-arched, dense eyebrows ---
r_associated #0: 35 -->
en:stye
n1=en:high-arched, dense eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:histiocytic deposits in eyelids ---
r_associated #0: 35 -->
en:stye
n1=en:histiocytic deposits in eyelids | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:horizontal nystagmus (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:horizontal nystagmus (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hypermetropia (meb) ---
r_associated #0: 35 -->
en:stye
n1=en:hypermetropia (meb) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hyperpigmentation of the macula (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:hyperpigmentation of the macula (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hyperreflectivity of nerve cell layer ---
r_associated #0: 35 -->
en:stye
n1=en:hyperreflectivity of nerve cell layer | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hypometric horizontal saccades ---
r_associated #0: 35 -->
en:stye
n1=en:hypometric horizontal saccades | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hypoplastic eyebrows ---
r_associated #0: 35 -->
en:stye
n1=en:hypoplastic eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hypoplastic lacrimal duct ---
r_associated #0: 35 -->
en:stye
n1=en:hypoplastic lacrimal duct | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:hypoplastic oculomotor nerves, bilateral ---
r_associated #0: 35 -->
en:stye
n1=en:hypoplastic oculomotor nerves, bilateral | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:impaired smooth pursuit in adult patients ---
r_associated #0: 35 -->
en:stye
n1=en:impaired smooth pursuit in adult patients | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:inability to fully close eyes during sleep ---
r_associated #0: 35 -->
en:stye
n1=en:inability to fully close eyes during sleep | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:inability to raise eyes above midline ---
r_associated #0: 35 -->
en:stye
n1=en:inability to raise eyes above midline | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:juvenile cortical cataract ---
r_associated #0: 35 -->
en:stye
n1=en:juvenile cortical cataract | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:lack of pupillary dilation in the dark ---
r_associated #0: 35 -->
en:stye
n1=en:lack of pupillary dilation in the dark | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:lack of visual tracking ---
r_associated #0: 35 -->
en:stye
n1=en:lack of visual tracking | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:lacrimal duct imperforation (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:lacrimal duct imperforation (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:lacrimal puncta, absence of ---
r_associated #0: 35 -->
en:stye
n1=en:lacrimal puncta, absence of | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:large prominent eyes ---
r_associated #0: 35 -->
en:stye
n1=en:large prominent eyes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:laterally displaced inner canthi (dystopia canthorum) (95 to 99%) ---
r_associated #0: 35 -->
en:stye
n1=en:laterally displaced inner canthi (dystopia canthorum) (95 to 99%) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:limbal stem cell insufficiency ---
r_associated #0: 35 -->
en:stye
n1=en:limbal stem cell insufficiency | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:long, curly dark upper eyelashes (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:long, curly dark upper eyelashes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:long, curved eyelashes ---
r_associated #0: 35 -->
en:stye
n1=en:long, curved eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:macular atrophy (1 patient) ---
r_associated #0: 35 -->
en:stye
n1=en:macular atrophy (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:macular atrophy, marked ---
r_associated #0: 35 -->
en:stye
n1=en:macular atrophy, marked | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:macular edema ---
r_associated #0: 35 -->
en:stye
n1=en:macular edema | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:macular translucency (variable) ---
r_associated #0: 35 -->
en:stye
n1=en:macular translucency (variable) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:marcus gunn jaw winking (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:marcus gunn jaw winking (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:marked thickening of descemet membrane ---
r_associated #0: 35 -->
en:stye
n1=en:marked thickening of descemet membrane | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:medial flaring of the eyebrow ---
r_associated #0: 35 -->
en:stye
n1=en:medial flaring of the eyebrow | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:meibomian gland discharge ---
r_associated #0: 35 -->
en:stye
n1=en:meibomian gland discharge | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:microblepharon ---
r_associated #0: 35 -->
en:stye
n1=en:microblepharon | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:microphthalmia (wws) ---
r_associated #0: 35 -->
en:stye
n1=en:microphthalmia (wws) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:microsaccadic pursuit ---
r_associated #0: 35 -->
en:stye
n1=en:microsaccadic pursuit | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:mild temporal optic nerve pallor ---
r_associated #0: 35 -->
en:stye
n1=en:mild temporal optic nerve pallor | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:nasolacrimal duct obstruction due to ectropion of lower eyelids (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:nasolacrimal duct obstruction due to ectropion of lower eyelids (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:night blindness (onset in teens) ---
r_associated #0: 35 -->
en:stye
n1=en:night blindness (onset in teens) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:no light-evoked response on electroretinogram (erg) ---
r_associated #0: 35 -->
en:stye
n1=en:no light-evoked response on electroretinogram (erg) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:no retinitis pigmentosa ---
r_associated #0: 35 -->
en:stye
n1=en:no retinitis pigmentosa | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:no visual attention ---
r_associated #0: 35 -->
en:stye
n1=en:no visual attention | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:nonspecific granular appearance of retinal pigment epithelium ---
r_associated #0: 35 -->
en:stye
n1=en:nonspecific granular appearance of retinal pigment epithelium | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:normal fundus on ophthalmoscopy ---
r_associated #0: 35 -->
en:stye
n1=en:normal fundus on ophthalmoscopy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:normal palpebral fissures ---
r_associated #0: 35 -->
en:stye
n1=en:normal palpebral fissures | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:normal rod function on erg ---
r_associated #0: 35 -->
en:stye
n1=en:normal rod function on erg | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:nyctalopia (in some patients) ---
r_associated #0: 35 -->
en:stye
n1=en:nyctalopia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:nystagmus (1 patient) ---
r_associated #0: 35 -->
en:stye
n1=en:nystagmus (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:nystagmus (rare) ---
r_associated #0: 35 -->
en:stye
n1=en:nystagmus (rare) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:oblique palpebral fissures ---
r_associated #0: 35 -->
en:stye
n1=en:oblique palpebral fissures | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:ocular albinism, tyrosinase-positive ---
r_associated #0: 35 -->
en:stye
n1=en:ocular albinism, tyrosinase-positive | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:ocular muscle palsies ---
r_associated #0: 35 -->
en:stye
n1=en:ocular muscle palsies | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:opacities in embryonic, fetal, and infantile nuclei ---
r_associated #0: 35 -->
en:stye
n1=en:opacities in embryonic, fetal, and infantile nuclei | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:open-angle glaucoma due to pupillary and ciliary block ---
r_associated #0: 35 -->
en:stye
n1=en:open-angle glaucoma due to pupillary and ciliary block | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:optic atrophy, mild (in 1 patient) ---
r_associated #0: 35 -->
en:stye
n1=en:optic atrophy, mild (in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:optic disc dysplasia ---
r_associated #0: 35 -->
en:stye
n1=en:optic disc dysplasia | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:optic disc pallor (in older patients) ---
r_associated #0: 35 -->
en:stye
n1=en:optic disc pallor (in older patients) | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:orbital separation diminished ---
r_associated #0: 35 -->
en:stye
n1=en:orbital separation diminished | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:pediatric adverse events terminology ---
r_associated #0: 35 -->
en:stye
n1=en:pediatric adverse events terminology | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:persistent hyperplastic primary vitreous ---
r_associated #0: 35 -->
en:stye
n1=en:persistent hyperplastic primary vitreous | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:prominent eyes ---
r_associated #0: 35 -->
en:stye
n1=en:prominent eyes | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:shallow orbits ---
r_associated #0: 35 -->
en:stye
n1=en:shallow orbits | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:skin abscess ---
r_associated #0: 35 -->
en:stye
n1=en:skin abscess | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:tearing ---
r_associated #0: 35 -->
en:stye
n1=en:tearing | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:tell sb about something ---
r_associated #0: 35 -->
en:stye
n1=en:tell sb about something | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:tell sb about sth ---
r_associated #0: 35 -->
en:stye
n1=en:tell sb about sth | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:to tell sb about sth ---
r_associated #0: 35 -->
en:stye
n1=en:to tell sb about sth | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:upward slant of palpebral fissure ---
r_associated #0: 35 -->
en:stye
n1=en:upward slant of palpebral fissure | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:uvea ---
r_associated #0: 35 -->
en:stye
n1=en:uvea | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:vertical gaze palsy ---
r_associated #0: 35 -->
en:stye
n1=en:vertical gaze palsy | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:visual impairment ---
r_associated #0: 35 -->
en:stye
n1=en:visual impairment | n2=en:stye | rel=r_associated | relid=0 | w=35
- en:warn somebody that ---
r_associated #0: 35 -->
en:stye
n1=en:warn somebody that | n2=en:stye | rel=r_associated | relid=0 | w=35
- enseigner quelque chose à ---
r_associated #0: 35 -->
en:stye
n1=enseigner quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=35
- eye ---
r_associated #0: 35 -->
en:stye
n1=eye | n2=en:stye | rel=r_associated | relid=0 | w=35
- hyperplasie du vitré primitif ---
r_associated #0: 35 -->
en:stye
n1=hyperplasie du vitré primitif | n2=en:stye | rel=r_associated | relid=0 | w=35
- indiquer qch à quelqu'un ---
r_associated #0: 35 -->
en:stye
n1=indiquer qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=35
- malformation oculaire ---
r_associated #0: 35 -->
en:stye
n1=malformation oculaire | n2=en:stye | rel=r_associated | relid=0 | w=35
- nystagmus de fixation pathologique ---
r_associated #0: 35 -->
en:stye
n1=nystagmus de fixation pathologique | n2=en:stye | rel=r_associated | relid=0 | w=35
- oeil ---
r_associated #0: 35 -->
en:stye
n1=oeil | n2=en:stye | rel=r_associated | relid=0 | w=35
- parler de qch à quelqu'un ---
r_associated #0: 35 -->
en:stye
n1=parler de qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=35
- s'aboucher avec ---
r_associated #0: 35 -->
en:stye
n1=s'aboucher avec | n2=en:stye | rel=r_associated | relid=0 | w=35
- s'aboucher avec qqn ---
r_associated #0: 35 -->
en:stye
n1=s'aboucher avec qqn | n2=en:stye | rel=r_associated | relid=0 | w=35
- trouble de la vue ---
r_associated #0: 35 -->
en:stye
n1=trouble de la vue | n2=en:stye | rel=r_associated | relid=0 | w=35
- uvée ---
r_associated #0: 35 -->
en:stye
n1=uvée | n2=en:stye | rel=r_associated | relid=0 | w=35
- être en rapport avec qn ---
r_associated #0: 35 -->
en:stye
n1=être en rapport avec qn | n2=en:stye | rel=r_associated | relid=0 | w=35
- œil ---
r_associated #0: 35 -->
en:stye
n1=œil | n2=en:stye | rel=r_associated | relid=0 | w=35
- Kjer (atrophie optique de type) ---
r_associated #0: 34 -->
en:stye
n1=Kjer (atrophie optique de type) | n2=en:stye | rel=r_associated | relid=0 | w=34
- clou palpébral ---
r_associated #0: 34 -->
en:stye
n1=clou palpébral | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abnormal conjugate eye movement ---
r_associated #0: 34 -->
en:stye
n1=en:abnormal conjugate eye movement | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abnormal electrooculogram (eog) ---
r_associated #0: 34 -->
en:stye
n1=en:abnormal electrooculogram (eog) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abnormal vestibuloocular reflex (vor) ---
r_associated #0: 34 -->
en:stye
n1=en:abnormal vestibuloocular reflex (vor) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abnormality of the eyebrow ---
r_associated #0: 34 -->
en:stye
n1=en:abnormality of the eyebrow | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abolished electroretinogram (erg) (76%) ---
r_associated #0: 34 -->
en:stye
n1=en:abolished electroretinogram (erg) (76%) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:abscess of eye ---
r_associated #0: 34 -->
en:stye
n1=en:abscess of eye | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:absence of ptosis ---
r_associated #0: 34 -->
en:stye
n1=en:absence of ptosis | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:absent anterior chamber of eye ---
r_associated #0: 34 -->
en:stye
n1=en:absent anterior chamber of eye | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:absent iris stromal pattern ---
r_associated #0: 34 -->
en:stye
n1=en:absent iris stromal pattern | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:absent retinal pigment ---
r_associated #0: 34 -->
en:stye
n1=en:absent retinal pigment | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:absent visual evoked potentials ---
r_associated #0: 34 -->
en:stye
n1=en:absent visual evoked potentials | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:achromatic retinal patches ---
r_associated #0: 34 -->
en:stye
n1=en:achromatic retinal patches | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:altered visual acuity ---
r_associated #0: 34 -->
en:stye
n1=en:altered visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:anterior uveitis ---
r_associated #0: 34 -->
en:stye
n1=en:anterior uveitis | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:aphakic glaucoma ---
r_associated #0: 34 -->
en:stye
n1=en:aphakic glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:apparent hypertelorism ---
r_associated #0: 34 -->
en:stye
n1=en:apparent hypertelorism | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:apraxia of eyelid ---
r_associated #0: 34 -->
en:stye
n1=en:apraxia of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:arched, sparse eyebrows ---
r_associated #0: 34 -->
en:stye
n1=en:arched, sparse eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:astigmatism (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:astigmatism (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:attenuation of retinal blood vessels ---
r_associated #0: 34 -->
en:stye
n1=en:attenuation of retinal blood vessels | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bilateral nuclear cataract, congenital ---
r_associated #0: 34 -->
en:stye
n1=en:bilateral nuclear cataract, congenital | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bilateral posterior subcapsular cataracts ---
r_associated #0: 34 -->
en:stye
n1=en:bilateral posterior subcapsular cataracts | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:blue eyes (japanese patients) ---
r_associated #0: 34 -->
en:stye
n1=en:blue eyes (japanese patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:blurred vision, episodic ---
r_associated #0: 34 -->
en:stye
n1=en:blurred vision, episodic | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bone spicule pigment deposits in periphery and mid periphery ---
r_associated #0: 34 -->
en:stye
n1=en:bone spicule pigment deposits in periphery and mid periphery | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bone spicule pigmentation of retina (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:bone spicule pigmentation of retina (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bone spicules ---
r_associated #0: 34 -->
en:stye
n1=en:bone spicules | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:bone-spicule pigment deposits, retinal ---
r_associated #0: 34 -->
en:stye
n1=en:bone-spicule pigment deposits, retinal | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:buphthalmos (wws) ---
r_associated #0: 34 -->
en:stye
n1=en:buphthalmos (wws) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cataract, lamellar (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:cataract, lamellar (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:central corneal thickness decreased ---
r_associated #0: 34 -->
en:stye
n1=en:central corneal thickness decreased | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:central hypofluorescence or hyperfluorescence on fluorescein angiography ---
r_associated #0: 34 -->
en:stye
n1=en:central hypofluorescence or hyperfluorescence on fluorescein angiography | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:chemically induced ---
r_associated #0: 34 -->
en:stye
n1=en:chemically induced | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:choroidal sclerosis (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:choroidal sclerosis (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:choroidal vessels visible ---
r_associated #0: 34 -->
en:stye
n1=en:choroidal vessels visible | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:chronic tearing ---
r_associated #0: 34 -->
en:stye
n1=en:chronic tearing | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:clinical anophthalmia, unilateral/bilateral (87%) ---
r_associated #0: 34 -->
en:stye
n1=en:clinical anophthalmia, unilateral/bilateral (87%) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cogwheel ocular pursuit ---
r_associated #0: 34 -->
en:stye
n1=en:cogwheel ocular pursuit | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:coloboma (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:coloboma (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:coloboma (wws) ---
r_associated #0: 34 -->
en:stye
n1=en:coloboma (wws) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:coloboma of eyelids, iris, and choroid ---
r_associated #0: 34 -->
en:stye
n1=en:coloboma of eyelids, iris, and choroid | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:colobomas (iris, choroid, retina, disc, and optic nerve) ---
r_associated #0: 34 -->
en:stye
n1=en:colobomas (iris, choroid, retina, disc, and optic nerve) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:color vision disturbance in protan, deutan, and tritan axes ---
r_associated #0: 34 -->
en:stye
n1=en:color vision disturbance in protan, deutan, and tritan axes | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cone and rod responses borderline or nondetectable on electroretinography (erg) by the second decade of life ---
r_associated #0: 34 -->
en:stye
n1=en:cone and rod responses borderline or nondetectable on electroretinography (erg) by the second decade of life | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cone implicit times consistent with progressive disease ---
r_associated #0: 34 -->
en:stye
n1=en:cone implicit times consistent with progressive disease | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:congenital cataract ---
r_associated #0: 34 -->
en:stye
n1=en:congenital cataract | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:congenital keratoglobus ---
r_associated #0: 34 -->
en:stye
n1=en:congenital keratoglobus | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:conjunctival crystals ---
r_associated #0: 34 -->
en:stye
n1=en:conjunctival crystals | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:conjunctival irritation ---
r_associated #0: 34 -->
en:stye
n1=en:conjunctival irritation | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:corneal scar ---
r_associated #0: 34 -->
en:stye
n1=en:corneal scar | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cortical visual impairment (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:cortical visual impairment (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:cystic retinal degeneration ---
r_associated #0: 34 -->
en:stye
n1=en:cystic retinal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:deformed pupils ---
r_associated #0: 34 -->
en:stye
n1=en:deformed pupils | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:diplopias, intermittent ---
r_associated #0: 34 -->
en:stye
n1=en:diplopias, intermittent | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:dominance, ocular ---
r_associated #0: 34 -->
en:stye
n1=en:dominance, ocular | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:downslanting palpebral fissures (6 of 22) ---
r_associated #0: 34 -->
en:stye
n1=en:downslanting palpebral fissures (6 of 22) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:duane retraction syndrome (34%) ---
r_associated #0: 34 -->
en:stye
n1=en:duane retraction syndrome (34%) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:early glaucoma ---
r_associated #0: 34 -->
en:stye
n1=en:early glaucoma | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:ectopia lentis, isolated (congenital lens dislocation) ---
r_associated #0: 34 -->
en:stye
n1=en:ectopia lentis, isolated (congenital lens dislocation) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:electroretinograms markedly reduced or completely extinct ---
r_associated #0: 34 -->
en:stye
n1=en:electroretinograms markedly reduced or completely extinct | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:electroretinograms unrecordable at birth or in infancy ---
r_associated #0: 34 -->
en:stye
n1=en:electroretinograms unrecordable at birth or in infancy | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:epiphora (classic feature) ---
r_associated #0: 34 -->
en:stye
n1=en:epiphora (classic feature) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:esotropia with accommodative compensation ---
r_associated #0: 34 -->
en:stye
n1=en:esotropia with accommodative compensation | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:eversion of lateral third of lower eyelids ---
r_associated #0: 34 -->
en:stye
n1=en:eversion of lateral third of lower eyelids | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:exophthalmos, mild ---
r_associated #0: 34 -->
en:stye
n1=en:exophthalmos, mild | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:exotropia, secondary ---
r_associated #0: 34 -->
en:stye
n1=en:exotropia, secondary | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:extinguished responses on electroretinography ---
r_associated #0: 34 -->
en:stye
n1=en:extinguished responses on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:extraocular muscles are not involved ---
r_associated #0: 34 -->
en:stye
n1=en:extraocular muscles are not involved | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:eye infections, bacterial ---
r_associated #0: 34 -->
en:stye
n1=en:eye infections, bacterial | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:eyebrows slanted upward ---
r_associated #0: 34 -->
en:stye
n1=en:eyebrows slanted upward | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:eyelid colobomata (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:eyelid colobomata (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:fine lens opacities (carrier females) ---
r_associated #0: 34 -->
en:stye
n1=en:fine lens opacities (carrier females) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:greatly reduced light-adapted scotopic and photopic erg by 7th decade ---
r_associated #0: 34 -->
en:stye
n1=en:greatly reduced light-adapted scotopic and photopic erg by 7th decade | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:hooded eyelids ---
r_associated #0: 34 -->
en:stye
n1=en:hooded eyelids | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:horizontal nystagmus (5%) ---
r_associated #0: 34 -->
en:stye
n1=en:horizontal nystagmus (5%) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:horizontal oval-shaped fovea (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:horizontal oval-shaped fovea (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:hypermetropia (36%) ---
r_associated #0: 34 -->
en:stye
n1=en:hypermetropia (36%) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:hypesthetic cornea ---
r_associated #0: 34 -->
en:stye
n1=en:hypesthetic cornea | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:hypometric vertical saccades ---
r_associated #0: 34 -->
en:stye
n1=en:hypometric vertical saccades | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:hypoplasia of the ocular nerve ---
r_associated #0: 34 -->
en:stye
n1=en:hypoplasia of the ocular nerve | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:impaired smooth pursuit ---
r_associated #0: 34 -->
en:stye
n1=en:impaired smooth pursuit | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:impaired vestibuloocular reflex (vor) ---
r_associated #0: 34 -->
en:stye
n1=en:impaired vestibuloocular reflex (vor) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:impaired visual fields ---
r_associated #0: 34 -->
en:stye
n1=en:impaired visual fields | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:inability to raise one or both eyes above midline ---
r_associated #0: 34 -->
en:stye
n1=en:inability to raise one or both eyes above midline | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:increased intercanthal distance ---
r_associated #0: 34 -->
en:stye
n1=en:increased intercanthal distance | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:infective uveitis ---
r_associated #0: 34 -->
en:stye
n1=en:infective uveitis | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:interpupillary:len:pt:face:qn ---
r_associated #0: 34 -->
en:stye
n1=en:interpupillary:len:pt:face:qn | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:iridocorneal angle maldevelopment ---
r_associated #0: 34 -->
en:stye
n1=en:iridocorneal angle maldevelopment | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:iris malformation or hypoplasia (wws) ---
r_associated #0: 34 -->
en:stye
n1=en:iris malformation or hypoplasia (wws) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:irregular eyebrows ---
r_associated #0: 34 -->
en:stye
n1=en:irregular eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:irregular white dots at the vitreoretinal interface ---
r_associated #0: 34 -->
en:stye
n1=en:irregular white dots at the vitreoretinal interface | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:kayser-fleischer ring ---
r_associated #0: 34 -->
en:stye
n1=en:kayser-fleischer ring | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:keep someone in the loop ---
r_associated #0: 34 -->
en:stye
n1=en:keep someone in the loop | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lack of blink reflex (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:lack of blink reflex (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lacrimal apparatus ---
r_associated #0: 34 -->
en:stye
n1=en:lacrimal apparatus | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:late-onset corneal degeneration ---
r_associated #0: 34 -->
en:stye
n1=en:late-onset corneal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:leukocoria ---
r_associated #0: 34 -->
en:stye
n1=en:leukocoria | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lisch nodules (iris hamartomas) ---
r_associated #0: 34 -->
en:stye
n1=en:lisch nodules (iris hamartomas) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lisch nodules (iris hamartomas) may or may not be present ---
r_associated #0: 34 -->
en:stye
n1=en:lisch nodules (iris hamartomas) may or may not be present | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:long eyelashes (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:long eyelashes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lower eyelid coloboma ---
r_associated #0: 34 -->
en:stye
n1=en:lower eyelid coloboma | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lower eyelid epiblepharon ---
r_associated #0: 34 -->
en:stye
n1=en:lower eyelid epiblepharon | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:lower lacrimal dystopia ---
r_associated #0: 34 -->
en:stye
n1=en:lower lacrimal dystopia | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:macular ectopia ---
r_associated #0: 34 -->
en:stye
n1=en:macular ectopia | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:marcus gunn phenomenon ---
r_associated #0: 34 -->
en:stye
n1=en:marcus gunn phenomenon | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:microcystic epithelial edema ---
r_associated #0: 34 -->
en:stye
n1=en:microcystic epithelial edema | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:microphthalmia (1 patient) ---
r_associated #0: 34 -->
en:stye
n1=en:microphthalmia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:mild retinal arteriolar constriction ---
r_associated #0: 34 -->
en:stye
n1=en:mild retinal arteriolar constriction | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:myopia of variable severity ---
r_associated #0: 34 -->
en:stye
n1=en:myopia of variable severity | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:myopia, apparent with age ---
r_associated #0: 34 -->
en:stye
n1=en:myopia, apparent with age | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:myopia, infantile ---
r_associated #0: 34 -->
en:stye
n1=en:myopia, infantile | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:nasolacrimal duct obstruction (classic feature) ---
r_associated #0: 34 -->
en:stye
n1=en:nasolacrimal duct obstruction (classic feature) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:night blindness (onset in first decade) ---
r_associated #0: 34 -->
en:stye
n1=en:night blindness (onset in first decade) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:night blindness onset during teen years ---
r_associated #0: 34 -->
en:stye
n1=en:night blindness onset during teen years | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:no other ocular defects ---
r_associated #0: 34 -->
en:stye
n1=en:no other ocular defects | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:nondetectable electroretinogram, all components, in older individuals ---
r_associated #0: 34 -->
en:stye
n1=en:nondetectable electroretinogram, all components, in older individuals | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:nondetectable scotopic electroretinogram with relative preservation of photopic and pattern elements in younger patients ---
r_associated #0: 34 -->
en:stye
n1=en:nondetectable scotopic electroretinogram with relative preservation of photopic and pattern elements in younger patients | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:normal vitreous ---
r_associated #0: 34 -->
en:stye
n1=en:normal vitreous | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:nystagmus, congenital horizontal pendular ---
r_associated #0: 34 -->
en:stye
n1=en:nystagmus, congenital horizontal pendular | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:occasional cataracts ---
r_associated #0: 34 -->
en:stye
n1=en:occasional cataracts | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:ocular muscle ---
r_associated #0: 34 -->
en:stye
n1=en:ocular muscle | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:oculodigital sign of franceschetti ---
r_associated #0: 34 -->
en:stye
n1=en:oculodigital sign of franceschetti | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:oculomotor apraxia (56% of patients) ---
r_associated #0: 34 -->
en:stye
n1=en:oculomotor apraxia (56% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:oculomotor apraxia (in 86% of patients) ---
r_associated #0: 34 -->
en:stye
n1=en:oculomotor apraxia (in 86% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic atrophy (1 family) ---
r_associated #0: 34 -->
en:stye
n1=en:optic atrophy (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic atrophy by 2 years of age ---
r_associated #0: 34 -->
en:stye
n1=en:optic atrophy by 2 years of age | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic cupping ---
r_associated #0: 34 -->
en:stye
n1=en:optic cupping | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic disc atrophy (in some older patients) ---
r_associated #0: 34 -->
en:stye
n1=en:optic disc atrophy (in some older patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic nerve atrophy (in some patients) ---
r_associated #0: 34 -->
en:stye
n1=en:optic nerve atrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:optic nerve atrophy, bilateral ---
r_associated #0: 34 -->
en:stye
n1=en:optic nerve atrophy, bilateral | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:parakeratosis ---
r_associated #0: 34 -->
en:stye
n1=en:parakeratosis | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:perforation of cornea ---
r_associated #0: 34 -->
en:stye
n1=en:perforation of cornea | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:repeat something to somebody ---
r_associated #0: 34 -->
en:stye
n1=en:repeat something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:retinal thinning ---
r_associated #0: 34 -->
en:stye
n1=en:retinal thinning | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:roentgenographic ---
r_associated #0: 34 -->
en:stye
n1=en:roentgenographic | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:stargardt disease ---
r_associated #0: 34 -->
en:stye
n1=en:stargardt disease | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:strabismus syndrome ---
r_associated #0: 34 -->
en:stye
n1=en:strabismus syndrome | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:teach something to somebody ---
r_associated #0: 34 -->
en:stye
n1=en:teach something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=34
- en:visual cortex disorder ---
r_associated #0: 34 -->
en:stye
n1=en:visual cortex disorder | n2=en:stye | rel=r_associated | relid=0 | w=34
- héméralopie congénitale stationnaire dominante de type III ---
r_associated #0: 34 -->
en:stye
n1=héméralopie congénitale stationnaire dominante de type III | n2=en:stye | rel=r_associated | relid=0 | w=34
- paralysie de la verticalité du regard ---
r_associated #0: 34 -->
en:stye
n1=paralysie de la verticalité du regard | n2=en:stye | rel=r_associated | relid=0 | w=34
- répéter [qch] à [qqn] ---
r_associated #0: 34 -->
en:stye
n1=répéter [qch] à [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=34
- répéter quelque chose à quelqu'un ---
r_associated #0: 34 -->
en:stye
n1=répéter quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=34
- strabismus ---
r_associated #0: 34 -->
en:stye
n1=strabismus | n2=en:stye | rel=r_associated | relid=0 | w=34
- dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique ---
r_associated #0: 33 -->
en:stye
n1=dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique | n2=en:stye | rel=r_associated | relid=0 | w=33
- dystrophie des cônes liée au sexe avec reflet rétinien jaune-vert ---
r_associated #0: 33 -->
en:stye
n1=dystrophie des cônes liée au sexe avec reflet rétinien jaune-vert | n2=en:stye | rel=r_associated | relid=0 | w=33
- en:paralysis of vertical gaze ---
r_associated #0: 33 -->
en:stye
n1=en:paralysis of vertical gaze | n2=en:stye | rel=r_associated | relid=0 | w=33
- hypoesthésie cornéenne familiale ---
r_associated #0: 33 -->
en:stye
n1=hypoesthésie cornéenne familiale | n2=en:stye | rel=r_associated | relid=0 | w=33
- syndrome de Stilling-Türk-Duane ---
r_associated #0: 33 -->
en:stye
n1=syndrome de Stilling-Türk-Duane | n2=en:stye | rel=r_associated | relid=0 | w=33
- dystrophie des cônes liée au sexe ---
r_associated #0: 32 -->
en:stye
n1=dystrophie des cônes liée au sexe | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:Duane's syndrome ---
r_associated #0: 32 -->
en:stye
n1=en:Duane's syndrome | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:abnormal pupillary light reflex ---
r_associated #0: 32 -->
en:stye
n1=en:abnormal pupillary light reflex | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:abnormality of retinal pigmentation ---
r_associated #0: 32 -->
en:stye
n1=en:abnormality of retinal pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:abscess of eyelid ---
r_associated #0: 32 -->
en:stye
n1=en:abscess of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:absent abducens nerve on the affected side of synergistic divergence ---
r_associated #0: 32 -->
en:stye
n1=en:absent abducens nerve on the affected side of synergistic divergence | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:absent pupillary reaction ---
r_associated #0: 32 -->
en:stye
n1=en:absent pupillary reaction | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:absent tears ---
r_associated #0: 32 -->
en:stye
n1=en:absent tears | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:acute intraocular hypertension (rare) ---
r_associated #0: 32 -->
en:stye
n1=en:acute intraocular hypertension (rare) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:amblyopia (1 patient) ---
r_associated #0: 32 -->
en:stye
n1=en:amblyopia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:aniridia ---
r_associated #0: 32 -->
en:stye
n1=en:aniridia | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:anterior stromal haziness ---
r_associated #0: 32 -->
en:stye
n1=en:anterior stromal haziness | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:arterial attenuation ---
r_associated #0: 32 -->
en:stye
n1=en:arterial attenuation | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:arteriolar attenuation (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:arteriolar attenuation (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:astigmatism, variable ---
r_associated #0: 32 -->
en:stye
n1=en:astigmatism, variable | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:asymmetry of intraocular pressure ---
r_associated #0: 32 -->
en:stye
n1=en:asymmetry of intraocular pressure | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:attenuated arteries ---
r_associated #0: 32 -->
en:stye
n1=en:attenuated arteries | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bacterial endophthalmitis ---
r_associated #0: 32 -->
en:stye
n1=en:bacterial endophthalmitis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bilateral red-speckled retinal pigment epithelium ---
r_associated #0: 32 -->
en:stye
n1=en:bilateral red-speckled retinal pigment epithelium | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bilateral subretinal masses ---
r_associated #0: 32 -->
en:stye
n1=en:bilateral subretinal masses | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:blindness (6 to 14 years) ---
r_associated #0: 32 -->
en:stye
n1=en:blindness (6 to 14 years) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:blindness, postretinal ---
r_associated #0: 32 -->
en:stye
n1=en:blindness, postretinal | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bone corpuscle-like pigmentation in equatorial and peripheral areas ---
r_associated #0: 32 -->
en:stye
n1=en:bone corpuscle-like pigmentation in equatorial and peripheral areas | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bone spicule pigmentation ---
r_associated #0: 32 -->
en:stye
n1=en:bone spicule pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bulging eyes (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:bulging eyes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:bull's eye macular lesion ---
r_associated #0: 32 -->
en:stye
n1=en:bull's eye macular lesion | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataract, anterior polar, congenital or early-onset (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:cataract, anterior polar, congenital or early-onset (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataract, fan-shaped ---
r_associated #0: 32 -->
en:stye
n1=en:cataract, fan-shaped | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataract, progressive (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:cataract, progressive (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataract, zonular pulverulent 1 ---
r_associated #0: 32 -->
en:stye
n1=en:cataract, zonular pulverulent 1 | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataracts develop in second or third decade ---
r_associated #0: 32 -->
en:stye
n1=en:cataracts develop in second or third decade | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cataracts, crenated ---
r_associated #0: 32 -->
en:stye
n1=en:cataracts, crenated | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:chorioectopia ---
r_associated #0: 32 -->
en:stye
n1=en:chorioectopia | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:chorioretinal dystrophy ---
r_associated #0: 32 -->
en:stye
n1=en:chorioretinal dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:choroidal and/or chorioretinal disorder ---
r_associated #0: 32 -->
en:stye
n1=en:choroidal and/or chorioretinal disorder | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:choroidal atrophy (rare) ---
r_associated #0: 32 -->
en:stye
n1=en:choroidal atrophy (rare) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:choroidoretinal degeneration (1 patient) ---
r_associated #0: 32 -->
en:stye
n1=en:choroidoretinal degeneration (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:chronic blepharitis ---
r_associated #0: 32 -->
en:stye
n1=en:chronic blepharitis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:clear corneas ---
r_associated #0: 32 -->
en:stye
n1=en:clear corneas | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:coloboma of optic disc ---
r_associated #0: 32 -->
en:stye
n1=en:coloboma of optic disc | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:combined hamartoma of the retinal pigment epithelium and retina ---
r_associated #0: 32 -->
en:stye
n1=en:combined hamartoma of the retinal pigment epithelium and retina | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:congenital bilateral cataracts ---
r_associated #0: 32 -->
en:stye
n1=en:congenital bilateral cataracts | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:congenital blepharophimosis ---
r_associated #0: 32 -->
en:stye
n1=en:congenital blepharophimosis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:congenital blepharophimosis of lower eyelid ---
r_associated #0: 32 -->
en:stye
n1=en:congenital blepharophimosis of lower eyelid | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:congenital fibrosis of the extraocular muscles (1 family) ---
r_associated #0: 32 -->
en:stye
n1=en:congenital fibrosis of the extraocular muscles (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:conjunctival whitish salt-like deposits ---
r_associated #0: 32 -->
en:stye
n1=en:conjunctival whitish salt-like deposits | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:corneal hypoesthesia ---
r_associated #0: 32 -->
en:stye
n1=en:corneal hypoesthesia | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cortical blindness (in one patient) ---
r_associated #0: 32 -->
en:stye
n1=en:cortical blindness (in one patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:cystoid macular retinal degeneration ---
r_associated #0: 32 -->
en:stye
n1=en:cystoid macular retinal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:dark choroid (rare) ---
r_associated #0: 32 -->
en:stye
n1=en:dark choroid (rare) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:decreased night vision (early in course of disease) ---
r_associated #0: 32 -->
en:stye
n1=en:decreased night vision (early in course of disease) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:deep-set eyes (in 2 patients) ---
r_associated #0: 32 -->
en:stye
n1=en:deep-set eyes (in 2 patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:deep-set eyes (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:deep-set eyes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:deformity of eyelid ---
r_associated #0: 32 -->
en:stye
n1=en:deformity of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:delayed eye opening as a neonate (up to 2 weeks) ---
r_associated #0: 32 -->
en:stye
n1=en:delayed eye opening as a neonate (up to 2 weeks) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:displaced pupils ---
r_associated #0: 32 -->
en:stye
n1=en:displaced pupils | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:dry conjunctival mucosae ---
r_associated #0: 32 -->
en:stye
n1=en:dry conjunctival mucosae | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:epicanthal folds (3/4 patients) ---
r_associated #0: 32 -->
en:stye
n1=en:epicanthal folds (3/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:esotropia (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:esotropia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:eversion of the lower eyelids ---
r_associated #0: 32 -->
en:stye
n1=en:eversion of the lower eyelids | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:extraocular muscle fibrosis ---
r_associated #0: 32 -->
en:stye
n1=en:extraocular muscle fibrosis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:eye inflammation (1 patient) ---
r_associated #0: 32 -->
en:stye
n1=en:eye inflammation (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:fixation nystagmus ---
r_associated #0: 32 -->
en:stye
n1=en:fixation nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:flat electroretinogram (erg) ---
r_associated #0: 32 -->
en:stye
n1=en:flat electroretinogram (erg) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:flat-appearing iris ---
r_associated #0: 32 -->
en:stye
n1=en:flat-appearing iris | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:foveoschisis ---
r_associated #0: 32 -->
en:stye
n1=en:foveoschisis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:funduscopic examination normal ---
r_associated #0: 32 -->
en:stye
n1=en:funduscopic examination normal | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:gonococcal infection of eye ---
r_associated #0: 32 -->
en:stye
n1=en:gonococcal infection of eye | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:granular deposits replace epithelial basement membrane ---
r_associated #0: 32 -->
en:stye
n1=en:granular deposits replace epithelial basement membrane | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:gum infection ---
r_associated #0: 32 -->
en:stye
n1=en:gum infection | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:high myopia (1 patient) ---
r_associated #0: 32 -->
en:stye
n1=en:high myopia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:high refractive errors (hyperopia, myopia, with-the-rule astigmatism) ---
r_associated #0: 32 -->
en:stye
n1=en:high refractive errors (hyperopia, myopia, with-the-rule astigmatism) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:horizontal gaze palsy ---
r_associated #0: 32 -->
en:stye
n1=en:horizontal gaze palsy | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:horizontal or rotary nystagmus ---
r_associated #0: 32 -->
en:stye
n1=en:horizontal or rotary nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:hyperopia, high ---
r_associated #0: 32 -->
en:stye
n1=en:hyperopia, high | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:hyperplastic vitreous ---
r_associated #0: 32 -->
en:stye
n1=en:hyperplastic vitreous | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:impaired ocular adduction ---
r_associated #0: 32 -->
en:stye
n1=en:impaired ocular adduction | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:impairment of extraocular movement (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:impairment of extraocular movement (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:impetigo of eyelid ---
r_associated #0: 32 -->
en:stye
n1=en:impetigo of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:inability to raise eyes above horizontal midline ---
r_associated #0: 32 -->
en:stye
n1=en:inability to raise eyes above horizontal midline | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:increased axial globe length ---
r_associated #0: 32 -->
en:stye
n1=en:increased axial globe length | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:increased density of the upper eyelid eyelashes ---
r_associated #0: 32 -->
en:stye
n1=en:increased density of the upper eyelid eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:increased ocular axial length (35 mm vs. 24 mm in normal non-myopes) ---
r_associated #0: 32 -->
en:stye
n1=en:increased ocular axial length (35 mm vs. 24 mm in normal non-myopes) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:infantile nystagmus ---
r_associated #0: 32 -->
en:stye
n1=en:infantile nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:infra-orbital fold ---
r_associated #0: 32 -->
en:stye
n1=en:infra-orbital fold | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:intraretinal pigmentation ---
r_associated #0: 32 -->
en:stye
n1=en:intraretinal pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:iridoretinal coloboma ---
r_associated #0: 32 -->
en:stye
n1=en:iridoretinal coloboma | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:irregular pursuit ---
r_associated #0: 32 -->
en:stye
n1=en:irregular pursuit | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:irritation of eye with itching (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:irritation of eye with itching (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:lacrimal duct aplasia or stenosis (25% of patients) ---
r_associated #0: 32 -->
en:stye
n1=en:lacrimal duct aplasia or stenosis (25% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:left eye ---
r_associated #0: 32 -->
en:stye
n1=en:left eye | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:long curly eyelashes ---
r_associated #0: 32 -->
en:stye
n1=en:long curly eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:long narrow palpebral fissures (1 patient) ---
r_associated #0: 32 -->
en:stye
n1=en:long narrow palpebral fissures (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:loss of visual acuity (late) ---
r_associated #0: 32 -->
en:stye
n1=en:loss of visual acuity (late) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:macular degeneration ---
r_associated #0: 32 -->
en:stye
n1=en:macular degeneration | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:macular striae ---
r_associated #0: 32 -->
en:stye
n1=en:macular striae | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:microcornea (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:microcornea (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:microphthalmia (rare) ---
r_associated #0: 32 -->
en:stye
n1=en:microphthalmia (rare) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:multiple retinal holes ---
r_associated #0: 32 -->
en:stye
n1=en:multiple retinal holes | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:myopia (in most patients) ---
r_associated #0: 32 -->
en:stye
n1=en:myopia (in most patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:nail infection ---
r_associated #0: 32 -->
en:stye
n1=en:nail infection | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:no ocular symptoms ---
r_associated #0: 32 -->
en:stye
n1=en:no ocular symptoms | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:nystagmus (1 family) ---
r_associated #0: 32 -->
en:stye
n1=en:nystagmus (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:nystagmus (infancy) ---
r_associated #0: 32 -->
en:stye
n1=en:nystagmus (infancy) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:nystagmus, horizontal, mild ---
r_associated #0: 32 -->
en:stye
n1=en:nystagmus, horizontal, mild | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:ocular globe large ---
r_associated #0: 32 -->
en:stye
n1=en:ocular globe large | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:oculocutaneous hypopigmentation (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:oculocutaneous hypopigmentation (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:oculogyric eye movements ---
r_associated #0: 32 -->
en:stye
n1=en:oculogyric eye movements | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:oculomotor apraxia (in some patients) ---
r_associated #0: 32 -->
en:stye
n1=en:oculomotor apraxia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:ophthalmoplegia (1 family) ---
r_associated #0: 32 -->
en:stye
n1=en:ophthalmoplegia (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:ophthalmoplegia, mild ---
r_associated #0: 32 -->
en:stye
n1=en:ophthalmoplegia, mild | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:phlegmonous dacryocystitis ---
r_associated #0: 32 -->
en:stye
n1=en:phlegmonous dacryocystitis | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:short palpebral fissure ---
r_associated #0: 32 -->
en:stye
n1=en:short palpebral fissure | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:staphylococcal eye infection ---
r_associated #0: 32 -->
en:stye
n1=en:staphylococcal eye infection | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:tell sb something ---
r_associated #0: 32 -->
en:stye
n1=en:tell sb something | n2=en:stye | rel=r_associated | relid=0 | w=32
- en:weak extraocular muscles ---
r_associated #0: 32 -->
en:stye
n1=en:weak extraocular muscles | n2=en:stye | rel=r_associated | relid=0 | w=32
- notifier quelqu'un de quelque chose ---
r_associated #0: 32 -->
en:stye
n1=notifier quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=32
- épidémiologique ---
r_associated #0: 32 -->
en:stye
n1=épidémiologique | n2=en:stye | rel=r_associated | relid=0 | w=32
- asynergie oculo-palpébrale ---
r_associated #0: 31 -->
en:stye
n1=asynergie oculo-palpébrale | n2=en:stye | rel=r_associated | relid=0 | w=31
- compère-loriot ---
r_associated #0: 31 -->
en:stye
n1=compère-loriot | n2=en:stye | rel=r_associated | relid=0 | w=31
- cécité nocturne ---
r_associated #0: 31 -->
en:stye
n1=cécité nocturne | n2=en:stye | rel=r_associated | relid=0 | w=31
- dyschromatopsie ---
r_associated #0: 31 -->
en:stye
n1=dyschromatopsie | n2=en:stye | rel=r_associated | relid=0 | w=31
- emmétropie ---
r_associated #0: 31 -->
en:stye
n1=emmétropie | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:'empty' vitreous with fibrillary condensations (childhood) ---
r_associated #0: 31 -->
en:stye
n1=en:'empty' vitreous with fibrillary condensations (childhood) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:'key-hole' iris, retina, choroid coloboma ---
r_associated #0: 31 -->
en:stye
n1=en:'key-hole' iris, retina, choroid coloboma | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium (rpe) on optical coherence tomography (oct) ---
r_associated #0: 31 -->
en:stye
n1=en:abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium (rpe) on optical coherence tomography (oct) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:abnormal retinal vessels ---
r_associated #0: 31 -->
en:stye
n1=en:abnormal retinal vessels | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:absent corneal reflex response ---
r_associated #0: 31 -->
en:stye
n1=en:absent corneal reflex response | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:absent eyebrows and eyelashes ---
r_associated #0: 31 -->
en:stye
n1=en:absent eyebrows and eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:absent iris pigment ---
r_associated #0: 31 -->
en:stye
n1=en:absent iris pigment | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:absent rod-and cone-mediated responses on erg (late) ---
r_associated #0: 31 -->
en:stye
n1=en:absent rod-and cone-mediated responses on erg (late) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:alacrima - hypolacrimation, severe ---
r_associated #0: 31 -->
en:stye
n1=en:alacrima - hypolacrimation, severe | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:anterior chamber angle open with grade iii-iv gonioscopy ---
r_associated #0: 31 -->
en:stye
n1=en:anterior chamber angle open with grade iii-iv gonioscopy | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:anterior chamber dysgenesis ---
r_associated #0: 31 -->
en:stye
n1=en:anterior chamber dysgenesis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:atretic lacrimal punctum ---
r_associated #0: 31 -->
en:stye
n1=en:atretic lacrimal punctum | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:bartonella henselae neuroretinitis ---
r_associated #0: 31 -->
en:stye
n1=en:bartonella henselae neuroretinitis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:blepharophimosis, mild ---
r_associated #0: 31 -->
en:stye
n1=en:blepharophimosis, mild | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:blindness (wws) ---
r_associated #0: 31 -->
en:stye
n1=en:blindness (wws) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:blindness by third decade ---
r_associated #0: 31 -->
en:stye
n1=en:blindness by third decade | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:blue sclerae (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:blue sclerae (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:bluish sclerae in infancy (rare) ---
r_associated #0: 31 -->
en:stye
n1=en:bluish sclerae in infancy (rare) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:bone-spicule pigment depositions (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:bone-spicule pigment depositions (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cararacts ---
r_associated #0: 31 -->
en:stye
n1=en:cararacts | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataract, congenital (nuclear, sutural, or stellate cortical) ---
r_associated #0: 31 -->
en:stye
n1=en:cataract, congenital (nuclear, sutural, or stellate cortical) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataract, congenital (rare) ---
r_associated #0: 31 -->
en:stye
n1=en:cataract, congenital (rare) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataract, posterior polar (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:cataract, posterior polar (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataract, progressive, juvenile-onset (lamellar, cortical, nuclear embryonic, or y-sutural) ---
r_associated #0: 31 -->
en:stye
n1=en:cataract, progressive, juvenile-onset (lamellar, cortical, nuclear embryonic, or y-sutural) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataracts (1 patient) ---
r_associated #0: 31 -->
en:stye
n1=en:cataracts (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:cataracts, rapid-onset ---
r_associated #0: 31 -->
en:stye
n1=en:cataracts, rapid-onset | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:choroidal neovascularization (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:choroidal neovascularization (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:coloboma (in some patients with larger microdeletion) ---
r_associated #0: 31 -->
en:stye
n1=en:coloboma (in some patients with larger microdeletion) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:colorblindness, severe to complete ---
r_associated #0: 31 -->
en:stye
n1=en:colorblindness, severe to complete | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:conductive hearing loss ---
r_associated #0: 31 -->
en:stye
n1=en:conductive hearing loss | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:congenital cataracts (1 family) ---
r_associated #0: 31 -->
en:stye
n1=en:congenital cataracts (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:conjugated horizontal gaze palsy ---
r_associated #0: 31 -->
en:stye
n1=en:conjugated horizontal gaze palsy | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:constricted visual fields by age 20 years ---
r_associated #0: 31 -->
en:stye
n1=en:constricted visual fields by age 20 years | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:corneal and retinal calcification ---
r_associated #0: 31 -->
en:stye
n1=en:corneal and retinal calcification | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:corneal clouding (detroit type 107680.0011, apoa1 deficiency 107680.0014) ---
r_associated #0: 31 -->
en:stye
n1=en:corneal clouding (detroit type 107680.0011, apoa1 deficiency 107680.0014) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:corneal dystrophy (onset early in childhood) ---
r_associated #0: 31 -->
en:stye
n1=en:corneal dystrophy (onset early in childhood) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:corneal opacities (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:corneal opacities (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:corneal sensitivity impairment (hypesthesia) ---
r_associated #0: 31 -->
en:stye
n1=en:corneal sensitivity impairment (hypesthesia) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:decreased visual acuity, slowly progressive ---
r_associated #0: 31 -->
en:stye
n1=en:decreased visual acuity, slowly progressive | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:delayed pupillary responses (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:delayed pupillary responses (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:discontinuity and degeneration of the endothelial cell layer ---
r_associated #0: 31 -->
en:stye
n1=en:discontinuity and degeneration of the endothelial cell layer | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:drooping eyelid ---
r_associated #0: 31 -->
en:stye
n1=en:drooping eyelid | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:dystrophy does not recur after penetrating keratoplasty ---
r_associated #0: 31 -->
en:stye
n1=en:dystrophy does not recur after penetrating keratoplasty | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:early-onset corneal degeneration ---
r_associated #0: 31 -->
en:stye
n1=en:early-onset corneal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:ectropion (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:ectropion (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:elevated papillomacular retinal fold ---
r_associated #0: 31 -->
en:stye
n1=en:elevated papillomacular retinal fold | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:epicanthal folds, mild ---
r_associated #0: 31 -->
en:stye
n1=en:epicanthal folds, mild | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:episodic ptosis ---
r_associated #0: 31 -->
en:stye
n1=en:episodic ptosis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:excess skin and muscle of eyelid ---
r_associated #0: 31 -->
en:stye
n1=en:excess skin and muscle of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:exotropia (1 patient) ---
r_associated #0: 31 -->
en:stye
n1=en:exotropia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:external ophthalmoplegia affecting upward and lateral gaze ---
r_associated #0: 31 -->
en:stye
n1=en:external ophthalmoplegia affecting upward and lateral gaze | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:extraocular muscle weakness, mild (1 patient) ---
r_associated #0: 31 -->
en:stye
n1=en:extraocular muscle weakness, mild (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:eyelid cyst ---
r_associated #0: 31 -->
en:stye
n1=en:eyelid cyst | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:eyelid margin crusting ---
r_associated #0: 31 -->
en:stye
n1=en:eyelid margin crusting | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:eyelid rash ---
r_associated #0: 31 -->
en:stye
n1=en:eyelid rash | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:eyelid xanthoma ---
r_associated #0: 31 -->
en:stye
n1=en:eyelid xanthoma | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:eyes fixed in extreme abduction (exotropia strabismus fixus) ---
r_associated #0: 31 -->
en:stye
n1=en:eyes fixed in extreme abduction (exotropia strabismus fixus) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:fine peripheral pigmentary mottling ---
r_associated #0: 31 -->
en:stye
n1=en:fine peripheral pigmentary mottling | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:focal acute inflammation ---
r_associated #0: 31 -->
en:stye
n1=en:focal acute inflammation | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:folliculitis of lids ---
r_associated #0: 31 -->
en:stye
n1=en:folliculitis of lids | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:gray, granular-appearing maculae ---
r_associated #0: 31 -->
en:stye
n1=en:gray, granular-appearing maculae | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:high arched eyebrows ---
r_associated #0: 31 -->
en:stye
n1=en:high arched eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:histopathology shows hyaline changes consistent with granular dystrophy in the anterior stroma ---
r_associated #0: 31 -->
en:stye
n1=en:histopathology shows hyaline changes consistent with granular dystrophy in the anterior stroma | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:hypotelorism (19%) ---
r_associated #0: 31 -->
en:stye
n1=en:hypotelorism (19%) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:hypotelorism (in 2 patients) ---
r_associated #0: 31 -->
en:stye
n1=en:hypotelorism (in 2 patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:infective scleritis ---
r_associated #0: 31 -->
en:stye
n1=en:infective scleritis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:initial loss of central visual acuity and color vision ---
r_associated #0: 31 -->
en:stye
n1=en:initial loss of central visual acuity and color vision | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:involuntary spasms of eyelid closure (blepharospasm) ---
r_associated #0: 31 -->
en:stye
n1=en:involuntary spasms of eyelid closure (blepharospasm) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:keratoglobus ---
r_associated #0: 31 -->
en:stye
n1=en:keratoglobus | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:long upslanting palpebral fissures (1/4 patients) ---
r_associated #0: 31 -->
en:stye
n1=en:long upslanting palpebral fissures (1/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:loss of periorbital fat ---
r_associated #0: 31 -->
en:stye
n1=en:loss of periorbital fat | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:loss of vision ---
r_associated #0: 31 -->
en:stye
n1=en:loss of vision | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:loss of vision (34%) ---
r_associated #0: 31 -->
en:stye
n1=en:loss of vision (34%) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:macular atrophy, mild (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:macular atrophy, mild (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:macular cherry-red spots (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:macular cherry-red spots (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:maculopathy (uncommon) ---
r_associated #0: 31 -->
en:stye
n1=en:maculopathy (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:marked pallor of mucous membranes ---
r_associated #0: 31 -->
en:stye
n1=en:marked pallor of mucous membranes | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:medially flared eyebrows ---
r_associated #0: 31 -->
en:stye
n1=en:medially flared eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:microphthalmia, mild ---
r_associated #0: 31 -->
en:stye
n1=en:microphthalmia, mild | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:microphthalmia, mild (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:microphthalmia, mild (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:mild palpebral ptosis ---
r_associated #0: 31 -->
en:stye
n1=en:mild palpebral ptosis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:minor photophobia ---
r_associated #0: 31 -->
en:stye
n1=en:minor photophobia | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:multiple rows of eyelashes ---
r_associated #0: 31 -->
en:stye
n1=en:multiple rows of eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:myopia, low to moderate (-12.12 d to +7.25 d) ---
r_associated #0: 31 -->
en:stye
n1=en:myopia, low to moderate (-12.12 d to +7.25 d) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:night blindness beginning in the 6th decade ---
r_associated #0: 31 -->
en:stye
n1=en:night blindness beginning in the 6th decade | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:normal eyelashes ---
r_associated #0: 31 -->
en:stye
n1=en:normal eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:nuclear cataract ---
r_associated #0: 31 -->
en:stye
n1=en:nuclear cataract | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:null point shifts every few seconds to minutes ---
r_associated #0: 31 -->
en:stye
n1=en:null point shifts every few seconds to minutes | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:nystagmus, minimal rotational (rare) ---
r_associated #0: 31 -->
en:stye
n1=en:nystagmus, minimal rotational (rare) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:nystagmus, moderate ---
r_associated #0: 31 -->
en:stye
n1=en:nystagmus, moderate | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:obliteration of peripheral retinal blood vessels (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:obliteration of peripheral retinal blood vessels (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:ocular cyst, inferior ---
r_associated #0: 31 -->
en:stye
n1=en:ocular cyst, inferior | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:ocular disturbances, nonspecific ---
r_associated #0: 31 -->
en:stye
n1=en:ocular disturbances, nonspecific | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:oculogyric crisis ---
r_associated #0: 31 -->
en:stye
n1=en:oculogyric crisis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:oculopalpebral synechia ---
r_associated #0: 31 -->
en:stye
n1=en:oculopalpebral synechia | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:optic disc pallor (less common) ---
r_associated #0: 31 -->
en:stye
n1=en:optic disc pallor (less common) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:optic disc pallor in fourth decade of life ---
r_associated #0: 31 -->
en:stye
n1=en:optic disc pallor in fourth decade of life | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:optic nerve atrophy, progressive ---
r_associated #0: 31 -->
en:stye
n1=en:optic nerve atrophy, progressive | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:optic nerve hypoplasia or agenesis ---
r_associated #0: 31 -->
en:stye
n1=en:optic nerve hypoplasia or agenesis | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:orbital cyst ---
r_associated #0: 31 -->
en:stye
n1=en:orbital cyst | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:periorbital edema ---
r_associated #0: 31 -->
en:stye
n1=en:periorbital edema | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:poor visual acuity ---
r_associated #0: 31 -->
en:stye
n1=en:poor visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:septic rash ---
r_associated #0: 31 -->
en:stye
n1=en:septic rash | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:skin graft infection ---
r_associated #0: 31 -->
en:stye
n1=en:skin graft infection | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:soft lens ---
r_associated #0: 31 -->
en:stye
n1=en:soft lens | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:strabismus (in some patients) ---
r_associated #0: 31 -->
en:stye
n1=en:strabismus (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:upper eyelid ---
r_associated #0: 31 -->
en:stye
n1=en:upper eyelid | n2=en:stye | rel=r_associated | relid=0 | w=31
- en:vitreoretinochoroidopathy (disorder) ---
r_associated #0: 31 -->
en:stye
n1=en:vitreoretinochoroidopathy (disorder) | n2=en:stye | rel=r_associated | relid=0 | w=31
- enophtalmie ---
r_associated #0: 31 -->
en:stye
n1=enophtalmie | n2=en:stye | rel=r_associated | relid=0 | w=31
- héméralopie congénitale stationnaire de type III apparentée à la rhodopsine ---
r_associated #0: 31 -->
en:stye
n1=héméralopie congénitale stationnaire de type III apparentée à la rhodopsine | n2=en:stye | rel=r_associated | relid=0 | w=31
- informer quelqu'un de qqch ---
r_associated #0: 31 -->
en:stye
n1=informer quelqu'un de qqch | n2=en:stye | rel=r_associated | relid=0 | w=31
- leucocorie ---
r_associated #0: 31 -->
en:stye
n1=leucocorie | n2=en:stye | rel=r_associated | relid=0 | w=31
- parakératose ---
r_associated #0: 31 -->
en:stye
n1=parakératose | n2=en:stye | rel=r_associated | relid=0 | w=31
- persistance du vitré primitif ---
r_associated #0: 31 -->
en:stye
n1=persistance du vitré primitif | n2=en:stye | rel=r_associated | relid=0 | w=31
- sinusite ---
r_associated #0: 31 -->
en:stye
n1=sinusite | n2=en:stye | rel=r_associated | relid=0 | w=31
- trouble de la vision ---
r_associated #0: 31 -->
en:stye
n1=trouble de la vision | n2=en:stye | rel=r_associated | relid=0 | w=31
- Déficience visuelle ---
r_associated #0: 30 -->
en:stye
n1=Déficience visuelle | n2=en:stye | rel=r_associated | relid=0 | w=30
- Glande lacrymale ---
r_associated #0: 30 -->
en:stye
n1=Glande lacrymale | n2=en:stye | rel=r_associated | relid=0 | w=30
- Glasgow (score de) ---
r_associated #0: 30 -->
en:stye
n1=Glasgow (score de) | n2=en:stye | rel=r_associated | relid=0 | w=30
- Uukuniemi (virus) ---
r_associated #0: 30 -->
en:stye
n1=Uukuniemi (virus) | n2=en:stye | rel=r_associated | relid=0 | w=30
- arc sénile ---
r_associated #0: 30 -->
en:stye
n1=arc sénile | n2=en:stye | rel=r_associated | relid=0 | w=30
- atrophie optique, surdité, épilepsie, spasticité et décès précoce ---
r_associated #0: 30 -->
en:stye
n1=atrophie optique, surdité, épilepsie, spasticité et décès précoce | n2=en:stye | rel=r_associated | relid=0 | w=30
- blépharite ---
r_associated #0: 30 -->
en:stye
n1=blépharite | n2=en:stye | rel=r_associated | relid=0 | w=30
- cataracte congénitale, microcornée ou microphtalmie légère ---
r_associated #0: 30 -->
en:stye
n1=cataracte congénitale, microcornée ou microphtalmie légère | n2=en:stye | rel=r_associated | relid=0 | w=30
- chagrin d'amour ---
r_associated #0: 30 -->
en:stye
n1=chagrin d'amour | n2=en:stye | rel=r_associated | relid=0 | w=30
- conjonctivite lacrymale ---
r_associated #0: 30 -->
en:stye
n1=conjonctivite lacrymale | n2=en:stye | rel=r_associated | relid=0 | w=30
- cécité ---
r_associated #0: 30 -->
en:stye
n1=cécité | n2=en:stye | rel=r_associated | relid=0 | w=30
- d' Hérelle (phénomène de) ---
r_associated #0: 30 -->
en:stye
n1=d' Hérelle (phénomène de) | n2=en:stye | rel=r_associated | relid=0 | w=30
- déchirement intérieur ---
r_associated #0: 30 -->
en:stye
n1=déchirement intérieur | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:abnormal dark-adaptation, midperipheral scotoma ---
r_associated #0: 30 -->
en:stye
n1=en:abnormal dark-adaptation, midperipheral scotoma | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:abnormal fibrils in stroma on electron microscopy ---
r_associated #0: 30 -->
en:stye
n1=en:abnormal fibrils in stroma on electron microscopy | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:abnormal lens suspensory ligament ---
r_associated #0: 30 -->
en:stye
n1=en:abnormal lens suspensory ligament | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:abnormal saccades ---
r_associated #0: 30 -->
en:stye
n1=en:abnormal saccades | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:absence of exophthalmos ---
r_associated #0: 30 -->
en:stye
n1=en:absence of exophthalmos | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:achromatopsia 1 ---
r_associated #0: 30 -->
en:stye
n1=en:achromatopsia 1 | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:acute lacrimal canaliculitis ---
r_associated #0: 30 -->
en:stye
n1=en:acute lacrimal canaliculitis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:adduction palsy, usually bilateral ---
r_associated #0: 30 -->
en:stye
n1=en:adduction palsy, usually bilateral | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:alacrima (dry eye syndrome) ---
r_associated #0: 30 -->
en:stye
n1=en:alacrima (dry eye syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:anisocoria (in 1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:anisocoria (in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:anisocoria (unequal pupal size) ---
r_associated #0: 30 -->
en:stye
n1=en:anisocoria (unequal pupal size) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:apraxia of eyelid opening ---
r_associated #0: 30 -->
en:stye
n1=en:apraxia of eyelid opening | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:arcus adiposus ---
r_associated #0: 30 -->
en:stye
n1=en:arcus adiposus | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:arcus senilis ---
r_associated #0: 30 -->
en:stye
n1=en:arcus senilis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:astigmatism (1 family) ---
r_associated #0: 30 -->
en:stye
n1=en:astigmatism (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:asymmetric pendular movements ---
r_associated #0: 30 -->
en:stye
n1=en:asymmetric pendular movements | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:atrophic macular disease ---
r_associated #0: 30 -->
en:stye
n1=en:atrophic macular disease | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:be in touch with sb ---
r_associated #0: 30 -->
en:stye
n1=en:be in touch with sb | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:benign essential blepharospasm ---
r_associated #0: 30 -->
en:stye
n1=en:benign essential blepharospasm | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:bilateral cataracts ---
r_associated #0: 30 -->
en:stye
n1=en:bilateral cataracts | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:bilateral chorioretinopathy ---
r_associated #0: 30 -->
en:stye
n1=en:bilateral chorioretinopathy | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blepharitis, recurrent, due to infection with staphylococcus aureus ---
r_associated #0: 30 -->
en:stye
n1=en:blepharitis, recurrent, due to infection with staphylococcus aureus | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blepharophimosis (uncommon) ---
r_associated #0: 30 -->
en:stye
n1=en:blepharophimosis (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blepharoptosis (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:blepharoptosis (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blindness (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:blindness (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blindness in infancy or very early childhood ---
r_associated #0: 30 -->
en:stye
n1=en:blindness in infancy or very early childhood | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blindness may occur in affected infants ---
r_associated #0: 30 -->
en:stye
n1=en:blindness may occur in affected infants | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:blue sclera in infancy ---
r_associated #0: 30 -->
en:stye
n1=en:blue sclera in infancy | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:bull's eye maculopathy (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:bull's eye maculopathy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cataract (alport syndrome with macrothrombocytopenia) ---
r_associated #0: 30 -->
en:stye
n1=en:cataract (alport syndrome with macrothrombocytopenia) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cataract, laminar ---
r_associated #0: 30 -->
en:stye
n1=en:cataract, laminar | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cataracts (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:cataracts (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cherry-red maculae (50%) ---
r_associated #0: 30 -->
en:stye
n1=en:cherry-red maculae (50%) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:choroid atrophy (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:choroid atrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:clinically 'silent' nystagmus evident on eye movement recording in carrier females ---
r_associated #0: 30 -->
en:stye
n1=en:clinically 'silent' nystagmus evident on eye movement recording in carrier females | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:coloboma, choreoretinal ---
r_associated #0: 30 -->
en:stye
n1=en:coloboma, choreoretinal | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:complete blindness between ages 40-50 years ---
r_associated #0: 30 -->
en:stye
n1=en:complete blindness between ages 40-50 years | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:concretion in palpebral conjunctiva ---
r_associated #0: 30 -->
en:stye
n1=en:concretion in palpebral conjunctiva | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cone-dystrophy ---
r_associated #0: 30 -->
en:stye
n1=en:cone-dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:congenital ankyloblepharon ---
r_associated #0: 30 -->
en:stye
n1=en:congenital ankyloblepharon | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:congenital complete achromatopsia ---
r_associated #0: 30 -->
en:stye
n1=en:congenital complete achromatopsia | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:congenital hypertrophy of retinal pigment epithelium ---
r_associated #0: 30 -->
en:stye
n1=en:congenital hypertrophy of retinal pigment epithelium | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:congenital stationary ---
r_associated #0: 30 -->
en:stye
n1=en:congenital stationary | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:congenital strabismus ---
r_associated #0: 30 -->
en:stye
n1=en:congenital strabismus | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:conjunctival injection, ipsilateral ---
r_associated #0: 30 -->
en:stye
n1=en:conjunctival injection, ipsilateral | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:conjunctivitis, episodic ---
r_associated #0: 30 -->
en:stye
n1=en:conjunctivitis, episodic | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:contact ---
r_associated #0: 30 -->
en:stye
n1=en:contact | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:controlling officer ---
r_associated #0: 30 -->
en:stye
n1=en:controlling officer | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:cortical blindness (1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:cortical blindness (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:curly eyebrows ---
r_associated #0: 30 -->
en:stye
n1=en:curly eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:deafness ---
r_associated #0: 30 -->
en:stye
n1=en:deafness | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:decreased light- and dark-adapted electroretinogram amplitude ---
r_associated #0: 30 -->
en:stye
n1=en:decreased light- and dark-adapted electroretinogram amplitude | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:decreased night vision ---
r_associated #0: 30 -->
en:stye
n1=en:decreased night vision | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:decreased visual acuity (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:decreased visual acuity (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:delayed visual-evoked potential ---
r_associated #0: 30 -->
en:stye
n1=en:delayed visual-evoked potential | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:dermoid choristoma of eye proper ---
r_associated #0: 30 -->
en:stye
n1=en:dermoid choristoma of eye proper | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:desk officer ---
r_associated #0: 30 -->
en:stye
n1=en:desk officer | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:dislocated lens (upward) ---
r_associated #0: 30 -->
en:stye
n1=en:dislocated lens (upward) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:divide ---
r_associated #0: 30 -->
en:stye
n1=en:divide | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:duane syndrome (abducens palsy with retracted globe) ---
r_associated #0: 30 -->
en:stye
n1=en:duane syndrome (abducens palsy with retracted globe) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:early onset of decreased visual acuity: nonrecordable cone pattern on electroretinogram ---
r_associated #0: 30 -->
en:stye
n1=en:early onset of decreased visual acuity: nonrecordable cone pattern on electroretinogram | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:endothelial cell death with hypertrophy and polymorphism of surviving cells ---
r_associated #0: 30 -->
en:stye
n1=en:endothelial cell death with hypertrophy and polymorphism of surviving cells | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:epicanthal folds (68%) ---
r_associated #0: 30 -->
en:stye
n1=en:epicanthal folds (68%) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:epicanthic folds (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:epicanthic folds (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:epicanthus (in one family) ---
r_associated #0: 30 -->
en:stye
n1=en:epicanthus (in one family) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:epidemiologic ---
r_associated #0: 30 -->
en:stye
n1=en:epidemiologic | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:epiretinal membranes, with wrinkling of retina ---
r_associated #0: 30 -->
en:stye
n1=en:epiretinal membranes, with wrinkling of retina | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:eventual loss of peripheral vision and night blindness ---
r_associated #0: 30 -->
en:stye
n1=en:eventual loss of peripheral vision and night blindness | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:exotropia (severe cases) ---
r_associated #0: 30 -->
en:stye
n1=en:exotropia (severe cases) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:exudative vitreoretinopathy (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:exudative vitreoretinopathy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:eyelid edema, ipsilateral ---
r_associated #0: 30 -->
en:stye
n1=en:eyelid edema, ipsilateral | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:eyelid erythema ---
r_associated #0: 30 -->
en:stye
n1=en:eyelid erythema | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:eyelid hooding ---
r_associated #0: 30 -->
en:stye
n1=en:eyelid hooding | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:eyelid myotonia ---
r_associated #0: 30 -->
en:stye
n1=en:eyelid myotonia | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:flat anterior chamber (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:flat anterior chamber (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:fundus albipunctatus ---
r_associated #0: 30 -->
en:stye
n1=en:fundus albipunctatus | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:fused eyes (1 family) ---
r_associated #0: 30 -->
en:stye
n1=en:fused eyes (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:gaze limitation ---
r_associated #0: 30 -->
en:stye
n1=en:gaze limitation | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:get in contact with ---
r_associated #0: 30 -->
en:stye
n1=en:get in contact with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:get in touch with ---
r_associated #0: 30 -->
en:stye
n1=en:get in touch with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:give advance warning ---
r_associated #0: 30 -->
en:stye
n1=en:give advance warning | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:give some advance warning ---
r_associated #0: 30 -->
en:stye
n1=en:give some advance warning | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:gliosis of optic nerve ---
r_associated #0: 30 -->
en:stye
n1=en:gliosis of optic nerve | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:gray, crumb-like granular deposits in anterior third of stroma ---
r_associated #0: 30 -->
en:stye
n1=en:gray, crumb-like granular deposits in anterior third of stroma | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:heartache ---
r_associated #0: 30 -->
en:stye
n1=en:heartache | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:heavy horizontal eyebrows ---
r_associated #0: 30 -->
en:stye
n1=en:heavy horizontal eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:heterochromia iridis (complete or partial) ---
r_associated #0: 30 -->
en:stye
n1=en:heterochromia iridis (complete or partial) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:high lens-to-eye volume ratio ---
r_associated #0: 30 -->
en:stye
n1=en:high lens-to-eye volume ratio | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:histology shows degeneration of retinal ganglion cells ---
r_associated #0: 30 -->
en:stye
n1=en:histology shows degeneration of retinal ganglion cells | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hordeolum externum ---
r_associated #0: 30 -->
en:stye
n1=en:hordeolum externum | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:horizontal nystagmus (in 1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:horizontal nystagmus (in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:horizontal saccades ---
r_associated #0: 30 -->
en:stye
n1=en:horizontal saccades | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hyperfluorescent ring in area of macular lesions on fluorescein angiography ---
r_associated #0: 30 -->
en:stye
n1=en:hyperfluorescent ring in area of macular lesions on fluorescein angiography | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypermetropia (1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:hypermetropia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypermetropic astigmatism (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:hypermetropic astigmatism (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypertelorism (2/4 patients) ---
r_associated #0: 30 -->
en:stye
n1=en:hypertelorism (2/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypertelorism (in 1 family) ---
r_associated #0: 30 -->
en:stye
n1=en:hypertelorism (in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypertelorism, mild ---
r_associated #0: 30 -->
en:stye
n1=en:hypertelorism, mild | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypertropia ---
r_associated #0: 30 -->
en:stye
n1=en:hypertropia | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypometric saccades (about half of patients) ---
r_associated #0: 30 -->
en:stye
n1=en:hypometric saccades (about half of patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:hypoplasia or absence of optic nerve ---
r_associated #0: 30 -->
en:stye
n1=en:hypoplasia or absence of optic nerve | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:impaired pupillary response to light ---
r_associated #0: 30 -->
en:stye
n1=en:impaired pupillary response to light | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:impaired pursuit initiation and maintenance ---
r_associated #0: 30 -->
en:stye
n1=en:impaired pursuit initiation and maintenance | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:impaired retinal vasculogenesis ---
r_associated #0: 30 -->
en:stye
n1=en:impaired retinal vasculogenesis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:inability to suppress vestibuloocular reflex (vor) ---
r_associated #0: 30 -->
en:stye
n1=en:inability to suppress vestibuloocular reflex (vor) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:infectious keratitis ---
r_associated #0: 30 -->
en:stye
n1=en:infectious keratitis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:irides blue-gray to light brown ---
r_associated #0: 30 -->
en:stye
n1=en:irides blue-gray to light brown | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:iridogoniodysgenesis (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:iridogoniodysgenesis (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:iris discoloration ---
r_associated #0: 30 -->
en:stye
n1=en:iris discoloration | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:iris hypopigmentation ---
r_associated #0: 30 -->
en:stye
n1=en:iris hypopigmentation | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:iris strands attached to schwalbe line bridging the iridocorneal angle ---
r_associated #0: 30 -->
en:stye
n1=en:iris strands attached to schwalbe line bridging the iridocorneal angle | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:irregular pigmentation of fovea with atrophy of rpe (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:irregular pigmentation of fovea with atrophy of rpe (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:keep sb informed ---
r_associated #0: 30 -->
en:stye
n1=en:keep sb informed | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:lacrimal gland ---
r_associated #0: 30 -->
en:stye
n1=en:lacrimal gland | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:lateral displacement of medial canthi ---
r_associated #0: 30 -->
en:stye
n1=en:lateral displacement of medial canthi | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:lid lag ---
r_associated #0: 30 -->
en:stye
n1=en:lid lag | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:long eyelashes in irregular rows ---
r_associated #0: 30 -->
en:stye
n1=en:long eyelashes in irregular rows | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:long palpebral fissure ---
r_associated #0: 30 -->
en:stye
n1=en:long palpebral fissure | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:loss of peripheral visual fields (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:loss of peripheral visual fields (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:lost love ---
r_associated #0: 30 -->
en:stye
n1=en:lost love | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:love pain ---
r_associated #0: 30 -->
en:stye
n1=en:love pain | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:lower eyelid ectropion ---
r_associated #0: 30 -->
en:stye
n1=en:lower eyelid ectropion | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:macular hypoplasia ---
r_associated #0: 30 -->
en:stye
n1=en:macular hypoplasia | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:make contact with ---
r_associated #0: 30 -->
en:stye
n1=en:make contact with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:megophthalmos ---
r_associated #0: 30 -->
en:stye
n1=en:megophthalmos | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:microphthalmia (ipsilateral to facial hemangioma) ---
r_associated #0: 30 -->
en:stye
n1=en:microphthalmia (ipsilateral to facial hemangioma) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:microspherophakia (small, spherical lens) (74%) ---
r_associated #0: 30 -->
en:stye
n1=en:microspherophakia (small, spherical lens) (74%) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:mild photophobia ---
r_associated #0: 30 -->
en:stye
n1=en:mild photophobia | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:mild retinopathy ---
r_associated #0: 30 -->
en:stye
n1=en:mild retinopathy | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:moderate atrophy of optic disc ---
r_associated #0: 30 -->
en:stye
n1=en:moderate atrophy of optic disc | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:movement of visual image - finding ---
r_associated #0: 30 -->
en:stye
n1=en:movement of visual image - finding | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:myopia (reported in 1 family) ---
r_associated #0: 30 -->
en:stye
n1=en:myopia (reported in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:night blindness (infancy and early childhood) ---
r_associated #0: 30 -->
en:stye
n1=en:night blindness (infancy and early childhood) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:night blindness followed by complete blindness ---
r_associated #0: 30 -->
en:stye
n1=en:night blindness followed by complete blindness | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:no retinal degeneration ---
r_associated #0: 30 -->
en:stye
n1=en:no retinal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nonprogressive restrictive ophthalmoplegia (superior rectus, inferior oblique, levator palpebralis dysfunction) ---
r_associated #0: 30 -->
en:stye
n1=en:nonprogressive restrictive ophthalmoplegia (superior rectus, inferior oblique, levator palpebralis dysfunction) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nonreactive, fixed narrowing of the pupil ('microcoria') ---
r_associated #0: 30 -->
en:stye
n1=en:nonreactive, fixed narrowing of the pupil ('microcoria') | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal color vision ---
r_associated #0: 30 -->
en:stye
n1=en:normal color vision | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal eyelashes, eyebrows ---
r_associated #0: 30 -->
en:stye
n1=en:normal eyelashes, eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal or decreased cone and rod responses on electroretinography ---
r_associated #0: 30 -->
en:stye
n1=en:normal or decreased cone and rod responses on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal or reduced responses on electroretinography ---
r_associated #0: 30 -->
en:stye
n1=en:normal or reduced responses on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal retinal and pupillary reflexes between episodes ---
r_associated #0: 30 -->
en:stye
n1=en:normal retinal and pupillary reflexes between episodes | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:normal scotopic responses on rod electroretinogram (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:normal scotopic responses on rod electroretinogram (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nyctalopia, congenital (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:nyctalopia, congenital (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nystagmus ---
r_associated #0: 30 -->
en:stye
n1=en:nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nystagmus (type i) ---
r_associated #0: 30 -->
en:stye
n1=en:nystagmus (type i) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nystagmus on lateral gaze ---
r_associated #0: 30 -->
en:stye
n1=en:nystagmus on lateral gaze | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nystagmus, horizontal ---
r_associated #0: 30 -->
en:stye
n1=en:nystagmus, horizontal | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:nystagmus, horizontal (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:nystagmus, horizontal (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ocular abnormalities often persist between attacks ---
r_associated #0: 30 -->
en:stye
n1=en:ocular abnormalities often persist between attacks | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ocular rupture ---
r_associated #0: 30 -->
en:stye
n1=en:ocular rupture | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ocular syphilis ---
r_associated #0: 30 -->
en:stye
n1=en:ocular syphilis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:oculomotor nerve paralysis ---
r_associated #0: 30 -->
en:stye
n1=en:oculomotor nerve paralysis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:opacification of the corneal epithelium ---
r_associated #0: 30 -->
en:stye
n1=en:opacification of the corneal epithelium | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ophthalmoparesis ---
r_associated #0: 30 -->
en:stye
n1=en:ophthalmoparesis | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ophthalmoparesis (less common) ---
r_associated #0: 30 -->
en:stye
n1=en:ophthalmoparesis (less common) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:ophthalmoparesis (with longer disease duration) ---
r_associated #0: 30 -->
en:stye
n1=en:ophthalmoparesis (with longer disease duration) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic atrophy (may be asymptomatic in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:optic atrophy (may be asymptomatic in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic atrophy (reported in 1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:optic atrophy (reported in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic disc drusen (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:optic disc drusen (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic disc edema ---
r_associated #0: 30 -->
en:stye
n1=en:optic disc edema | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic disc pallor (in some patients) ---
r_associated #0: 30 -->
en:stye
n1=en:optic disc pallor (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic nerve hypoplasia (1 patient) ---
r_associated #0: 30 -->
en:stye
n1=en:optic nerve hypoplasia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:optic nerve hypoplasia, segmental (rare) ---
r_associated #0: 30 -->
en:stye
n1=en:optic nerve hypoplasia, segmental (rare) | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:pharmacotherapeutic ---
r_associated #0: 30 -->
en:stye
n1=en:pharmacotherapeutic | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:prominent supraorbital ridges ---
r_associated #0: 30 -->
en:stye
n1=en:prominent supraorbital ridges | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:pupil diameter:len:pt:eye.right:qn:manual ---
r_associated #0: 30 -->
en:stye
n1=en:pupil diameter:len:pt:eye.right:qn:manual | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:recurrent erosion of cornea ---
r_associated #0: 30 -->
en:stye
n1=en:recurrent erosion of cornea | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:sensorimotor disorder of eyelid ---
r_associated #0: 30 -->
en:stye
n1=en:sensorimotor disorder of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:shredding ---
r_associated #0: 30 -->
en:stye
n1=en:shredding | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:slanted eyes ---
r_associated #0: 30 -->
en:stye
n1=en:slanted eyes | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:sorrow of love ---
r_associated #0: 30 -->
en:stye
n1=en:sorrow of love | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:swollen tear duct ---
r_associated #0: 30 -->
en:stye
n1=en:swollen tear duct | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:therapeutic aspects ---
r_associated #0: 30 -->
en:stye
n1=en:therapeutic aspects | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to be in touch with sb ---
r_associated #0: 30 -->
en:stye
n1=en:to be in touch with sb | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to contact ---
r_associated #0: 30 -->
en:stye
n1=en:to contact | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to get in contact with ---
r_associated #0: 30 -->
en:stye
n1=en:to get in contact with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to get in touch with ---
r_associated #0: 30 -->
en:stye
n1=en:to get in touch with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to keep sb informed ---
r_associated #0: 30 -->
en:stye
n1=en:to keep sb informed | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:to make contact with ---
r_associated #0: 30 -->
en:stye
n1=en:to make contact with | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:tuberculosis, ocular ---
r_associated #0: 30 -->
en:stye
n1=en:tuberculosis, ocular | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:unhappy love affair ---
r_associated #0: 30 -->
en:stye
n1=en:unhappy love affair | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:warn sb about something ---
r_associated #0: 30 -->
en:stye
n1=en:warn sb about something | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:warn sb of something ---
r_associated #0: 30 -->
en:stye
n1=en:warn sb of something | n2=en:stye | rel=r_associated | relid=0 | w=30
- en:warn somebody about something ---
r_associated #0: 30 -->
en:stye
n1=en:warn somebody about something | n2=en:stye | rel=r_associated | relid=0 | w=30
- entrer en contact avec ---
r_associated #0: 30 -->
en:stye
n1=entrer en contact avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- entrer en liaison avec ---
r_associated #0: 30 -->
en:stye
n1=entrer en liaison avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- entrer en relation avec ---
r_associated #0: 30 -->
en:stye
n1=entrer en relation avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- faire savoir qch à qn ---
r_associated #0: 30 -->
en:stye
n1=faire savoir qch à qn | n2=en:stye | rel=r_associated | relid=0 | w=30
- fundus albipunctatus ---
r_associated #0: 30 -->
en:stye
n1=fundus albipunctatus | n2=en:stye | rel=r_associated | relid=0 | w=30
- furoncle de la paupière ---
r_associated #0: 30 -->
en:stye
n1=furoncle de la paupière | n2=en:stye | rel=r_associated | relid=0 | w=30
- glande lacrymale ---
r_associated #0: 30 -->
en:stye
n1=glande lacrymale | n2=en:stye | rel=r_associated | relid=0 | w=30
- indiquer quelque chose à quelqu'un ---
r_associated #0: 30 -->
en:stye
n1=indiquer quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=30
- mettre en danger ---
r_associated #0: 30 -->
en:stye
n1=mettre en danger | n2=en:stye | rel=r_associated | relid=0 | w=30
- notifier qn de quelque chose ---
r_associated #0: 30 -->
en:stye
n1=notifier qn de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=30
- officier traitant ---
r_associated #0: 30 -->
en:stye
n1=officier traitant | n2=en:stye | rel=r_associated | relid=0 | w=30
- panaris ---
r_associated #0: 30 -->
en:stye
n1=panaris | n2=en:stye | rel=r_associated | relid=0 | w=30
- peine d'amour ---
r_associated #0: 30 -->
en:stye
n1=peine d'amour | n2=en:stye | rel=r_associated | relid=0 | w=30
- peine de cœur ---
r_associated #0: 30 -->
en:stye
n1=peine de cœur | n2=en:stye | rel=r_associated | relid=0 | w=30
- peine de coeur ---
r_associated #0: 30 -->
en:stye
n1=peine de coeur | n2=en:stye | rel=r_associated | relid=0 | w=30
- peine de cœur ---
r_associated #0: 30 -->
en:stye
n1=peine de cœur | n2=en:stye | rel=r_associated | relid=0 | w=30
- prendre contact avec ---
r_associated #0: 30 -->
en:stye
n1=prendre contact avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- répéter [qch] à ---
r_associated #0: 30 -->
en:stye
n1=répéter [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=30
- répéter quelque chose à ---
r_associated #0: 30 -->
en:stye
n1=répéter quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=30
- se mettre en contact avec ---
r_associated #0: 30 -->
en:stye
n1=se mettre en contact avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- se mettre en rapport avec ---
r_associated #0: 30 -->
en:stye
n1=se mettre en rapport avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- tenir qn informé ---
r_associated #0: 30 -->
en:stye
n1=tenir qn informé | n2=en:stye | rel=r_associated | relid=0 | w=30
- yeux bridés ---
r_associated #0: 30 -->
en:stye
n1=yeux bridés | n2=en:stye | rel=r_associated | relid=0 | w=30
- être en communication avec ---
r_associated #0: 30 -->
en:stye
n1=être en communication avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- être en contact avec ---
r_associated #0: 30 -->
en:stye
n1=être en contact avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- être en contact avec qn ---
r_associated #0: 30 -->
en:stye
n1=être en contact avec qn | n2=en:stye | rel=r_associated | relid=0 | w=30
- être en liaison avec ---
r_associated #0: 30 -->
en:stye
n1=être en liaison avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- être en rapport avec ---
r_associated #0: 30 -->
en:stye
n1=être en rapport avec | n2=en:stye | rel=r_associated | relid=0 | w=30
- apprendre [qch] à ---
r_associated #0: 29 -->
en:stye
n1=apprendre [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=29
- atrophie optique infantile héréditaire compliquée de Behr ---
r_associated #0: 29 -->
en:stye
n1=atrophie optique infantile héréditaire compliquée de Behr | n2=en:stye | rel=r_associated | relid=0 | w=29
- cécité nocturne congénitale stationnaire ---
r_associated #0: 29 -->
en:stye
n1=cécité nocturne congénitale stationnaire | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:abnormal appearance of eyes ---
r_associated #0: 29 -->
en:stye
n1=en:abnormal appearance of eyes | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:abnormal visual evoked responses (vep) ---
r_associated #0: 29 -->
en:stye
n1=en:abnormal visual evoked responses (vep) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:abnormal, jerky eye movements ---
r_associated #0: 29 -->
en:stye
n1=en:abnormal, jerky eye movements | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:absence of ophthalmoparesis ---
r_associated #0: 29 -->
en:stye
n1=en:absence of ophthalmoparesis | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:albinism, ocular ---
r_associated #0: 29 -->
en:stye
n1=en:albinism, ocular | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:albinoid fundi ---
r_associated #0: 29 -->
en:stye
n1=en:albinoid fundi | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:altered retinal vascular permeability with lipid exudation ---
r_associated #0: 29 -->
en:stye
n1=en:altered retinal vascular permeability with lipid exudation | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:alternating esotropia (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:alternating esotropia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:anterior segment dysgenesis (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:anterior segment dysgenesis (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:atrophy around the optic disc (in carrier females) ---
r_associated #0: 29 -->
en:stye
n1=en:atrophy around the optic disc (in carrier females) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:avascular patches on conjunctiva and other eye regions ---
r_associated #0: 29 -->
en:stye
n1=en:avascular patches on conjunctiva and other eye regions | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:bacterial corneal ulcer ---
r_associated #0: 29 -->
en:stye
n1=en:bacterial corneal ulcer | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:band-shaped spheroid corneal degeneration ---
r_associated #0: 29 -->
en:stye
n1=en:band-shaped spheroid corneal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:blindness (onset in fourth or fifth decade) ---
r_associated #0: 29 -->
en:stye
n1=en:blindness (onset in fourth or fifth decade) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:blockage of the lacrimal ducts ---
r_associated #0: 29 -->
en:stye
n1=en:blockage of the lacrimal ducts | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:blue sclera ---
r_associated #0: 29 -->
en:stye
n1=en:blue sclera | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:blue sclerae at birth becoming normal with age ---
r_associated #0: 29 -->
en:stye
n1=en:blue sclerae at birth becoming normal with age | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:bull's-eye macular retinal pigment epithelium changes ---
r_associated #0: 29 -->
en:stye
n1=en:bull's-eye macular retinal pigment epithelium changes | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cataract, nuclear (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:cataract, nuclear (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cataract, posterior polar, congenital progressive ---
r_associated #0: 29 -->
en:stye
n1=en:cataract, posterior polar, congenital progressive | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cataracts (e.g. 180380.0016) ---
r_associated #0: 29 -->
en:stye
n1=en:cataracts (e.g. 180380.0016) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cataracts (later onset) ---
r_associated #0: 29 -->
en:stye
n1=en:cataracts (later onset) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cataracts, bilateral nuclear, present at birth or developing in infancy ---
r_associated #0: 29 -->
en:stye
n1=en:cataracts, bilateral nuclear, present at birth or developing in infancy | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:central scotomata on photopic and dark-adapted perimetry testing ---
r_associated #0: 29 -->
en:stye
n1=en:central scotomata on photopic and dark-adapted perimetry testing | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:clear to faintly hazy corneas ---
r_associated #0: 29 -->
en:stye
n1=en:clear to faintly hazy corneas | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:coloboma of the iris (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:coloboma of the iris (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:coloboma, isolated (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:coloboma, isolated (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:coloboma, retinochoroidal (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:coloboma, retinochoroidal (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:color vision defect ---
r_associated #0: 29 -->
en:stye
n1=en:color vision defect | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:compression of optic nerve ---
r_associated #0: 29 -->
en:stye
n1=en:compression of optic nerve | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cone responses decreased on erg ---
r_associated #0: 29 -->
en:stye
n1=en:cone responses decreased on erg | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:congenital ankyloblepharon filiforme ---
r_associated #0: 29 -->
en:stye
n1=en:congenital ankyloblepharon filiforme | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:congenital nuclear cataract (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:congenital nuclear cataract (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:corneal abscess ---
r_associated #0: 29 -->
en:stye
n1=en:corneal abscess | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:corneal clouding (in some) ---
r_associated #0: 29 -->
en:stye
n1=en:corneal clouding (in some) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:corneal lipid deposit ---
r_associated #0: 29 -->
en:stye
n1=en:corneal lipid deposit | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:cystic maculopathy ---
r_associated #0: 29 -->
en:stye
n1=en:cystic maculopathy | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:decreased visual acuity, nonprogressive ---
r_associated #0: 29 -->
en:stye
n1=en:decreased visual acuity, nonprogressive | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:deeper, fusiform lattice deposits develop later ---
r_associated #0: 29 -->
en:stye
n1=en:deeper, fusiform lattice deposits develop later | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:diffuse pigment epithelial disturbances ---
r_associated #0: 29 -->
en:stye
n1=en:diffuse pigment epithelial disturbances | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:dilated superficial vessels give 'red eye' appearance ---
r_associated #0: 29 -->
en:stye
n1=en:dilated superficial vessels give 'red eye' appearance | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:disorder of macula of retina ---
r_associated #0: 29 -->
en:stye
n1=en:disorder of macula of retina | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:downslanting palpebral fissures (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:downslanting palpebral fissures (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:duane anomaly (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:duane anomaly (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ectopia lentis spherophakia (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:ectopia lentis spherophakia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ectopic lens ---
r_associated #0: 29 -->
en:stye
n1=en:ectopic lens | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:esotropia with hypermetropia and strabismus (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:esotropia with hypermetropia and strabismus (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:esotropias, secondary ---
r_associated #0: 29 -->
en:stye
n1=en:esotropias, secondary | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:excavation of optic disc (pits) ---
r_associated #0: 29 -->
en:stye
n1=en:excavation of optic disc (pits) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:exotropia (less common) ---
r_associated #0: 29 -->
en:stye
n1=en:exotropia (less common) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:external ophthalmoplegia (less common) ---
r_associated #0: 29 -->
en:stye
n1=en:external ophthalmoplegia (less common) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:eye discharge ---
r_associated #0: 29 -->
en:stye
n1=en:eye discharge | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:eye irritation ---
r_associated #0: 29 -->
en:stye
n1=en:eye irritation | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:eyelid irritation ---
r_associated #0: 29 -->
en:stye
n1=en:eyelid irritation | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:eyelid malposition ---
r_associated #0: 29 -->
en:stye
n1=en:eyelid malposition | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:eyelid myoclonus ---
r_associated #0: 29 -->
en:stye
n1=en:eyelid myoclonus | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:failure to fixate on objects ---
r_associated #0: 29 -->
en:stye
n1=en:failure to fixate on objects | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:floaters, flashing lights, visual field cuts ---
r_associated #0: 29 -->
en:stye
n1=en:floaters, flashing lights, visual field cuts | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:focal atrophy of choroid ---
r_associated #0: 29 -->
en:stye
n1=en:focal atrophy of choroid | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:fundus atrophy ---
r_associated #0: 29 -->
en:stye
n1=en:fundus atrophy | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:gerontoxon ---
r_associated #0: 29 -->
en:stye
n1=en:gerontoxon | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:glaucoma (50% of males) ---
r_associated #0: 29 -->
en:stye
n1=en:glaucoma (50% of males) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:globe retraction and deviation on adduction ---
r_associated #0: 29 -->
en:stye
n1=en:globe retraction and deviation on adduction | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:glomeruloid vascular proliferation in the retina ---
r_associated #0: 29 -->
en:stye
n1=en:glomeruloid vascular proliferation in the retina | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:gradual progressive loss of central visual acuity ---
r_associated #0: 29 -->
en:stye
n1=en:gradual progressive loss of central visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:granular fundus ---
r_associated #0: 29 -->
en:stye
n1=en:granular fundus | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hearing loss, sensorineural, progressive post-lingual ---
r_associated #0: 29 -->
en:stye
n1=en:hearing loss, sensorineural, progressive post-lingual | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hemorrhage beneath internal limiting membrane due to leaking macroaneurysms ---
r_associated #0: 29 -->
en:stye
n1=en:hemorrhage beneath internal limiting membrane due to leaking macroaneurysms | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:histopathology shows fusiform amyloid deposits in the deeper stroma as seen in lattice dystrophy ---
r_associated #0: 29 -->
en:stye
n1=en:histopathology shows fusiform amyloid deposits in the deeper stroma as seen in lattice dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:horner syndrome ---
r_associated #0: 29 -->
en:stye
n1=en:horner syndrome | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hyaline body ---
r_associated #0: 29 -->
en:stye
n1=en:hyaline body | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hypertelorism (major feature) ---
r_associated #0: 29 -->
en:stye
n1=en:hypertelorism (major feature) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hypopigmented iris ---
r_associated #0: 29 -->
en:stye
n1=en:hypopigmented iris | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hypoplastic iris stroma ---
r_associated #0: 29 -->
en:stye
n1=en:hypoplastic iris stroma | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:hypotelorism (1 patient) ---
r_associated #0: 29 -->
en:stye
n1=en:hypotelorism (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:impaired ocular abduction ---
r_associated #0: 29 -->
en:stye
n1=en:impaired ocular abduction | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:impaired ocular movements ---
r_associated #0: 29 -->
en:stye
n1=en:impaired ocular movements | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:impairment of compensatory eye movement reflexes ---
r_associated #0: 29 -->
en:stye
n1=en:impairment of compensatory eye movement reflexes | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:inflamed lacrimal canaliculus with calculus ---
r_associated #0: 29 -->
en:stye
n1=en:inflamed lacrimal canaliculus with calculus | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:injury to eyelid ---
r_associated #0: 29 -->
en:stye
n1=en:injury to eyelid | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:intraretinal splitting ---
r_associated #0: 29 -->
en:stye
n1=en:intraretinal splitting | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:iridescent posterior subcapsular cataract ---
r_associated #0: 29 -->
en:stye
n1=en:iridescent posterior subcapsular cataract | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:iris color blue to brown ---
r_associated #0: 29 -->
en:stye
n1=en:iris color blue to brown | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:iris stromal atrophy (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:iris stromal atrophy (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:irregular nystagmus ---
r_associated #0: 29 -->
en:stye
n1=en:irregular nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:juvenile posterior subcapsular lenticular opacities ---
r_associated #0: 29 -->
en:stye
n1=en:juvenile posterior subcapsular lenticular opacities | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:keratoconus, bilateral ---
r_associated #0: 29 -->
en:stye
n1=en:keratoconus, bilateral | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lack of visual contact ---
r_associated #0: 29 -->
en:stye
n1=en:lack of visual contact | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lack of visual fixation ---
r_associated #0: 29 -->
en:stye
n1=en:lack of visual fixation | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lacrimal duct defect ---
r_associated #0: 29 -->
en:stye
n1=en:lacrimal duct defect | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lacrimal duct obstruction ---
r_associated #0: 29 -->
en:stye
n1=en:lacrimal duct obstruction | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lacrimal gland aplasia/hypoplasia ---
r_associated #0: 29 -->
en:stye
n1=en:lacrimal gland aplasia/hypoplasia | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lagophthalmos (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:lagophthalmos (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lenticular 'spoke-like' opacities ---
r_associated #0: 29 -->
en:stye
n1=en:lenticular 'spoke-like' opacities | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:lid, lash and lacrimal infections, irritations and inflammations ---
r_associated #0: 29 -->
en:stye
n1=en:lid, lash and lacrimal infections, irritations and inflammations | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:limited extraocular movements (1 family) ---
r_associated #0: 29 -->
en:stye
n1=en:limited extraocular movements (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:long eyelashes (54%) ---
r_associated #0: 29 -->
en:stye
n1=en:long eyelashes (54%) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:long, prominent eyelashes ---
r_associated #0: 29 -->
en:stye
n1=en:long, prominent eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:long, straight eyelashes ---
r_associated #0: 29 -->
en:stye
n1=en:long, straight eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:loss of central vision between ages 25-30 years ---
r_associated #0: 29 -->
en:stye
n1=en:loss of central vision between ages 25-30 years | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:loss of color vision, progressive ---
r_associated #0: 29 -->
en:stye
n1=en:loss of color vision, progressive | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:loss of vision (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:loss of vision (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:macular corneal dystrophy ---
r_associated #0: 29 -->
en:stye
n1=en:macular corneal dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:macular dysfunction, marked, on electroretinography ---
r_associated #0: 29 -->
en:stye
n1=en:macular dysfunction, marked, on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:medullated corneal nerve fibers ---
r_associated #0: 29 -->
en:stye
n1=en:medullated corneal nerve fibers | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:megaloblepharon (large eyelids) ---
r_associated #0: 29 -->
en:stye
n1=en:megaloblepharon (large eyelids) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:microphthalmia (15%) ---
r_associated #0: 29 -->
en:stye
n1=en:microphthalmia (15%) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:microphthalmia (some) ---
r_associated #0: 29 -->
en:stye
n1=en:microphthalmia (some) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:microphthalmia, posterior (nanophthalmos) ---
r_associated #0: 29 -->
en:stye
n1=en:microphthalmia, posterior (nanophthalmos) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:morning glory optic disc ---
r_associated #0: 29 -->
en:stye
n1=en:morning glory optic disc | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:morning glory-like dysplastic macropapillae ---
r_associated #0: 29 -->
en:stye
n1=en:morning glory-like dysplastic macropapillae | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:myopia (onset before 6 years) ---
r_associated #0: 29 -->
en:stye
n1=en:myopia (onset before 6 years) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:myopia (onset in first decade) ---
r_associated #0: 29 -->
en:stye
n1=en:myopia (onset in first decade) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:no lisch nodules ---
r_associated #0: 29 -->
en:stye
n1=en:no lisch nodules | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:no visual tracking ---
r_associated #0: 29 -->
en:stye
n1=en:no visual tracking | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:nonaxial myopia ---
r_associated #0: 29 -->
en:stye
n1=en:nonaxial myopia | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:normal or decreased arden ratios on electrooculography ---
r_associated #0: 29 -->
en:stye
n1=en:normal or decreased arden ratios on electrooculography | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:normal photopic and scotopic responses on electroretinography (erg) ---
r_associated #0: 29 -->
en:stye
n1=en:normal photopic and scotopic responses on electroretinography (erg) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:normal to near-normal visual acuity in carrier females (20/30-20/20) ---
r_associated #0: 29 -->
en:stye
n1=en:normal to near-normal visual acuity in carrier females (20/30-20/20) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:nystagmus (may be permanent in 50% of patients) ---
r_associated #0: 29 -->
en:stye
n1=en:nystagmus (may be permanent in 50% of patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:nystagmus (patient a) ---
r_associated #0: 29 -->
en:stye
n1=en:nystagmus (patient a) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:nystagmus in adult patients ---
r_associated #0: 29 -->
en:stye
n1=en:nystagmus in adult patients | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:nystagmus, rotary (in some patients) ---
r_associated #0: 29 -->
en:stye
n1=en:nystagmus, rotary (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ocular colobomas (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:ocular colobomas (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ocular paresis ---
r_associated #0: 29 -->
en:stye
n1=en:ocular paresis | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:oculomotor apraxia (rare) ---
r_associated #0: 29 -->
en:stye
n1=en:oculomotor apraxia (rare) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:oculomotor apraxia (variable) ---
r_associated #0: 29 -->
en:stye
n1=en:oculomotor apraxia (variable) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:only upward-growing eyebrows (uncommon) ---
r_associated #0: 29 -->
en:stye
n1=en:only upward-growing eyebrows (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ophthalmoplegia (in 20%) ---
r_associated #0: 29 -->
en:stye
n1=en:ophthalmoplegia (in 20%) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ophthalmoplegia (in some) ---
r_associated #0: 29 -->
en:stye
n1=en:ophthalmoplegia (in some) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:optic degeneration ---
r_associated #0: 29 -->
en:stye
n1=en:optic degeneration | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:optic nerve dysplasia ---
r_associated #0: 29 -->
en:stye
n1=en:optic nerve dysplasia | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:optic nerve hypoplasia (less common) ---
r_associated #0: 29 -->
en:stye
n1=en:optic nerve hypoplasia (less common) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:other visual disturbances ---
r_associated #0: 29 -->
en:stye
n1=en:other visual disturbances | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:psychology qualifier ---
r_associated #0: 29 -->
en:stye
n1=en:psychology qualifier | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:retinal hemangioma ---
r_associated #0: 29 -->
en:stye
n1=en:retinal hemangioma | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:retinal microaneurysm ---
r_associated #0: 29 -->
en:stye
n1=en:retinal microaneurysm | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:retinal pigmentation ---
r_associated #0: 29 -->
en:stye
n1=en:retinal pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:retinitis punctata albescens (disorder) ---
r_associated #0: 29 -->
en:stye
n1=en:retinitis punctata albescens (disorder) | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:ripping ---
r_associated #0: 29 -->
en:stye
n1=en:ripping | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:senile macular degeneration ---
r_associated #0: 29 -->
en:stye
n1=en:senile macular degeneration | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:to beckon to sb ---
r_associated #0: 29 -->
en:stye
n1=en:to beckon to sb | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:to tell sb sth ---
r_associated #0: 29 -->
en:stye
n1=en:to tell sb sth | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:vesicular herpes simplex eyelid dermatitis ---
r_associated #0: 29 -->
en:stye
n1=en:vesicular herpes simplex eyelid dermatitis | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:whitlow ---
r_associated #0: 29 -->
en:stye
n1=en:whitlow | n2=en:stye | rel=r_associated | relid=0 | w=29
- mettre en garde [qqn] ---
r_associated #0: 29 -->
en:stye
n1=mettre en garde [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=29
- ripping ---
r_associated #0: 29 -->
en:stye
n1=ripping | n2=en:stye | rel=r_associated | relid=0 | w=29
- se tenir informé ---
r_associated #0: 29 -->
en:stye
n1=se tenir informé | n2=en:stye | rel=r_associated | relid=0 | w=29
- en:abduction palsy, usually bilateral ---
r_associated #0: 28 -->
en:stye
n1=en:abduction palsy, usually bilateral | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal distribution of retinal arterioles and venules ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal distribution of retinal arterioles and venules | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal eyebrows ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal iris pigmentation ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal iris pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal ocular motility ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal ocular motility | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal pursuit ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal pursuit | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal visual evoked potential (vep) ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal visual evoked potential (vep) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:abnormal/absent meibomian glands ---
r_associated #0: 28 -->
en:stye
n1=en:abnormal/absent meibomian glands | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:absence of central fovea of macula on optical coherence tomography ---
r_associated #0: 28 -->
en:stye
n1=en:absence of central fovea of macula on optical coherence tomography | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:absence of flash-evoked visual responses (ver) ---
r_associated #0: 28 -->
en:stye
n1=en:absence of flash-evoked visual responses (ver) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:absent a- and b-waves under scotopic conditions ---
r_associated #0: 28 -->
en:stye
n1=en:absent a- and b-waves under scotopic conditions | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:almond-shaped eyes (1 patient) ---
r_associated #0: 28 -->
en:stye
n1=en:almond-shaped eyes (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:anisometropia ---
r_associated #0: 28 -->
en:stye
n1=en:anisometropia | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:anomalous discs ---
r_associated #0: 28 -->
en:stye
n1=en:anomalous discs | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:anophthalmos ---
r_associated #0: 28 -->
en:stye
n1=en:anophthalmos | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:aphakia, congenital primary ---
r_associated #0: 28 -->
en:stye
n1=en:aphakia, congenital primary | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:aplastic/hypoplastic lacrimal glands ---
r_associated #0: 28 -->
en:stye
n1=en:aplastic/hypoplastic lacrimal glands | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:arched eyebrows (1/4 patients) ---
r_associated #0: 28 -->
en:stye
n1=en:arched eyebrows (1/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:arched eyebrows (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:arched eyebrows (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:asymmetric palpebral fissure ---
r_associated #0: 28 -->
en:stye
n1=en:asymmetric palpebral fissure | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:asymmetric pupils (rare) ---
r_associated #0: 28 -->
en:stye
n1=en:asymmetric pupils (rare) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:attenuation of retinal vessels ---
r_associated #0: 28 -->
en:stye
n1=en:attenuation of retinal vessels | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bacterial conjunctivitis ---
r_associated #0: 28 -->
en:stye
n1=en:bacterial conjunctivitis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bacterial dacryocystitis ---
r_associated #0: 28 -->
en:stye
n1=en:bacterial dacryocystitis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:band-shaped opacity ---
r_associated #0: 28 -->
en:stye
n1=en:band-shaped opacity | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bilateral intraocular pressures greater than or equal to 22 mmhg ---
r_associated #0: 28 -->
en:stye
n1=en:bilateral intraocular pressures greater than or equal to 22 mmhg | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bilateral macular retinal pigment epithelial mottling ---
r_associated #0: 28 -->
en:stye
n1=en:bilateral macular retinal pigment epithelial mottling | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bilateral ptosis ---
r_associated #0: 28 -->
en:stye
n1=en:bilateral ptosis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:blue-gray irides (adult) ---
r_associated #0: 28 -->
en:stye
n1=en:blue-gray irides (adult) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bone spicule-like pigmentation (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:bone spicule-like pigmentation (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:broad dense laterally descending eyebrows ---
r_associated #0: 28 -->
en:stye
n1=en:broad dense laterally descending eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:broad nasal tip ---
r_associated #0: 28 -->
en:stye
n1=en:broad nasal tip | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:broad palpebral fissures (1 patient) ---
r_associated #0: 28 -->
en:stye
n1=en:broad palpebral fissures (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:bulbar conjunctivitis ---
r_associated #0: 28 -->
en:stye
n1=en:bulbar conjunctivitis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:buphthalmia ---
r_associated #0: 28 -->
en:stye
n1=en:buphthalmia | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:buphthalmos (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:buphthalmos (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataract, coppock-like ---
r_associated #0: 28 -->
en:stye
n1=en:cataract, coppock-like | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataract, marner type ---
r_associated #0: 28 -->
en:stye
n1=en:cataract, marner type | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataract, nuclear coralliform ---
r_associated #0: 28 -->
en:stye
n1=en:cataract, nuclear coralliform | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataract, pulverulent ---
r_associated #0: 28 -->
en:stye
n1=en:cataract, pulverulent | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataracts (less common) ---
r_associated #0: 28 -->
en:stye
n1=en:cataracts (less common) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cataracts, congenital (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:cataracts, congenital (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:choriocapillaris atrophy ---
r_associated #0: 28 -->
en:stye
n1=en:choriocapillaris atrophy | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:chorioretinal atrophic lacunae ---
r_associated #0: 28 -->
en:stye
n1=en:chorioretinal atrophic lacunae | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:chorioretinal coloboma (rare) ---
r_associated #0: 28 -->
en:stye
n1=en:chorioretinal coloboma (rare) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cloudy corneas (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:cloudy corneas (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:colobomas of optic disk, choroid, ciliary body, and iris ---
r_associated #0: 28 -->
en:stye
n1=en:colobomas of optic disk, choroid, ciliary body, and iris | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:colorblindness, blue cone monochromacy type ---
r_associated #0: 28 -->
en:stye
n1=en:colorblindness, blue cone monochromacy type | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:complicated strabismus ---
r_associated #0: 28 -->
en:stye
n1=en:complicated strabismus | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cone-driven 1-hz response with unusual waveform on electroretinography ---
r_associated #0: 28 -->
en:stye
n1=en:cone-driven 1-hz response with unusual waveform on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:congenital blepharophimosis of upper eyelid ---
r_associated #0: 28 -->
en:stye
n1=en:congenital blepharophimosis of upper eyelid | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:congenital cataract (males) ---
r_associated #0: 28 -->
en:stye
n1=en:congenital cataract (males) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:congenital fibrosis of the extraocular muscles (9%) ---
r_associated #0: 28 -->
en:stye
n1=en:congenital fibrosis of the extraocular muscles (9%) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:conjunctiva shows dilated blood vessels ---
r_associated #0: 28 -->
en:stye
n1=en:conjunctiva shows dilated blood vessels | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cornea plana (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:cornea plana (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:corneal endothelial dystrophy (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:corneal endothelial dystrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:corneal reflex reduced ---
r_associated #0: 28 -->
en:stye
n1=en:corneal reflex reduced | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cortical punctate or pulverulent opacities (in carrier females) ---
r_associated #0: 28 -->
en:stye
n1=en:cortical punctate or pulverulent opacities (in carrier females) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cupping of optic nerve head ---
r_associated #0: 28 -->
en:stye
n1=en:cupping of optic nerve head | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cutaneolacrimal fistulae ---
r_associated #0: 28 -->
en:stye
n1=en:cutaneolacrimal fistulae | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cyclopia (5%) ---
r_associated #0: 28 -->
en:stye
n1=en:cyclopia (5%) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:cytoid body ---
r_associated #0: 28 -->
en:stye
n1=en:cytoid body | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased electroretinogram (erg) ---
r_associated #0: 28 -->
en:stye
n1=en:decreased electroretinogram (erg) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased electroretinogram (erg) response ---
r_associated #0: 28 -->
en:stye
n1=en:decreased electroretinogram (erg) response | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased night vision, childhood-onset ---
r_associated #0: 28 -->
en:stye
n1=en:decreased night vision, childhood-onset | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased or absent electroretinogram (erg) ---
r_associated #0: 28 -->
en:stye
n1=en:decreased or absent electroretinogram (erg) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased pupillary accommodation ---
r_associated #0: 28 -->
en:stye
n1=en:decreased pupillary accommodation | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:decreased visual acuity in early childhood ---
r_associated #0: 28 -->
en:stye
n1=en:decreased visual acuity in early childhood | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:difficulty reading ---
r_associated #0: 28 -->
en:stye
n1=en:difficulty reading | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:diffuse or localized pigmentary changes, with bone spicules in some patients ---
r_associated #0: 28 -->
en:stye
n1=en:diffuse or localized pigmentary changes, with bone spicules in some patients | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:diminished amplitude on erg ---
r_associated #0: 28 -->
en:stye
n1=en:diminished amplitude on erg | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:disc hemorrhage ---
r_associated #0: 28 -->
en:stye
n1=en:disc hemorrhage | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:disease transmission qualifier ---
r_associated #0: 28 -->
en:stye
n1=en:disease transmission qualifier | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:districhiasis ---
r_associated #0: 28 -->
en:stye
n1=en:districhiasis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:downslanting palpebral fissure (male) ---
r_associated #0: 28 -->
en:stye
n1=en:downslanting palpebral fissure (male) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:downward gaze ---
r_associated #0: 28 -->
en:stye
n1=en:downward gaze | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:dyschromatopsia (some) ---
r_associated #0: 28 -->
en:stye
n1=en:dyschromatopsia (some) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:ectopia lentis (64%) ---
r_associated #0: 28 -->
en:stye
n1=en:ectopia lentis (64%) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:electroretinography responses nondetectable (in most patients) ---
r_associated #0: 28 -->
en:stye
n1=en:electroretinography responses nondetectable (in most patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:elevated intraocular pressure (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:elevated intraocular pressure (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:elicited repetitive daily blindness (erdb) ---
r_associated #0: 28 -->
en:stye
n1=en:elicited repetitive daily blindness (erdb) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:emmetropia ---
r_associated #0: 28 -->
en:stye
n1=en:emmetropia | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:ethnologic ---
r_associated #0: 28 -->
en:stye
n1=en:ethnologic | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:external ophthalmoplegia (uncommon) ---
r_associated #0: 28 -->
en:stye
n1=en:external ophthalmoplegia (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:external ophthalmoplegia, progressive (rare) ---
r_associated #0: 28 -->
en:stye
n1=en:external ophthalmoplegia, progressive (rare) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:extinguished electroretinograms in second or third decade ---
r_associated #0: 28 -->
en:stye
n1=en:extinguished electroretinograms in second or third decade | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:eyelid thickening ---
r_associated #0: 28 -->
en:stye
n1=en:eyelid thickening | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:fine corneal opacities ---
r_associated #0: 28 -->
en:stye
n1=en:fine corneal opacities | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:fine horizontal nystagmus ---
r_associated #0: 28 -->
en:stye
n1=en:fine horizontal nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:foreign body sensation if erosions occur ---
r_associated #0: 28 -->
en:stye
n1=en:foreign body sensation if erosions occur | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:foreign-body sensation (early symptom) ---
r_associated #0: 28 -->
en:stye
n1=en:foreign-body sensation (early symptom) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:friction blister with infection ---
r_associated #0: 28 -->
en:stye
n1=en:friction blister with infection | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:good visual acuity ---
r_associated #0: 28 -->
en:stye
n1=en:good visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:head-eye lag ---
r_associated #0: 28 -->
en:stye
n1=en:head-eye lag | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:heavy, arched eyebrows ---
r_associated #0: 28 -->
en:stye
n1=en:heavy, arched eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:high reflectivity of fundus (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:high reflectivity of fundus (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:hypertelorism (100%) ---
r_associated #0: 28 -->
en:stye
n1=en:hypertelorism (100%) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:hypertrichosis of eyebrows, mild ---
r_associated #0: 28 -->
en:stye
n1=en:hypertrichosis of eyebrows, mild | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:hypopigmented ocular fundus ---
r_associated #0: 28 -->
en:stye
n1=en:hypopigmented ocular fundus | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:hypotelorism (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:hypotelorism (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:impaired night vision ---
r_associated #0: 28 -->
en:stye
n1=en:impaired night vision | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:impaired visually enhanced vestibuloocular reflex (vvor) ---
r_associated #0: 28 -->
en:stye
n1=en:impaired visually enhanced vestibuloocular reflex (vvor) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:infra-orbital crease ---
r_associated #0: 28 -->
en:stye
n1=en:infra-orbital crease | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:inner heartache ---
r_associated #0: 28 -->
en:stye
n1=en:inner heartache | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:insidious, painless, nonpitting eyelid edema ---
r_associated #0: 28 -->
en:stye
n1=en:insidious, painless, nonpitting eyelid edema | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:intraretinal pigmentation in the midperiphery ---
r_associated #0: 28 -->
en:stye
n1=en:intraretinal pigmentation in the midperiphery | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:iridocorneal adhesions ---
r_associated #0: 28 -->
en:stye
n1=en:iridocorneal adhesions | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:iris dysplasia (goniodysgenesis) ---
r_associated #0: 28 -->
en:stye
n1=en:iris dysplasia (goniodysgenesis) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:jaundice ---
r_associated #0: 28 -->
en:stye
n1=en:jaundice | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:lacrimation, ipsilateral ---
r_associated #0: 28 -->
en:stye
n1=en:lacrimation, ipsilateral | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:large, prominent eyebrow ---
r_associated #0: 28 -->
en:stye
n1=en:large, prominent eyebrow | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:lens subluxation (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:lens subluxation (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:lens subluxation or dislocation ---
r_associated #0: 28 -->
en:stye
n1=en:lens subluxation or dislocation | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:limited eyelid closure (1/4 patients) ---
r_associated #0: 28 -->
en:stye
n1=en:limited eyelid closure (1/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:lipemia retinalis (in severe cases) ---
r_associated #0: 28 -->
en:stye
n1=en:lipemia retinalis (in severe cases) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:low intraocular pressure (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:low intraocular pressure (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:macular or extramacular punctate yellow lesions ---
r_associated #0: 28 -->
en:stye
n1=en:macular or extramacular punctate yellow lesions | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:macular pigmentary changes ---
r_associated #0: 28 -->
en:stye
n1=en:macular pigmentary changes | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:marked amplitude reduction and delay of a- and b-waves on electroretinography, more severe in scotopic than photopic system ---
r_associated #0: 28 -->
en:stye
n1=en:marked amplitude reduction and delay of a- and b-waves on electroretinography, more severe in scotopic than photopic system | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:marked macular degeneration ---
r_associated #0: 28 -->
en:stye
n1=en:marked macular degeneration | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:microcornea (2 of 5 patients) ---
r_associated #0: 28 -->
en:stye
n1=en:microcornea (2 of 5 patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:microphthalmos ---
r_associated #0: 28 -->
en:stye
n1=en:microphthalmos | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:mild peripheral retinal pigmentary changes ---
r_associated #0: 28 -->
en:stye
n1=en:mild peripheral retinal pigmentary changes | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:miosis due to decreased function of dilator muscle ---
r_associated #0: 28 -->
en:stye
n1=en:miosis due to decreased function of dilator muscle | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:misrouting of the optic nerves at the chiasm ---
r_associated #0: 28 -->
en:stye
n1=en:misrouting of the optic nerves at the chiasm | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:mizuo-nakamura phenomenon (fundus color changes from red in the dark-adapted state to golden after light exposure) ---
r_associated #0: 28 -->
en:stye
n1=en:mizuo-nakamura phenomenon (fundus color changes from red in the dark-adapted state to golden after light exposure) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:myopia, moderate to high ---
r_associated #0: 28 -->
en:stye
n1=en:myopia, moderate to high | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:neutral palpebral fissures ---
r_associated #0: 28 -->
en:stye
n1=en:neutral palpebral fissures | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:no heterochromia irides ---
r_associated #0: 28 -->
en:stye
n1=en:no heterochromia irides | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:normal lacrimal puncta ---
r_associated #0: 28 -->
en:stye
n1=en:normal lacrimal puncta | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:normal lacrimation ---
r_associated #0: 28 -->
en:stye
n1=en:normal lacrimation | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:normal vision (females) ---
r_associated #0: 28 -->
en:stye
n1=en:normal vision (females) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus (females) ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus (females) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus (reported in 1 patient) ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus (reported in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus (uncommon) ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus, horizontal gaze-evoked ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus, horizontal gaze-evoked | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus, jerky ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus, jerky | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus, jerky, horizontal, congenital ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus, jerky, horizontal, congenital | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:nystagmus, vertical (rare) ---
r_associated #0: 28 -->
en:stye
n1=en:nystagmus, vertical (rare) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:oculodigital reflex (in some patients) ---
r_associated #0: 28 -->
en:stye
n1=en:oculodigital reflex (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:oculogyric dystonic spasms ---
r_associated #0: 28 -->
en:stye
n1=en:oculogyric dystonic spasms | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:ophthalmoplegia, nonprogressive restrictive, bilateral or unilateral ---
r_associated #0: 28 -->
en:stye
n1=en:ophthalmoplegia, nonprogressive restrictive, bilateral or unilateral | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:optic atrophy (1 patient) ---
r_associated #0: 28 -->
en:stye
n1=en:optic atrophy (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:optic atrophy (seen in patients older than 45 years) ---
r_associated #0: 28 -->
en:stye
n1=en:optic atrophy (seen in patients older than 45 years) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:optic atrophy (uncommon) ---
r_associated #0: 28 -->
en:stye
n1=en:optic atrophy (uncommon) | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:optic disc hyperplasia ---
r_associated #0: 28 -->
en:stye
n1=en:optic disc hyperplasia | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:optic dysplasia ---
r_associated #0: 28 -->
en:stye
n1=en:optic dysplasia | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:periorbital hyperpigmentation ---
r_associated #0: 28 -->
en:stye
n1=en:periorbital hyperpigmentation | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:retinoblastoma ---
r_associated #0: 28 -->
en:stye
n1=en:retinoblastoma | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:sinuitis ---
r_associated #0: 28 -->
en:stye
n1=en:sinuitis | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:small vessel retinal infarcts and aneurysms ---
r_associated #0: 28 -->
en:stye
n1=en:small vessel retinal infarcts and aneurysms | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:tell sb sth ---
r_associated #0: 28 -->
en:stye
n1=en:tell sb sth | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:visual acuity log mar.right:cmplx:pt:eye.right:qn ---
r_associated #0: 28 -->
en:stye
n1=en:visual acuity log mar.right:cmplx:pt:eye.right:qn | n2=en:stye | rel=r_associated | relid=0 | w=28
- en:wave at somebody ---
r_associated #0: 28 -->
en:stye
n1=en:wave at somebody | n2=en:stye | rel=r_associated | relid=0 | w=28
- fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique ---
r_associated #0: 28 -->
en:stye
n1=fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique | n2=en:stye | rel=r_associated | relid=0 | w=28
- inculquer quelque chose à ---
r_associated #0: 28 -->
en:stye
n1=inculquer quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=28
- mettre [qqn] en garde ---
r_associated #0: 28 -->
en:stye
n1=mettre [qqn] en garde | n2=en:stye | rel=r_associated | relid=0 | w=28
- rétinoblastome ---
r_associated #0: 28 -->
en:stye
n1=rétinoblastome | n2=en:stye | rel=r_associated | relid=0 | w=28
- Coeur brisé ---
r_associated #0: 27 -->
en:stye
n1=Coeur brisé | n2=en:stye | rel=r_associated | relid=0 | w=27
- Duane (syndrome de) ---
r_associated #0: 27 -->
en:stye
n1=Duane (syndrome de) | n2=en:stye | rel=r_associated | relid=0 | w=27
- atrophie optique-paraplégie spastique ---
r_associated #0: 27 -->
en:stye
n1=atrophie optique-paraplégie spastique | n2=en:stye | rel=r_associated | relid=0 | w=27
- cataracte congénitale ---
r_associated #0: 27 -->
en:stye
n1=cataracte congénitale | n2=en:stye | rel=r_associated | relid=0 | w=27
- colobome de l'iris avec ptosis, hypertélorisme et retard mental ---
r_associated #0: 27 -->
en:stye
n1=colobome de l'iris avec ptosis, hypertélorisme et retard mental | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:abnormal iris vasculature ---
r_associated #0: 27 -->
en:stye
n1=en:abnormal iris vasculature | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:abnormal visual evoked potential ---
r_associated #0: 27 -->
en:stye
n1=en:abnormal visual evoked potential | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:absence of eyebrows ---
r_associated #0: 27 -->
en:stye
n1=en:absence of eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:absence of foveal pit ---
r_associated #0: 27 -->
en:stye
n1=en:absence of foveal pit | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:acute vision loss due to optic nerve infarction (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:acute vision loss due to optic nerve infarction (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:almond-shaped eyes ---
r_associated #0: 27 -->
en:stye
n1=en:almond-shaped eyes | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:amblyopia (reported in 1 family) ---
r_associated #0: 27 -->
en:stye
n1=en:amblyopia (reported in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:anisocoria due to autonomic dysfunction ---
r_associated #0: 27 -->
en:stye
n1=en:anisocoria due to autonomic dysfunction | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:anomalous optic disc ---
r_associated #0: 27 -->
en:stye
n1=en:anomalous optic disc | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:anterior eye defects ---
r_associated #0: 27 -->
en:stye
n1=en:anterior eye defects | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:anterior eye segment ---
r_associated #0: 27 -->
en:stye
n1=en:anterior eye segment | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:antimongoloid slant (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:antimongoloid slant (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:attenuated blood vessels in periphery ---
r_associated #0: 27 -->
en:stye
n1=en:attenuated blood vessels in periphery | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:attenuation of retinal arterioles ---
r_associated #0: 27 -->
en:stye
n1=en:attenuation of retinal arterioles | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:bilateral hyperopia ---
r_associated #0: 27 -->
en:stye
n1=en:bilateral hyperopia | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:bilateral infraducted eye position (downward gaze) ---
r_associated #0: 27 -->
en:stye
n1=en:bilateral infraducted eye position (downward gaze) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:blepharophimosis (36%) ---
r_associated #0: 27 -->
en:stye
n1=en:blepharophimosis (36%) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:blepharospasm may occur ---
r_associated #0: 27 -->
en:stye
n1=en:blepharospasm may occur | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:blindness (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:blindness (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:blue-green irides ---
r_associated #0: 27 -->
en:stye
n1=en:blue-green irides | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:blue-white dots throughout lens, more numerous in cortex ---
r_associated #0: 27 -->
en:stye
n1=en:blue-white dots throughout lens, more numerous in cortex | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:bone spicule pigment in periphery ---
r_associated #0: 27 -->
en:stye
n1=en:bone spicule pigment in periphery | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:bone-spicule-like pigmentary changes ---
r_associated #0: 27 -->
en:stye
n1=en:bone-spicule-like pigmentary changes | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:brittle and sparse eyelashes ---
r_associated #0: 27 -->
en:stye
n1=en:brittle and sparse eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cataract, complete (in affected males) ---
r_associated #0: 27 -->
en:stye
n1=en:cataract, complete (in affected males) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cataracts (in older patients) ---
r_associated #0: 27 -->
en:stye
n1=en:cataracts (in older patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cataracts (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:cataracts (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cataracts, cortical pulverulent, juvenile-onset ---
r_associated #0: 27 -->
en:stye
n1=en:cataracts, cortical pulverulent, juvenile-onset | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:central guttae, unilateral or bilateral ---
r_associated #0: 27 -->
en:stye
n1=en:central guttae, unilateral or bilateral | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cherry-red maculae (less common) ---
r_associated #0: 27 -->
en:stye
n1=en:cherry-red maculae (less common) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cherry-red spot (type ii, infantile and juvenile and type i) ---
r_associated #0: 27 -->
en:stye
n1=en:cherry-red spot (type ii, infantile and juvenile and type i) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:chorioretinal degeneration ---
r_associated #0: 27 -->
en:stye
n1=en:chorioretinal degeneration | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:coloboma of choroid ---
r_associated #0: 27 -->
en:stye
n1=en:coloboma of choroid | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:coloboma of optic nerve (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:coloboma of optic nerve (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:conjunctival telangiectasia (reported in 1 family) ---
r_associated #0: 27 -->
en:stye
n1=en:conjunctival telangiectasia (reported in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:conjunctivitis, recurrent ---
r_associated #0: 27 -->
en:stye
n1=en:conjunctivitis, recurrent | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:corneal clouding (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:corneal clouding (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:corneal endothelial guttata and folds ---
r_associated #0: 27 -->
en:stye
n1=en:corneal endothelial guttata and folds | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:corneal infection ---
r_associated #0: 27 -->
en:stye
n1=en:corneal infection | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:corneal vascularization extending to central cornea ---
r_associated #0: 27 -->
en:stye
n1=en:corneal vascularization extending to central cornea | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:corpus vitreum ---
r_associated #0: 27 -->
en:stye
n1=en:corpus vitreum | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:cyst associated with dysplastic globe (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:cyst associated with dysplastic globe (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:decreased visual acuity (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:decreased visual acuity (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:deep-set eyes (1 patient) ---
r_associated #0: 27 -->
en:stye
n1=en:deep-set eyes (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:deep-set eyes (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:deep-set eyes (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:dense, posterior cortical cataract (carrier females) ---
r_associated #0: 27 -->
en:stye
n1=en:dense, posterior cortical cataract (carrier females) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:difficulties with night vision (reported in 1 family) ---
r_associated #0: 27 -->
en:stye
n1=en:difficulties with night vision (reported in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:discus nervi optici ---
r_associated #0: 27 -->
en:stye
n1=en:discus nervi optici | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:downbeat nystagmus ---
r_associated #0: 27 -->
en:stye
n1=en:downbeat nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:downslanting palpebral fissures (in 2/4 patients) ---
r_associated #0: 27 -->
en:stye
n1=en:downslanting palpebral fissures (in 2/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:duane anomaly (less common) ---
r_associated #0: 27 -->
en:stye
n1=en:duane anomaly (less common) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:dyschromatopsia (1 patient) ---
r_associated #0: 27 -->
en:stye
n1=en:dyschromatopsia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:dysmetric saccades ---
r_associated #0: 27 -->
en:stye
n1=en:dysmetric saccades | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:dystopia canthorum absent ---
r_associated #0: 27 -->
en:stye
n1=en:dystopia canthorum absent | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:eccentric pupil (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:eccentric pupil (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:electroretinography (erg) shows decreased amplitudes ---
r_associated #0: 27 -->
en:stye
n1=en:electroretinography (erg) shows decreased amplitudes | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:electroretinography responses diminished or undetectable ---
r_associated #0: 27 -->
en:stye
n1=en:electroretinography responses diminished or undetectable | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:enlarged corneal diameters (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:enlarged corneal diameters (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:enlarged lacrimal glands ---
r_associated #0: 27 -->
en:stye
n1=en:enlarged lacrimal glands | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:epicanthal folds (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:epicanthal folds (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:exophthalmos, bilateral ---
r_associated #0: 27 -->
en:stye
n1=en:exophthalmos, bilateral | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:exposure conjunctivitis/keratitis ---
r_associated #0: 27 -->
en:stye
n1=en:exposure conjunctivitis/keratitis | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:extraocular movement difficulties ---
r_associated #0: 27 -->
en:stye
n1=en:extraocular movement difficulties | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:eye poking ---
r_associated #0: 27 -->
en:stye
n1=en:eye poking | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:eyebrows wiry and disorganized ---
r_associated #0: 27 -->
en:stye
n1=en:eyebrows wiry and disorganized | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:focal retinal infarction ---
r_associated #0: 27 -->
en:stye
n1=en:focal retinal infarction | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:foveal hyperfluorescence ---
r_associated #0: 27 -->
en:stye
n1=en:foveal hyperfluorescence | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:fundus dystrophy ---
r_associated #0: 27 -->
en:stye
n1=en:fundus dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:gaze-evoked horizontal nystagmus (not always present) ---
r_associated #0: 27 -->
en:stye
n1=en:gaze-evoked horizontal nystagmus (not always present) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:gerontotoxon ---
r_associated #0: 27 -->
en:stye
n1=en:gerontotoxon | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:glaucoma may precede development of neuropathy ---
r_associated #0: 27 -->
en:stye
n1=en:glaucoma may precede development of neuropathy | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:globular deposits along major vascular arcades ---
r_associated #0: 27 -->
en:stye
n1=en:globular deposits along major vascular arcades | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:high intraocular pressure (reported in 1 family) ---
r_associated #0: 27 -->
en:stye
n1=en:high intraocular pressure (reported in 1 family) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:horizontal gaze nystagmus ---
r_associated #0: 27 -->
en:stye
n1=en:horizontal gaze nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:humor vitreus ---
r_associated #0: 27 -->
en:stye
n1=en:humor vitreus | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hypermyelinated retinal nerve fibers ---
r_associated #0: 27 -->
en:stye
n1=en:hypermyelinated retinal nerve fibers | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hyperreflectivity of ganglion cell layer ---
r_associated #0: 27 -->
en:stye
n1=en:hyperreflectivity of ganglion cell layer | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hypertelorism (males and females) ---
r_associated #0: 27 -->
en:stye
n1=en:hypertelorism (males and females) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hypometric saccades (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:hypometric saccades (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hypoplastic orbital ridges ---
r_associated #0: 27 -->
en:stye
n1=en:hypoplastic orbital ridges | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:hypotelorism (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:hypotelorism (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:impaired pupillary constriction to light ---
r_associated #0: 27 -->
en:stye
n1=en:impaired pupillary constriction to light | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:increased error rates of memory-guided saccades (40%) ---
r_associated #0: 27 -->
en:stye
n1=en:increased error rates of memory-guided saccades (40%) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:infective corneal ulcer ---
r_associated #0: 27 -->
en:stye
n1=en:infective corneal ulcer | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:inferonasal iris coloboma ---
r_associated #0: 27 -->
en:stye
n1=en:inferonasal iris coloboma | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:iris hypoperfusion resulting from degenerated stromal vessels ---
r_associated #0: 27 -->
en:stye
n1=en:iris hypoperfusion resulting from degenerated stromal vessels | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:lack of ocular fixation (1 patient) ---
r_associated #0: 27 -->
en:stye
n1=en:lack of ocular fixation (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:lacrimation, episodic ---
r_associated #0: 27 -->
en:stye
n1=en:lacrimation, episodic | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:large-appearing eyes ---
r_associated #0: 27 -->
en:stye
n1=en:large-appearing eyes | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:loxophthalmus ---
r_associated #0: 27 -->
en:stye
n1=en:loxophthalmus | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:macular pallor with prominence of fovea centralis (cherry red spot) ---
r_associated #0: 27 -->
en:stye
n1=en:macular pallor with prominence of fovea centralis (cherry red spot) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:macular pigment migration ---
r_associated #0: 27 -->
en:stye
n1=en:macular pigment migration | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:micronystagmus (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:micronystagmus (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:microphthalmia, bilateral (isolated feature in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:microphthalmia, bilateral (isolated feature in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:microphthalmia, unilateral or bilateral ---
r_associated #0: 27 -->
en:stye
n1=en:microphthalmia, unilateral or bilateral | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:microsclerocornea ---
r_associated #0: 27 -->
en:stye
n1=en:microsclerocornea | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:mild vision impairment ---
r_associated #0: 27 -->
en:stye
n1=en:mild vision impairment | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:mildly reduced visual acuity ---
r_associated #0: 27 -->
en:stye
n1=en:mildly reduced visual acuity | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:moderate central loss of visual acuity in males (20/60) ---
r_associated #0: 27 -->
en:stye
n1=en:moderate central loss of visual acuity in males (20/60) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:monopia ---
r_associated #0: 27 -->
en:stye
n1=en:monopia | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:myopia, mild ---
r_associated #0: 27 -->
en:stye
n1=en:myopia, mild | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:no response to dim stimuli in dark-adapted state on electroretinography ---
r_associated #0: 27 -->
en:stye
n1=en:no response to dim stimuli in dark-adapted state on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:normal eyelid ---
r_associated #0: 27 -->
en:stye
n1=en:normal eyelid | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:nystagmus, horizontal, mild (44%) ---
r_associated #0: 27 -->
en:stye
n1=en:nystagmus, horizontal, mild (44%) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:nystagmus, mild ---
r_associated #0: 27 -->
en:stye
n1=en:nystagmus, mild | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:nystagmus, pendular (primarily in childhood) ---
r_associated #0: 27 -->
en:stye
n1=en:nystagmus, pendular (primarily in childhood) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:ocular gaze palsies (onset in second decade) ---
r_associated #0: 27 -->
en:stye
n1=en:ocular gaze palsies (onset in second decade) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:ocular hypoplasia (1 patient) ---
r_associated #0: 27 -->
en:stye
n1=en:ocular hypoplasia (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:oculoglandular syndrome ---
r_associated #0: 27 -->
en:stye
n1=en:oculoglandular syndrome | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:oculomotor apraxia ---
r_associated #0: 27 -->
en:stye
n1=en:oculomotor apraxia | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:opacities in embryonal nuclei ---
r_associated #0: 27 -->
en:stye
n1=en:opacities in embryonal nuclei | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:open eye ---
r_associated #0: 27 -->
en:stye
n1=en:open eye | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:optic atrophy (67%) ---
r_associated #0: 27 -->
en:stye
n1=en:optic atrophy (67%) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:optic atrophy (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:optic atrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:optic atrophy (rare) ---
r_associated #0: 27 -->
en:stye
n1=en:optic atrophy (rare) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:optic atrophy, congenital ---
r_associated #0: 27 -->
en:stye
n1=en:optic atrophy, congenital | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:optic nerve hypoplasia (in some patients) ---
r_associated #0: 27 -->
en:stye
n1=en:optic nerve hypoplasia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:orbicularis oculi ---
r_associated #0: 27 -->
en:stye
n1=en:orbicularis oculi | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:other disorders of eye ---
r_associated #0: 27 -->
en:stye
n1=en:other disorders of eye | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:papilledema ---
r_associated #0: 27 -->
en:stye
n1=en:papilledema | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:punctate keratitis ---
r_associated #0: 27 -->
en:stye
n1=en:punctate keratitis | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:sees haloes around lights ---
r_associated #0: 27 -->
en:stye
n1=en:sees haloes around lights | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:skin and subcutaneous tissue infections nec ---
r_associated #0: 27 -->
en:stye
n1=en:skin and subcutaneous tissue infections nec | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:stenosis of lacrimal punctum ---
r_associated #0: 27 -->
en:stye
n1=en:stenosis of lacrimal punctum | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:tarsal cyst ---
r_associated #0: 27 -->
en:stye
n1=en:tarsal cyst | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:tortuosity of conjunctival vessels ---
r_associated #0: 27 -->
en:stye
n1=en:tortuosity of conjunctival vessels | n2=en:stye | rel=r_associated | relid=0 | w=27
- en:visual disturbance ---
r_associated #0: 27 -->
en:stye
n1=en:visual disturbance | n2=en:stye | rel=r_associated | relid=0 | w=27
- entretenir [qqn] de [qch] ---
r_associated #0: 27 -->
en:stye
n1=entretenir [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=27
- ethnologique ---
r_associated #0: 27 -->
en:stye
n1=ethnologique | n2=en:stye | rel=r_associated | relid=0 | w=27
- mettre en danger [qqn] ---
r_associated #0: 27 -->
en:stye
n1=mettre en danger [qqn] | n2=en:stye | rel=r_associated | relid=0 | w=27
- mettre quelqu'un en danger ---
r_associated #0: 27 -->
en:stye
n1=mettre quelqu'un en danger | n2=en:stye | rel=r_associated | relid=0 | w=27
- orgelets ---
r_associated #0: 27 -->
en:stye
n1=orgelets | n2=en:stye | rel=r_associated | relid=0 | w=27
- amblyopie crépusculaire ---
r_associated #0: 26 -->
en:stye
n1=amblyopie crépusculaire | n2=en:stye | rel=r_associated | relid=0 | w=26
- anophtalmie bilatérale complète (vraie ou primitive) ---
r_associated #0: 26 -->
en:stye
n1=anophtalmie bilatérale complète (vraie ou primitive) | n2=en:stye | rel=r_associated | relid=0 | w=26
- asynergie oculopalpébrale ---
r_associated #0: 26 -->
en:stye
n1=asynergie oculopalpébrale | n2=en:stye | rel=r_associated | relid=0 | w=26
- atrophie optique ---
r_associated #0: 26 -->
en:stye
n1=atrophie optique | n2=en:stye | rel=r_associated | relid=0 | w=26
- atrophie optique tardive liée au sexe ---
r_associated #0: 26 -->
en:stye
n1=atrophie optique tardive liée au sexe | n2=en:stye | rel=r_associated | relid=0 | w=26
- atrophie optique, cataracte, et troubles neurologiques ---
r_associated #0: 26 -->
en:stye
n1=atrophie optique, cataracte, et troubles neurologiques | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:abnormal color vision ---
r_associated #0: 26 -->
en:stye
n1=en:abnormal color vision | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:abnormal flash visual evoked potentials (vep) ---
r_associated #0: 26 -->
en:stye
n1=en:abnormal flash visual evoked potentials (vep) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:abnormality of the optic nerve ---
r_associated #0: 26 -->
en:stye
n1=en:abnormality of the optic nerve | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:abscess of external auditory canal ---
r_associated #0: 26 -->
en:stye
n1=en:abscess of external auditory canal | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:absence of foveal hyperpigmentation ---
r_associated #0: 26 -->
en:stye
n1=en:absence of foveal hyperpigmentation | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:absent eyebrows (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:absent eyebrows (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:absent eyelashes (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:absent eyelashes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:absent foveal reflex (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:absent foveal reflex (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:absent miebomian glands ---
r_associated #0: 26 -->
en:stye
n1=en:absent miebomian glands | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:acne ciliaris ---
r_associated #0: 26 -->
en:stye
n1=en:acne ciliaris | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:albinotic optic disc ---
r_associated #0: 26 -->
en:stye
n1=en:albinotic optic disc | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:altered vertical eye movements ---
r_associated #0: 26 -->
en:stye
n1=en:altered vertical eye movements | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:altered visual evoked potentials (1/4 patients) ---
r_associated #0: 26 -->
en:stye
n1=en:altered visual evoked potentials (1/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:amyloid deposition in the vitreous humor (variable expression) ---
r_associated #0: 26 -->
en:stye
n1=en:amyloid deposition in the vitreous humor (variable expression) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:anisocoria ---
r_associated #0: 26 -->
en:stye
n1=en:anisocoria | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ankyloblepharon filiforme ---
r_associated #0: 26 -->
en:stye
n1=en:ankyloblepharon filiforme | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:anophthalmia, clinical, unilateral or bilateral ---
r_associated #0: 26 -->
en:stye
n1=en:anophthalmia, clinical, unilateral or bilateral | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:astigmatism (1 patient) ---
r_associated #0: 26 -->
en:stye
n1=en:astigmatism (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:astigmatism (rare) ---
r_associated #0: 26 -->
en:stye
n1=en:astigmatism (rare) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:atopic conjunctivitis ---
r_associated #0: 26 -->
en:stye
n1=en:atopic conjunctivitis | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:atrophic optic fundi ---
r_associated #0: 26 -->
en:stye
n1=en:atrophic optic fundi | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:attenuated retinal blood vessels ---
r_associated #0: 26 -->
en:stye
n1=en:attenuated retinal blood vessels | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:axenfeld-rieger anomalies (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:axenfeld-rieger anomalies (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bacterial keratitis ---
r_associated #0: 26 -->
en:stye
n1=en:bacterial keratitis | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:band-shaped, whorled microcystic dystrophy of the corneal epithelium ---
r_associated #0: 26 -->
en:stye
n1=en:band-shaped, whorled microcystic dystrophy of the corneal epithelium | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bilateral microphthalmos ---
r_associated #0: 26 -->
en:stye
n1=en:bilateral microphthalmos | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:blurred vision (early symptom) ---
r_associated #0: 26 -->
en:stye
n1=en:blurred vision (early symptom) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bone spicule-like pigmentation ---
r_associated #0: 26 -->
en:stye
n1=en:bone spicule-like pigmentation | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bone-spicule pattern of pigmentary deposits in retinal midperiphery ---
r_associated #0: 26 -->
en:stye
n1=en:bone-spicule pattern of pigmentary deposits in retinal midperiphery | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bone-spicule pigmentation in periphery ---
r_associated #0: 26 -->
en:stye
n1=en:bone-spicule pigmentation in periphery | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:both eyes ---
r_associated #0: 26 -->
en:stye
n1=en:both eyes | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bright blue irides ---
r_associated #0: 26 -->
en:stye
n1=en:bright blue irides | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:bull's eye maculae ---
r_associated #0: 26 -->
en:stye
n1=en:bull's eye maculae | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:canaliculitis ---
r_associated #0: 26 -->
en:stye
n1=en:canaliculitis | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cataract (in 2 brothers) ---
r_associated #0: 26 -->
en:stye
n1=en:cataract (in 2 brothers) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cataract, anterior polar ---
r_associated #0: 26 -->
en:stye
n1=en:cataract, anterior polar | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cataract, posterior subcapsular (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:cataract, posterior subcapsular (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cataract, postnatal, bilateral dense nuclear ---
r_associated #0: 26 -->
en:stye
n1=en:cataract, postnatal, bilateral dense nuclear | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:central cataracts ---
r_associated #0: 26 -->
en:stye
n1=en:central cataracts | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:central retinal vessel vascular tortuosity (acute phase) ---
r_associated #0: 26 -->
en:stye
n1=en:central retinal vessel vascular tortuosity (acute phase) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:centrocecal scotoma (acute phase) ---
r_associated #0: 26 -->
en:stye
n1=en:centrocecal scotoma (acute phase) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:choroideremia ---
r_associated #0: 26 -->
en:stye
n1=en:choroideremia | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:choroidoretinal degeneration (starting in the midperiphery of the fundus and progressing centrally and peripherally) ---
r_associated #0: 26 -->
en:stye
n1=en:choroidoretinal degeneration (starting in the midperiphery of the fundus and progressing centrally and peripherally) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:coloboma (1 patient) ---
r_associated #0: 26 -->
en:stye
n1=en:coloboma (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:coloboma of the iris (rare) ---
r_associated #0: 26 -->
en:stye
n1=en:coloboma of the iris (rare) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:coloboma of the retina ---
r_associated #0: 26 -->
en:stye
n1=en:coloboma of the retina | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:color vision deficit, green or red-green ---
r_associated #0: 26 -->
en:stye
n1=en:color vision deficit, green or red-green | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:congenital stapes ankylosis ---
r_associated #0: 26 -->
en:stye
n1=en:congenital stapes ankylosis | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal and lenticular opacities ---
r_associated #0: 26 -->
en:stye
n1=en:corneal and lenticular opacities | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal crystalline deposits ---
r_associated #0: 26 -->
en:stye
n1=en:corneal crystalline deposits | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal erosions (1 patient) ---
r_associated #0: 26 -->
en:stye
n1=en:corneal erosions (1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal opacification, partial or total ---
r_associated #0: 26 -->
en:stye
n1=en:corneal opacification, partial or total | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal opacities on slit-lamp examination ---
r_associated #0: 26 -->
en:stye
n1=en:corneal opacities on slit-lamp examination | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal reflex absent ---
r_associated #0: 26 -->
en:stye
n1=en:corneal reflex absent | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:corneal rupture ---
r_associated #0: 26 -->
en:stye
n1=en:corneal rupture | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cortical blindness (in 1 moroccan patient) ---
r_associated #0: 26 -->
en:stye
n1=en:cortical blindness (in 1 moroccan patient) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:curled eyelashes ---
r_associated #0: 26 -->
en:stye
n1=en:curled eyelashes | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cystic degeneration of the macula (rare) ---
r_associated #0: 26 -->
en:stye
n1=en:cystic degeneration of the macula (rare) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:cystoid macular edema (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:cystoid macular edema (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:decreased iris pigment ---
r_associated #0: 26 -->
en:stye
n1=en:decreased iris pigment | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:deep-set eyes (in early childhood) ---
r_associated #0: 26 -->
en:stye
n1=en:deep-set eyes (in early childhood) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:diminished pupillary light responses ---
r_associated #0: 26 -->
en:stye
n1=en:diminished pupillary light responses | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:divergent strabismus ---
r_associated #0: 26 -->
en:stye
n1=en:divergent strabismus | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:downslanting palpebral fissures (in 1 of 2 patients) ---
r_associated #0: 26 -->
en:stye
n1=en:downslanting palpebral fissures (in 1 of 2 patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:early onset night blindness and abnormal fundus (e.g. 180380.0013) ---
r_associated #0: 26 -->
en:stye
n1=en:early onset night blindness and abnormal fundus (e.g. 180380.0013) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:elongated palpebral fissures ---
r_associated #0: 26 -->
en:stye
n1=en:elongated palpebral fissures | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:endophtalmy ---
r_associated #0: 26 -->
en:stye
n1=en:endophtalmy | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:esotropia (about half of patients) ---
r_associated #0: 26 -->
en:stye
n1=en:esotropia (about half of patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:exophthalmos due to hyperthyroidism ---
r_associated #0: 26 -->
en:stye
n1=en:exophthalmos due to hyperthyroidism | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:eyelid disorder ---
r_associated #0: 26 -->
en:stye
n1=en:eyelid disorder | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:eyelid infection ---
r_associated #0: 26 -->
en:stye
n1=en:eyelid infection | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:eyes fixed in hypotrophic eye position (severe cases) ---
r_associated #0: 26 -->
en:stye
n1=en:eyes fixed in hypotrophic eye position (severe cases) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:focal retinal edema ---
r_associated #0: 26 -->
en:stye
n1=en:focal retinal edema | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:frontalis overaction, pronounced ---
r_associated #0: 26 -->
en:stye
n1=en:frontalis overaction, pronounced | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:fundi show dilated blood vessels with corkscrew-like tortuosity ---
r_associated #0: 26 -->
en:stye
n1=en:fundi show dilated blood vessels with corkscrew-like tortuosity | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:glaucoma, open-angle, early-onset (occurs in patients with nonsense or truncating mutations in the sbf2 gene) ---
r_associated #0: 26 -->
en:stye
n1=en:glaucoma, open-angle, early-onset (occurs in patients with nonsense or truncating mutations in the sbf2 gene) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:glistening white dots in fundus ---
r_associated #0: 26 -->
en:stye
n1=en:glistening white dots in fundus | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hereditary macular coloboma ---
r_associated #0: 26 -->
en:stye
n1=en:hereditary macular coloboma | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:high myopia (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:high myopia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hyperopia (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:hyperopia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hyperplastic primary vitreous (wws) ---
r_associated #0: 26 -->
en:stye
n1=en:hyperplastic primary vitreous (wws) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hypertrophic conjunctivae ---
r_associated #0: 26 -->
en:stye
n1=en:hypertrophic conjunctivae | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hypertropia (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:hypertropia (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hypopigmentation of eyelid ---
r_associated #0: 26 -->
en:stye
n1=en:hypopigmentation of eyelid | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:hypoplasia of the ciliary body ---
r_associated #0: 26 -->
en:stye
n1=en:hypoplasia of the ciliary body | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ictal and interictal diplopia ---
r_associated #0: 26 -->
en:stye
n1=en:ictal and interictal diplopia | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:impaired corneal reflex ---
r_associated #0: 26 -->
en:stye
n1=en:impaired corneal reflex | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:increased retinal vascular permeability ---
r_associated #0: 26 -->
en:stye
n1=en:increased retinal vascular permeability | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:increased retinal vascularity ---
r_associated #0: 26 -->
en:stye
n1=en:increased retinal vascularity | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:increased vascular tortuosity (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:increased vascular tortuosity (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:internal hordeolum ---
r_associated #0: 26 -->
en:stye
n1=en:internal hordeolum | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:intraretinal pigment deposition extending to posterior pole (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:intraretinal pigment deposition extending to posterior pole (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:iris transillumination with pigment dispersion ---
r_associated #0: 26 -->
en:stye
n1=en:iris transillumination with pigment dispersion | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:keratoconus, severe anterior (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:keratoconus, severe anterior (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:lacrimal duct fistula (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:lacrimal duct fistula (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:large eyebrows ---
r_associated #0: 26 -->
en:stye
n1=en:large eyebrows | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:lens opacities (type ii, infantile and juvenile) ---
r_associated #0: 26 -->
en:stye
n1=en:lens opacities (type ii, infantile and juvenile) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:lens opacity, mild (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:lens opacity, mild (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:low arden ratio on electrooculography ---
r_associated #0: 26 -->
en:stye
n1=en:low arden ratio on electrooculography | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:macular retinal pigment epithelial changes (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:macular retinal pigment epithelial changes (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:make something public ---
r_associated #0: 26 -->
en:stye
n1=en:make something public | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:markedly constricted visual fields ---
r_associated #0: 26 -->
en:stye
n1=en:markedly constricted visual fields | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:mental retardation ---
r_associated #0: 26 -->
en:stye
n1=en:mental retardation | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:microphthalmia, severe, bilateral ---
r_associated #0: 26 -->
en:stye
n1=en:microphthalmia, severe, bilateral | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:microspherophakia (small, spherical lens) (94%) ---
r_associated #0: 26 -->
en:stye
n1=en:microspherophakia (small, spherical lens) (94%) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:mild depression and delay in both scotopic and photopic function on electroretinography ---
r_associated #0: 26 -->
en:stye
n1=en:mild depression and delay in both scotopic and photopic function on electroretinography | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:mild proptosis ---
r_associated #0: 26 -->
en:stye
n1=en:mild proptosis | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:morning glory disc anomaly (1 family) ---
r_associated #0: 26 -->
en:stye
n1=en:morning glory disc anomaly (1 family) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:myopia (1/4 patients) ---
r_associated #0: 26 -->
en:stye
n1=en:myopia (1/4 patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:myopia, high-grade bilateral (range -5.50 to -50 diopters, average adult refractive error -13.925 diopters) ---
r_associated #0: 26 -->
en:stye
n1=en:myopia, high-grade bilateral (range -5.50 to -50 diopters, average adult refractive error -13.925 diopters) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:nail bed infection ---
r_associated #0: 26 -->
en:stye
n1=en:nail bed infection | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no cataract (epstein syndrome) ---
r_associated #0: 26 -->
en:stye
n1=en:no cataract (epstein syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no cataracts ---
r_associated #0: 26 -->
en:stye
n1=en:no cataracts | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no cherry red spots ---
r_associated #0: 26 -->
en:stye
n1=en:no cherry red spots | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no corneal erosions ---
r_associated #0: 26 -->
en:stye
n1=en:no corneal erosions | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no nystagmus ---
r_associated #0: 26 -->
en:stye
n1=en:no nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:no retinopathy ---
r_associated #0: 26 -->
en:stye
n1=en:no retinopathy | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:nonrecordable or severely reduced rod pattern on electroretinogram ---
r_associated #0: 26 -->
en:stye
n1=en:nonrecordable or severely reduced rod pattern on electroretinogram | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:normal or reduced electrooculographic (eog) results ---
r_associated #0: 26 -->
en:stye
n1=en:normal or reduced electrooculographic (eog) results | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:normal sclerae ---
r_associated #0: 26 -->
en:stye
n1=en:normal sclerae | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:nuclear cataract (in some patients) retinal dystrophy (in some patients) ---
r_associated #0: 26 -->
en:stye
n1=en:nuclear cataract (in some patients) retinal dystrophy (in some patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ocular albinism (reported in 1 patient) ---
r_associated #0: 26 -->
en:stye
n1=en:ocular albinism (reported in 1 patient) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ocular flutter ---
r_associated #0: 26 -->
en:stye
n1=en:ocular flutter | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ocular infections (smq) ---
r_associated #0: 26 -->
en:stye
n1=en:ocular infections (smq) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ocular pain, episodic ---
r_associated #0: 26 -->
en:stye
n1=en:ocular pain, episodic | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:ocular pursuit poor or absent ---
r_associated #0: 26 -->
en:stye
n1=en:ocular pursuit poor or absent | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:optic atrophy (in 1 of 3 patients) ---
r_associated #0: 26 -->
en:stye
n1=en:optic atrophy (in 1 of 3 patients) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:optic atrophy (patient a) ---
r_associated #0: 26 -->
en:stye
n1=en:optic atrophy (patient a) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:optic head drusen (yellowish-white irregularities of optic disc) ---
r_associated #0: 26 -->
en:stye
n1=en:optic head drusen (yellowish-white irregularities of optic disc) | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:optical coherence tomography shows normal retina and retinal pigment epithelium overlying the sclerochoroidal lesions ---
r_associated #0: 26 -->
en:stye
n1=en:optical coherence tomography shows normal retina and retinal pigment epithelium overlying the sclerochoroidal lesions | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:periorbital infection ---
r_associated #0: 26 -->
en:stye
n1=en:periorbital infection | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:periorbital wrinkles ---
r_associated #0: 26 -->
en:stye
n1=en:periorbital wrinkles | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:retina abnormality ---
r_associated #0: 26 -->
en:stye
n1=en:retina abnormality | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:retinal hemorrhage ---
r_associated #0: 26 -->
en:stye
n1=en:retinal hemorrhage | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:stenosis of nasolacrimal duct ---
r_associated #0: 26 -->
en:stye
n1=en:stenosis of nasolacrimal duct | n2=en:stye | rel=r_associated | relid=0 | w=26
- en:visual acuity log mar.left:cmplx:pt:eye.left:qn ---
r_associated #0: 26 -->
en:stye
n1=en:visual acuity log mar.left:cmplx:pt:eye.left:qn | n2=en:stye | rel=r_associated | relid=0 | w=26
- gérontoxon ---
r_associated #0: 26 -->
en:stye
n1=gérontoxon | n2=en:stye | rel=r_associated | relid=0 | w=26
- mettre [qqn] en danger ---
r_associated #0: 26 -->
en:stye
n1=mettre [qqn] en danger | n2=en:stye | rel=r_associated | relid=0 | w=26
- aniridie, microcornée et cataracte régressive ---
r_associated #0: 25 -->
en:stye
n1=aniridie, microcornée et cataracte régressive | n2=en:stye | rel=r_associated | relid=0 | w=25
- anophtalmie avec anomalies associées ---
r_associated #0: 25 -->
en:stye
n1=anophtalmie avec anomalies associées | n2=en:stye | rel=r_associated | relid=0 | w=25
- blépharophimosis-ptosis-épicanthus inversus (syndrome) ---
r_associated #0: 25 -->
en:stye
n1=blépharophimosis-ptosis-épicanthus inversus (syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=25
- dire qch à quelqu'un ---
r_associated #0: 25 -->
en:stye
n1=dire qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:Stargardt disease ---
r_associated #0: 25 -->
en:stye
n1=en:Stargardt disease | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:advise sb of something ---
r_associated #0: 25 -->
en:stye
n1=en:advise sb of something | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:and myopathy ---
r_associated #0: 25 -->
en:stye
n1=en:and myopathy | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:announce sth to somebody ---
r_associated #0: 25 -->
en:stye
n1=en:announce sth to somebody | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:be in touch with [sb] ---
r_associated #0: 25 -->
en:stye
n1=en:be in touch with [sb] | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:discuss something with somebody ---
r_associated #0: 25 -->
en:stye
n1=en:discuss something with somebody | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:hyaloid body ---
r_associated #0: 25 -->
en:stye
n1=en:hyaloid body | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:love sickness ---
r_associated #0: 25 -->
en:stye
n1=en:love sickness | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:lovesickness ---
r_associated #0: 25 -->
en:stye
n1=en:lovesickness | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:nursing therapy ---
r_associated #0: 25 -->
en:stye
n1=en:nursing therapy | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:put something to somebody ---
r_associated #0: 25 -->
en:stye
n1=en:put something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:put sth to somebody ---
r_associated #0: 25 -->
en:stye
n1=en:put sth to somebody | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:squinting ---
r_associated #0: 25 -->
en:stye
n1=en:squinting | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:sticky rye ---
r_associated #0: 25 -->
en:stye
n1=en:sticky rye | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:structure of anterior pole of eye ---
r_associated #0: 25 -->
en:stye
n1=en:structure of anterior pole of eye | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:structure of internal axis of eyeball ---
r_associated #0: 25 -->
en:stye
n1=en:structure of internal axis of eyeball | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:structure of posterior pole of eye ---
r_associated #0: 25 -->
en:stye
n1=en:structure of posterior pole of eye | n2=en:stye | rel=r_associated | relid=0 | w=25
- en:vitreum ---
r_associated #0: 25 -->
en:stye
n1=en:vitreum | n2=en:stye | rel=r_associated | relid=0 | w=25
- lentigines multiples (syndrome des) ---
r_associated #0: 25 -->
en:stye
n1=lentigines multiples (syndrome des) | n2=en:stye | rel=r_associated | relid=0 | w=25
- maladie d'amour ---
r_associated #0: 25 -->
en:stye
n1=maladie d'amour | n2=en:stye | rel=r_associated | relid=0 | w=25
- proptosis ---
r_associated #0: 25 -->
en:stye
n1=proptosis | n2=en:stye | rel=r_associated | relid=0 | w=25
- uvéite ---
r_associated #0: 25 -->
en:stye
n1=uvéite | n2=en:stye | rel=r_associated | relid=0 | w=25
- annoncer [qch] à ---
r_associated #0: 24 -->
en:stye
n1=annoncer [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=24
- apraxie oculomotrice de Cogan ---
r_associated #0: 24 -->
en:stye
n1=apraxie oculomotrice de Cogan | n2=en:stye | rel=r_associated | relid=0 | w=24
- atrophie optique congénitale ou infantile précoce ---
r_associated #0: 24 -->
en:stye
n1=atrophie optique congénitale ou infantile précoce | n2=en:stye | rel=r_associated | relid=0 | w=24
- atrophie optique infantile avec chorée et paraplégie spastique ---
r_associated #0: 24 -->
en:stye
n1=atrophie optique infantile avec chorée et paraplégie spastique | n2=en:stye | rel=r_associated | relid=0 | w=24
- atrophie optique, surdité, ophtalmoplégie et myopathie ---
r_associated #0: 24 -->
en:stye
n1=atrophie optique, surdité, ophtalmoplégie et myopathie | n2=en:stye | rel=r_associated | relid=0 | w=24
- cataracte congénitale avec micro-phtalmie ---
r_associated #0: 24 -->
en:stye
n1=cataracte congénitale avec micro-phtalmie | n2=en:stye | rel=r_associated | relid=0 | w=24
- distichiase ---
r_associated #0: 24 -->
en:stye
n1=distichiase | n2=en:stye | rel=r_associated | relid=0 | w=24
- dégénérescence maculaire ---
r_associated #0: 24 -->
en:stye
n1=dégénérescence maculaire | n2=en:stye | rel=r_associated | relid=0 | w=24
- en:double vision ---
r_associated #0: 24 -->
en:stye
n1=en:double vision | n2=en:stye | rel=r_associated | relid=0 | w=24
- en:teach sb sth ---
r_associated #0: 24 -->
en:stye
n1=en:teach sb sth | n2=en:stye | rel=r_associated | relid=0 | w=24
- en:tear gland ---
r_associated #0: 24 -->
en:stye
n1=en:tear gland | n2=en:stye | rel=r_associated | relid=0 | w=24
- en:to let sb know sth ---
r_associated #0: 24 -->
en:stye
n1=en:to let sb know sth | n2=en:stye | rel=r_associated | relid=0 | w=24
- en:to signal to sb ---
r_associated #0: 24 -->
en:stye
n1=en:to signal to sb | n2=en:stye | rel=r_associated | relid=0 | w=24
- inculquer [qch] à ---
r_associated #0: 24 -->
en:stye
n1=inculquer [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=24
- tenir qn au courant ---
r_associated #0: 24 -->
en:stye
n1=tenir qn au courant | n2=en:stye | rel=r_associated | relid=0 | w=24
- Ambard (constante d') ---
r_associated #0: 23 -->
en:stye
n1=Ambard (constante d') | n2=en:stye | rel=r_associated | relid=0 | w=23
- apprendre qch à quelqu'un ---
r_associated #0: 23 -->
en:stye
n1=apprendre qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=23
- cils longs (syndrome des) ---
r_associated #0: 23 -->
en:stye
n1=cils longs (syndrome des) | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:almond eyes ---
r_associated #0: 23 -->
en:stye
n1=en:almond eyes | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:antritis ---
r_associated #0: 23 -->
en:stye
n1=en:antritis | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:corrective contact lens ---
r_associated #0: 23 -->
en:stye
n1=en:corrective contact lens | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:detachment of vitreous body ---
r_associated #0: 23 -->
en:stye
n1=en:detachment of vitreous body | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:epidemiological ---
r_associated #0: 23 -->
en:stye
n1=en:epidemiological | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:give somebody a warning ---
r_associated #0: 23 -->
en:stye
n1=en:give somebody a warning | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:leucocoria ---
r_associated #0: 23 -->
en:stye
n1=en:leucocoria | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:ocular disorder ---
r_associated #0: 23 -->
en:stye
n1=en:ocular disorder | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:slit eyes ---
r_associated #0: 23 -->
en:stye
n1=en:slit eyes | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:spastic paraplegia ---
r_associated #0: 23 -->
en:stye
n1=en:spastic paraplegia | n2=en:stye | rel=r_associated | relid=0 | w=23
- en:synaphymenitis ---
r_associated #0: 23 -->
en:stye
n1=en:synaphymenitis | n2=en:stye | rel=r_associated | relid=0 | w=23
- entretenir quelqu'un de quelque chose ---
r_associated #0: 23 -->
en:stye
n1=entretenir quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=23
- immense chagrin ---
r_associated #0: 23 -->
en:stye
n1=immense chagrin | n2=en:stye | rel=r_associated | relid=0 | w=23
- inculquer ---
r_associated #0: 23 -->
en:stye
n1=inculquer | n2=en:stye | rel=r_associated | relid=0 | w=23
- mettre en danger quelqu'un ---
r_associated #0: 23 -->
en:stye
n1=mettre en danger quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=23
- mettre la puce à l'oreille ---
r_associated #0: 23 -->
en:stye
n1=mettre la puce à l'oreille | n2=en:stye | rel=r_associated | relid=0 | w=23
- sigle pour circulation extracorporelle ---
r_associated #0: 23 -->
en:stye
n1=sigle pour circulation extracorporelle | n2=en:stye | rel=r_associated | relid=0 | w=23
- alerter [qqn] de [qch] ---
r_associated #0: 22 -->
en:stye
n1=alerter [qqn] de [qch] | n2=en:stye | rel=r_associated | relid=0 | w=22
- aniridie, ataxie cérébelleuse et déficience mentale ---
r_associated #0: 22 -->
en:stye
n1=aniridie, ataxie cérébelleuse et déficience mentale | n2=en:stye | rel=r_associated | relid=0 | w=22
- annoncer quelque chose à ---
r_associated #0: 22 -->
en:stye
n1=annoncer quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=22
- apprendre quelque chose à ---
r_associated #0: 22 -->
en:stye
n1=apprendre quelque chose à | n2=en:stye | rel=r_associated | relid=0 | w=22
- dégénérescence spinocérébelleuse avec dystrophie cornéenne maculaire, cataracte congénitale et myopie ---
r_associated #0: 22 -->
en:stye
n1=dégénérescence spinocérébelleuse avec dystrophie cornéenne maculaire, cataracte congénitale et myopie | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:exomphalos ---
r_associated #0: 22 -->
en:stye
n1=en:exomphalos | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:give a heads up ---
r_associated #0: 22 -->
en:stye
n1=en:give a heads up | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:meibomian cyst ---
r_associated #0: 22 -->
en:stye
n1=en:meibomian cyst | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:nerve head ---
r_associated #0: 22 -->
en:stye
n1=en:nerve head | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:optic neuritis ---
r_associated #0: 22 -->
en:stye
n1=en:optic neuritis | n2=en:stye | rel=r_associated | relid=0 | w=22
- en:sagging ---
r_associated #0: 22 -->
en:stye
n1=en:sagging | n2=en:stye | rel=r_associated | relid=0 | w=22
- enseigner [qch] à ---
r_associated #0: 22 -->
en:stye
n1=enseigner [qch] à | n2=en:stye | rel=r_associated | relid=0 | w=22
- point aveugle ---
r_associated #0: 22 -->
en:stye
n1=point aveugle | n2=en:stye | rel=r_associated | relid=0 | w=22
- proptose oculaire ---
r_associated #0: 22 -->
en:stye
n1=proptose oculaire | n2=en:stye | rel=r_associated | relid=0 | w=22
- radiographique ---
r_associated #0: 22 -->
en:stye
n1=radiographique | n2=en:stye | rel=r_associated | relid=0 | w=22
- tenir à jour ---
r_associated #0: 22 -->
en:stye
n1=tenir à jour | n2=en:stye | rel=r_associated | relid=0 | w=22
- uvéite intermédiaire ---
r_associated #0: 22 -->
en:stye
n1=uvéite intermédiaire | n2=en:stye | rel=r_associated | relid=0 | w=22
- acanthose ---
r_associated #0: 21 -->
en:stye
n1=acanthose | n2=en:stye | rel=r_associated | relid=0 | w=21
- aniridie ---
r_associated #0: 21 -->
en:stye
n1=aniridie | n2=en:stye | rel=r_associated | relid=0 | w=21
- aniridie partielle avec agénésie rénale unilatérale et retard psychomoteur ---
r_associated #0: 21 -->
en:stye
n1=aniridie partielle avec agénésie rénale unilatérale et retard psychomoteur | n2=en:stye | rel=r_associated | relid=0 | w=21
- anisométropie ---
r_associated #0: 21 -->
en:stye
n1=anisométropie | n2=en:stye | rel=r_associated | relid=0 | w=21
- atrophie optique polyneuropathie et surdité ---
r_associated #0: 21 -->
en:stye
n1=atrophie optique polyneuropathie et surdité | n2=en:stye | rel=r_associated | relid=0 | w=21
- buphtalmie ---
r_associated #0: 21 -->
en:stye
n1=buphtalmie | n2=en:stye | rel=r_associated | relid=0 | w=21
- cataracte liée au sexe avec dent de Hutchinson ---
r_associated #0: 21 -->
en:stye
n1=cataracte liée au sexe avec dent de Hutchinson | n2=en:stye | rel=r_associated | relid=0 | w=21
- choroïdérémie ---
r_associated #0: 21 -->
en:stye
n1=choroïdérémie | n2=en:stye | rel=r_associated | relid=0 | w=21
- compère-loriot
(orgelet) ---
r_associated #0: 21 -->
en:stye
n1=compère-loriot (orgelet) | n2=en:stye | rel=r_associated | relid=0 | w=21
- crise oculogyre ---
r_associated #0: 21 -->
en:stye
n1=crise oculogyre | n2=en:stye | rel=r_associated | relid=0 | w=21
- dire qch à qn ---
r_associated #0: 21 -->
en:stye
n1=dire qch à qn | n2=en:stye | rel=r_associated | relid=0 | w=21
- dire quelque chose à quelqu'un ---
r_associated #0: 21 -->
en:stye
n1=dire quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:absent corpus callosum ---
r_associated #0: 21 -->
en:stye
n1=en:absent corpus callosum | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:conjonctivitis ---
r_associated #0: 21 -->
en:stye
n1=en:conjonctivitis | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:diaphragmatic hernia ---
r_associated #0: 21 -->
en:stye
n1=en:diaphragmatic hernia | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:lazy eye ---
r_associated #0: 21 -->
en:stye
n1=en:lazy eye | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:neovascularisation ---
r_associated #0: 21 -->
en:stye
n1=en:neovascularisation | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:ophthalmoplegia ---
r_associated #0: 21 -->
en:stye
n1=en:ophthalmoplegia | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:slanting eyes ---
r_associated #0: 21 -->
en:stye
n1=en:slanting eyes | n2=en:stye | rel=r_associated | relid=0 | w=21
- en:slitty-eyes ---
r_associated #0: 21 -->
en:stye
n1=en:slitty-eyes | n2=en:stye | rel=r_associated | relid=0 | w=21
- grain d'orge ---
r_associated #0: 21 -->
en:stye
n1=grain d'orge | n2=en:stye | rel=r_associated | relid=0 | w=21
- hypopion ---
r_associated #0: 21 -->
en:stye
n1=hypopion | n2=en:stye | rel=r_associated | relid=0 | w=21
- néovascularisation ---
r_associated #0: 21 -->
en:stye
n1=néovascularisation | n2=en:stye | rel=r_associated | relid=0 | w=21
- sclérotique bleue ---
r_associated #0: 21 -->
en:stye
n1=sclérotique bleue | n2=en:stye | rel=r_associated | relid=0 | w=21
- se tenir au courant ---
r_associated #0: 21 -->
en:stye
n1=se tenir au courant | n2=en:stye | rel=r_associated | relid=0 | w=21
- sigle : GAO ---
r_associated #0: 21 -->
en:stye
n1=sigle : GAO | n2=en:stye | rel=r_associated | relid=0 | w=21
- troubles de la vision ---
r_associated #0: 21 -->
en:stye
n1=troubles de la vision | n2=en:stye | rel=r_associated | relid=0 | w=21
- uvéite à hypopyon ---
r_associated #0: 21 -->
en:stye
n1=uvéite à hypopyon | n2=en:stye | rel=r_associated | relid=0 | w=21
- yeux ---
r_associated #0: 21 -->
en:stye
n1=yeux | n2=en:stye | rel=r_associated | relid=0 | w=21
- Lens ---
r_associated #0: 20 -->
en:stye
n1=Lens | n2=en:stye | rel=r_associated | relid=0 | w=20
- Rétinoblastome ---
r_associated #0: 20 -->
en:stye
n1=Rétinoblastome | n2=en:stye | rel=r_associated | relid=0 | w=20
- Strabisme ---
r_associated #0: 20 -->
en:stye
n1=Strabisme | n2=en:stye | rel=r_associated | relid=0 | w=20
- Trachome ---
r_associated #0: 20 -->
en:stye
n1=Trachome | n2=en:stye | rel=r_associated | relid=0 | w=20
- abcès ---
r_associated #0: 20 -->
en:stye
n1=abcès | n2=en:stye | rel=r_associated | relid=0 | w=20
- acné ---
r_associated #0: 20 -->
en:stye
n1=acné | n2=en:stye | rel=r_associated | relid=0 | w=20
- acné ciliaire ---
r_associated #0: 20 -->
en:stye
n1=acné ciliaire | n2=en:stye | rel=r_associated | relid=0 | w=20
- ampoule ---
r_associated #0: 20 -->
en:stye
n1=ampoule | n2=en:stye | rel=r_associated | relid=0 | w=20
- ampoule
(cloque) ---
r_associated #0: 20 -->
en:stye
n1=ampoule (cloque) | n2=en:stye | rel=r_associated | relid=0 | w=20
- anatomie ---
r_associated #0: 20 -->
en:stye
n1=anatomie | n2=en:stye | rel=r_associated | relid=0 | w=20
- bactérie ---
r_associated #0: 20 -->
en:stye
n1=bactérie | n2=en:stye | rel=r_associated | relid=0 | w=20
- blépharo-conjonctivite de l'acné rosacée ---
r_associated #0: 20 -->
en:stye
n1=blépharo-conjonctivite de l'acné rosacée | n2=en:stye | rel=r_associated | relid=0 | w=20
- bosse ---
r_associated #0: 20 -->
en:stye
n1=bosse | n2=en:stye | rel=r_associated | relid=0 | w=20
- cancer ---
r_associated #0: 20 -->
en:stye
n1=cancer | n2=en:stye | rel=r_associated | relid=0 | w=20
- cancérologie ---
r_associated #0: 20 -->
en:stye
n1=cancérologie | n2=en:stye | rel=r_associated | relid=0 | w=20
- carcinologie ---
r_associated #0: 20 -->
en:stye
n1=carcinologie | n2=en:stye | rel=r_associated | relid=0 | w=20
- carcinologie
(oncologie) ---
r_associated #0: 20 -->
en:stye
n1=carcinologie (oncologie) | n2=en:stye | rel=r_associated | relid=0 | w=20
- chalaze ---
r_associated #0: 20 -->
en:stye
n1=chalaze | n2=en:stye | rel=r_associated | relid=0 | w=20
- compère loriot ---
r_associated #0: 20 -->
en:stye
n1=compère loriot | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:advise somebody that ---
r_associated #0: 20 -->
en:stye
n1=en:advise somebody that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:eye and eyelid infections ---
r_associated #0: 20 -->
en:stye
n1=en:eye and eyelid infections | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:give sb notice of sth ---
r_associated #0: 20 -->
en:stye
n1=en:give sb notice of sth | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:impart something to somebody ---
r_associated #0: 20 -->
en:stye
n1=en:impart something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:inform sb that ---
r_associated #0: 20 -->
en:stye
n1=en:inform sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:instil something in somebody ---
r_associated #0: 20 -->
en:stye
n1=en:instil something in somebody | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:instill something in somebody ---
r_associated #0: 20 -->
en:stye
n1=en:instill something in somebody | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:leukokoria ---
r_associated #0: 20 -->
en:stye
n1=en:leukokoria | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:medicine ---
r_associated #0: 20 -->
en:stye
n1=en:medicine | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:neoplasm ---
r_associated #0: 20 -->
en:stye
n1=en:neoplasm | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:put somebody on his/her guard ---
r_associated #0: 20 -->
en:stye
n1=en:put somebody on his/her guard | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:tell sb that ---
r_associated #0: 20 -->
en:stye
n1=en:tell sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:tell somebody that ---
r_associated #0: 20 -->
en:stye
n1=en:tell somebody that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:to inform sb that ---
r_associated #0: 20 -->
en:stye
n1=en:to inform sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:to tell sb that ---
r_associated #0: 20 -->
en:stye
n1=en:to tell sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:to warn sb that ---
r_associated #0: 20 -->
en:stye
n1=en:to warn sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- en:warn sb that ---
r_associated #0: 20 -->
en:stye
n1=en:warn sb that | n2=en:stye | rel=r_associated | relid=0 | w=20
- enflure ---
r_associated #0: 20 -->
en:stye
n1=enflure | n2=en:stye | rel=r_associated | relid=0 | w=20
- excroissance ---
r_associated #0: 20 -->
en:stye
n1=excroissance | n2=en:stye | rel=r_associated | relid=0 | w=20
- fibrome ---
r_associated #0: 20 -->
en:stye
n1=fibrome | n2=en:stye | rel=r_associated | relid=0 | w=20
- furoncle ---
r_associated #0: 20 -->
en:stye
n1=furoncle | n2=en:stye | rel=r_associated | relid=0 | w=20
- glande de Meibomius ---
r_associated #0: 20 -->
en:stye
n1=glande de Meibomius | n2=en:stye | rel=r_associated | relid=0 | w=20
- glande de Zeis ---
r_associated #0: 20 -->
en:stye
n1=glande de Zeis | n2=en:stye | rel=r_associated | relid=0 | w=20
- infection ---
r_associated #0: 20 -->
en:stye
n1=infection | n2=en:stye | rel=r_associated | relid=0 | w=20
- kyste ---
r_associated #0: 20 -->
en:stye
n1=kyste | n2=en:stye | rel=r_associated | relid=0 | w=20
- loriot ---
r_associated #0: 20 -->
en:stye
n1=loriot | n2=en:stye | rel=r_associated | relid=0 | w=20
- loupe ---
r_associated #0: 20 -->
en:stye
n1=loupe | n2=en:stye | rel=r_associated | relid=0 | w=20
- maladie ---
r_associated #0: 20 -->
en:stye
n1=maladie | n2=en:stye | rel=r_associated | relid=0 | w=20
- maladies ---
r_associated #0: 20 -->
en:stye
n1=maladies | n2=en:stye | rel=r_associated | relid=0 | w=20
- médecine ---
r_associated #0: 20 -->
en:stye
n1=médecine | n2=en:stye | rel=r_associated | relid=0 | w=20
- médecine spécialisée ---
r_associated #0: 20 -->
en:stye
n1=médecine spécialisée | n2=en:stye | rel=r_associated | relid=0 | w=20
- néoplasme ---
r_associated #0: 20 -->
en:stye
n1=néoplasme | n2=en:stye | rel=r_associated | relid=0 | w=20
- oncologie ---
r_associated #0: 20 -->
en:stye
n1=oncologie | n2=en:stye | rel=r_associated | relid=0 | w=20
- ophtalmologie ---
r_associated #0: 20 -->
en:stye
n1=ophtalmologie | n2=en:stye | rel=r_associated | relid=0 | w=20
- orgelet externe ---
r_associated #0: 20 -->
en:stye
n1=orgelet externe | n2=en:stye | rel=r_associated | relid=0 | w=20
- parler de qch à qn ---
r_associated #0: 20 -->
en:stye
n1=parler de qch à qn | n2=en:stye | rel=r_associated | relid=0 | w=20
- parler de quelque chose à quelqu'un ---
r_associated #0: 20 -->
en:stye
n1=parler de quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=20
- pathologie ---
r_associated #0: 20 -->
en:stye
n1=pathologie | n2=en:stye | rel=r_associated | relid=0 | w=20
- petit furoncle ---
r_associated #0: 20 -->
en:stye
n1=petit furoncle | n2=en:stye | rel=r_associated | relid=0 | w=20
- petit oeil ---
r_associated #0: 20 -->
en:stye
n1=petit oeil | n2=en:stye | rel=r_associated | relid=0 | w=20
- processus pathologique ---
r_associated #0: 20 -->
en:stye
n1=processus pathologique | n2=en:stye | rel=r_associated | relid=0 | w=20
- spécialités médicales ---
r_associated #0: 20 -->
en:stye
n1=spécialités médicales | n2=en:stye | rel=r_associated | relid=0 | w=20
- tubérosité ---
r_associated #0: 20 -->
en:stye
n1=tubérosité | n2=en:stye | rel=r_associated | relid=0 | w=20
- tumeur ---
r_associated #0: 20 -->
en:stye
n1=tumeur | n2=en:stye | rel=r_associated | relid=0 | w=20
- tumeurs ---
r_associated #0: 20 -->
en:stye
n1=tumeurs | n2=en:stye | rel=r_associated | relid=0 | w=20
- tuméfaction ---
r_associated #0: 20 -->
en:stye
n1=tuméfaction | n2=en:stye | rel=r_associated | relid=0 | w=20
- BNV ---
r_associated #0: 15 -->
en:stye
n1=BNV | n2=en:stye | rel=r_associated | relid=0 | w=15
- C?ur brisé ---
r_associated #0: 15 -->
en:stye
n1=C?ur brisé | n2=en:stye | rel=r_associated | relid=0 | w=15
- Dégénérescence maculaire ---
r_associated #0: 15 -->
en:stye
n1=Dégénérescence maculaire | n2=en:stye | rel=r_associated | relid=0 | w=15
- EMLA ® (crème) ---
r_associated #0: 15 -->
en:stye
n1=EMLA ® (crème) | n2=en:stye | rel=r_associated | relid=0 | w=15
- Enzymologie ---
r_associated #0: 15 -->
en:stye
n1=Enzymologie | n2=en:stye | rel=r_associated | relid=0 | w=15
- Germiston (virus) ---
r_associated #0: 15 -->
en:stye
n1=Germiston (virus) | n2=en:stye | rel=r_associated | relid=0 | w=15
- Humeur vitrée ---
r_associated #0: 15 -->
en:stye
n1=Humeur vitrée | n2=en:stye | rel=r_associated | relid=0 | w=15
- Parasitologie ---
r_associated #0: 15 -->
en:stye
n1=Parasitologie | n2=en:stye | rel=r_associated | relid=0 | w=15
- Sinusite ---
r_associated #0: 15 -->
en:stye
n1=Sinusite | n2=en:stye | rel=r_associated | relid=0 | w=15
- Trouble de la vision ---
r_associated #0: 15 -->
en:stye
n1=Trouble de la vision | n2=en:stye | rel=r_associated | relid=0 | w=15
- conjonctif (tissu) ---
r_associated #0: 15 -->
en:stye
n1=conjonctif (tissu) | n2=en:stye | rel=r_associated | relid=0 | w=15
- cyclope (oeil) ---
r_associated #0: 15 -->
en:stye
n1=cyclope (oeil) | n2=en:stye | rel=r_associated | relid=0 | w=15
- cæcité ---
r_associated #0: 15 -->
en:stye
n1=cæcité | n2=en:stye | rel=r_associated | relid=0 | w=15
- cécité des rivières ---
r_associated #0: 15 -->
en:stye
n1=cécité des rivières | n2=en:stye | rel=r_associated | relid=0 | w=15
- cécité monoculaire transitoire ---
r_associated #0: 15 -->
en:stye
n1=cécité monoculaire transitoire | n2=en:stye | rel=r_associated | relid=0 | w=15
- distance interpédiculaire (mesure de la) ---
r_associated #0: 15 -->
en:stye
n1=distance interpédiculaire (mesure de la) | n2=en:stye | rel=r_associated | relid=0 | w=15
- en:give sb notice of something ---
r_associated #0: 15 -->
en:stye
n1=en:give sb notice of something | n2=en:stye | rel=r_associated | relid=0 | w=15
- en:tumour ---
r_associated #0: 15 -->
en:stye
n1=en:tumour | n2=en:stye | rel=r_associated | relid=0 | w=15
- en:vision disorder ---
r_associated #0: 15 -->
en:stye
n1=en:vision disorder | n2=en:stye | rel=r_associated | relid=0 | w=15
- fulminans (purpura) ---
r_associated #0: 15 -->
en:stye
n1=fulminans (purpura) | n2=en:stye | rel=r_associated | relid=0 | w=15
- humeur (stimulant de l') ---
r_associated #0: 15 -->
en:stye
n1=humeur (stimulant de l') | n2=en:stye | rel=r_associated | relid=0 | w=15
- hémorragie digestive occulte (mesure radio isotopique d'une) ---
r_associated #0: 15 -->
en:stye
n1=hémorragie digestive occulte (mesure radio isotopique d'une) | n2=en:stye | rel=r_associated | relid=0 | w=15
- maladie de benson ---
r_associated #0: 15 -->
en:stye
n1=maladie de benson | n2=en:stye | rel=r_associated | relid=0 | w=15
- notifier qn de qch ---
r_associated #0: 15 -->
en:stye
n1=notifier qn de qch | n2=en:stye | rel=r_associated | relid=0 | w=15
- uvéite hétéro-immune ---
r_associated #0: 15 -->
en:stye
n1=uvéite hétéro-immune | n2=en:stye | rel=r_associated | relid=0 | w=15
- anisocorie ---
r_associated #0: 11 -->
en:stye
n1=anisocorie | n2=en:stye | rel=r_associated | relid=0 | w=11
- blépharophimosis congénital ---
r_associated #0: 11 -->
en:stye
n1=blépharophimosis congénital | n2=en:stye | rel=r_associated | relid=0 | w=11
- strabique ---
r_associated #0: 11 -->
en:stye
n1=strabique | n2=en:stye | rel=r_associated | relid=0 | w=11
- Amblyopie ---
r_associated #0: 10 -->
en:stye
n1=Amblyopie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Anisocorie ---
r_associated #0: 10 -->
en:stye
n1=Anisocorie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Blindness ---
r_associated #0: 10 -->
en:stye
n1=Blindness | n2=en:stye | rel=r_associated | relid=0 | w=10
- Cancérologie ---
r_associated #0: 10 -->
en:stye
n1=Cancérologie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Conjonctivite ---
r_associated #0: 10 -->
en:stye
n1=Conjonctivite | n2=en:stye | rel=r_associated | relid=0 | w=10
- Cécité ---
r_associated #0: 10 -->
en:stye
n1=Cécité | n2=en:stye | rel=r_associated | relid=0 | w=10
- D-glycitol ---
r_associated #0: 10 -->
en:stye
n1=D-glycitol | n2=en:stye | rel=r_associated | relid=0 | w=10
- D-glycérate-déshydrogénase ---
r_associated #0: 10 -->
en:stye
n1=D-glycérate-déshydrogénase | n2=en:stye | rel=r_associated | relid=0 | w=10
- D-pénicillamine ---
r_associated #0: 10 -->
en:stye
n1=D-pénicillamine | n2=en:stye | rel=r_associated | relid=0 | w=10
- D-xylose ---
r_associated #0: 10 -->
en:stye
n1=D-xylose | n2=en:stye | rel=r_associated | relid=0 | w=10
- Diplopie ---
r_associated #0: 10 -->
en:stye
n1=Diplopie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Dyschromatopsie ---
r_associated #0: 10 -->
en:stye
n1=Dyschromatopsie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Dégénérescence maculaire liée à l'âge ---
r_associated #0: 10 -->
en:stye
n1=Dégénérescence maculaire liée à l'âge | n2=en:stye | rel=r_associated | relid=0 | w=10
- Exophtalmie ---
r_associated #0: 10 -->
en:stye
n1=Exophtalmie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Fibrome ---
r_associated #0: 10 -->
en:stye
n1=Fibrome | n2=en:stye | rel=r_associated | relid=0 | w=10
- Furoncle ---
r_associated #0: 10 -->
en:stye
n1=Furoncle | n2=en:stye | rel=r_associated | relid=0 | w=10
- GERV ---
r_associated #0: 10 -->
en:stye
n1=GERV | n2=en:stye | rel=r_associated | relid=0 | w=10
- Glaucome ---
r_associated #0: 10 -->
en:stye
n1=Glaucome | n2=en:stye | rel=r_associated | relid=0 | w=10
- Huxley (couche de) ---
r_associated #0: 10 -->
en:stye
n1=Huxley (couche de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Hypertélorisme ---
r_associated #0: 10 -->
en:stye
n1=Hypertélorisme | n2=en:stye | rel=r_associated | relid=0 | w=10
- Hémianopsie ---
r_associated #0: 10 -->
en:stye
n1=Hémianopsie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Leuckart (canal de) ---
r_associated #0: 10 -->
en:stye
n1=Leuckart (canal de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Néoplasme ---
r_associated #0: 10 -->
en:stye
n1=Néoplasme | n2=en:stye | rel=r_associated | relid=0 | w=10
- Officier traitant ---
r_associated #0: 10 -->
en:stye
n1=Officier traitant | n2=en:stye | rel=r_associated | relid=0 | w=10
- Ophtalmopathie ---
r_associated #0: 10 -->
en:stye
n1=Ophtalmopathie | n2=en:stye | rel=r_associated | relid=0 | w=10
- Panaris ---
r_associated #0: 10 -->
en:stye
n1=Panaris | n2=en:stye | rel=r_associated | relid=0 | w=10
- Paraquat ® (intoxication par le) ---
r_associated #0: 10 -->
en:stye
n1=Paraquat ® (intoxication par le) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Ptose ---
r_associated #0: 10 -->
en:stye
n1=Ptose | n2=en:stye | rel=r_associated | relid=0 | w=10
- Ptôse ---
r_associated #0: 10 -->
en:stye
n1=Ptôse | n2=en:stye | rel=r_associated | relid=0 | w=10
- Stargardt (maladie de ) ---
r_associated #0: 10 -->
en:stye
n1=Stargardt (maladie de ) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Stilling-Türk-Duane (syndrome de) ---
r_associated #0: 10 -->
en:stye
n1=Stilling-Türk-Duane (syndrome de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Stormoken-Sjaatadt-Langslet (syndrome de) ---
r_associated #0: 10 -->
en:stye
n1=Stormoken-Sjaatadt-Langslet (syndrome de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Sylvius (scissure de) ---
r_associated #0: 10 -->
en:stye
n1=Sylvius (scissure de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Treft-Sanborn-Carey (syndrome de) ---
r_associated #0: 10 -->
en:stye
n1=Treft-Sanborn-Carey (syndrome de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Trouble de la vue ---
r_associated #0: 10 -->
en:stye
n1=Trouble de la vue | n2=en:stye | rel=r_associated | relid=0 | w=10
- Troubles de la vision ---
r_associated #0: 10 -->
en:stye
n1=Troubles de la vision | n2=en:stye | rel=r_associated | relid=0 | w=10
- Tunbridge et Paley (maladie de) ---
r_associated #0: 10 -->
en:stye
n1=Tunbridge et Paley (maladie de) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Xanthoma ---
r_associated #0: 10 -->
en:stye
n1=Xanthoma | n2=en:stye | rel=r_associated | relid=0 | w=10
- Xanthome ---
r_associated #0: 10 -->
en:stye
n1=Xanthome | n2=en:stye | rel=r_associated | relid=0 | w=10
- afficher [qch] ---
r_associated #0: 10 -->
en:stye
n1=afficher [qch] | n2=en:stye | rel=r_associated | relid=0 | w=10
- afficher quelque chose ---
r_associated #0: 10 -->
en:stye
n1=afficher quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=10
- alerter quelqu'un de quelque chose ---
r_associated #0: 10 -->
en:stye
n1=alerter quelqu'un de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=10
- ambiguus ---
r_associated #0: 10 -->
en:stye
n1=ambiguus | n2=en:stye | rel=r_associated | relid=0 | w=10
- ambigüité ---
r_associated #0: 10 -->
en:stye
n1=ambigüité | n2=en:stye | rel=r_associated | relid=0 | w=10
- ambigüité sexuelle ---
r_associated #0: 10 -->
en:stye
n1=ambigüité sexuelle | n2=en:stye | rel=r_associated | relid=0 | w=10
- ambigüité spectrale ---
r_associated #0: 10 -->
en:stye
n1=ambigüité spectrale | n2=en:stye | rel=r_associated | relid=0 | w=10
- angl. NSE ---
r_associated #0: 10 -->
en:stye
n1=angl. NSE | n2=en:stye | rel=r_associated | relid=0 | w=10
- aniline (intoxication par l') ---
r_associated #0: 10 -->
en:stye
n1=aniline (intoxication par l') | n2=en:stye | rel=r_associated | relid=0 | w=10
- antrite ---
r_associated #0: 10 -->
en:stye
n1=antrite | n2=en:stye | rel=r_associated | relid=0 | w=10
- arriération ---
r_associated #0: 10 -->
en:stye
n1=arriération | n2=en:stye | rel=r_associated | relid=0 | w=10
- atrophie optique, surdité neurogène, amyotrophie distale neurogénique ---
r_associated #0: 10 -->
en:stye
n1=atrophie optique, surdité neurogène, amyotrophie distale neurogénique | n2=en:stye | rel=r_associated | relid=0 | w=10
- aviser qn de qch ---
r_associated #0: 10 -->
en:stye
n1=aviser qn de qch | n2=en:stye | rel=r_associated | relid=0 | w=10
- cécité centrale ---
r_associated #0: 10 -->
en:stye
n1=cécité centrale | n2=en:stye | rel=r_associated | relid=0 | w=10
- cécité corticale, retard mental et polydactylie post-axiale ---
r_associated #0: 10 -->
en:stye
n1=cécité corticale, retard mental et polydactylie post-axiale | n2=en:stye | rel=r_associated | relid=0 | w=10
- cécité d' Episkopi ---
r_associated #0: 10 -->
en:stye
n1=cécité d' Episkopi | n2=en:stye | rel=r_associated | relid=0 | w=10
- cécité d'Episkopi ---
r_associated #0: 10 -->
en:stye
n1=cécité d'Episkopi | n2=en:stye | rel=r_associated | relid=0 | w=10
- d-dimère ---
r_associated #0: 10 -->
en:stye
n1=d-dimère | n2=en:stye | rel=r_associated | relid=0 | w=10
- d-pénicillamine ---
r_associated #0: 10 -->
en:stye
n1=d-pénicillamine | n2=en:stye | rel=r_associated | relid=0 | w=10
- d-tubocurarine ---
r_associated #0: 10 -->
en:stye
n1=d-tubocurarine | n2=en:stye | rel=r_associated | relid=0 | w=10
- d-urobiline ---
r_associated #0: 10 -->
en:stye
n1=d-urobiline | n2=en:stye | rel=r_associated | relid=0 | w=10
- d-urobilinogène ---
r_associated #0: 10 -->
en:stye
n1=d-urobilinogène | n2=en:stye | rel=r_associated | relid=0 | w=10
- d4T ---
r_associated #0: 10 -->
en:stye
n1=d4T | n2=en:stye | rel=r_associated | relid=0 | w=10
- dabigratan etexilate ---
r_associated #0: 10 -->
en:stye
n1=dabigratan etexilate | n2=en:stye | rel=r_associated | relid=0 | w=10
- dacarbazine ---
r_associated #0: 10 -->
en:stye
n1=dacarbazine | n2=en:stye | rel=r_associated | relid=0 | w=10
- daclastavir ---
r_associated #0: 10 -->
en:stye
n1=daclastavir | n2=en:stye | rel=r_associated | relid=0 | w=10
- dacron ---
r_associated #0: 10 -->
en:stye
n1=dacron | n2=en:stye | rel=r_associated | relid=0 | w=10
- dacryocystectomie ---
r_associated #0: 10 -->
en:stye
n1=dacryocystectomie | n2=en:stye | rel=r_associated | relid=0 | w=10
- dacryocèle congénital ---
r_associated #0: 10 -->
en:stye
n1=dacryocèle congénital | n2=en:stye | rel=r_associated | relid=0 | w=10
- disque du nerf optique ---
r_associated #0: 10 -->
en:stye
n1=disque du nerf optique | n2=en:stye | rel=r_associated | relid=0 | w=10
- donner un avertissement ---
r_associated #0: 10 -->
en:stye
n1=donner un avertissement | n2=en:stye | rel=r_associated | relid=0 | w=10
- débilité mentale ---
r_associated #0: 10 -->
en:stye
n1=débilité mentale | n2=en:stye | rel=r_associated | relid=0 | w=10
- déception sentimentale ---
r_associated #0: 10 -->
en:stye
n1=déception sentimentale | n2=en:stye | rel=r_associated | relid=0 | w=10
- dégénérescence sénile de la macula ---
r_associated #0: 10 -->
en:stye
n1=dégénérescence sénile de la macula | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:Ambard's formula ---
r_associated #0: 10 -->
en:stye
n1=en:Ambard's formula | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:Asian eyes ---
r_associated #0: 10 -->
en:stye
n1=en:Asian eyes | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:Kjer type optic atrophy ---
r_associated #0: 10 -->
en:stye
n1=en:Kjer type optic atrophy | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:Kjer's type ---
r_associated #0: 10 -->
en:stye
n1=en:Kjer's type | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:Stilling-Türk-Duane's syndrome ---
r_associated #0: 10 -->
en:stye
n1=en:Stilling-Türk-Duane's syndrome | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:age related macular degeneration (AMD) ---
r_associated #0: 10 -->
en:stye
n1=en:age related macular degeneration (AMD) | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:alert sb to sth ---
r_associated #0: 10 -->
en:stye
n1=en:alert sb to sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:and dementia ---
r_associated #0: 10 -->
en:stye
n1=en:and dementia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:and hypogonadotropic hypogonadism ---
r_associated #0: 10 -->
en:stye
n1=en:and hypogonadotropic hypogonadism | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:and microgenitalism ---
r_associated #0: 10 -->
en:stye
n1=en:and microgenitalism | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:and sensorineural deafness ---
r_associated #0: 10 -->
en:stye
n1=en:and sensorineural deafness | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:be in contact with ---
r_associated #0: 10 -->
en:stye
n1=en:be in contact with | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:be in contact with [sb/sth] ---
r_associated #0: 10 -->
en:stye
n1=en:be in contact with [sb/sth] | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:blepharophimosis ---
r_associated #0: 10 -->
en:stye
n1=en:blepharophimosis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:bony frailty with craniostenosis ---
r_associated #0: 10 -->
en:stye
n1=en:bony frailty with craniostenosis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:buphtalmia ---
r_associated #0: 10 -->
en:stye
n1=en:buphtalmia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:buphthalmos ---
r_associated #0: 10 -->
en:stye
n1=en:buphthalmos | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:buphthalmus ---
r_associated #0: 10 -->
en:stye
n1=en:buphthalmus | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:cataract ---
r_associated #0: 10 -->
en:stye
n1=en:cataract | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:congenital stationary rhodopsin-related ---
r_associated #0: 10 -->
en:stye
n1=en:congenital stationary rhodopsin-related | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:connective tissue ---
r_associated #0: 10 -->
en:stye
n1=en:connective tissue | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:cyclops eye ---
r_associated #0: 10 -->
en:stye
n1=en:cyclops eye | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:enophtalmos ---
r_associated #0: 10 -->
en:stye
n1=en:enophtalmos | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:establish a connection ---
r_associated #0: 10 -->
en:stye
n1=en:establish a connection | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:ethnological ---
r_associated #0: 10 -->
en:stye
n1=en:ethnological | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:facial clefting syndrome ---
r_associated #0: 10 -->
en:stye
n1=en:facial clefting syndrome | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:familial ---
r_associated #0: 10 -->
en:stye
n1=en:familial | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:familial bilateral ---
r_associated #0: 10 -->
en:stye
n1=en:familial bilateral | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:felon ---
r_associated #0: 10 -->
en:stye
n1=en:felon | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:felon (obsolète) ---
r_associated #0: 10 -->
en:stye
n1=en:felon (obsolète) | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:give a head's up ---
r_associated #0: 10 -->
en:stye
n1=en:give a head's up | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:give a signal ---
r_associated #0: 10 -->
en:stye
n1=en:give a signal | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:give a tip-off ---
r_associated #0: 10 -->
en:stye
n1=en:give a tip-off | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:heart-break ---
r_associated #0: 10 -->
en:stye
n1=en:heart-break | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:heart-grief ---
r_associated #0: 10 -->
en:stye
n1=en:heart-grief | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:heartbreaking situation ---
r_associated #0: 10 -->
en:stye
n1=en:heartbreaking situation | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:hyperacanthosis ---
r_associated #0: 10 -->
en:stye
n1=en:hyperacanthosis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:hypospadias ---
r_associated #0: 10 -->
en:stye
n1=en:hypospadias | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:inform that ---
r_associated #0: 10 -->
en:stye
n1=en:inform that | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:intermediate uveitis ---
r_associated #0: 10 -->
en:stye
n1=en:intermediate uveitis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:irideremia ---
r_associated #0: 10 -->
en:stye
n1=en:irideremia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:iris coloboma with ptosis ---
r_associated #0: 10 -->
en:stye
n1=en:iris coloboma with ptosis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:keep abreast of something ---
r_associated #0: 10 -->
en:stye
n1=en:keep abreast of something | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:keep yourself informed ---
r_associated #0: 10 -->
en:stye
n1=en:keep yourself informed | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:late optic atrophy ---
r_associated #0: 10 -->
en:stye
n1=en:late optic atrophy | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:let know that ---
r_associated #0: 10 -->
en:stye
n1=en:let know that | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:let sb know sth ---
r_associated #0: 10 -->
en:stye
n1=en:let sb know sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:make one aware ---
r_associated #0: 10 -->
en:stye
n1=en:make one aware | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:microtia ---
r_associated #0: 10 -->
en:stye
n1=en:microtia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:mood stimulant ---
r_associated #0: 10 -->
en:stye
n1=en:mood stimulant | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:multiple lentigines syndrome ---
r_associated #0: 10 -->
en:stye
n1=en:multiple lentigines syndrome | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:myopia ---
r_associated #0: 10 -->
en:stye
n1=en:myopia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:notify sb of sth ---
r_associated #0: 10 -->
en:stye
n1=en:notify sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:of the posterior pole ---
r_associated #0: 10 -->
en:stye
n1=en:of the posterior pole | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:ogle ---
r_associated #0: 10 -->
en:stye
n1=en:ogle | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:panaritium ---
r_associated #0: 10 -->
en:stye
n1=en:panaritium | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:parfois héréditaire autosomique dominante ---
r_associated #0: 10 -->
en:stye
n1=en:parfois héréditaire autosomique dominante | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:polysyndactyly syndrome ---
r_associated #0: 10 -->
en:stye
n1=en:polysyndactyly syndrome | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:put a bee in someone's bonnet ---
r_associated #0: 10 -->
en:stye
n1=en:put a bee in someone's bonnet | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:put a bug in someone's ear ---
r_associated #0: 10 -->
en:stye
n1=en:put a bug in someone's ear | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:put at risk ---
r_associated #0: 10 -->
en:stye
n1=en:put at risk | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:radiographic ---
r_associated #0: 10 -->
en:stye
n1=en:radiographic | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:raise a red flag ---
r_associated #0: 10 -->
en:stye
n1=en:raise a red flag | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:raise an alarm bell ---
r_associated #0: 10 -->
en:stye
n1=en:raise an alarm bell | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:recommend something to somebody ---
r_associated #0: 10 -->
en:stye
n1=en:recommend something to somebody | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:recommend sth to sb ---
r_associated #0: 10 -->
en:stye
n1=en:recommend sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:recommend sth to somebody ---
r_associated #0: 10 -->
en:stye
n1=en:recommend sth to somebody | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:reticular pigmentary ---
r_associated #0: 10 -->
en:stye
n1=en:reticular pigmentary | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:set off a warning ---
r_associated #0: 10 -->
en:stye
n1=en:set off a warning | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:slant-eyes ---
r_associated #0: 10 -->
en:stye
n1=en:slant-eyes | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:slanty eyes ---
r_associated #0: 10 -->
en:stye
n1=en:slanty eyes | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:something that breaks one's heart ---
r_associated #0: 10 -->
en:stye
n1=en:something that breaks one's heart | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:spinocerebellar ataxia ---
r_associated #0: 10 -->
en:stye
n1=en:spinocerebellar ataxia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:spinocerebellar degeneration with macular corneal dystrophy ---
r_associated #0: 10 -->
en:stye
n1=en:spinocerebellar degeneration with macular corneal dystrophy | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:stay informed ---
r_associated #0: 10 -->
en:stye
n1=en:stay informed | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to alert sb to sth ---
r_associated #0: 10 -->
en:stye
n1=en:to alert sb to sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to be in contact with ---
r_associated #0: 10 -->
en:stye
n1=en:to be in contact with | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to be in contact with sb ---
r_associated #0: 10 -->
en:stye
n1=en:to be in contact with sb | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to inform sb about sth ---
r_associated #0: 10 -->
en:stye
n1=en:to inform sb about sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to notify sb of sth ---
r_associated #0: 10 -->
en:stye
n1=en:to notify sb of sth | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:to recommend sth to sb ---
r_associated #0: 10 -->
en:stye
n1=en:to recommend sth to sb | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:uveitis ---
r_associated #0: 10 -->
en:stye
n1=en:uveitis | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:with growth retardation ---
r_associated #0: 10 -->
en:stye
n1=en:with growth retardation | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:with myopia ---
r_associated #0: 10 -->
en:stye
n1=en:with myopia | n2=en:stye | rel=r_associated | relid=0 | w=10
- en:with tapetal-like sheen ---
r_associated #0: 10 -->
en:stye
n1=en:with tapetal-like sheen | n2=en:stye | rel=r_associated | relid=0 | w=10
- enseigner qch à qn ---
r_associated #0: 10 -->
en:stye
n1=enseigner qch à qn | n2=en:stye | rel=r_associated | relid=0 | w=10
- enseigner qch à quelqu'un ---
r_associated #0: 10 -->
en:stye
n1=enseigner qch à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=10
- enseigner quelque chose à quelqu'un ---
r_associated #0: 10 -->
en:stye
n1=enseigner quelque chose à quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=10
- entrer en contact ---
r_associated #0: 10 -->
en:stye
n1=entrer en contact | n2=en:stye | rel=r_associated | relid=0 | w=10
- fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique; ---
r_associated #0: 10 -->
en:stye
n1=fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique; | n2=en:stye | rel=r_associated | relid=0 | w=10
- garder le contact avec ---
r_associated #0: 10 -->
en:stye
n1=garder le contact avec | n2=en:stye | rel=r_associated | relid=0 | w=10
- glaucome à angle fermé ---
r_associated #0: 10 -->
en:stye
n1=glaucome à angle fermé | n2=en:stye | rel=r_associated | relid=0 | w=10
- glaucome à pression normale ---
r_associated #0: 10 -->
en:stye
n1=glaucome à pression normale | n2=en:stye | rel=r_associated | relid=0 | w=10
- hernie diaphragmatique ---
r_associated #0: 10 -->
en:stye
n1=hernie diaphragmatique | n2=en:stye | rel=r_associated | relid=0 | w=10
- hyodésoxycholique (acide) ---
r_associated #0: 10 -->
en:stye
n1=hyodésoxycholique (acide) | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertensinase ---
r_associated #0: 10 -->
en:stye
n1=hypertensinase | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertensine ---
r_associated #0: 10 -->
en:stye
n1=hypertensine | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertensinogène ---
r_associated #0: 10 -->
en:stye
n1=hypertensinogène | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertension ---
r_associated #0: 10 -->
en:stye
n1=hypertension | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertension abdominale ---
r_associated #0: 10 -->
en:stye
n1=hypertension abdominale | n2=en:stye | rel=r_associated | relid=0 | w=10
- hypertension artérielle ---
r_associated #0: 10 -->
en:stye
n1=hypertension artérielle | n2=en:stye | rel=r_associated | relid=0 | w=10
- impartir [qch] à [qch] ---
r_associated #0: 10 -->
en:stye
n1=impartir [qch] à [qch] | n2=en:stye | rel=r_associated | relid=0 | w=10
- impartir quelque chose à quelque chose ---
r_associated #0: 10 -->
en:stye
n1=impartir quelque chose à quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=10
- informer qn de qch ---
r_associated #0: 10 -->
en:stye
n1=informer qn de qch | n2=en:stye | rel=r_associated | relid=0 | w=10
- informer qqn de qqch ---
r_associated #0: 10 -->
en:stye
n1=informer qqn de qqch | n2=en:stye | rel=r_associated | relid=0 | w=10
- maintenir à jour ---
r_associated #0: 10 -->
en:stye
n1=maintenir à jour | n2=en:stye | rel=r_associated | relid=0 | w=10
- maladie de Stargardt ---
r_associated #0: 10 -->
en:stye
n1=maladie de Stargardt | n2=en:stye | rel=r_associated | relid=0 | w=10
- mettre en garde quelqu'un ---
r_associated #0: 10 -->
en:stye
n1=mettre en garde quelqu'un | n2=en:stye | rel=r_associated | relid=0 | w=10
- mettre quelqu'un en garde ---
r_associated #0: 10 -->
en:stye
n1=mettre quelqu'un en garde | n2=en:stye | rel=r_associated | relid=0 | w=10
- nystagmus ---
r_associated #0: 10 -->
en:stye
n1=nystagmus | n2=en:stye | rel=r_associated | relid=0 | w=10
- nystagmus héréditaire vertical ---
r_associated #0: 10 -->
en:stye
n1=nystagmus héréditaire vertical | n2=en:stye | rel=r_associated | relid=0 | w=10
- névrite optique ---
r_associated #0: 10 -->
en:stye
n1=névrite optique | n2=en:stye | rel=r_associated | relid=0 | w=10
- omphalocèle ---
r_associated #0: 10 -->
en:stye
n1=omphalocèle | n2=en:stye | rel=r_associated | relid=0 | w=10
- organisateur (centre) ---
r_associated #0: 10 -->
en:stye
n1=organisateur (centre) | n2=en:stye | rel=r_associated | relid=0 | w=10
- papille duodénale (petite) ---
r_associated #0: 10 -->
en:stye
n1=papille duodénale (petite) | n2=en:stye | rel=r_associated | relid=0 | w=10
- parakeratosis ---
r_associated #0: 10 -->
en:stye
n1=parakeratosis | n2=en:stye | rel=r_associated | relid=0 | w=10
- paraplégie spastique familiale ---
r_associated #0: 10 -->
en:stye
n1=paraplégie spastique familiale | n2=en:stye | rel=r_associated | relid=0 | w=10
- rester en contact avec ---
r_associated #0: 10 -->
en:stye
n1=rester en contact avec | n2=en:stye | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire, surdité, retard mental, et hypogonadisme ---
r_associated #0: 10 -->
en:stye
n1=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | n2=en:stye | rel=r_associated | relid=0 | w=10
- sinus urogénital (partie vésicale du) ---
r_associated #0: 10 -->
en:stye
n1=sinus urogénital (partie vésicale du) | n2=en:stye | rel=r_associated | relid=0 | w=10
- surdité ---
r_associated #0: 10 -->
en:stye
n1=surdité | n2=en:stye | rel=r_associated | relid=0 | w=10
- syndrome cataracte-ataxie-surdité et retard mental ---
r_associated #0: 10 -->
en:stye
n1=syndrome cataracte-ataxie-surdité et retard mental | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécardiographie ---
r_associated #0: 10 -->
en:stye
n1=télécardiographie | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécardiophone ---
r_associated #0: 10 -->
en:stye
n1=télécardiophone | n2=en:stye | rel=r_associated | relid=0 | w=10
- téléclitoridie ---
r_associated #0: 10 -->
en:stye
n1=téléclitoridie | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécobalt ---
r_associated #0: 10 -->
en:stye
n1=télécobalt | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécobalt-thérapie ---
r_associated #0: 10 -->
en:stye
n1=télécobalt-thérapie | n2=en:stye | rel=r_associated | relid=0 | w=10
- téléconsultation ---
r_associated #0: 10 -->
en:stye
n1=téléconsultation | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécrâne ---
r_associated #0: 10 -->
en:stye
n1=télécrâne | n2=en:stye | rel=r_associated | relid=0 | w=10
- télécæsiothérapie ---
r_associated #0: 10 -->
en:stye
n1=télécæsiothérapie | n2=en:stye | rel=r_associated | relid=0 | w=10
- télédermatologie ---
r_associated #0: 10 -->
en:stye
n1=télédermatologie | n2=en:stye | rel=r_associated | relid=0 | w=10
- télédiastole ---
r_associated #0: 10 -->
en:stye
n1=télédiastole | n2=en:stye | rel=r_associated | relid=0 | w=10
- télédétection ---
r_associated #0: 10 -->
en:stye
n1=télédétection | n2=en:stye | rel=r_associated | relid=0 | w=10
- urticaire-surdité-amylose rénale ---
r_associated #0: 10 -->
en:stye
n1=urticaire-surdité-amylose rénale | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéite auto-immune ---
r_associated #0: 10 -->
en:stye
n1=uvéite auto-immune | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéite basale ---
r_associated #0: 10 -->
en:stye
n1=uvéite basale | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéite phacoantigénique ---
r_associated #0: 10 -->
en:stye
n1=uvéite phacoantigénique | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéite postérieure ---
r_associated #0: 10 -->
en:stye
n1=uvéite postérieure | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéite sympathique ---
r_associated #0: 10 -->
en:stye
n1=uvéite sympathique | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéoméningite ---
r_associated #0: 10 -->
en:stye
n1=uvéoméningite | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéonévraxite ---
r_associated #0: 10 -->
en:stye
n1=uvéonévraxite | n2=en:stye | rel=r_associated | relid=0 | w=10
- uvéoparotidite ---
r_associated #0: 10 -->
en:stye
n1=uvéoparotidite | n2=en:stye | rel=r_associated | relid=0 | w=10
- xanthique (lithiase) ---
r_associated #0: 10 -->
en:stye
n1=xanthique (lithiase) | n2=en:stye | rel=r_associated | relid=0 | w=10
- yeux en amande ---
r_associated #0: 10 -->
en:stye
n1=yeux en amande | n2=en:stye | rel=r_associated | relid=0 | w=10
- érogène (zone) ---
r_associated #0: 10 -->
en:stye
n1=érogène (zone) | n2=en:stye | rel=r_associated | relid=0 | w=10
- Œil ---
r_associated #0: 10 -->
en:stye
n1=Œil | n2=en:stye | rel=r_associated | relid=0 | w=10
- Entropion ---
r_associated #0: 5 -->
en:stye
n1=Entropion | n2=en:stye | rel=r_associated | relid=0 | w=5
- Inculquer ---
r_associated #0: 5 -->
en:stye
n1=Inculquer | n2=en:stye | rel=r_associated | relid=0 | w=5
- Microbiologique ---
r_associated #0: 5 -->
en:stye
n1=Microbiologique | n2=en:stye | rel=r_associated | relid=0 | w=5
- Neuropathie optique ---
r_associated #0: 5 -->
en:stye
n1=Neuropathie optique | n2=en:stye | rel=r_associated | relid=0 | w=5
- Ophtalmologie ---
r_associated #0: 5 -->
en:stye
n1=Ophtalmologie | n2=en:stye | rel=r_associated | relid=0 | w=5
- Spécialités médicales ---
r_associated #0: 5 -->
en:stye
n1=Spécialités médicales | n2=en:stye | rel=r_associated | relid=0 | w=5
- Tuméfaction ---
r_associated #0: 5 -->
en:stye
n1=Tuméfaction | n2=en:stye | rel=r_associated | relid=0 | w=5
- absence de chambre antérieure de l'oeil ---
r_associated #0: 5 -->
en:stye
n1=absence de chambre antérieure de l'oeil | n2=en:stye | rel=r_associated | relid=0 | w=5
- absence de sourcils ---
r_associated #0: 5 -->
en:stye
n1=absence de sourcils | n2=en:stye | rel=r_associated | relid=0 | w=5
- absence de sourcils et de cils ---
r_associated #0: 5 -->
en:stye
n1=absence de sourcils et de cils | n2=en:stye | rel=r_associated | relid=0 | w=5
- amblyopie avec retard mental et retard de croissance ---
r_associated #0: 5 -->
en:stye
n1=amblyopie avec retard mental et retard de croissance | n2=en:stye | rel=r_associated | relid=0 | w=5
- amblyopie fonctionnelle ---
r_associated #0: 5 -->
en:stye
n1=amblyopie fonctionnelle | n2=en:stye | rel=r_associated | relid=0 | w=5
- amblyopie organique ---
r_associated #0: 5 -->
en:stye
n1=amblyopie organique | n2=en:stye | rel=r_associated | relid=0 | w=5
- amblyoscope ---
r_associated #0: 5 -->
en:stye
n1=amblyoscope | n2=en:stye | rel=r_associated | relid=0 | w=5
- anomalie des cils ---
r_associated #0: 5 -->
en:stye
n1=anomalie des cils | n2=en:stye | rel=r_associated | relid=0 | w=5
- anomalie du sourcil ---
r_associated #0: 5 -->
en:stye
n1=anomalie du sourcil | n2=en:stye | rel=r_associated | relid=0 | w=5
- apparence anormale des yeux ---
r_associated #0: 5 -->
en:stye
n1=apparence anormale des yeux | n2=en:stye | rel=r_associated | relid=0 | w=5
- atténuation des vaisseaux sanguins rétiniens ---
r_associated #0: 5 -->
en:stye
n1=atténuation des vaisseaux sanguins rétiniens | n2=en:stye | rel=r_associated | relid=0 | w=5
- conjonctive limbique ---
r_associated #0: 5 -->
en:stye
n1=conjonctive limbique | n2=en:stye | rel=r_associated | relid=0 | w=5
- conjonctive palpébrale ---
r_associated #0: 5 -->
en:stye
n1=conjonctive palpébrale | n2=en:stye | rel=r_associated | relid=0 | w=5
- conjonctive paracornéenne ---
r_associated #0: 5 -->
en:stye
n1=conjonctive paracornéenne | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclopeptide ---
r_associated #0: 5 -->
en:stye
n1=cyclopeptide | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophiline ---
r_associated #0: 5 -->
en:stye
n1=cyclophiline | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophorie ---
r_associated #0: 5 -->
en:stye
n1=cyclophorie | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophosphamide ---
r_associated #0: 5 -->
en:stye
n1=cyclophosphamide | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophotocoagulation endoscopique ---
r_associated #0: 5 -->
en:stye
n1=cyclophotocoagulation endoscopique | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophrénie ---
r_associated #0: 5 -->
en:stye
n1=cyclophrénie | n2=en:stye | rel=r_associated | relid=0 | w=5
- cyclophyllidés ---
r_associated #0: 5 -->
en:stye
n1=cyclophyllidés | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité aux couleurs ---
r_associated #0: 5 -->
en:stye
n1=cécité aux couleurs | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité corticale ---
r_associated #0: 5 -->
en:stye
n1=cécité corticale | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité corticale chromatique ---
r_associated #0: 5 -->
en:stye
n1=cécité corticale chromatique | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité de changement ---
r_associated #0: 5 -->
en:stye
n1=cécité de changement | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité des cônes ---
r_associated #0: 5 -->
en:stye
n1=cécité des cônes | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité des neiges ---
r_associated #0: 5 -->
en:stye
n1=cécité des neiges | n2=en:stye | rel=r_associated | relid=0 | w=5
- cécité diurne ---
r_associated #0: 5 -->
en:stye
n1=cécité diurne | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance interplanale maximale ---
r_associated #0: 5 -->
en:stye
n1=distance interplanale maximale | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance interpupillaire ---
r_associated #0: 5 -->
en:stye
n1=distance interpupillaire | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance intertrochantérique ---
r_associated #0: 5 -->
en:stye
n1=distance intertrochantérique | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance nuque-mur ---
r_associated #0: 5 -->
en:stye
n1=distance nuque-mur | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance phylogénique ---
r_associated #0: 5 -->
en:stye
n1=distance phylogénique | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance phylogénétique ---
r_associated #0: 5 -->
en:stye
n1=distance phylogénétique | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance plan bicanthal externe-apex temporaux ---
r_associated #0: 5 -->
en:stye
n1=distance plan bicanthal externe-apex temporaux | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance source-axe ---
r_associated #0: 5 -->
en:stye
n1=distance source-axe | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance source-peau ---
r_associated #0: 5 -->
en:stye
n1=distance source-peau | n2=en:stye | rel=r_associated | relid=0 | w=5
- distance vertex-coccyx ---
r_associated #0: 5 -->
en:stye
n1=distance vertex-coccyx | n2=en:stye | rel=r_associated | relid=0 | w=5
- distension urinaire ---
r_associated #0: 5 -->
en:stye
n1=distension urinaire | n2=en:stye | rel=r_associated | relid=0 | w=5
- distension vésicale ---
r_associated #0: 5 -->
en:stye
n1=distension vésicale | n2=en:stye | rel=r_associated | relid=0 | w=5
- distension vésicale hydrostatique ---
r_associated #0: 5 -->
en:stye
n1=distension vésicale hydrostatique | n2=en:stye | rel=r_associated | relid=0 | w=5
- distomatoses pulmonaires ---
r_associated #0: 5 -->
en:stye
n1=distomatoses pulmonaires | n2=en:stye | rel=r_associated | relid=0 | w=5
- distomiase ---
r_associated #0: 5 -->
en:stye
n1=distomiase | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:acne vulgaris ---
r_associated #0: 5 -->
en:stye
n1=en:acne vulgaris | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:boil
(en:swelling) ---
r_associated #0: 5 -->
en:stye
n1=en:boil (en:swelling) | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:inculcate something in ---
r_associated #0: 5 -->
en:stye
n1=en:inculcate something in | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:instil something into ---
r_associated #0: 5 -->
en:stye
n1=en:instil something into | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:pink-eye ---
r_associated #0: 5 -->
en:stye
n1=en:pink-eye | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:point something out to somebody ---
r_associated #0: 5 -->
en:stye
n1=en:point something out to somebody | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:point sth out to sb ---
r_associated #0: 5 -->
en:stye
n1=en:point sth out to sb | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:point sth out to somebody ---
r_associated #0: 5 -->
en:stye
n1=en:point sth out to somebody | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:sty ---
r_associated #0: 5 -->
en:stye
n1=en:sty | n2=en:stye | rel=r_associated | relid=0 | w=5
- fumarase ---
r_associated #0: 5 -->
en:stye
n1=fumarase | n2=en:stye | rel=r_associated | relid=0 | w=5
- fumarylacétoacétase ---
r_associated #0: 5 -->
en:stye
n1=fumarylacétoacétase | n2=en:stye | rel=r_associated | relid=0 | w=5
- fumarylacétoacétate hydrolase ---
r_associated #0: 5 -->
en:stye
n1=fumarylacétoacétate hydrolase | n2=en:stye | rel=r_associated | relid=0 | w=5
- fumée toxique ---
r_associated #0: 5 -->
en:stye
n1=fumée toxique | n2=en:stye | rel=r_associated | relid=0 | w=5
- fundoplication ---
r_associated #0: 5 -->
en:stye
n1=fundoplication | n2=en:stye | rel=r_associated | relid=0 | w=5
- fundoplicature ---
r_associated #0: 5 -->
en:stye
n1=fundoplicature | n2=en:stye | rel=r_associated | relid=0 | w=5
- glaucome à angle étroit ---
r_associated #0: 5 -->
en:stye
n1=glaucome à angle étroit | n2=en:stye | rel=r_associated | relid=0 | w=5
- gérodermie ostéodysplasique héréditaire de Bamatter-Franceschetti-Klein-Sierro ---
r_associated #0: 5 -->
en:stye
n1=gérodermie ostéodysplasique héréditaire de Bamatter-Franceschetti-Klein-Sierro | n2=en:stye | rel=r_associated | relid=0 | w=5
- gérontologie ---
r_associated #0: 5 -->
en:stye
n1=gérontologie | n2=en:stye | rel=r_associated | relid=0 | w=5
- gérontophilie ---
r_associated #0: 5 -->
en:stye
n1=gérontophilie | n2=en:stye | rel=r_associated | relid=0 | w=5
- gérontopsychiatrie ---
r_associated #0: 5 -->
en:stye
n1=gérontopsychiatrie | n2=en:stye | rel=r_associated | relid=0 | w=5
- humeur aqueuse ---
r_associated #0: 5 -->
en:stye
n1=humeur aqueuse | n2=en:stye | rel=r_associated | relid=0 | w=5
- humeur de Scarpa ---
r_associated #0: 5 -->
en:stye
n1=humeur de Scarpa | n2=en:stye | rel=r_associated | relid=0 | w=5
- hémorragie du nouveau-né ---
r_associated #0: 5 -->
en:stye
n1=hémorragie du nouveau-né | n2=en:stye | rel=r_associated | relid=0 | w=5
- irido-cornéo-endothélial (syndrome) ---
r_associated #0: 5 -->
en:stye
n1=irido-cornéo-endothélial (syndrome) | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentigo actinique ---
r_associated #0: 5 -->
en:stye
n1=lentigo actinique | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentigo maligna melanoma ---
r_associated #0: 5 -->
en:stye
n1=lentigo maligna melanoma | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentigo malin des vieillards de Dubreuilh ---
r_associated #0: 5 -->
en:stye
n1=lentigo malin des vieillards de Dubreuilh | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentigo solaire ---
r_associated #0: 5 -->
en:stye
n1=lentigo solaire | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentigo sénile ---
r_associated #0: 5 -->
en:stye
n1=lentigo sénile | n2=en:stye | rel=r_associated | relid=0 | w=5
- lentille collagène ---
r_associated #0: 5 -->
en:stye
n1=lentille collagène | n2=en:stye | rel=r_associated | relid=0 | w=5
- maladies occulaire ---
r_associated #0: 5 -->
en:stye
n1=maladies occulaire | n2=en:stye | rel=r_associated | relid=0 | w=5
- mouvement conjugué anormal des yeux ---
r_associated #0: 5 -->
en:stye
n1=mouvement conjugué anormal des yeux | n2=en:stye | rel=r_associated | relid=0 | w=5
- mouvements oculaires saccadés et anormaux ---
r_associated #0: 5 -->
en:stye
n1=mouvements oculaires saccadés et anormaux | n2=en:stye | rel=r_associated | relid=0 | w=5
- nystagmus (zone de moindre) ---
r_associated #0: 5 -->
en:stye
n1=nystagmus (zone de moindre) | n2=en:stye | rel=r_associated | relid=0 | w=5
- ophthalmologie ---
r_associated #0: 5 -->
en:stye
n1=ophthalmologie | n2=en:stye | rel=r_associated | relid=0 | w=5
- paraphimosis (réduction d'un) ---
r_associated #0: 5 -->
en:stye
n1=paraphimosis (réduction d'un) | n2=en:stye | rel=r_associated | relid=0 | w=5
- poils de brosse (image en) ---
r_associated #0: 5 -->
en:stye
n1=poils de brosse (image en) | n2=en:stye | rel=r_associated | relid=0 | w=5
- sourcils anormaux ---
r_associated #0: 5 -->
en:stye
n1=sourcils anormaux | n2=en:stye | rel=r_associated | relid=0 | w=5
- vaisseaux sanguins atténués en périphérie ---
r_associated #0: 5 -->
en:stye
n1=vaisseaux sanguins atténués en périphérie | n2=en:stye | rel=r_associated | relid=0 | w=5
- vaisseaux sanguins rétiniens atténués ---
r_associated #0: 5 -->
en:stye
n1=vaisseaux sanguins rétiniens atténués | n2=en:stye | rel=r_associated | relid=0 | w=5
- en:have one's beady eye on ---
r_associated #0: -10 -->
en:stye
n1=en:have one's beady eye on | n2=en:stye | rel=r_associated | relid=0 | w=-10
- en:have one's eye on ---
r_associated #0: -10 -->
en:stye
n1=en:have one's eye on | n2=en:stye | rel=r_associated | relid=0 | w=-10
- en:to have one's beady eye on ---
r_associated #0: -24 -->
en:stye
n1=en:to have one's beady eye on | n2=en:stye | rel=r_associated | relid=0 | w=-24
- en:to have one's eye on ---
r_associated #0: -30 -->
en:stye
n1=en:to have one's eye on | n2=en:stye | rel=r_associated | relid=0 | w=-30
- loucher sur ---
r_associated #0: -30 -->
en:stye
n1=loucher sur | n2=en:stye | rel=r_associated | relid=0 | w=-30
- tenir quelqu'un informé de qqch ---
r_associated #0: -61 -->
en:stye
n1=tenir quelqu'un informé de qqch | n2=en:stye | rel=r_associated | relid=0 | w=-61
- tenir quelqu'un informé de quelque chose ---
r_associated #0: -65 -->
en:stye
n1=tenir quelqu'un informé de quelque chose | n2=en:stye | rel=r_associated | relid=0 | w=-65
|